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Summary 
Neutrophils provide a rapid first response to invading pathogens and orchestrate the immune 
response. They are able to employ potent antipathogenic mechanisms such as phagocytosis, 
reactive oxygen species (ROS) generation, protease release from granules, and formation of 
neutrophil extracellular traps (NETs). Despite this, certain pathogens have evolved 
mechanisms to benefit from neutrophil effector functions. Human cytomegalovirus (HCMV) 
is a clinically important pathogen that infects the majority of the human population. Monocytes 
are considered the main vehicle of HCMV dissemination throughout the body, but little 
research has been done on its interaction with neutrophils. The virus encodes a range of 
immunomodulatory proteins including an IL-8 homologue that acts as a powerful neutrophil 
chemoattractant. Viral conservation of a protein that recruits neutrophils to the site of HCMV 
infection suggests that the interaction between neutrophils and HCMV provides an overall 
advantage to the virus, but little evidence exists so far to suggest this is the case. 
  
Here I report that human peripheral blood neutrophils exposed to a clinical strain of HCMV 
display a profound survival phenotype, as assessed by morphology, phosphatidylserine 
exposure, cell permeability, and caspase-3/7 activity. This occurs in the absence of viral gene 
production. Neutrophils also upregulated their release of inflammatory cytokines in response 
to HCMV, with higher concentrations of IL-6, IL-8, and MIP-1α detected in the secretomes of 
infected neutrophils. These secretomes induced monocyte chemotaxis and increased monocyte 
permissivity to HCMV infection, as well as augmented survival in healthy, uninfected 
neutrophils.  
 
These experiments were confirmed with clean HCMV after the discovery of contaminating 
Mycoplasma spp. in the viral inocula of the initial experiments. Mycoplasma-HCMV 
coinfection induced an autophagic phenotype in neutrophils, as assessed by Western blotting 
and qPCR of autophagy-related components. Inhibition of autophagy using 3-MA reversed a 
profound survival effect. The unintended inclusion of Mycoplasma spp. further led to the 
serendipitous discovery of yet another pathogenic ability to overcome neutrophil immune 
functions: contaminating Mycoplasma spp. as well as Mycoplasma pneumoniae profoundly 
degraded NETs. These extracellular chromatin structures were stimulated using PMA or 
pyocyanin, and their release was dependent on the generation of ROS: severely ROS-deficient 
murine bone marrow neutrophils were unable to generate NETs. However, small amounts of 
ROS were sufficient for NETs generation, as neutrophils from acute respiratory distress 
syndrome patients, including many that had attenuated ROS-responses, were still capable of 
NETs generation. The NETs-degradative properties of mycoplasma were confirmed by 
fluorescence confocal and scanning electron microscopy, as well as spectrophotometry and 
agarose gel electrophoresis. 
 
This study demonstrates that two pervasive pathogens, HCMV and M. pneumoniae, both 
frequently found in coinfections in clinical contexts, are able to overcome neutrophil 
antipathogenic mechanisms to potentially enhance pathogen dissemination. These data provide 
not only a novel example of manipulation of an anti-viral response in a cell not productively 
infected, but also a novel example of pathogenic NETs degradation. These findings may have 
implications on our understanding of mycoplasma and HCMV pathogenesis and provide new 
targets for the generation of therapies 
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1 Abstract 
Neutrophils provide a rapid first response to invading pathogens and orchestrate the immune 
response.  They are able to employ potent antipathogenic mechanisms such as phagocytosis, 
reactive oxygen species (ROS) generation, protease release from granules, and formation of 
neutrophil extracellular traps (NETs).  Despite this, certain pathogens have evolved 
mechanisms to benefit from neutrophil effector functions.  Human cytomegalovirus 
(HCMV) is a clinically important pathogen that infects the majority of the human 
population.  Monocytes are considered the main vehicle of HCMV dissemination throughout 
the body, but little research has been done on its interaction with neutrophils.  The virus 
encodes a range of immunomodulatory proteins including an IL-8 homologue that acts as a 
powerful neutrophil chemoattractant.  Viral conservation of a protein that recruits 
neutrophils to the site of HCMV infection suggests that the interaction between neutrophils 
and HCMV provides an overall advantage to the virus, but little evidence exists so far to 
further suggest this is the case. 
  
Here I report that human peripheral blood neutrophils exposed to a clinical strain of HCMV 
display a profound survival phenotype, as assessed by morphology, phosphatidylserine 
exposure, cell permeability, and caspase-3/7 activity.  This occurs in the absence of viral 
gene production.  Neutrophils also upregulated their release of inflammatory cytokines in 
response to HCMV, with higher concentrations of IL-6, IL-8, and MIP-1α detected in the 
secretomes of infected neutrophils.  These secretomes induced monocyte chemotaxis and 
increased monocyte permissivity to HCMV infection, as well as augmented survival in 
healthy, uninfected neutrophils.  
 
These experiments were confirmed with clean HCMV after the discovery of contaminating 
Mycoplasma spp. in the viral inocula of the initial experiments. Mycoplasma-HCMV 
coinfection induced an autophagic phenotype in neutrophils, as assessed by western blotting 
and qPCR of autophagy-related components. Inhibition of autophagy using 3-MA reversed 
a profound survival effect. The unintended inclusion of Mycoplasma spp. further led to the 
serendipitous discovery of yet another pathogenic ability to overcome neutrophil immune 
functions: contaminating Mycoplasma spp. as well as Mycoplasma pneumoniae profoundly 
degraded NETs.  These extracellular chromatin structures were stimulated using PMA or 
pyocyanin, and their release was dependent on the generation of ROS:  severely ROS-
deficient murine bone marrow neutrophils were unable to generate NETs.  However, small 
amounts of ROS were sufficient for NETs generation, as neutrophils from acute respiratory 
distress syndrome patients, including many that had attenuated ROS-responses, were still 
capable of NETs generation.  The NETs-degradative properties of mycoplasma were 
confirmed by fluorescence confocal and scanning electron microscopy, as well as 
spectrophotometry and agarose gel electrophoresis. 
 
This study demonstrates that two pervasive pathogens, HCMV and M. pneumoniae, both 
frequently found in coinfections in clinical contexts, are able to overcome neutrophil 
antipathogenic mechanisms to potentially enhance pathogen dissemination.  These data 
provide not only a novel example of manipulation of an anti-viral response in a cell not 
productively infected, but also a novel example of pathogenic NETs degradation. These 
findings may have implications on our understanding of mycoplasma and HCMV 
pathogenesis and provide new targets for the generation of therapies.
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2 Introduction 
2.1 The Neutrophil 
2.1.1 Role in health and disease 
Neutrophil granulocytes, comprising over half of all white blood cells, are terminally 
differentiated cells that play a critical role in innate and acquired immunity.  They are 
phagocytic cells that form the first line of defence against invading microbes, and are an 
integral regulator of the inflammatory process – a physiological response to infective insults 
and tissue injury.  Their importance is demonstrated in people with neutropenia – low 
neutrophil counts, with chronic granulomatous disease (CGD) – a genetic disorder impairing 
neutrophil generation of toxic oxygen radicals, and with leukocyte adhesion deficiency – a 
genetic disorder impairing neutrophil recruitment to sites of infection (Bodey et al., 1966; 
Crowley et al., 1980).  People with these conditions have higher rates and impaired 
resolution of infection (Summers et al., 2010). 
Despite their clear beneficial role, many of the cellular properties that allow neutrophils to 
efficiently eliminate invading microbes can also cause bystander tissue injury and immune-
mediated disease (Cowburn et al., 2008).  Therefore, neutrophil numbers and activation 
status must be tightly regulated.  Homeostasis is maintained by balancing mechanisms such 
as neutrophil production (granulopoiesis), storage, and release by the bone marrow, 
migration between different intravascular pools in the body, and by programmed cell death 
and removal (Summers et al., 2010). 
2.1.2 Production and release 
Within the haematopoietic cords of the bone marrow, myeloid progenitor cells common to 
granulocytes, monocytes, erythroblasts, and platelets respond to selective transcription 
factors and proteins such as granulocyte-macrophage colony-stimulating factor (GM-CSF) 
to give rise to 50 to 100 billion neutrophils per day (Friedman, 2002; Price et al., 1979).  
Following their production and maturation, neutrophils are retained in the post-mitotic pool 
of the bone marrow through the interaction of C-X-C chemokine receptor type 4 (CXCR4) 
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on neutrophils and stromal cell-derived factor-1 (SDF-1) expressed by bone marrow stromal 
cells, as well as through other integrin interactions (Summers et al., 2010).  Disruption of 
these interactions, such as by granulocyte colony-stimulating factor (G-CSF)-mediated 
reduction of CXCR4 surface expression, releases neutrophils from the post-mitotic pool of 
the bone marrow (Devine et al., 2008). 
Resting mature neutrophils once released from the bone marrow are located in 
approximately equal proportions in the actively circulating (or ‘freely’ circulating) and 
‘marginated’ intravascular pools, the latter in organs such as the liver and spleen (Peters, 
1998; Peters et al., 1985).  These marginated neutrophils transit slowly through small 
capillaries and sinusoids and form intravascular pools of neutrophils that move freely 
between the marginated and circulating pools.  During physical exercise neutrophils shift 
from the marginated to the freely circulating pool, and following an infective challenge, 
inflammatory mediators are released from the site of infection and elevate bone marrow 
production and release of neutrophils, and increase the size of both these pools. 
2.1.3 Priming 
Neutrophils carry a powerful arsenal of anti-pathogenic mechanisms that can cause 
significant bystander tissue injury.  Therefore, their effector functions must be carefully 
controlled.  Resting neutrophils do not express their full anti-pathogenic capacity.  Instead 
they must be conditioned, or ‘primed’.  Pathogen-associated molecular patterns (PAMPS) 
such as bacterial lipopolysaccharides (LPSs), and inflammatory mediators such as GM-CSF, 
interferon-γ (IFNγ), and tumour necrosis factor (TNF)-α that are released by cells including 
endothelial cells and resident macrophages can all prime neutrophils to respond to infective 
insults with greater anti-pathogenic responses than those observed in resting neutrophils, but 
stimulate only minimal effector functions on their own (Condliffe et al., 1998). Primed 
neutrophils challenged with the bacterial tri-peptide N-formylmethionyl-leucyl-
phenylalanine (fMLP) respond with an exogenous respiratory burst 20-times more powerful 
than that in unprimed, resting cells (Condliffe et al., 1998).  Depending on the priming agent, 
priming can be associated with other consequences, such as potentiation of granule release, 
cell polarisation, enhanced integrin expression (CD18/11b), and delayed apoptosis.  For 
example, priming can modify the actin cytoskeleton, decreasing the deformability of the cell 
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and causing its sequestration in the capillary beds of inflamed tissue (Ekpenyong et al., 
2017).  This is an important step in the process of neutrophil recruitment. 
2.1.4 Recruitment to sites of infection 
During inflammation, gradients of chemoattractant stimuli are formed, engaging neutrophil 
surface receptors, activating signalling pathways that stimulate cytoskeletal rearrangements 
and the expression of surface markers, leading them to the sites of infection (Ley et al., 
2007).  This process occurs through steps including leukocyte rolling, arrest, and 
transmigration through the blood vessel wall.  Chemotactic factors include inflammatory 
cytokines such as interleukin (IL)-8, leukotriene B4, and IFNγ that are released by activated 
cells, such as resident tissue macrophages and vascular endothelial cells at inflamed sites. 
In response to inflammatory mediators such as IL-1β, histamine, and TNF-α and other 
‘alarm’ signals operating through toll like receptors (TLRs) 2 or 4, Weibel-Palade storage 
bodies within activated endothelial cells merge with the cell surface, incorporating P- and 
E-selectins to the plasma membrane (Ley et al., 2007).  Neutrophils probe the endothelial 
layer for activated cells and interact with these endothelial selectins through the 
constitutively neutrophil-expressed L-selectin (Lawrence et al., 1994).  This selectin 
interaction ‘captures’ neutrophils and initiates rolling along the vascular endothelium.  
Rolling velocity decreases with the subsequent engagement of β2-integrins, which are also 
upregulated following stimulation by factors including IL-8 and platelet-activating factor 
(PAF).  Integrin interaction causes cell arrest and mediates transmigration through the 
endothelium via either a paracellular or, remarkably, a transcellular route.  Finally, 
neutrophils penetrate the pericyte layer and basement membrane of the vasculature into the 
infected or injured interstitial tissue in a process that may combine integrin interaction and 
the secretion of proteases such as neutrophil elastase (Ley et al., 2007).  Neutrophils are 
highly mobile and are the first cells recruited to infected sites, where they accumulate 
rapidly.  There, high concentrations of chemoattractants such as neutrophil-derived 
leukotriene B4 and other pro-inflammatory factors activate neutrophil clustering (referred 
to as ‘neutrophil swarming’) and effector functions to engage and fight pathogens (Kienle 
and Lämmermann, 2016; Lämmermann et al., 2013).  
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2.1.5 Activation and killing 
Neutrophils engage with, and are activated by, invading microbes through a multitude of 
surface receptors including antibody receptors (FcRs), complement receptors (CRs), and 
TLRs, which recognize PAMPs (Hayashi, Means, and Luster 2003).  Once engaged, 
neutrophils employ three main killing pathways, using digestive enzymes, reactive oxygen 
species (ROS), and neutrophil extracellular traps (NETs). 
Starting in early activation, neutrophils exocytose granules, reservoirs of anti-pathogenic 
proteins that include proteolytic enzymes, and release a variety of ROS, and inflammatory 
mediators (Faurschou and Borregaard, 2003).  The primary (azurophil) granules contain the 
most potent antipathogenic agents and are only released in response to powerful stimulators 
such as cytochalasin B or phorbol myristate acetate (PMA). These granules contain an array 
of acidic hydrolyses and antimicrobial proteins including neutrophil elastase (NE) and 
myeloperoxidase (MPO).  
Granules are delivered either into the phagosome containing a phagocytosed pathogen, or to 
the plasma membrane, releasing its cytotoxic contents to the exterior environment.  These 
result in a powerful killing effect but the latter mechanism can also cause significant 
bystander tissue injury.  Neutrophils attempt to control the potential for injury by regulating 
tightly the contents and sensitivity to exocytosis of different granules, with the elastase-rich 
azurophilic granules being the last to degranulate (Borregaard and Cowland, 1997; Fox et 
al., 2010). 
Membrane-bound nicotinamide adenine dinucleotide phosphate (NADPH) oxidase on the 
plasma membrane and phagosome membrane generates superoxide anions, which can be 
converted to even more toxic agents such as hydrogen peroxide and hypochlorous acid.  
These ROS react avidly with organic molecules, and have been suggested to have a potent 
microbial killing effect.  However, there is growing evidence that ROS are not directly 
antimicrobial, but rather induce conditions that are conducive to bacterial killing (Segal, 
2005).  They are also involved in other processes such as programmed cell death, autophagy, 
and the generation of NETs. 
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The third pathogen-killing pathway involves the formation and extracellular release of 
NETs, formed of chromatin and coated in granule proteins.  Physical entrapment of 
pathogens by NETs restricts their movement and creates a microenvironment of 
concentrated antimicrobial agents (Brinkmann et al., 2004).  There is conflicting evidence 
as to whether NETs actively kill microbes or solely immobilise them, and potentially 
opsonise them for phagocyte recognition (Menegazzi et al., 2012). 
2.1.6 Resolution 
The body faces constant infective and injurious insults, and even those inducing a striking 
neutrophil influx are typically resolved with minimal tissue injury.  This requires the 
promotion of monocyte influx and an inhibition of neutrophil recruitment.  Neutrophils 
present in the inflamed tissue must be cleared, followed by reparative mechanisms to 
regenerate healthy tissue architecture (Savill et al., 2002).  Indeed, the neutralisation of the 
infective insult typically blocks very rapidly further neutrophil influx (typically within 
hours) and prompts resolution.  This is mediated by the production of anti-inflammatory 
mediators such as lipoxins, resolvins, and protectins (Serhan and Savill, 2005).  For example, 
lipoxins block neutrophil adhesion and transmigration through the blood vessel wall (Serhan 
et al., 1995) and promote monocyte infiltration (Maddox and Serhan, 1996).  These 
inflammatory monocytes also ingest apoptotic neutrophils and release neutrophil ‘death 
triggers’ such as Fas ligand (FasL), increasing neutrophil apoptosis (Brown and Savill, 1999; 
Godson et al., 2000).  Indeed, the beneficial resolution to inflammation relies on the 
programmed cell death and the prompt removal of neutrophils after the infective insult has 
been repressed (Knapp et al., 2003). 
2.2 Neutrophil apoptosis 
Neutrophils are short-lived cells, which in the circulation have a half-life of between 8-20 
hours (Farahi et al., 2012; Homburg and Roos, 1996).  There are 50 - 100 billion neutrophils 
produced and released from the bone marrow daily (Summers et al., 2010).  To maintain 
homeostasis, the same number must be removed.  During infection, the numbers of 
neutrophils released into the circulation can rise even further (c. 1012/day), and after 
elimination of the invading microbe these neutrophils must be promptly removed to 
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minimise their cytotoxic effects.  This occurs mainly through random uptake by the liver, 
spleen and bone marrow, followed by the remarkable events of apoptosis, a form of 
programmed cell death (Moulding et al., 2001).  Apoptosis is distinct from necrosis, where 
uncontrolled death leads to cell lysis and the release of toxic cellular contents that damage 
tissue and drive inflammation.  Instead, apoptosis is closely regulated and is one of the main 
mechanisms underlying myeloid cell homeostasis and the healthy resolution of acute 
inflammation (Duffin et al., 2010).   
Neutrophil apoptosis aids inflammatory resolution through the down-regulation of pro-
inflammatory events such as neutrophil chemotactic factor release, NADPH oxidase 
activation, degranulation, and NETs release (Douda et al., 2014).  Apoptosis also enhances 
the release of anti-inflammatory lactoferrin, which acts on granulocyte signalling pathways 
to impair neutrophil infiltration (Bournazou et al., 2009).   
Apoptosis initiates the externalization of phosphatidylserine (PS), delivering anti-
inflammatory signals to other cells (Nakahashi-Oda et al., 2012) and prompting recognition 
and phagocytic removal of apoptotic neutrophils by macrophages.  Key in the process of 
apoptosis is the activation of cysteine proteases called caspases (Figure 1).  Caspases are 
produced as inactive zymogens (Riedl and Shi, 2004).  Initiator caspases such as caspase-2, 
-8, -9, and -10 are auto-activated, while effector caspases such as caspase-3, -6, and -7 are 
activated after cleavage by an initiator caspase.  Caspase activation must be tightly regulated 
as pathway activation leads to a caspase cascade, cleaving downstream cellular targets and 
leading to cell death.  In addition to losing their functional properties, apoptotic neutrophils 
also undergo extreme morphological changes such as the condensation of the cytoplasm and 
of chromatin, and a rounding of the multilobed nucleus (Savill and Haslett, 1995).  These 
morphological changes allow for convenient identification of apoptotic neutrophils by light 
microscopy.  Also, externalised and exposed PS binds fluorescently-labelled Annexin V, 
allowing for the identification of apoptotic neutrophils using techniques such as flow 
cytometry (Vermes et al., 1995).  
  
Apoptosome
Figure 1.  Apoptosis signalling pathways
Apoptosis initiated by an extrinsic stimuli such as from receptor binding by Fas ligand (FasL) or tumour 
necrosis factor (TNF)-α reveals an intracellular death domain that activate caspases, initiating apoptosis.  
TNF-α-binding also induces NF-κB -dependent pro-survival effects.  In neutrophils, FasL-binding also 
activates the intrinsic pathway.  The intrinsic pathway is regulated by the balance of pro-survival and 
pro-apoptotic Bcl-2 family member proteins.  When BH3-only proteins sufficiently inhibit pro-survival 
proteins, Bax and Bak are freed to permeabilize the outer mitochondrial membrane and release of 
pro-apoptotic factors that form the caspase-activating apoptosome, and inhibit the inhibitor of apoptosis 
proteins (IAPs).  The pathways converge at caspase-3, and are connected to one another through tBid 
activation.
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Neutrophil longevity can be markedly increased by survival signals, and in inflamed tissue 
neutrophil longevity can be increased to several days if not longer.  Delayed apoptosis has 
been demonstrated in neutrophils exposed to inflammatory mediators such as GM-CSF 
(Brach et al., 1992), microbial pathogens such as Mycobacterium tuberculosis (Blomgran et 
al., 2012) and human cytomegalovirus (Skarman et al., 2006), and to certain micro-
environmental factors such as hypoxia (Hannah et al., 1995; Walmsley et al., 2005).  In the 
inflammatory context, delaying apoptosis may allow neutrophils to better combat invading 
pathogens.  Many inflammatory factors that delay apoptosis also potentiate neutrophil 
release of lytic enzymes and ROS (Droemann et al., 2000). 
In addition to apoptosis and necrosis, other neutrophil processes such as specific 
macroautophagic or NETs-releasing pathways can lead to cell death. 
2.3 Neutrophil Extracellular Traps  
The known array of neutrophil antipathogenic mechanisms was broadened dramatically 13 
years ago with the finding that neutrophils can form extracellular strands or ‘traps’ of 
chromatin coated in granule proteins (Figure 2; Brinkmann et al., 2004); these occur in 
response to a variety of agents including bacteria, viruses, parasites, and chemical factors 
from calcium ionophores to PMA.  The discovery of these NETs catalysed a growing body 
of research that has demonstrated the ability of NETs to capture pathogens in many in vivo 
contexts, restrict their movement, and surrounds them in a microenvironment of 
concentrated antimicrobial agents (Yipp and Kubes, 2013).  For example, human 
immunodeficiency virus (HIV)-1 stimulation of TLRs 7 and 8 induces NETs that are able to 
capture the virus and neutralise it using NETs-bound MPO and α-defensin (Saitoh et al., 
2012).  This mechanism can be distinguished from other forms of cell death such as necrosis 
or apoptosis by its unique extracellular morphology, and the presence of citrullinated 
histones and proteases on chromatin. 
While the classically described NET pathway commits neutrophils to death, many pathogens 
induce what has been described as a 'vital NETosis', where the neutrophil chemotactic and 
phagocytic functions remain intact, even as the cell becomes anuclear (Yipp and Kubes, 
2013).  In the classical, 'suicidal pathway', agonists such as PMA or IL-8 activate the raf-
Introduction 
 
19 
1919 
mitogen-activated protein kinase kinase (MEK) – extracellular signal-regulated kinase 
(ERK) pathway, which drives a ROS response that leads to granule membrane disintegration 
and release of NE and MPO.  NE translocates to the nucleus and cleaves histones (Metzler 
et al., 2014; Papayannopoulos et al., 2010), and along with MPO decondenses chromatin 
and breaks down the nuclear membrane.  This process releases deoxyribonucleic acid 
(DNA), associated histones, and proteases into the cytosol where they mix to form NETs.  
Eventually the plasma member ruptures and these NETs diffuse from the cell (Yipp and 
Kubes, 2013).  Extracellular release of DNA occurs within 2-3 hours of stimulation. An 
NADPH oxidase-independent pathway has also been described (Douda et al., 2015).  Here, 
agents such as calcium ionophore increases intracellular calcium concentrations. 
Peptidylarginine deiminase 4 (PAD4), a protein citrullinating enzyme in neutrophils, binds 
calcium and translocates into the nuclease where it de-iminates positively charged arginine 
residues on histones H3 and H4.  The resulting uncharged histones separates from negatively 
charged DNA, decondensing the nucleosome.  In contrast, a 'vital NETosis' has been 
 
Figure 2. Neutrophil extracellular trap (NET) release. (1) Upon stimulation by a variety 
of triggers, including many pathogens, neutrophils release NETs into the extracellular 
space. (2) These structures are composed of DNA coated with histones and chromatin, 
and trap microbes in a concentrated environment of antimicrobial proteins, such as 
neutrophil elastase and myeloperoxidase. Insets are images showing (left) human NETs 
released by phorbol myristate acetate–stimulated neutrophils by fluorescence 
microscopy using Sytox Green (arrows), and (right) green-stained Salmonella 
typhimurium bacteria (arrows) trapped in murine NETs. (3) As well as exerting 
antimicrobial effects, NETs may play a proinflammatory role contributing to the 
pathogenesis of conditions, such as acute lung injury and venous thromboembolism. 
Figure taken from Storisteanu et al. 2017. 
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identified as a rapid (under 30 minutes) neutrophil response to certain bacteria.  For Gram-
negative bacteria including Escherichia coli, TLR4-activated platelets stimulate NETs 
through a direct CD11a interaction with neutrophils, whereas Gram-positive bacteria such 
as Staphylococcus aureus activate neutrophil TLR2 and CR3, leading to induction of 
NETosis.  Much remains to be elucidated regarding the mechanisms between stimulation 
and NETs release, but fluorescence and electron micrographs show that the nuclear and 
plasma membrane appears to stay intact.   
The electrostatic charge of nucleic acid (Yipp and Kubes, 2013) as well as collectin 
mediators such as surfactant protein D (Douda et al., 2011) make pathogens very adherent 
to NETs.  While it remains contentious whether microbes ensnared by NETs are killed, there 
are many examples of the ability of NETs to capture a diverse range of pathogens including 
HIV-1, Salmonella typhimurium, and Candida albicans.  Spinning disk confocal intravital 
microscopy has shown chemotaxing neutrophils releasing NETs in the hepatic sinusoids, 
which was dependent on integrin LFA-1 (lymphocyte function-associated antigen 1) 
neutrophil-platelet interaction, that captured circulating E. coli and prevented its 
dissemination (McDonald et al., 2012).  Neutrophils can spread NETs over wide distances 
in vivo.  Kubes et al. suggest that DNA-binding sites on fibronectin may provide an 
explanation for the ability of NETs to spread so widely in tissues (Yipp and Kubes, 2013). 
Beyond trapping and immobilising pathogens, other suggested anti-pathogenic effects of 
NETs include the ability to neutralise virulence factors such as IpaB from Shigella flexneri 
(Brinkmann et al., 2004), inhibition of Aspergillus growth via calprotectin-mediated 
chelation of zinc (Bianchi et al., 2009), and opsonisation of A fumigatus (Jaillon et al., 2007).  
Some evidence also exists for the ability of NETs to kill pathogens.  For example, 
neutrophils treated with cytochalasin D, which largely inhibits phagocytosis and thus the 
traditional neutrophil-killing mechanisms, are still bactericidal (Brinkmann et al., 2004).  
Treatment of these neutrophils with DNase or anti-histone antibody diminishes killing.  
NETs have also been shown to directly kill pathogens including Aspergillus (Bianchi et al., 
2009), Staphylococcus aureus (Pilsczek et al., 2010), Group A Streptococci (Buchanan et 
al., 2006), and Candida albicans yeast and hyphal forms (Urban et al., 2006), and indeed 
NETs-associated molecules such as NE and MPO have long been recognised for their 
pathogen-killing properties (Segal, 2005). However, other laboratories have failed to show 
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NETs killing, for example finding that Staphylococcus aureus trapped by NETs were able 
to proliferate after release using deoxyribonuclease (DNase; Menegazzi et al., 2012). 
However, the trapping of bacteria by NETs may reduce proliferation, and prevent pathogen 
dissemination, such as between regions of the lungs or into circulation (Beiter et al., 2006).  
Likewise, the growing evidence that many pathogens have developed NET evasion 
mechanisms supports the idea that NETs are an important defensive mechanism (Storisteanu 
et al., 2017)  For example, a recent study by Yamamoto et al. (2017) shows that NETs are 
released in response to M. pneumoniae, but can be degraded by a microbial extracellular 
nuclease. Similar nuclease-mediated mechanisms have been demonstrated in pathogens 
including S. aureus, Vibrio cholerae, and Group A Streptococcus (Storisteanu et al., 2017). 
This area is further discussed in the introduction to Chapter 5. 
2.4 Autophagy 
Autophagy, a catabolic pathway common to all eukaryotes, is used to recycle cell 
components in order to maintain homeostasis, or degrade unwanted endogenous (e.g. 
damaged organelles) or exogenous (e.g. pathogens) constituents.  It is triggered by a variety 
of stressors including starvation, hypoxia, ROS, and endoplasmic reticulum (ER) stress (He 
and Klionsky, 2009), and is implicated in many processes relevant to human health, from 
aging, cancer, neurodegeneration, to immunity (Choi et al., 2013). 
Autophagy includes three main processes:  chaperone-mediated autophagy, micro-
autophagy, and macro-autophagy.  In macro-autophagy, henceforth referred to simply as 
autophagy, cytosolic components are surrounded by a double lipid membrane called an 
autophagosome, and subsequently degraded after fusion with lysosomes.  This mechanism 
has been associated with many leukocytes mechanisms including prolonged cell survival, 
programmed cell death, phagocytosis, cytokine secretion, and neutrophil extracellular traps 
(Itakura and McCarty, 2013).  
Autophagy has been best studied in yeast, where 32 autophagy-related genes (Atg) have 
been identified.  While much remains to be known about this process in mammalian cells, 
many Atg homologues have been found in mammals. 
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2.4.1 Nucleation 
The process of nucleation begins with the formation of a lipid bilayer called 
the phagophore.  In mammals this membrane is thought to originate from the endoplasmic 
reticulum (Hayashi-Nishino et al., 2009; Ylä-Anttila et al., 2009), although contributions 
from the Golgi apparatus, endosomes (Ktistakis et al., 2011; Mizushima and Klionsky, 2007;  
Yipp et al., 2012), or de novo formation have also been suggested.  Autophagy is negatively 
regulated by the target of rapamycin (TOR) kinase (mTOR in mammals) which, when 
inhibited, releases the ULK1 complex (ULK1/2-Atg12-FIP200-Atg101) allowing it to 
associate with the phagophore (Levine et al., 2011).  This leads to phagophore recruitment 
of a class III PI3-kinase complex containing vesicular protein sorting (Vps) 34 bound to 
Beclin-1 and Atg14.  Vps34 uses phosphatidylinositol to generate phosphatidylinositol 3-
phosphate (PI3P) to lengthen the phagophore and recruit other autophagy proteins. 
2.4.2 Elongation 
Atg7 works with other Atg protein enzymes to form two key conjugates: the Atg12-Atg5 
conjugate, and phosphatidylethanolamine (PE) conjugates such as LC3A/B (Nakatogawa et 
al., 2009).  LC3A/B-I exists as a cytosolic protein which, upon activation of autophagy, is 
cleaved by the cysteine protease Atg4, exposing a carboxyterminal glycine that is activated 
by Atg 7 and subsequently conjugated with PE making LC3A/B-II.  Levels of the LC3A/B-
II conjugated form increase in autophagy, making it a convenient marker.  The Atg12-Atg5 
conjugate meanwhile pairs with Atg16L dimers and together curve the extending 
phagophore by asymmetrically recruiting LC3A/B-II.  LC3A/B-II forms different protein-
protein interactions that are likely important in selective cargo recruitment (Glick et al., 
2010).   
2.4.3 Lysosome fusion 
The autophagosome forms when the ends of the phagophore fuse.  At this point many of the 
autophagy proteins are returned to the cytoplasm while the autophagosome undergoes 
lysosome-associated membrane protein 2 (LAMP-2) dependent fusion with the lysosome, 
though it has been suggested that fusion with endosomes can also occur before lysosomal 
fusion (Eskelinen, 2005).  While the outer autophagosome membrane merges with the 
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lysosome during fusion, the inner membrane is degraded along with its contents by 
lysosomal hydrolases such as proteases, lipases, and cathepsins.  The resulting products are 
later transported to the cytosol to be used by the cell. 
2.4.4 Xenophagy 
As well as targeting endogenous cellular components for degradation, autophagy targets and 
degrades many intracellular pathogens in a process known as xenophagy.  This process has 
been shown to be important in protection against bacteria, parasites, fungi, and viruses, 
including Herpes simplex virus-1 (Sumpter and Levine, 2010).  Xenophagy is increasingly 
being recognised as a crucial pathway in innate immunity (Sumpter and Levine, 2010).  The 
targeting of endogenous and exogenous components to the growing phagophore likely 
occurs through similar processes involving polyubiquitin tags and adaptor molecules that 
contain an LC3-interacting region (LIR) (Levine et al., 2011). 
Autophagy is also important in other immune functions, from modulation of the 
inflammatory response to the control of NETosis (Itakura and McCarty, 2013; Park et al., 
2017; Remijsen et al., 2011).  For example, Itakura and McCarty (2013) have found that 
mTOR prevents autophagy and NET formation after fMLP treatment, while treatment with 
a combination of fMLP and rapamycin, an inhibitor of mTOR, drives autophagy and 
consequent citrullination of histones and NET formation.  mTOR also negatively regulates 
autophagy and downstream NET formation induced by LPS-stimulated post-transcriptional 
control of hypoxia-inducible factor-1α expression (McInturff et al., 2012). 
2.4.5 Signalling pathways 
PAMPs are recognised by pattern recognition receptors (PRRs) such as TLRs.  Stimulation 
of cell PRRs induce innate immunity responses such as effector functions, inflammatory 
cytokine production and release, and increasingly evidence shows that a subset of these 
receptors activate the autophagy pathway. 
Leucine-rich regions on pathogens form PAMPs that are recognised by the 12 identified 
TLRs, many of which have been found to induce autophagy under certain conditions.  For 
example, the TLR3 agonist poly(I:C), TLR4 agonist LPS, TLR2/6 agonist zymosan, and 
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TLR7 agonist ssRNA (single-stranded ribonucleic acid) have all been found to induce 
autophagy in murine macrophages (Delgado et al., 2008; Xu et al., 2007).  There is also 
evidence that combinations of PAMPs may induce autophagy where they do not 
individually.  Pathogens have also been found to induce autophagy in the absence of obvious 
PAMP stimulation (Delgado et al., 2008; Sumpter and Levine, 2010). 
While there is no one clear common pathway to these autophagy-inducing TLRs, TLRs often 
stimulate mitogen-activated protein kinases (MAPKs) such as c-Jun N-terminal kinase 
(JNK), or myeloid differentiation primary response 88 (MYD88), which may initiate 
autophagy through B-cell lymphoma (Bcl)-2 disruption.  Bcl-2 binds the Bcl-2 homology 3 
(BH3) domain of Beclin-1, inhibiting autophagy by interfering with the Vps34/Beclin-1 
complex (Glick et al., 2010).  Pathways including JNK-1 and TLR/MyD88 disrupt Bcl-2 
binding and free the Vps34/Beclin complex to induce autophagy (Shi and Kehrl, 
2008).  Also, ROS generated through cytokines such as TNF-α have been found to induce 
autophagy by regulating the activity of Atg4, and a number of pathways downstream of TLR 
activation induce NADPH oxidase activation and ROS production (Scherz-Shouval et al., 
2007).  It has been suggested that autophagy protects against ROS-mediated cell damage, 
preventing cell death from tolerable amounts of ROS.  However, higher concentrations of 
ROS, as for example driven by PMA, may overwhelm the protective capacity of autophagy, 
inducing cell death as well as autophagy (Mitroulis et al., 2010), and in the case of 
neutrophils, NETosis. 
2.4.6 Autophagy in neutrophils 
Many factors have been found to induce an 'autophagic signature' in neutrophils, as assessed 
by western blotting for LC3A/B conversion, upregulated expression of ATG genes, and 
MDC staining of acidified vacuoles.  These include cytokines such as IL-1β, pathogens such 
as E. coli, TLR agonists including LPS, peptidoglycan (PGN), and R848, and chemical 
stimuli such as PMA (Mitroulis et al., 2010). 
The use of autophagy inhibitors 3-methyladenine (3-MA) and chloroquine (CQ) increased 
the rates of constitutive apoptosis (Pliyev and Menshikov, 2012), in accordance with the 
paradigm that autophagy is a protective mechanism to prevent the accumulation of unwanted 
or dangerous constituents, such as misfolded proteins and damaged organelles.  However, 
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these inhibitors also attenuated TNF-α-mediated apoptosis, demonstrating that autophagy 
can also act as a positive regulator of apoptosis in neutrophils, at least in the presence of 
TNF-α, which has differential effects on neutrophil apoptosis (Murray et al., 
1995).  Autophagy also plays a crucial role in the generation of NETs (Remijsen et al., 
2011), again associating it with a cell-death pathway. 
2.4.7 Cytomegalovirus and autophagy 
Though xenophagy is a major innate immunity process and is crucial to the neutralisation of 
many pathogens, several viruses are able to subvert or counteract the pathway.  This can 
occur either at the induction of autophagy, or during the maturation of the autophagosome 
by preventing fusion with the lysosome.  For example, HIV encodes for the protein Nef, 
which, like the matrix protein M2 of influenza A, can block autophagosome-lysosome fusion 
(Gannagé et al., 2009; Kyei et al., 2009).  Other viruses prevent the induction of autophagy 
by directly inhibiting Beclin-1.  Human Herpesvirus (HHV)-8 and mouse herpesvirus strain 
68 (HV-68) encode Bcl-2 homologues that also inactivate Beclin-1.  Human 
cytomegalovirus (HCMV) has been found to induce autophagy in fibroblasts within 2 hours 
(Chaumorcel et al., 2008; McFarlane et al., 2011).  This occurred independently of 
productive infection as UV-killed HCMV also induced autophagy.  However, at later time 
points with live virus, autophagy decreased below constitutive rates in a manner dependent 
on productive HCMV infection (Chaumorcel et al., 2008).  It was found that at these later 
time points the HCMV-encoded protein TRS1 was expressed.  The N-terminal region of 
TRS1 was able to directly bind Beclin-1 and inhibit autophagy (Chaumorcel et al., 2012). 
2.5 Cytomegalovirus 
HCMV is a clinically important pathogen that infects 50-90% of the population.  While it 
causes severe disease solely in neonates or immunocompromised adults (Boeckh and 
Geballe, 2011), primary infection is followed by life-long latent infection and sporadic 
subclinical reactivation that must be consistently suppressed by the immune system.  
Because of its extremely high tropism, the virus infects a wide range of cells and tissues 
(Sinzger et al., 2008).  HCMV is the number one viral cause of birth defects and has been 
highlighted as a high priority level target for vaccine development by the US Institute of 
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Medicine (Stratton et al., 2000).  Research into the virus is constrained by the difficulty of 
generating relevant animal models due to differences between species-specific 
cytomegalovirus strains, and by the reliance on extensively passaged virus strains (Prichard 
et al., 2001).  For example, commonly used laboratory strains such as Towne and AD169 
lack sequences that encode proteins including vCXC1, an IL-8 homologue, that are found 
in clinical isolates such as the Merlin strain virus (Penfold et al., 1999).   
 
2.5.1 Transmission 
The infectious HCMV virion is roughly 230 nm in diameter and holds ~235 kbp of linear 
double-stranded DNA that encodes ~165 genes protected in an icosahedral capsid.  This is 
surrounded by a 50 nm tegument layer which is bound by a 10 nm trilaminate membrane 
envelope.  These outer two layers contain both virus-encoded and host proteins and RNAs 
crucial to viral mechanisms such as transmission.  Transmission of HCMV occurs via bodily 
fluids such as breast milk or saliva, and through transplacental transfer or solid-organ or 
hematopoietic stem cell transplant (Sinzger et al., 1995; Stagno et al., 1980).  Primary 
infection begins with viral replication in mucosal epithelial cells.  While primary infection 
is typically subclinical, some persons may experience mild symptoms resembling 
mononucleosis (e.g. fever and swelling of the lymph nodes).  This is followed by lifelong 
latency, which is common to all herpesviruses, and sporadic reactivation that is typically 
quiesced by immunosurveillance.  Clinical disease typically only occurs from primary 
infection or reactivation in immunocompromised or immunosuppressed individuals, such as 
patients with acquired immune deficiency syndrome (AIDS) or transplant recipients under 
immunosuppressive therapy (Drew, 1988; Rubin, 1990).  Transplacental infection of 
prenates can cause neurological damage that may lead to developmental problems and 
deafness, making HCMV the number one viral cause of birth defects. 
 
2.5.2 Infection 
HCMV enveloped particles and dense bodies are able to enter cells immediately following 
contact with the cell membrane, with entry in vitro typically taking less than 60 seconds 
(Topilko and Michelson, 1994).  Viral glycoproteins such as gB and gH attach to the cell, 
and HCMV enters the cell by direct fusion or through the endocytic pathway.  Envelope 
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fusion with the plasma membrane releases the nucleocapsid into the cytoplasm.  The 
nucleocapsids are translocated to the nucleus, releasing their DNA and initiating the 
expression of viral immediate early (IE) 1 and IE-2 genes (Crough and Khanna, 2009).   
 
Viral gene expression occurs in three stages, beginning with expression of IE genes that 
modify the cellular environment and prepare it for productive infection and viral DNA 
production (Colberg-Poley, 1996; Fortunato et al., 2000; Goldmacher, 2004; Stenberg, 
1996).  IE expression is necessary for expression of the following group of genes termed 
'early' (E) genes, which are critical to enable replication of the viral DNA (Spector, 1996).  
Finally, late genes encode structural proteins for the production of new virions.  Major and 
minor capsid proteins as well as assembly precursors are made in the cytoplasm.  They 
contain a nuclear localisation signal and are shipped to the nucleus where they coalesce to 
form a pro-capsid.  This includes a break in the icosahedral structure where the portal-
protein complex is incorporated.  Internal scaffolds are broken down using proteases and 
replaced by genomic DNA, which enters through the portal, forming a complete 
nucleocapsid.   
 
The particle buds out from the nucleus, gaining a membrane that is lost when fusing and 
exiting the ER.  In the cytoplasm, the naked particle acquires its final tegument proteins 
before budding into and out of the Golgi apparatus, picking up two membranes.  The outer 
layer is lost when the particle finally exocytoses through the host cell plasma membrane, 
exiting the cell with a single membrane (Eickmann et al., 2006).  Infected cells may also 
lyse, releasing a variety of virion particles.  After release, the virus disseminates to a variety 
of cell types, especially monocytic cells, which are important to the establishment of latent 
infection.  During this time viral gene expression is restricted to limit immune recognition 
(Crough and Khanna, 2009).  The mechanism to establish HCMV latency is unknown.  It 
may be that after attachment and entry the virus enters the latent stage directly without de 
novo viral gene expression, or that it produces select viral proteins to establish latency, or 
that latency always follows productive infection (Crough and Khanna, 2009). 
 
The ratio of non-infectious to infectious particles produced by an infected cell is variable 
between strains, and several types of viral particles exist.  Transmission electron microscopy 
(TEM) of the AD169 strain of HCMV found 7 types of virus particles (Topilko and 
Michelson, 1994b).  A-capsids (0.6% of particles produced) are a shell composed of the 4 
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integral proteins that make the icosahedral nucleocapsid and are devoid of genetic 
material.  B- (1.0%) and C- (2.5%) capsids include the components of an A-capsid, but B-
capsids have internal scaffold proteins and C-capsids contain the DNA genome and a 
number of tegument proteins.  Non-infectious enveloped particles (NIEPs; 4.7%) are 
enveloped B-capsids.  eA-capsids are enveloped A-capsids (3.0%), and dense bodies (DBs; 
50.2%) are enveloped, large aggregates of the tegument protein, pUL83.  The final 
proportion of particles (38.0%) are enveloped with complete intact teguments and 
nucleocapsids, and are infectious.  The viral genome can be found in diverse cell types 
including macrophages, lymphocytes, immature dendritic cells, and endothelial cells, 
though it is not clear whether some of these cells may have phagocytosed particles or are 
indeed productively infected.  Peripheral blood monocytes are the main vehicle for HCMV 
dissemination and latency, though the genome is present in fewer than 1 in 10,000 
monocytes, with each infected cell containing only 2 to 13 copies of the virus genome 
(Crough and Khanna, 2009; Slobedman and Mocarski, 1999). The relationship between 
HCMV and neutrophils has been hotly debated, and is reviewed in detail in Section 4.1.1.   
 
2.6 Project aims  
The nature of the relationship between HCMV and neutrophils has been difficult to resolve. 
Previous findings that HCMV encodes a potent neutrophil chemoattractant yet enhances 
classic neutrophil effector functions suggests a complex relationship, potentially beneficial 
to the virus or to overall viral infection, exists. I hoped to elucidate this relationship and 
propose that the interaction between neutrophils and HCMV provides an overall advantage 
to the virus, which benefits from or exploits neutrophil effector and/or immunomodulatory 
functions.  Specifically, I hypothesised that HCMV induces neutrophils to release factors 
that increase neutrophil survival, monocyte recruitment, and permissivity to HCMV 
infection. This study specifically asked,  
1) How does HCMV affect neutrophil survival?  
This was studied using neutrophils isolated from human peripheral blood cultured in vitro 
in the presence or absence of infectious and UV-killed Merlin strain HCMV.  Morphology, 
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Annexin V/propidium iodide (PI) staining, and caspase-3/7 activity was used to determine 
levels of apoptosis.  The induction of autophagy and its potential influence on neutrophil 
survival was assessed using western blotting and apoptosis assays with autophagy inhibitors. 
2) How does HCMV affect the release of inflammatory immunomodulatory signals by 
neutrophils?  
Neutrophils were cultured in vitro in the presence or absence of HCMV, and at 20 hours, 
supernatants were collected and used to culture fresh neutrophils and monocytes.  The effect 
of these ‘secretomes’ on neutrophil survival and autophagy were assessed using methods 
outlined above under aim 1. A transwell migration assay and IE detection assay (see Section 
3.6.2) assessed the secretome effect on monocyte recruitment and permissivity to infection.  
The release by HCMV-treated neutrophils of inflammatory cytokines was detected using a 
membrane-based antibody array.   
3) How does HCMV affect other neutrophil effector functions including reactive 
oxygen species generation and extracellular trap release? 
The ability of ROS-deficient neutrophils (mutant murine bone marrow neutrophils, and 
peripheral blood or alveolar neutrophils from acute respiratory distress syndrome patients) 
to generate NETs was assessed with fluorescence spectrophotometry and electron 
microscopy.  ROS generation was quantified in response to HCMV in healthy peripheral 
blood neutrophils using chemiluminescence assay, and the effect of HCMV on NETs was 
studied using spectrophotometry, fluorescence and electron microscopy, and agarose gel 
electrophoresis.
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3 Materials and Methods 
The recombinant human cytokines, GM-CSF and TNF-α, were obtained from R&D Systems 
(Oxon, UK) and reconstituted in sterile Dulbecco’s phosphate buffered saline without 
calcium or magnesium (PBS-/-) and kept at -80°C.  Neutrophils were treated with 
bafilomycin-A1 (30 nM; Sigma-Aldrich, Poole, UK), PMA (20-200 nM; Sigma-Aldrich) 
and pyocyanin (10 µM; Sigma-Aldrich).  The following inhibitors were added to neutrophils 
30 minutes before treatments:  3-MA (autophagy inhibitor; 5 mM; Sigma-Aldrich), CLI-095 
(TLR4 inhibitor; 1 µg/ml; Invivogen, San Diego, USA), LY 294002 (Phosphoinositide 3-
kinase (PI3K) inhibitor; 10 μM; Cayman Chemical, Ann Arbor, USA), U 0126 (MEK 1 and 
2 inhibitor; 10 μM; Calbiochem, La Jolla, USA), BAY-11-7085 (nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-κB) inhibitor, 3 μM; Cayman Chemical, Ann Arbor, 
USA).  Primers for reverse transcription polymerase chain reaction (RT-PCR) were 
purchased from Qiagen (Crawley, UK).  Immunoblotting was conducted using LC3A/B 
polyclonal antibody produced in rabbit, (Cell Signalling Technology, Inc., Danvers, USA), 
which recognises LCB-I and II isoforms, β-actin monoclonal antibody produced in mouse 
(Sigma-Aldrich), and anti-rabbit or anti-mouse horseradish peroxidase (HRP)-conjugated 
polyclonal immunoglobulins produced in goat (Dako; Ely, UK). 
All other consumable materials used are detailed in Table 1 at the end of Chapter 3.  
3.1 Neutrophil isolation 
This study used human peripheral blood neutrophils donated by healthy non-medicated adult 
volunteers and was approved by the Local Research Ethics Committee, UK (06/Q0108/281).  
Neutrophils were isolated using discontinuous plasma-Percoll gradients as previously 
described by Haslett et al. (1985).  The procedure was performed at room temperature under 
sterile conditions in a laminar flow cell culture hood (Microflow Class II safety cabinet) 
using endotoxin-free tissue culture equipment and reagents.  Centrifugations (Hettich Rotina 
420R) were also conducted at room temperature.  Cells were incubated at 37°C in a 5% CO2 
incubator in flat bottom, ultra-low attachment surface, 6, 12 or 96 well plates.  Except where 
noted, all reagents used were pre-warmed to 37oC.  Glass vials and pipettes were sterilised 
by autoclaving. 
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A 19-gauge butterfly needle was used to draw aliquots of 40 ml of blood (to a maximum of 
4 aliquots totalling 160 ml) by venepuncture into 50 ml syringes.  Blood was slowly ejected 
from the syringe down the side of a 50 ml polypropylene Falcon tube containing 4 ml of 
sodium citrate (3.8% in water for injection).  The tubes were gently inverted to mix the blood 
with sodium citrate to prevent clotting.  Centrifugation (320 g, 20 min) separated blood into 
a dense cell layer and a supernatant of platelet-rich plasma (PRP).   
To prepare autologous serum, 10 ml of PRP was transferred into a glass vial, vortexed with 
220 µl of 10 mM CaCl2, and incubated for at least 30 min.  Platelet-poor plasma (PPP) was 
prepared by transferring the remaining PRP into fresh 50 ml Falcon tubes and centrifuging 
(2500 g, 20 min).  The PPP supernatant was transferred into fresh 50 ml Falcon tubes. 
For each 10 ml of erythrocyte/leukocyte cell layer, 2.5 ml of 6% w/v dextran was added, 
and the total volume adjusted to 50 ml using sterile 0.9% saline.  The contents were mixed 
thoroughly but gently by inverting and rolling the tubes before allowing 30 to 40 min for the 
erythrocytes to sediment from the lighter leukocyte-rich layer.  The leukocyte-rich layer was 
collected into fresh Falcon tubes and centrifuged (320 g, 6 min).  Each pellet was 
resuspended in 1 ml PPP, and a maximum of 2 pellets transferred into each 15 ml Falcon 
tube using a Pasteur pipette.  Percoll at 4oC was brought to 90% (v/v) in 4oC sterile saline 
and mixed with PPP to final concentrations of 42% and 51% Percoll.  Using glass pipettes, 
the leukocytes were then under-layered with 2 ml of 42% Percoll-PPP, and further under-
layered with 51% Percoll-PPP before centrifuging (275 g, 13 min; low acceleration and no 
braking).  Using a Pasteur pipette, the monocyte-rich layer was removed from the plasma–
42% Percoll interface before harvesting neutrophils from the 42%–51% Percoll interface.  
Neutrophils were mixed with PPP and centrifuged (300 g, 10 min).  The supernatant was 
removed and the pellet resuspended in PBS without calcium or magnesium (PBS-/-).  At this 
step, neutrophil yields and purity were assessed before centrifugation (300 g, 10 min), 
removing the supernatant, and resuspending the pellet to 5 x 106 cells per ml in PBS with 
calcium and magnesium (PBS+/+). 
bc017643-/- bone marrow murine neutrophils were prepared by Dr David Thomas as part 
of a separate study (Thomas et al., 2017). bc017643 knockout mice were generated as part 
of the International Knockout Mouse Consortium (Skarnes et al., 2011) using a tm1a 
(KOMP) knockout-first approach, with the allele structure confirmed by PCR and 
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sequencing.  PBS-/- with 0.5% bovine serum albumin (BSA) at 4°C was used to flush bone 
marrow neutrophils from femurs and tibias of 6-10-week-old mice, and neutrophils were 
purified using a Neutrophil Isolation kit (Miltenyi Biotec) according to the manufacturer’s 
instructions. The care and use of all mice was in accordance with UK Home Office 
regulations (UK Animals Scientific Procedures Act 1986). 
Neutrophil yields were estimated using a Neubauer haemocytometer (Celeromics, Valencia, 
Spain).  To assess neutrophil purity, the cell suspension was prepared for light microscopy 
as detailed below in section 3.6.1, and at least 300 cells counted from each of 3 slides.  The 
mean neutrophil purity was 96.5% with eosinophils being the main contaminating cell 
(n=15).  Mononuclear cells were routinely <0.1% of the total cell differential. 
3.2 Cell culture 
Neutrophil-PBS+/+ suspensions were aliquoted as required for each treatment, centrifuged 
(300 g, 10 min, room temperature (RT)), and resuspended to 5 x 106 cells per ml in Iscove’s 
modified Dulbecco’s medium (IMDM) supplemented with 100 U/ml each of penicillin and 
streptomycin (P/S), and 10% (v/v) autologous serum for survival and autophagy 
experiments, or resuspended to 1 x 106 cells in IMDM with 5 µM Sytox Green for NETs 
experiments.  Cytokine treatments were prepared at 10x stock and aliquoted into wells with 
cells added on top.  For inhibitor treatments, cells were resuspended to 5 x 106 cells per ml 
in supplemented IMDM containing the inhibitor, and were incubated (30 min, 37oC) before 
plating.  Cells were plated onto 96-well plates for all experiments except for the electron 
microscopy studies, where cells were plated onto 12-well plates, and in gene expression 
experiments, where cells were plated onto 6-well plates.  Low-adherence plates were used 
for survival and autophagy experiments, and optically optimised plates used for all NETs 
experiments. 
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3.3 HCMV preparation 
The Merlin strain of HCMV was prepared on 2/4/2013 (henceforth referred to as Merlin A), 
on 14/01/2014 (Merlin B), on 08/28/2014 (Merlin C), on 04/06/15 (Merlin D), and AD169 
was prepared on 18/01/2014 (AD169). 
3.3.1 Growing human fetal foreskin fibroblasts (HFFs) and HCMV 
HCMV was grown by infecting HFFs cultured in Minimum Essential Media (MEM)-10 
(Life Technologies) with 10% fetal calf serum (FCS; pre-treated at 56oC for 30 minutes) and 
50 U/ml (1% v/v) P/S.  Supplemented MEM-10 media (MEM-10 with 10% FCS and 1% 
P/S, which is referred to simply as 'media' within section 3.3) from adhered, passage 16 
HFFs that were >90% confluent was aspirated and replaced with 
trypsin/ethylenediaminetetraacetic acid (EDTA) (GE Healthcare; 10 min, 37oC); this which 
was aspirated and replaced with media before splitting cells into 2 or 3 Corning Costar T-
162 flasks (Sigma-Aldrich).  After each splitting, cells were considered to be at passage 
N+1.  At passage 19, ten flasks of ~75% confluent HFFs were infected with seed stock 
Merlin at a multiplicity of infection (MOI) of 0.1.  To do this, the media was aspirated from 
the flasks and replaced with 5 ml media containing infectious Merlin and was incubated on 
a rocker (1 hr, RT).  The media was then replaced with 25 ml of fresh media and kept at 
37oC.  Media was replaced at 7, 14, 16, 18, and 21 days post-infection (dpi).  At 14 dpi, 50-
75% of HFFs displayed cytopathic effects of infection, and so media collected at 14, 16, 18, 
and 21 dpi were considered virus 'harvests' and centrifuged (3000 g, 20 min, RT).  Two 1 
ml aliquots of the supernatant were taken to test for infectivity, and the rest of the supernatant 
kept at -80oC to be used for HCMV purification.  To test the infectivity of harvests, 5 µl of 
each aliquot was added to wells of a 96 well plate with a confluent layer of healthy HFFs 
and incubated overnight before fixing and staining for fluorescent microscopy (see Section 
3.6.2). 
3.3.2 Purification of HCMV 
Virus was purified by centrifugation over sorbitol gradients. Sorbitol solutions of 20%, 30%, 
40%, 50%, 60%, and 70% were prepared by dissolving sorbitol in PBS -/- overnight on a 
rocker.  Virus harvests were thawed from -80oC in a water bath (37oC) for 2 hrs before 
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centrifugation (AVANTI J-25; Beckman Coulter; Wycombe Marsh, UK) in industrial 
methylated spirit (IMS)-cleaned Ultraclear 14 mm centrifuge tubes (2 hrs, 12,000 g, 4oC).  
Supernatants were removed and the virus pellet resuspended in 1 ml of PBS-/- per tube.  
Using strippettes, 1.6 ml of the sorbitol solutions were carefully layered in order of high to 
low density in each Ultraclear 14 mm centrifuge tube, and 1 ml of the virus suspension was 
added on top of the 20% layer before centrifugation (Optima L-90K ultracentrifuge, 
Beckman Coulter; 1 hr, 20,000 g, 4oC; minimum acceleration and no braking).  Pasteur 
pipettes were used to collect the 50% sorbitol solution layer and the 40%–50% and 50%–
60% interfaces.  Virus collections were washed in 40 ml PBS-/- and centrifuged (1 hr, 19,000 
g, 4oC).  The supernatant was removed and the virus pellet was either resuspended into 5 ml 
X-VIVO media with 10% FCS in the case of Merlin A, or into 5 ml IMDM in the case of 
Merlin B, Merlin C, and AD169.  Aliquots were tested for infectivity to estimate the 
concentration of infectious particles (see above) and stored at -80oC until use. 
3.4  Apoptosis assessments 
Apoptotic cell death was quantified by assessing neutrophil morphology, by differential 
binding of Annexin-V-fluorescein isothiocynate (FITC) and PI-permeability using flow 
cytometry, and by caspase-3/7 activity.   
3.4.1 Assessment by morphology 
Triplicate samples were prepared for light microscopy according to section 3.6.1 below.  
Apoptotic neutrophils were scored based on their distinctive apoptotic morphology (Savill 
et al., 1989) and reported as a mean percentage of total neutrophils ± the standard error of 
the mean (SEM). 
3.4.2 Assessment by flow cytometry 
Cells were also prepared for apoptosis assessment using flow cytometry (Vermes et al., 
1995).  Using a micropipettor with ‘cell-saver’ tips, 450 µl of cell-media suspension was 
removed from culture at 6 or 20 hours, and pulse centrifuged (Thermo Scientific Heraeus 
Fresco 21 Refrigerated Microcentrifuge; London, UK).  The supernatant was removed and 
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cells resuspended in 95 µl of Annexin V binding buffer with 1:18 dilutions of FITC-
conjugated recombinant human Annexin V and PI.  Single-stain controls were prepared in 
1:9 dilutions of either FITC-Annexin V or PI.  Annexin V binds PS, which is exposed on 
the cell surface of early and late apoptotic cells, and PI, a DNA stain that can only enter 
permeable, late-apoptotic or necrotic cells.  After a 30-minute incubation in the dark at 4oC, 
cells were transferred to polystyrene round-bottom tubes and analysed by flow cytometry 
(BD Biosciences LSRFortessa cell analyser). 
Identification of neutrophils based on forward-scatter / side-scatter dot plots and of viable, 
early-apoptotic, and late-apoptotic neutrophils on Annexin V-FITC/PI dot plots were 
conducted as previously substantiated (Majewska et al., 2000).  Data were analysed using 
FlowJo v10.0.2 software and cells identified as Annexin V-positive based on gating 
comparing to untreated controls were reported as a mean percentage of total neutrophils ± 
SEM. 
3.4.3 Assessment by caspase 3/7 activity assay 
Apoptosis was also quantified by assessing caspase-3/7 activity using Promega's Caspase-
Glo 3/7 assay according to manufacturer instructions.  150 µl of a solution containing lysis 
buffer and a luminogenic caspase-3/7 substrate was added to each well, mixed by pipetting, 
and transferred to luminometer plates (Berthold Technologies; Harpenden, UK).  Caspase-
3/7 cleavage releases aminoluciferin, a luciferase substrate that produces light following 
luciferase reaction.  After a 1-hour incubation at room temperature, light emission was 
recorded by a Berthold Centro LB 960 luminometer (Berthold Technologies) and subtracted 
from the values of blank reactions that included all components except for cells. 
3.5 Secretome analysis 
Secretomes were prepared by pulse centrifuging mock-infected, Merlin-treated, or UV-
Merlin-treated neutrophils cultured in IMDM containing penicillin and streptomycin and 
autologous serum at 37oC for 20 hours, and collecting the supernatant.  For survival and 
autophagy experiments, freshly isolated neutrophils were resuspended to 5 x 106 cells per 
ml in the supernatants, henceforth referred to as secretomes.  To assess the role of 
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macrophage inflammatory protein (MIP)-1α and β, secretomes were incubated at 4oC and 
rotated in 2 ml Eppendorf tubes for 1 hour with beads bound to human-MIP-1α monoclonal 
antibody (MAb; 50 µg/ml; AB270-NA; RnD systems, UK) and/or human-MIP-1β MAb (25 
µg/ml; AB270-NA; RnD systems, UK).  Samples were pulse centrifuged and freshly 
isolated neutrophils resuspended in the cytokine depleted supernatants. 
Membranes embedded with inflammatory cytokine antibodies (Human Cytokine Array; Ray 
Biotech; Norcross, USA) were incubated in blocking buffer for 30 minutes at room 
temperature before being replaced with neutrophil secretomes and incubated (5 hrs, RT).  
Membranes were then washed in Wash Buffers 1 and 2, incubated overnight at 4oC in 
Biotinylated Antibody Cocktail, washed, incubated in HRP-Streptavidin (2 hrs, RT), and 
washed before detection by chemiluminescence.  All incubations before the detection step 
were conducted on a rocker.  Equal volumes of detection buffers C and D were mixed and 
added to the membrane (2 min, RT) before the membranes were exposed to high 
performance chemiluminescence film in a cassette under red light and developed using the 
XO-Graph SRX-101A developer (Konica Minolta). 
3.6 Microscopy 
3.6.1 Preparation of cells for light microscopy 
Cells were harvested from 96 well plates at the time points indicated using a micropipettor 
with cell-saver tips to resuspend and collect cells.  Aliquots of 80 µl of the neutrophil 
suspension were cytocentrifuged (300 g, 3 min) in triplicate using a Shandon Cytospin 3 
(Shandon, UK), and thereafter air dried, fixed in methanol (4 min), and stained using the 
Diff-Quick™ stain kit.  After air-drying, cells were mounted using DPX and coated in 
mineral oil.  A minimum of 300 cells per slide were counted manually and scored in triplicate 
for neutrophil purity or apoptosis by oil immersion light microscopy (Olympus CX31RBSF; 
Essex, UK) at 64x objective magnification.  All slides were counted with the observer 
blinded to the experimental conditions. 
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3.6.2 Preparation of cells for fluorescence microscopy 
Freshly isolated blood and alveolar neutrophils suspended in IMDM were incubated with 
the extracellular DNA dye Sytox Green (5 µM; Life Technologies; Paisley, UK) in the 
presence or absence of PMA (20-200 nM; Sigma-Aldrich) and seeded onto 96 well glass 
bottom optical microplates (BD Biosciences; Oxford, UK).  NET formation was quantified 
hourly by measuring total fluorescence using a VICTOR3 1420 Workstation v3.00 software 
(PerkinElmer) with subtraction of the baseline fluorescence measurement.  
NET formation was also confirmed visually by fluorescence microscopy.  Samples were 
fixed by bringing the cell solution to 2-4% (v/v) paraformaldehyde (PFA; Thermo Fisher 
Scientific) in PBS+/+, and blocked in 2% BSA and 5% goat serum (Sigma-Aldrich).  
Citrullinated histones were detected using rabbit histone H3 (citrulline R2+R8+R17) 
antibody (1:500; ab5103; Abcam; Cambridge, UK) and anti-rabbit AlexaFluor 568 (1:500; 
Invitrogen; Paisley, UK) secondary antibody.  To assay IE expression in infected HFFs, cells 
were fixed in ethanol (50% (v/v), -20oC, overnight), washed in PBS-/- (10 min), and 
incubated with an anti-IE antibody (1:1000; Millipore; Darmstadt, Germany) followed by 
AlexaFluor 594 nm-conjugated goat anti-mouse antibody (1:1000; Millipore).  Nuclei were 
counterstained with Hoechst (1:1000; Sigma-Aldrich) or Sytox Green (1:1000).  All 
antibody incubations were for 1 hour at room temperature or overnight at 4oC. 
Fluorescence microscopy images were taken using a Leica TCS SPE confocal microscope 
on a 63x/1.40-0.60 oil-immersion objective using Leica Application Suite Advanced 
Fluorescence v2.7 software (Leica Microsystems).  For live cell imaging the Eclipse TE300 
(Nikon) and Image-Pro Plus software v7.0 (Media Cybernetics) was used. 
3.6.3 Preparation of cells for electron microscopy 
For scanning electron microscopy (SEM) images, neutrophils were resuspended in IMDM 
to 1.5 x 106 cells per ml and 500 µl of this suspension seeded onto 10 mm diameter poly-L 
coverslips in a 12 well plate.  After allowing 30 minutes at 37oC for the cells to adhere, 
Merlin A (MOI 10) and/or PMA (final concentration of 200 nM) were added.  Merlin A 
(MOI 10) was also added to selected treatments at 4 hours.  After 6 hours at 37oC, cells were 
fixed in 2% glutaraldehyde in 0.05 M sodium cacodylate buffer at pH 7.4.  In order to fix 
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delicate NETs structures, an equal volume of fixative was added gently to the cell solution 
for 15 minutes at room temperature before slowly aspirating the supernatant and adding 
fresh fixative and incubating at 4oC overnight.  The coverslips were rinsed in deionised water 
and were quench frozen, by plunging, cell face first into melting propane cooled in liquid 
nitrogen. The samples were freeze dried in a modified Edwards 306 Auto 306 carbon coating 
unit (Warley and Skepper, 2000).  After drying, the cells on cover-slips were glued to SEM 
stubs using colloidal silver. They were coated with 10 nm of gold in a Quorum/Emitech  
K575X sputter coater.  Treatments after cacodylate fixation were conducted by Dr Jeremy 
Skepper.  Samples were viewed and imaged in an FEL-Philips XL30 FEGSEM at 5 kV. 
Transmission electron microscopy was undertaken by Dr Andrew Cowburn and Dr Jeremy 
Skepper.  Neutrophils with and without Merlin were harvested by centrifugation, fixed in 
glutaraldehyde and osmium tetroxide, dehydrated in ethanol, embedded in Spurr's resin for 
sectioning, and imaged (CM 100 transmission electron microscope; Philips). 
3.7 Western blotting 
3.7.1 Preparation of cell lysates 
Cells treated with and without Merlin A, 3-MA, or bafilomycin-A1 were harvested at the 
time points indicated.  The pellets were collected and resuspended after centrifugation 
(12,000 g, 10 sec) and combined with a lysis buffer (Triton TX100 detergent, 0.1% v/v), 0.5 
mM benzamidine, 2 mM levamisole, 1 mM sodium orthovanadate, 0.5 mM dithiothreitol, 
10 mM KCl, 1.5 mM EDTA in 10 mM Tris-HCl pH 7.8 with cOmplete, Mini, EDTA-free 
Protease Inhibitor Cocktail (1 tablet to 10 ml of buffer) used at 100 µl per 5 x 106 cells).  
The solution was vortexed for 30 seconds before being stored on ice for 1 hour and frozen 
overnight at -80oC. 
The cell lysates were thawed and given a brief vortex and centrifugation (310 g, 5 min, 4oC).  
The supernatant was collected, and protein concentrations determined by bicinchoninic acid 
assay according to the manufacturer instructions.  A plate reader (Bio-Rad model 550 
microplate reader) was used to measure protein concentrations in duplicate, and a standard 
curve constructed from the range of known BSA concentrations. 
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Samples were prepared in a 6x sample buffer (375 mM Tris-HCl pH 6.8, 12% sodium 
dodecyl sulphate (SDS), 15% β-mercaptoethanol, 40% glycerol and 0.03% bromophenol 
blue) and heated at 99oC for 10 minutes. 
3.7.2 SDS-PAGE and western blotting 
A ProtoGel Sample Prep Kit was used to cast a 12% polyacrylamide separating gel (40% 
ProtoGel, 26% Resolving Buffer, 33% deionised water, 0.1% ammonium persulphate (APS), 
and 0.1% N,N,N’,N’-tetramethylethylenediamine (TEMED)) with a 4% polyacrylamide 
stacking gel (13% ProtoGel, 26% stacking buffer, 60% deionised water, 0.1% APS, and 0.1% 
TEMED).  Cell lysates (10 µg total protein) were loaded on the gel and a BLUeye Prestained 
Protein Ladder was used as a molecular weight marker (11 to 245 kDa).  Proteins were 
resolved by electrophoresis (Bio-Rad PowerPac Basic) at 100 V in running buffer (250 mM 
Tris/1.92 M glycine pH 8.3 and 0.1% SDS) before wet transfer (transfer buffer: 25 mM Trizma 
base, 190 mM glycine in 20% methanol (v/v)) to a methanol-equilibrated Immobilom-P 
polyvinylidene fluoride (PVDF) membrane at 75 V for 2 hours. 
Immunoblotting and washes were performed on laboratory rockers (Science Labs STR6 
Platform Rocker; Houston, USA) at 20 to 40 revolutions per minute.  The membrane was 
blocked for 1 hour at room temperature in 5% (w/v) non-fat milk powder in 1x PBS with 0.1% 
Tween-20 (w/v), before immunoblotting overnight at 4oC with anti-LC3A/B antibody diluted 
in 2.5% milk powder in PBS-Tween-20.  Three washes of 10 minutes at room temperature in 
PBS-Tween-20 were performed before incubating the membrane in HRP-conjugated goat 
anti-rabbit immunoglobulins diluted 5000 times in 2.5% milk powder in PBS-Tween-20 for 1 
hour at room temperature.  After 3 washes in PBS-Tween-20, membranes were coated for 2 
minutes in ECL Plus Western Blotting Detection System before being wrapped in Saran-film 
and developed using the XO-Graph SRX-101A developer (Konica Minolta) onto high 
performance chemiluminescence film in a cassette under red light.  The film was developed 
after varying exposure times to achieve optimal detection.  The membrane was then washed 
overnight at 4oC in PBS-Tween-20 before a 30-minute incubation at room temperature with 
anti-β-actin antibody diluted 5000-fold in 2.5% milk powder in PBS-Tween-20.  Three washes 
were again performed in PBS-Tween-20 and then the membrane was incubated (RT, 30 min) 
in HRP-conjugated goat anti-mouse immunoglobulins diluted 5000 times in 2.5% milk 
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powder in PBS-Tween-20.  The membrane was then developed after being coated in ECL 
chemiluminescence reagent, as detailed above. 
3.8 qPCR 
Cells were prepared according to sections 3.1 and 3.2.  Total RNA was isolated from 
neutrophils using TRI-reagent (Sigma-Aldrich) followed by clean-up and DNase digest 
using RNeasy column kits (Qiagen). First-strand synthesis was performed with 1 µg of RNA 
(high-capacity cDNA kit, Applied Biosystems). Relative gene expression was determined 
by quantitative polymerase chain reaction (qPCR; ABI) and amplified in Sybr-green master 
mix (Applied Biosystems) with relevant primers from Qiagen. Gene expression levels were 
relative to β-actin or β2-microglobulin using the 2-ΔΔCT method (Schmittgen and Livak, 
2008). 
3.9 ROS luminometry 
Neutrophils were resuspended to 5 x 106 cells per ml in PBS+/+ and seeded into a white low 
attachment 96-well luminometer plate (Berthold Technologies) preloaded with luminol 
(Sigma-Aldrich, 1 µM final concentration) and HRP (Sigma-Aldrich, P8375; 62.5 U/ml 
final concentration).  Treatments were added simultaneously to cell suspensions using a 
multichannel micropipettor, and light emission recorded using a Berthold Centro LB 960 
luminometer (Berthold Technologies) every six seconds for 1 hour at 37oC.  Measurements 
were averaged into bins of 1 minute. 
3.10 DNA agarose electrophoresis experiments 
Neutrophils were suspended to 1 x 106 cells per ml and cultured for 6 hours in 100 µl IMDM 
on optically optimised plates, with or without PMA (20 nM), Merlin A (MOI 3), or DNase 
(1 µl, RNeasy column kit, Qiagen).  25 µl of supernatant was removed from the surface of 
the wells and added to EDTA (final concentration 50 mM) to stop the reaction.  19 µl 
samples were then added to 1 µl loading dye (New England Biolabs) before running onto a 
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2% DNA agarose gel.  In a subsequent experiment, DNase I from bovine pancreas (Aldrich-
Sigma) or Merlin A were preincubated (30 min, 37oC) with or without actin from rabbit 
muscle (contains both G- and F-actin; Aldrich-Sigma) before addition of 2 µg calf thymus 
DNA (Aldrich-Sigma).  At 6 hours reactions were stopped using EDTA (50 mM) and 
samples run on a 1% DNA-agarose gel. 
Agarose (Sigma-Aldrich) was solubilised into TBE by microwaving and stirring before the 
addition of a 1:10,000 dilution of GelRed Nucleic Acid Gel Stain in Water (Stains double-
stranded DNA (dsDNA), ssDNA, and RNA; Biotium, Hayward, USA).  Gels were cast and 
a 100-base pair (bp) DNA ladder (New England Biolabs) and 20 µl of every sample loaded 
into wells before running the gel at 140 amps for up to 1 hour. 
3.11 Mycoplasma detection assay 
The MycoAlert Mycoplasma Detection Kit (Lonza) was used according to manufacturer 
instructions.  Briefly, in duplicate, cultures were centrifuged at 200 g for 5 minutes and the 
top 100 µl of supernatant placed in a cuvette and read in a luminometer as a baseline reading.  
This was repeated once after adding 100 µl of MycoAlert reagent to each sample and waiting 
5 minutes before taking a reading (Reading A), and finally repeated with 100 µl of 
MycoAlert substrate to each sample and waiting 10 minutes before taking Reading B.  100 
µl of MycoAlert buffer was used as a negative control.  The MycoAlert substrate reacts with 
certain mycoplasmal enzymes to convert adenosine diphosphate (ADP) to adenosine 
triphosphate (ATP).  Luciferase enzymes transfer the ATP into a light signal, which is read 
by a luminometer.  Therefore a high ratio of (Reading B)/(Reading A) indicates the presence 
of mycoplasma.  A ratio of <0.9 is considered mycoplasma-negative, 0.9-1.2 is considered 
a borderline result, and >1.2 is considered positive for mycoplasma.  This assay was 
conducted after incubating cultures at 37°C on days 0, 3 and 6. 
3.12 Statistical analysis 
Data represent the mean ± SEM of n independent experiments unless otherwise stated.  
Differences between groups were assessed by paired or unpaired Student’s t-test or by one-
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way analysis of variance (ANOVA) and post hoc analysis with Tukey's test or Dunnett’s 
multiple comparisons test versus controls.  Differences where p<0.05 were considered 
significant. Statistical analysis was performed in GraphPad Prism v5.02. 
Table 1.  Consumable materials used in this study 
Manufacturer Location Product 
Appleton Woods Birmingham, UK  Pasteur pipettes 
 Strippettes (10 ml, 25 ml) 
Applied Biosystems Foster City, USA  10x RT Buffer 
 10x RT Random Primers 
 dNTP mix 
 MultiScribe reverse transcriptase 
Baxter Healthcare Berkshire, UK  Sterile saline (0.9%) 
BD Biosciences Oxford, UK  Falcon flexible 96-well plates 
 FITC Annexin V Apoptosis Detection Kit I containing 10x Annexin V binding buffer (0.1 M 
Hepes/NaOH at pH 7.4, 1.4 M NaCl, 25 mM CaCl2) used at a 1:10 dilution, and FITC-Annexin 
V and PI used at a 1:18 dilution. 
 Polypropylene Falcon tubes (15 ml, 50 ml) 
 Polystyrene round bottom tube (5 ml) 
 Syringes (50 ml) 
Dow Chemical Midland, USA  Cling film 
Fisher Scientific Loughborough, UK  Potassium Chloride 
GE Healthcare Buckinghamshire, UK  Chromatography (blotting) paper 
 Dextran 500 
 ECL Plus Western Blotting Detection System 
 Hypercassette 
 Hyperfilm ECL 
 Percoll 
 Trypsin/EDTA 
Geneflow Lichfield, UK  BLUeye Prestained Protein Ladder 
Hospira Lake Forest, UK  19-gauge Butterfly needle 
Invitrogen Paisley, UK  Penicillin 
 ROX Reference Dye 
 Streptomycin 
Life Technologies Carlsbad, USA  Iscove's Modified Dulbecco's Medium 
 MicroAmp Fast Optical 96-well Reaction Plate with barcode (0.1 ml) 
 MicroAmp Fast Reaction Tubes (8 Tubes/Strip) 
 MicroAmp Optical 8-Cap Strip 
Martindale 
Pharmaceuticals 
Essex, UK  Sterile calcium chloride 
 Sterile sodium citrate 
Marvel Dublin, Ireland  Original dried skimmed milk powder 
Millipore Billerica, USA  Immobilon-P PVDF membrane 
Qiagen Crawley, UK  RNeasy Mini Kit containing RNeasy MinElute Spin Columns, Collection Tubes, Buffer RLT, 
Buffer RW1, Buffer RPE, and nuclease-free water, Buffer RDD 
 Quantitect Primer Assay 
Roche Applied Science Burgess Hill, USA  cOmplete, Mini, EDTA-free Protease Inhibitor Cocktail Tablets 
Shandon Lipshaw Pittsburgh, USA  Cytocentrifuge white filter cards 
 Diff-Quick stain kit  
  
Materials and Methods 
 
44 
4444 
Sigma-Aldrich St Louis, USA  2-Mercaptoethanol 
 6-, 12-, 96-well plates (flat bottom, ultra 
low attachment surface) 
 Absolute ethanol 
 Ammonium persulphate 
 Benzamidine hydrochloride hydrate 
 Bicinchoninic Acid Kit 
containing Bicinchoninic Acid Solution, 
4% (w/v) CuSO 4 • 5H2O Solution, 
and Protein Standard Solution 
 Calcium chloride 
 Dimethyl sulfoxide (DMSO) 
 DL-Dithiothreitol 
 Dulbecco’s phosphate buffered saline, with 
(PBS+/+) or without (PBS -/-) magnesium 
chloride and calcium chloride 
 Glycerol 
 Glycine 
 Levamisole 
 Mineral oil 
 N,N,N’,N’-tetramethylethylenediamine 
 Phosphate buffered saline tablets 
 Sodium orthovanadate 
 SYBR Green JumpStart Taq ReadyMix 
 TRI reagent 
 Triton TX100 
 Trizma base 
 Tween-20 
Starlab Milton Keynes, UK  Pipette tips (graduated, filter tip) 
VWR International 44ӿole, UK  5-Prime Phase lock gel tubes (heavy, 2 ml) 
 Chloroform 
 DPX mountant 
 EDTA disodium salt (0.1 mol) 
 Methanol 
 PCR Clean Eppendorfs (1.5 ml, 2 ml) 
 Propan-2-ol 
 Sodium dodecyl sulphate 
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4 HCMV induces neutrophil survival and autophagy 
4.1 Introduction 
4.1.1 Cytomegalovirus and the neutrophil 
The permissivity and susceptibility of neutrophils to HCMV infection has been hotly 
debated, with no clear resolution.  In some of the ex vivo studies that support neutrophils as 
an active site of infection (Fiala et al., 1975, 1977; Gadler et al., 1982; Garnett, 1982; Lang 
and Noren, 1968; Rinaldo et al., 1977; Zaia et al., 1984), neutrophils were co-cultured with 
infected fibroblast cell lines.  In these studies, it is impossible to preclude the possibility that 
neutrophils have phagocytosed virions, making them positive for HCMV DNA, or have 
phagocytosed viral RNA that was produced in other infected cells.  For example, recent 
studies suggesting that neutrophils harbour active HCMV have co-cultured neutrophils with 
infected human umbilical vein endothelial cells (HUVEC) or human embryonic lung 
fibroblasts (HELF) (Gerna et al., 2000; Saez-Lopez et al., 2005), or with infected pulmonary 
artery endothelial cells (Skarman et al., 2006), which are susceptible to the same issue given 
the highly phagocytic nature of neutrophils.  In latent seropositive patients, although HCMV 
can be found in bone-marrow myeloid progenitors (CD34+ cells; Mendelson, Monard, 
Sissons, & Sinclair, 1996), which give rise to neutrophils, highly sensitive PCR has not been 
able to detect the HCMV genome in these cells (Taylor-Wiedeman et al., 1991, 1993).  By 
contrast, a study using viraemic immuno-compromised patients isolated neutrophils using 
fluorescence-activated cell sorting (FACS) and detected HCMV DNA in 45% of samples, 
and 85.2% of these samples were positive for IE expression, concluding that neutrophils 
were likely sites for active HCMV infection (Gerna et al., 1992).  However, this study 
FACS-sorted for neutrophils using an antibody to CD16, which is also present on natural 
killer cells and monocytes.  More convincingly, Dankner et al. (1990) found that neutrophils 
from patients with HCMV viraemia were consistently positive for HCMV RNA and DNA 
using HCMV-specific probes and in situ cytohybridisation. 
Neutrophils have also been suggested to play a role in HCMV pathophysiology (Duggan et 
al., 1986; Granter et al., 1996), potentially by aiding virus dissemination from the site of 
infection.  For example, neutrophils that have taken up infectious virions were able to infect 
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naive fibroblasts (Saez-Lopez et al., 2005).  Interestingly, HCMV encodes a viral chemokine 
mimic, cCXC-1, which acts as an IL-8 homologue (Penfold et al., 1999).  IL-8 is a potent 
chemoattractant for neutrophils and other leukocytes. 
HCMV infection has been reported to delay apoptosis in neutrophils (Skarman et al., 2006);  
neutrophils co-cultured with infected HUVECs were >57% Annexin-negative (indicating 
viability) at 1 and 2 days, compared with 21% and 9% at days 1 and 2 respectively in 
uninfected neutrophils (Saez-Lopez et al., 2005).  Neutralisation of upregulated IL-8 release 
from infected HUVEC cells before the addition of neutrophils partially blocked this survival 
effect. 
Because patients with active HCMV infection have higher incidences of bacterial infections 
(Falagas et al., 1996; Rupprecht et al., 2001), Skarman et al. (2006) tested whether HCMV 
infection of neutrophils diminished their antipathogenic abilities.  Contrary to their 
expectations, they found that infected neutrophils had similar CD11b expression and 
increased intracellular free calcium in response to fMLP as compared to mock-infected cells.  
Infected neutrophils were also better able to phagocytose serum-opsonised yeast particles, 
suggesting that these cells do not become dysfunctional.  Few studies have investigated 
autophagy in neutrophils and the impact of HCMV infection in this process has not been 
studied. 
4.1.2 Chapter 4 aims 
1) Do neutrophils purified using discontinuous Percoll gradients undergo constitutive 
apoptosis in vitro as previously reported? 
To ensure my purification of neutrophils behave as previously documented, I conducted 
standard survival assays using GM-CSF and TNF-α and quantified survival by flow 
cytometric analysis and morphological assessment. 
2) How does HCMV affect neutrophil survival and autophagy?  
This was studied using neutrophils isolated from human peripheral blood cultured in vitro 
in the presence or absence of infectious and UV-killed Merlin strain of HCMV.  
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Morphology, Annexin V/PI staining, and caspase-3/7 activity was used to determine levels 
of apoptosis.  The induction of autophagy and its potential influence on neutrophil survival 
was assessed using western blotting and apoptosis assays with autophagy inhibitors. 
3) How does HCMV affect the release of inflammatory immunomodulatory signals 
by neutrophils?  
Neutrophils were cultured in vitro in the presence or absence of HCMV, and at 20 hours, 
supernatants were collected and used to culture fresh neutrophils.  The effect of these 
secretomes on survival and autophagy were assessed.  The release by HCMV-treated 
neutrophils of inflammatory cytokines was detected using a membrane-based antibody 
array. 
4.2 Results 
4.2.1 The effects of inflammatory cytokines on neutrophil survival 
Neutrophils used in the following experiments were isolated using discontinuous Percoll 
gradients, with neutrophils retrieved from the 42%–51% Percoll interface as identified under 
light microscopy by their pink staining and unique multilobed nucleus (Figure 3).  Apoptotic 
neutrophils can be distinguished by cell shrinkage, chromatin condensation, and the 
formation of a rounded pyknotic nucleus (Savill and Haslett, 1995), which is less prevalent 
at 20 hours in cells that have been treated with the survival factor GM-CSF.  Monocytes are 
separated from neutrophils in the discontinuous Percoll gradient and concentrate at the 
plasma–42% Percoll interface.  Percoll isolation yielded neutrophils that were ≥96.5% pure, 
with eosinophils being the major contaminating cell. 
Differential effects on neutrophil survival have been reported with the inflammatory 
cytokines GM-CSF (Brach et al., 1992) and TNF-α (Akgul and Edwards, 2003; Murray et 
al., 1995, 1997).  In order to confirm that the neutrophils I purified respond as previously 
published, freshly isolated human neutrophils were cultured in vitro at 5 x 106 cells per ml 
in supplemented IMDM in GM-CSF or TNF-α (Figure 4).   
  
Figure 3.  Isolation and culturing of neutrophils  
Blood cells are separated by a discontinuous plasma-Percoll gradient.  A mononuclear-rich cell layer is 
removed from the upper plasma-42% Percoll interface, polymorphonuclear cells are removed from the 
lower 42%-51% Percoll interface, and erythrocytes are pelleted. Depicted are photomicrographs under 
40x objective magnification of mononuclear cells and of neutrophils that have been freshly isolated, and 
neutrophils that have been incubated for 20 hours with or without GM-CSF treatment (10 ng/ml).  Arrows 
depict cells displaying apoptotic morphology, which is distinguished by cell shrinkage, chromatin condensa-
tion, and the formation of a rounded nucleus.
Mononuclear cellsFresh
20 hrs GM-CSF 20 hrs
Figure 4.  The effect of GM-CSF and TNF-α  on neutrophil survival
Neutrophils were treated with or without GM-CSF or TNF-α (10 ng/ml).  Apoptosis was quantified by 
assessing morphological features of apoptosis at 6 and 20 hours.  Data represent the mean ± SEM from 
n=8 independent experiments performed in triplicate.  Statistical analysis by one-way analysis of variance 
and Dunnett’s multiple comparisons test versus controls for 6 and 20 hour data (**p<0.01, ***p<0.001).
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Apoptosis was quantified after 6 and 20 hours by morphological assessment and/or by flow 
cytometric analysis after Annexin V-FITC and PI staining.  Morphological quantification of 
human neutrophils cultured in vitro showed spontaneous apoptosis in 6.7±2.2% of untreated 
neutrophils at 6 hours, and 63.0±4.8% at 20 hours (Figure 4).  TNF-α differentially increased 
apoptosis up to 22.3±4.9% at 6 hours (i.e. was pro-apoptotic at early times), but at 20 hours 
decreased the overall extent of apoptosis to 46.3±4.4% (p<0.01); this agrees with the 
previous findings of Murray et al. (1995).  GM-CSF consistently inhibited constitutive 
apoptosis, decreasing it to 10.7±1.6% (p<0.001) at 20 hours, and showing a small pro-
survival trend at 6 hours (p=0.12). 
4.2.2 Preparation of HCMV 
As shown in Figure 5, by 14 dpi, HFFs infected with 0.1 MOI Merlin-strain HCMV showed 
substantial cytopathic effects:  degradation of confluency as the cells withdraw their 
projections and round-up.  In order to assess whether infectious HCMV were being released 
extracellularly, 5 µl of infected-HFF media that was used to culture cells between days 7-
14, 14-16, 16-18, or 18-21 was harvested and added to a confluent layer of uninfected 
HFFs.  After 24 hours, these cells were fixed and stained for IE viral protein expression and 
counterstained with Hoechst, and the proportion of cells with viral expression scored.  Media 
harvested from days 7-14 infected only 10% of HFFs, whereas all other harvests infected at 
least 30% of the cells.  All four harvests were pooled before sorbitol purifying HCMV.  After 
purification, the virus was pelleted and resuspended into 5 ml of media.  Aliquots of the 
virus stock was added to confluent HFFs in order to calculate the concentration of infectious 
particles from every purification.  The probability that each HFF becomes infected by a virus 
is given by the Poisson distribution; this was used to estimate the concentration of infectious 
particles used in further experiments.  
16 dpi
14 dpi
21  dpi
18 dpi
Uninfected
Brightfield
14 dpi
Figure 5.  Infectivity of viral harvests
Media from cultures of human foreskin fibroblast (HFF) infected with Merlin strain HCMV (MOI 0.1) 
were replaced with fresh media at 7, 14, 16, 18, and 21 days post infection (dpi).  (A) Starting at 14 dpi, when 
substantial cytopathic effects were seen by bright field microscopy (left side), media was harvested, centrifuged 
(3000 g, 20 min, RT) and the supernatant was stored at -80oC for later purification.  5 µl of these harvests 
were added to wells of a 96-well plate with a confluent layer of healthy HFFs and incubated overnight.  Cells 
were fixed and stained for immediate early (IE) viral protein expression and counterstained with Hoechst.  
Scale bars show 50 µm.  (B) IE expression was scored in a minimum of 300 cells and expressed as percent 
infected.
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4.2.3 The effects of cytomegalovirus on neutrophil survival 
Light microscopy analysis of neutrophil morphology showed that Merlin (a clinical isolate 
HMCV strain) had a concentration-dependent effect on neutrophil survival when measured 
at 20 hours, significantly reducing constitutive apoptosis with MOIs as low as 0.05 (Figure 
6).  Scanning electron micrographs also showed that Merlin infection clearly reduced the 
number of neutrophils exhibiting the smooth surface morphology indicative of apoptosis. 
Flow cytometric analysis of neutrophils incubated for 20 hours and treated with FITC-tagged 
Annexin V and PI showed the presence of 3 cell populations:  Annexin V-/PI- viable cells, 
and Annexin V+/PI- and Annexin V+/PI+ cells indicating neutrophil populations undergoing 
early and late apoptosis respectively (Figure 7A).  Increasing concentrations of Merlin 
decreased the proportion of Annexin V+ cells, with an MOI of 3 reducing the proportion of 
Annexin V+ cells from 57.9±3.2% to 19.2±3.1% (SEM; p<0.001; Figure 7B).  Because 
apoptosis is caspase-3 and 7-dependent, I sought to confirm whether Merlin inhibits 
neutrophil apoptosis by also assaying the activity of these proteases (Figure 
7C).  Concordant with morphology and flow cytometry analysis, all treatments with Merlin 
significantly reduced caspase-3 and 7 activities.  DNA harvested and amplified from 
HCMV-treated neutrophils contained viral DNA (Figure 8A), and a small number of virions 
were visually identified inside treated neutrophils (Figure 8B).  PCR analysis showing that 
viral RNA was not present in infected neutrophils (conducted by my colleague Joanna 
Pocock and publish in Pocock et al., 2017) suggests that these cells are not permissive to 
productive HCMV infection (i.e. HCMV does not induce transcription of viral genes or 
undergo its replicative cycle in neutrophils), and indeed when Merlin is UV-killed before 
culture with neutrophils, constitutive apoptosis was also delayed (Pocock et al., 2017).  One 
hour prior to HCMV-treatment, neutrophils were incubated with TLR2/4 or TLR4 inhibitors 
(Figure 8C), or PI3-kinase, ERK1/2, or NF-κB inhibitors (Figure 8D). Blocking TLR2/4 or 
ERK1/2 partially reversed, and NF-κB inhibition most effectively reversed, the pro-survival 
effect of HCMV. 
4.2.4 The effects of cytomegalovirus on neutrophil autophagy 
Brightfield and transmission electron micrographs of Merlin-treated neutrophils taken in 
collaboration with Dr Andrew Cowburn show a highly vacuolated cell (Figure 9).   
Mock MOI 0.05 MOI 0.5 MOI 3
Figure 6.  Morphological analysis of HCMV-induced apoptosis in neutrophils 
Mock HCMV
Neutrophils were treated for 30 minutes with HCMV before being centrifuged and resuspended into virus-free 
media.  Apoptosis was assessed morphologically at 20 hours.  Light microscopy under 63x objective lens (top 
left) of cells infected with HCMV at a multiplicity of infection of 3 (high), 0.5 (medium) or 0.05 (low), scored for 
apoptosis at 20 hpi (top right; n=3; *p<0.05). Statistical analysis by ANOVA followed by Dunnett's multiple-
comparison test versus the control. Scanning electron microscopy (SEM; bottom images) of uninfected 
(Mock) and infected (HCMV) neutrophils.  Scale bars show 20 µm.  Most uninfected cells exhibit a smooth 
spherical shape indicative of apoptosis, in contrast to infected neutrophils.  After fixation, SEM images were 
prepared by Dr. Andrew Cowburn and Dr. Jeremy Skepper.
Figure 7.  HCMV inhibits the constitutive rate of neutrophil apoptosis
Neutrophils were infected with HCMV and incubated for 20 hours before measuring apoptosis.  (A) Representa-
tive plots of flow cytometric analysis.  (B) Flow cytometric analysis of neutrophil apoptosis at 20 hours in 
uninfected and HCMV-treated neutrophils (at multiplicities of infection of 0.3, 1, or 3; n=4).  (C) A luminescent 
assay for caspase-3 and -7 activity in uninfected and infected neutrophils at 20 hours (n=3).  Statistical analysis 
by one-way analysis of variance and Dunnett’s multiple comparisons test versus controls (**p<0.01, 
***p<0.001). 
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Figure 8.  HCMV enters neutrophils and induces TLR2 and NF-κB dependent survival
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(A) DNA harvested from neutrophils mock-infected (M) or infected by HCMV, isolated at 18 hours post-infection (hpi), 
then amplified in an IE72 PCR or GAPDH PCR control.  (B) Detection of viral particles (arrows) by transmission 
electron microscopy of infected neutrophils 30 min post infection.  After fixation, TEM images were prepared and taken 
by Dr. Andrew Cowburn and Dr. Jeremy Skepper. (C) 60 min prior to infection, neutrophils were incubated with 
TLR2/4 inhibitor (OxPAPC, which competes with CD14, LBP and MD2, thereby blocking the signaling of TLR2 and 
TLR4) or with TLR4 inhibitor (CLI-095, which blocks the signaling mediated by the intracellular domain of TLR4) and 
apoptosis assessed by morphology 18 hpi (n=3, *p<0.01).  (D) 60 min prior to infection, neutrophils were incubated with 
PI3-kinase (LY294002, 10µM), ERK1/2 (U0126, 1µM), and NF-κB (BAY-11-7085, 3µM) inhibitors and apoptosis assessed 
by morphologically at 18hpi (n=3, ** p<0.001, *p<0.01). Statistical analysis by ANOVA followed by Dunnett's multiple-
comparison test versus the controls.
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Figure 9.  HCMV induces vacuolisation and increased expression of autophagy-related transcripts 
(A) Representative brightfield (20 hpi) and scanning electron microscopy (3 and 20 hpi; scale bars show 500 nm) 
images of uninfected (Mock) or infected (HCMV) neutrophils.  Infected neutrophils appear highly vacuolated.  (B) 
Gene expression analysis of autophagy-associated genes in neutrophils 6 hpi.  Data shown as fold-change when 
compared to mock infection from 3 independent experiments (*p<0.05).  Experiments conducted in 
collaboration with Dr Andrew Cowburn.  
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This finding, along with the increased RNA expression of select autophagy-related genes 
observed in infected cells, suggested that HCMV might induce autophagy in neutrophils, as 
has been reported in fibroblasts (McFarlane et al., 2011).   
LC3A/B-I, which forms a 16-18 kDa band on western blot, is lipidated during autophagy 
into an active membrane-bound form that is essential for cargo-recruitment.  The lipidated 
form, LC3A/B-II, runs further on a gel and corresponds to a 14-16 kDa band.  Densitometry 
analysis of LC3A/B western blots showed increasing levels of LC3A/B-II in infected 
neutrophils compared to mock-treated cells (Figure 10A).  Because autophagy occurs 
constitutively at low levels, the increased lipidation of LC3A/B-II can result from either 
increased autophagy or the accumulation of autophagosomes due to blockage of 
autophagosome maturation.  To distinguish which of these two possibilities occurs with 
Merlin infection, neutrophils were pre-incubated with bafilomycin-A1, which inhibits late 
autophagy by blocking autophagosome maturation with the lysosome.  If Merlin blocks 
autophagosome maturation in the cell, the levels of lipidated LC3A/B-II should be similar 
when neutrophils are exposed either individually or simultaneously to Merlin and 
bafilomycin-A1.  However, the combined treatment of bafilomycin-A1 and Merlin 
substantially increased LC3A/B-I lipidation above the level of individual treatments (Figure 
10B), suggesting that HCMV induces autophagosome production rather than solely 
inhibition of its maturation. 
Autophagy is intricately linked to both cell death and survival processes.  In order to test 
whether autophagy was related to the delayed apoptosis observed in infected neutrophils, 
cells were pre-incubated with the autophagy inhibitor 3-MA for 30 minutes before 
infection.  3-MA preincubation indeed blocked the survival effect elicited by Merlin, further 
supporting a potential role of autophagy in HCMV-mediated survival of neutrophils (Figure 
10C). 
  
Figure 10.  HCMV induces autophagy in neutrophils 
(A) Densitometry analysis of LC3A/B-II and representative western blot of LC3A/B-I and LC3A/B-II 
from neutrophils mock-treated or infected with HCMV.  (B) Densitometry analysis of LC3A/B-II and 
representative western blot of LC3A/B-I and LC3A/B-II from neutrophils pre-treated with bafilomycin-A1 (Baf) 
before mock or HCMV treatment for 4 hrs.  (C) Morphological analysis at 18 hours for apoptosis of 
neutrophils pre-treated with autophagy inhibitor 3-methyladenine (3-MA) and an accompanying western blot 
from parallel 3-MA experiments of neutrophils incubated with or without HCMV.  Data shown as mean ± SEM 
from 3 independent experiments (*p<0.05, **p<0.01). Statistical analysis by ANOVA followed by Dunnett's 
multiple-comparison test versus the controls.
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4.2.5 Cytomegalovirus induction of a bioactive secretome 
Previous findings that HCMV encodes a neutrophil chemoattractant (Penfold et al., 1999), 
induces neutrophil effector function (Skarman et al., 2006), and increases survival, yet does 
not productively infect these cells, led us to hypothesise that perhaps the HCMV-treated 
neutrophil secretome may be advantageous to HCMV infection or dissemination.  An 
inflammation array analysis probed with media from mock- or Merlin-treated neutrophils 
showed that infected neutrophils secreted substantially higher levels of IL-6, IL-8, MCP-1, 
MIP-1α, and MIP-1β (Figure 11A).  
Upregulated release of monocyte chemoattractant protein (MCP)-1, a key regulator of 
monocyte migration, by HCMV-treated neutrophils suggested that the secretome may 
increase monocyte migration.  The release of MCP-1 to attract monocytes is a typical 
neutrophil response seen during infection; however, in the case of HCMV, infection of 
monocytes is seminal to the dissemination and persistence of the virus in vivo.  This was 
confirmed by showing that monocytes cultured in a transwell plate migrated more towards 
infected-neutrophil secretome compared to media alone (p<0.01) or uninfected-neutrophil 
secretome (p<0.03; Figure 11B).  To examine the effect of the secretome on monocyte 
permissivity to infection, autologous donor monocytes were incubated with media, mock-
infected neutrophil secretome, HCMV-treated neutrophil secretome, or IL-4/GM-CSF (to 
differentiate them into dendritic cells, which are very permissive to HCMV infection) before 
a 24-hour exposure to Merlin.  Monocytes that had been incubated with 'infected' neutrophil 
secretome had a significantly higher proportion of infected cells (p<0.05; Figure 11C), 
indicating that the neutrophil response to HCMV challenge results in a secretome response 
that attracts monocytes and causes them to be more susceptible and/or permissive to HCMV 
infection, and that this occurs without any evidence of direct integration of HCMV in the 
neutrophil.   
To determine whether HCMV-induction of survival and autophagy may also be due to 
secretome-mediated autocrine and/or paracrine effects, neutrophils were cultured in 
secretome harvested from untreated or HCMV-treated neutrophils.  The infected-neutrophil 
secretome significantly delayed apoptosis and induced LC3A/B-I lipidation, indicative of 
autophagy (Figure 12).   
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Figure 11.  HCMV-treated neutrophils release a bioactive secretome that promotes 
monocyte migration and differentiation to a permissive phenotype
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(A) Array analysis (left) of the secretomes from mock- and HCMV-treated neutrophils 18 hpi. Data analysis 
is from 2 independent experiments (mean ± SD) of which a representative blot is shown (right). UV-HCMV-
infected neutrophil secretome (n=1) produced a blot similar to infected neutrophils.  (B) Monocytes were 
cultured in transwell plates in the presence of media, neutrophil (PMN) media, infected PMN media, 
or media from LPS-activated monocytes. Migration was assessed blind by counting 5 fields of view in 
triplicate wells from 3 independent experiments; statistical analysis by ANOVA followed by Tukey's 
test. Fold change was expressed relative to normal media. (C) Autologous donor monocytes were 
cultured in media, PMN media, infected PMN media, or IL-4/GM-CSF-differentiated dendritic cells 
(DCs) and then infected with HCMV. 24 hpi cells were stained for IE gene expression and 
counterstained with Hoechst nuclear dye. Relative levels of infection were calculated from 10 fields of 
view (*p<0.05). After cell purification, experiments for panels B and C were conducted by Dr Matthew 
Reeves.
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Figure 12.  HCMV-infected neutrophils release a secretome that induces neutrophil survival and 
autophagy
(A) Freshly isolated neutrophils were cultured with control media, or media from mock- or HCMV-
infected neutrophils.  Apoptosis was determined at 20 hrs by morphology. (B) Densitometry analysis 
(top) of LC3A/B-II and representative Western blot (bottom) from neutrophils cultured with secretome 
from mock- or HCMV-infected neutrophils. Data shown as mean ± SEM from 3 independent 
experiments (*p<0.05, **p<0.01). Statistical analysis by ANOVA followed by Dunnett's multiple-comparison 
test versus the controls.
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4.3 Discussion 
4.3.1 HCMV delays constitutive neutrophil apoptosis 
The human peripheral blood neutrophils used in this study responded to TNF-α by 
stimulating apoptosis in a relatively small population of neutrophils at 6 hours, but overall, 
act to delay apoptosis at 20 hours, compared to untreated neutrophils, with GM-CSF 
significantly delaying neutrophils throughout (Figure 3, 4) – this is in line with data from 
other studies that use various neutrophil purification techniques. 
 
Merlin infection significantly altered the neutrophil apoptotic programme.  While the 
majority of untreated neutrophils cultured in vitro undergo apoptosis by 20 hours, as 
assessed by morphological changes (Figure 6), increased PS surface exposure, plasma 
membrane permeability, and caspase-3 and 7 activities (Figure 7), the exposure to as little 
as 0.3 MOI of Merlin significantly inhibited or delayed apoptosis.  Ex vivo agreement of 
these findings comes from neutrophils isolated from the blood and bronchoalveolar lavage 
fluid of a patient with CMV pneumonitis, which also show a strong survival phenotype (Dr 
Jatinder Juss, personal communication).  HCMV also prevents apoptosis in other cells 
including CD34+ haematopoietic cells and CD14+ monocytes, which HCMV uses for viral 
latency and persistence respectively (Chan et al., 2010; Reeves et al., 2012).  In cells 
permissive to infection, HCMV inhibits apoptosis using a broad array of viral proteins that 
target caspase-8 (UL36), mitochondrial membrane stability (UL37x1), ER stress (UL38), 
ATP production (Beta2.7), and PKR (TRS1;  Goldmacher et al., 1999; Reeves et al., 2007; 
Skaletskaya et al., 2001; Terhune et al., 2007).  This observed reversal of apoptosis by 
HCMV was recapitulated in ultrapure neutrophils (purity >99%; Dr Andrew Cowburn, 
personal communication).  To address the potential role of contaminating LPS towards the 
observed survival response, neutrophils were treated with excessively high concentrations 
of LPS, with only a minimal survival response found at the highest concentrations.  
Neutrophil responses to LPS have been documented to be dependent on the presence of 
monocytes (Sabroe et al., 2002). 
 
The ability of HCMV to productively infect neutrophils has been hotly contested (see 
Section 4.1.1).  RNA harvested from infected neutrophils prepared in this study was 
subsequently reverse transcribed and was not able to be amplified in an IE72 PCR, 
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demonstrating an absence of viral IE expression (Pocock et al., 2017).  These results suggest 
that, at least in vitro, healthy neutrophils are not productively infected by HCMV.  Therefore, 
the ability of Merlin to prevent constitutive cell death in neutrophils in this study appears to 
occur in the absence of viral lytic gene expression.  This survival response may be due to a 
virus–host receptor interaction, perhaps as a surface or post-entry event.  The presence of 
viral DNA in neutrophils and TEM images showing a small number of intact virions in 
vacuoles, show that HCMV was able to enter the cell, potentially through phagocytosis 
(Figure 8A, B).  Many PAMPs are recognised by neutrophil PRRs, including a range of 
TLRs.  Blocking TLR2/4 partially reversed the pro-survival effect of HCMV, though no 
reversal was seen when blocking TLR4 alone, suggesting a dominant role for TLR2 (Figure 
8C).  HCMV is a large virus that has the potential to bind to a wide variety of receptors 
including CD13 and platelet-derived growth factor receptor (PDGF-R)/epidermal growth 
factor receptor (EGFR).  However, blocking either of these receptors did not affect HCMV-
mediated survival (Dr Andrew Cowburn, personal communication).  It may be that the 
survival effect is caused by interaction with other receptors or a group of receptors, and that 
several survival mechanisms exist, producing redundancy. 
 
In neutrophils prepared in this study, the Merlin-driven survival response was partially 
dependent on ERK1/2 activation, with inhibition of the NF-κB pathway most effectively 
reversing survival (Figure 8D).  This is consistent with the finding that HCMV-treated 
neutrophils display increased phosphorylation of p38 and degradation of IκB.  Previous 
studies using pathway inhibitor assays have found that HCMV activation of PI3K and ERK-
MAPK pathways is important to HCMV-mediated survival in a variety of cells (Chan et al., 
2010; Reeves et al., 2012).  Consistent with this, NF-κB, MAPKs and PI3K are activated in 
GM-CSF and TNF-α survival pathways in neutrophils (Cowburn et al., 2004).  Along with 
the finding here that HCMV reduces the activity of caspases 3 and 7, host RNA expression 
of the caspase inhibitors cellular inhibitor of apoptosis (cIAP)-1 and cIAP2, as well as pro-
survival Bcl2A1, were found to be upregulated during HCMV infection of neutrophils (Dr 
Andrew Cowburn, personal communication).  Caspases are also responsible for the 
degradation of Mcl-1, which in neutrophils is a critical prosurvival protein (Cross et al., 
2008).  Merlin infection of neutrophils in this study also caused stabilisation of this protein 
(Pocock et al., 2017). 
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HCMV-treated neutrophils have previously been shown to be activated, increasing their 
survival as well as effector functions (Skarman et al., 2006), presumably an appropriate 
immune response to fight infection, and a response neutrophils elicit towards other 
pathogens including respiratory syncytial virus and Mycobacterium tuberculosis (Blomgran 
et al., 2012; Coleman et al., 2011; Jaovisidha et al., 1999).  However, in the case of HCMV, 
the secretome released by HCMV-treated neutrophils appears to provide a direct advantage 
to the virus due to its effects on monocyte migration and permissivity to infection.  These 
cells are critical to HCMV dissemination (Daley-Bauer et al., 2014), and the enhanced 
monocyte migration and subsequent differentiation to a permissive phenotype seen in this 
study was suggestive of a mechanism for efficient viral dissemination from the site of initial 
infection (Figure 11).  Further investigation by Dr Matthew Reeves (personal 
communication) into myeloid markers of differentiation and activation on monocytes found 
that the infected neutrophil secretome also downregulates molecules required for effective 
antigen presentation, including class II major histocompatibility complex (MHC), but did 
not affect molecules involved in migration or chemotaxis. 
 
4.3.2 HCMV induces neutrophil autophagy 
Autophagy plays a crucial role in pathogen defence and has only recently been identified in 
neutrophils (von Gunten et al., 2005; Huang et al., 2009).  The autophagic pathway 
orchestrates the intracellular digestion of pathogens and has been demonstrated to influence 
a broad number of other functions, including inflammatory cytokine production and the 
regulation of both cell survival and death (Murrow and Debnath, 2013).  Exposure of 
fibroblasts to HCMV or UV-inactivated HCMV also induces autophagy, though de novo 
viral protein synthesis of TRS1 later acts to inhibit autophagy, likely through its interaction 
with Beclin-1 (Chaumorcel et al., 2012).  This lends further evidence that neutrophils were 
not productively infected by Merlin, as autophagy occurred as late as 20 hours. 
Autophagy can act as a protective mechanism for cells undergoing stress, retaining their 
integrity and removing insults.  More recently, studies have identified complex cross-talk 
between autophagic and apoptotic proteins, such as between LC3A/B and Fas, and Bcl-2 
inhibition of Beclin (Chen et al., 2010; Pattingre et al., 2005).  Indeed, the relationship 
between autophagy and cell survival through inhibition of apoptosis is complex and 
convoluted, and different factors that increase or decrease autophagy may also increase or 
HCMV induces neutrophil survival and autophagy 
 
66 
6666 
decrease survival.  Class I PI3K, a potent survival signal, recruits Akt/protein kinase B 
(PKB), which, through Tor kinase, negatively regulates autophagy (i.e. increased survival, 
decreased autophagy).   Stimulation of the TNF-α receptor activates both the JNK pathway 
that activates autophagy, and caspase-8 and -10 through recruitment of Fas-associated 
protein with death domain (FADD) and TNF receptor type 1-associated death domain 
(TRADD), which can lead to apoptotic cell death (Baehrecke, 2005;  i.e. decreased survival, 
increased autophagy).  The cleavage of Atg5 by calpain not only prevents it from 
functioning in autophagy, but the cleaved product translocates to the mitochondria where it 
induces cytochrome C release and caspase activation, leading to apoptosis (Pattingre et al., 
2005;  i.e. decreased survival, decreased autophagy).  Conversely, class III PI3K increases 
Beclin-1 activation and is a positive regulator of autophagy  (Baehrecke, 2005;  i.e. increased 
survival, increased autophagy).  In this study, the pro-survival effect of HCMV was 
dependent on the induction of autophagy (Figure 10).  These effects indeed appear to have 
been driven by class III PI3K activation, as its inhibition with 3-MA reversed both HCMV-
mediated survival and autophagy.  This study therefore offers the first description of 
pathogen-induced cytoprotective autophagy in neutrophils.   
Autophagy and survival was also augmented by the infected neutrophil secretome (Figure 
12).  The upregulated release of IL-6, IL-8, MCP-1, MIP-1α, and MIP-1β from HCMV-
treated neutrophils was not responsible for this survival effect, as pre-heating the secretome 
at 56oC for 45 minutes to denature all proteins did not reverse the survival effect (Dr Joanna 
Pocock, personal communication), suggesting that perhaps a more heat-stable, possibly lipid 
mediator, may be involved. 
It remains unclear therefore whether the survival and autophagy induced by direct HCMV 
infection or contact (Figure 6, 7) is due to direct virus interaction or to the resulting 
secretome.  However, early results suggesting that the secretome-mediated survival is 
largely PI3K-dependent (Dr Andrew Cowburn, personal communication) while the survival 
from direct infection is largely NF-κB dependent (Figure 8D), suggesting that different, 
though potentially overlapping, processes operate to delay apoptosis. 
While autophagy can function to capture and disintegrate intracellular pathogens, some 
pathogens are able to disarm or benefit from the autophagic machinery.  For example, 
adherent-invasive E. coli can block the fusion of the autophagosome with the lysosome in 
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neutrophils, allowing it to survive in the cell (Chargui et al., 2012).  It is not clear whether 
or not the neutrophil autophagic programme results in the destruction of captured HCMV, 
however the associated pro-survival effect may benefit overall HCMV dissemination 
through the impact of the infected neutrophil secretome on monocytes. That is, at the 
sacrifice of some virions, HCMV may increase its opportunity to disseminate to new sites 
of infection. 
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5 HCMV inoculum degrades NETs 
5.1 Introduction 
The array of neutrophil anti-pathogenic mechanisms was broadened dramatically 13 years 
ago with the finding that neutrophils can release extracellular meshes of chromatin, which 
are coated in granule proteins (Brinkmann et al., 2004).  These NETs could be triggered by 
a variety of agents including bacteria, viruses, parasites and chemical factors such as PMA. 
The discovery has since catalysed a growing body of research and demonstrated the ability 
of NETs to capture pathogens in many in vivo contexts, to restrict their movement, and 
surround them with a microenvironment of concentrated antimicrobial agents (Yipp and 
Kubes, 2013).  
 
Most studies of NETs characterise the NADPH oxidase (NOX2)-dependent pathway, where 
agonists such as PMA or IL-8 activate the ERK cascade, which stimulates NOX2 and ROS 
production, which triggers granule membrane disintegration within the cell and the release 
of MPO and NE, which is translocated to the nucleus (Metzler et al., 2014; Papayannopoulos 
et al., 2010). There, NE cleaves histones, decondensing chromatin, and degrades the nuclear 
membrane releasing DNA, histones, and proteases into the cytosol. Here they combine to 
form NETs, preceding plasma membrane rupture and expulsion from the cell (Yipp and 
Kubes, 2013). There is more to be discovered about the signalling events which trigger NET 
formation as this response is not uniform or observed in every situation where NOX2 is 
activated (see Section 2.3). 
 
5.1.1 NETs evasion strategies 
While the immune system has evolved numerous strategies to neutralise pathogens, invading 
microbes have also developed a variety of techniques to evade host immune responses.  
Pathogens use diverse mechanisms to avoid immune action, such as inhibiting host 
inflammatory responses, degrading antimicrobial molecules with catalytic enzymes, and 
avoiding or resisting host proteases (Finlay and McFadden, 2006).  Research over the past 
decade has identified comparable mechanisms employed by pathogenic bacteria, viruses, 
and parasites that inhibit, degrade, or resist NETs (Figure 13). 
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Soon after their discovery, the evasion of NETs was suggested as a potential function of 
nucleases from Group A Streptococcus (Sumby et al., 2005).  In the following year, two 
groups demonstrated independently that the degradation of NETs by Streptococcus 
nucleases resulted in increased bacterial dissemination and pathogenicity (Beiter et al., 2006; 
Buchanan et al., 2006).  Research in NETs evasion remained centred on Streptococcus 
strains, with subsequent studies demonstrating the bacteria's ability to not only degrade 
NETs, but also inhibit their deployment by dampening the inflammatory response through 
"self" ligand mimicry (Carlin et al., 2009) and by cleaving the NETs-inducing cytokine IL-
8 (Zinkernagel et al., 2008), and to resist NETs entrapment through surface encapsulation 
and electrochemical modification (Wartha et al., 2007). 
Indeed, certain pathogens appear to resist NETs trapping and killing by mechanisms 
including biofilm formation and surface electrochemical modification. Modification or 
masking of the negatively charged bacterial surface by bacterial enzymes or a capsule 
exploits the cationic nature of most NET components, preventing the electrostatic attraction 
thought to be responsible for bacterial adherence (Wartha et al., 2007). Furthermore, certain 
virulence factors have been shown to confer resistance to the antimicrobial peptides present 
in NETs (Hong et al., 2009).  
A common pathogen strategy to counter neutrophil effector functions is to inhibit ROS 
pathways, and a handful of studies have shown that this capability may also down-regulate 
NETs induction. ROS inhibition may occur through interference with ERK phosphorylation 
Figure 13. The three main NET evasion strategies. Certain respiratory pathogens have evolved 
the ability to evade the antimicrobial effects of NETs, using three main mechanisms: inhibition of the 
release of NETs; degradation of NETs by the production of pathogen nucleases; and resistance to the 
effects of the antimicrobial proteins that are enmeshed within NETs. Figure modified from Storisteanu et 
al. 2017. 
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upstream of NADPH oxidase (Eby et al., 2014), or by pathogen induction of the NET-
suppressive cytokine IL-10 to block TLR-induced ROS generation (Carlin et al., 2009). 
Many pathogens are able to induce cellular IL-10, while some viruses encode their own IL-
10 homologues  (Ouyang et al., 2014). While induction of this immunosuppressive cytokine 
likely benefits infecting pathogens in several ways, the importance of its ability to down-
regulate NETs induction has yet to be determined. It is likely however that attenuation of 
ROS generation will prove to be a broad NET-evasion strategy employed by a variety of 
pathogens. 
Evidence that NETs evasion is a prevalent immune evasion strategy among diverse 
pathogens has been growing rapidly.  These include findings that S. aureus not only degrades 
NETs, but that the degraded products furthers disease progression (Thammavongsa et al., 
2013).  NETs evasion mechanisms have also been found in a virus (HIV-1; Saitoh et al., 
2012), and in a protozoan parasite (Leishmania infantum; Guimarães-Costa et al., 2014), 
which may also be advantaged during human transmission by a nuclease released in the 
saliva of its sandfly carrier (Chagas et al., 2014).  There is even evidence that neutrophils 
may attenuate pathogen-degradation of NETs: The antimicrobial peptide LL-37 
(cathelicidin) is constitutively expressed in neutrophils and present at high concentrations in 
NETs, however it loses its microbicidal activity when bound to DNA.  Neumann et al. (2014) 
found that purified neutrophil DNA and NETs released by PMA-treated neutrophils, when 
supplemented with LL-37, were resistant to degradation by S. aureus, S. pneumoniae, and 
GAS nucleases. These results were recapitulated using other cationic antimicrobial peptides 
(AMPs), with the cationicity of the agents correlating with the degree of resistance to 
degradation. The degradation, inhibition, and resistance of NETs appears to be a prevalent 
strategy to increase pathogen proliferation and dissemination. 
5.1.2 Chapter 5 aims 
1) What is the requirement of ROS generation for the induction of NETs? 
The ability of ROS-deficient or partially deficient neutrophils (mutant murine bone marrow 
neutrophils, and peripheral blood or alveolar neutrophils from people with acute respiratory 
distress syndrome (ARDS)) to generate NETs was assessed using chemiluminescence assay 
and fluorescence spectrophotometry and microscopy. 
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2) How does HCMV affect reactive oxygen species generation and extracellular trap 
release? 
ROS generation was quantified in response to HCMV in healthy peripheral blood 
neutrophils using chemiluminescence assay.  The effect of HCMV on NETs was studied 
using spectrophotometry, fluorescence and electron microscopy, and agarose gel 
electrophoresis. 
5.2 Results 
5.2.1 Reactive oxygen species and neutrophil extracellular traps 
Neutrophils release NETs in response to a variety of pathogens (Brinkmann et al., 
2004).  The classically described pathway of NET formation is dependent on ROS 
generation and autophagy (Itakura and McCarty, 2013; Park et al., 2017; Remijsen et al., 
2011).  Because HCMV induces ROS generation and autophagy, I wanted to explore 
whether HCMV may also induce NET formation.  I first sought to generate NETs using the 
well-established NETs-stimulant, PMA.  Neutrophils were seeded into wells with an 
optically optimised base and cultured in the presence or absence of PMA in combination 
with the cell impermeable DNA dye, Sytox Green.  When DNA is extruded extracellularly 
it is bound by Sytox Green and fluoresces when excited.  At every hour, a microplate 
fluorescence spectrometer excited DNA-bound Sytox Green using a 488 nm laser and 
quantified the fluorescence signal after it passed through a 550 nm filter.  After the final 
time point the samples were fixed and mounted in the wells, and fluorescence microscopy 
used to morphologically confirm the presence of NETs.  As little as 20 nM PMA was 
sufficient to induce neutrophil release of extracellular structures that fluoresced in the 
presence of Sytox Green and disintegrated following the addition of DNase (Figure 14).  To 
examine the requirement of ROS in the generation of NETs and confirm that these assays 
were compatible with detecting ROS-dependent release of NETs, I treated wild-type and 
bc017643-/- bone marrow murine neutrophils (prepared in separate study led by Dr David 
Thomas), which have defective NADPH oxidase activity, with PMA.  bc017643 encodes 
for the transmembrane protein Eros (essential for reactive oxygen species) (Thomas et al., 
2017). 
Figure 14.  Neutrophils release DNA extracellular traps in response to PMA
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Kinetic analysis of NET formation from 0 to 5 hours after stimulation with PMA (top, n=1).  Neutrophils were 
cultured with Sytox Green and 0, 20, 100, or 250 nM PMA.  Sytox Green fluoresence, indicative of 
externalised DNA, was measured with a fluorescence microplate reader.  Cells were fixed and images taken 
by immunofluorescence microscopy at 63x magnification (bottom).  
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The mutant neutrophils serve as a negative control and are unable to mount a ROS response 
to PMA or to fMLP stimulation after TNF-α priming (Figure 15A).  In response to PMA, 
Sytox Green fluorescence significantly increased in wild-type but not mutant neutrophils 
(Figure 15B).  These samples were then fixed for immunofluorescence imaging.   
During NET formation, histones are citrullinated during chromatin decondensation and 
provide a specific marker for NETs.  Using an antibody for citrullinated histone H3 I found 
that citrullinated histones co-localised with DNA only in the PMA-treated wild-type 
neutrophils, which were also morphologically distinct:  the nuclei were decondensed and 
distinct from the doughnut-shaped nucleus seen in other treatments, which are typical of 
viable mouse neutrophils (Figure 16). 
To explore further the relationship between ROS production and NETs extrusion further, 
blood and alveolar neutrophils were isolated from acute respiratory distress syndrome 
(ARDS) patients.  These neutrophils have widely varying abilities to mount an oxidative 
burst (Juss et al., 2016).  All neutrophils were able to release NETs upon stimulation of PMA 
or pyocyanin (Figure 17).  Pyocyanin is a clinically important virulence factor released by 
Pseudomonas aeruginosa that has recently been identified to induce NET formation (Rada 
et al., 2013).  The degree of NETs release did not appear to be related to the degree of ROS 
production.  For example, patient 21 (P21) mounted a ROS response that was only 25% of 
that observed from healthy control neutrophils (Juss et al., 2016), though PMA treatment 
induced a greater than 2-fold release of NETs compared to the healthy control.  The above 
murine and ARDS data suggest that while a threshold level of ROS generation is required 
to produce PMA-stimulated NETs, other factors then regulate the extent of this response. 
5.2.2 The effect of cytomegalovirus on ROS and NETs 
Previous research has found that HCMV activates neutrophils and stimulates an oxidative 
burst (Skarman et al., 2006).  Using a HRP-luminol based chemiluminescence assay, the 
kinetic profile of the oxidative burst produced by freshly isolated peripheral blood human 
neutrophils in response to a variety of agonists was recorded.  PMA and Merlin B both 
generated a significantly higher burst than the PBS-treated control (Figure 18A, B).  
Surprisingly, pyocyanin did not appear to generate a burst, contrary to previous findings 
(Rada et al., 2013).   
Figure 15.  Murine bc017643-/- bone marrow neutrophils have a defective capacity to generate 
reactive oxygen species and NETs with PMA stimulation
(A) Kinetics analysis using horseradish peroxidase (HRP)-luminol-dependent chemiluminescence assay of 
mutant murine bone marrow neutrophils stimulated with fMLP (left) or PMA (right) show a decreased capacity 
to generate reactive oxygen species (n=3).  (B) Kinetic analysis (left) of NET formation from 0 to 6 hours after 
stimulation with 20 nM PMA.  Bone marrow neutrophils were cultured with Sytox Green, with or without PMA.  
Sytox Green fluoresence, indicative of externalised DNA, was measured with a fluorescence microplate 
reader (n=3).  Presence or absence of NETs was confirmed visually using fluorescence microscopy. 
Extracellular DNA signal at 6 hours (right).  Statistical analysis by one-way ANOVA and post-hoc Tukey’s 
test for significance (***p<0.001).
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Figure 16.  Immunofluorescence microscopy images showing ROS-deficient neutrophils unable 
to NETose with PMA stimulation
Representative fluorescence microscopy images of murine bone marrow neutrophils cultured with or without 
PMA (20 nM) for 6 hours.  Histone H3 (citrulline R2+R8+R17) was visualised by AlexaFluor 568 staining, and 
DNA was visualised using Sytox Green dye.  DNA colocalised with citrillunated histones, indicative of neutrophil 
extracellular traps, appears yellow.  Data represent images typical of those produced in n=3 independent experi-
ments each performed in triplicate.  Bars show 20 µm.
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Figure 17. Capacity for NET formation from blood and alveolar neutrophils isolated from acute 
lung injury (ALI) patients
(A;  left) Kinetic analysis of NET formation in freshly isolated autologous blood (n=7) and alveolar (n=4) ALI 
neutrophils and healthy volunteer (HV) neutrophils cultured at 1x106 cells/ml in IMDM, with or without PMA (20 
nM).  Fluorescence of cell impermeable DNA dye, Sytox Green, was measured hourly using a microplate reader.  
(Right)  Fluorescence readings, indicating NET formation, at 4 hours after stimulation with PMA or pyocyanin (n 
≥3).  (B)  Representative images of NET formation with PMA treatment (20 nM;  bars represent 10 µm).  The 
presence of NETs were confirmed by fluorescence microscopy visualised using Sytox Green dye and antibodies 
against citrillinated histones.  Colocalisation of DNA and citrillinated histones, appearing yellow, indicate NET 
structures.
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Figure 18.  The effect of HCMV on neutrophil reactive oxygen species and neutrophil 
extracellular trap responses
(A) Kinetics analysis using horseradish peroxidase (HRP)-luminol-dependent chemiluminescence assay of 
neutrophil oxidative burst in response to PBS, pyocyanin (10 µM), Merlin B (MOI 0.1), or AD169 (MOI 0.1). 
Measurements were recorded at 6 second intervals over 1 hour.  Shown in (B) are peak oxidative bursts.  
Statistical analysis by repeated measures ANOVA and post-hoc Dunnett's test for 
significance from PBS treatment (**p<0.01, ***p<0.001).  (C, D) Neutrophils were cultured with Sytox 
Green in the presence or absence of 20 nM PMA , 10 µM pyocyanin (Pyo), or UV-killed HCMV (Merlin 
A, MOI 3, n=10; Merlin B, MOI 0.1, n=4; AD169, MOI 0.1, n=4).  (C) Kinetic analysis of NET formation 
from 0 to 4 hrs.  Sytox Green fluoresence, indicative of externalised DNA, was measured using a 
fluorescence microplate reader. (D) Fluorescence intensity at 4 hrs.  Presence or absence of NETs was 
confirmed visually using fluorescence microscopy.  Statistical analysis by one-way ANOVA and post-
hoc Dunnett’s test for significance between infected treatments and their non-infected controls (*p<0.05, 
**p<0.01). Data represent the mean ± SEM from n=4 independent experiments.  
BA
0 20 40 60
0
50000
100000
150000
200000
250000
PMA
Pyocyanin
Merlin B
AD169
PBS
Time (minutes)
PB
S
PM
A
Py
oc
ya
nin
Me
rlin
 B
AD
16
9
0
50000
100000
150000
200000
250000
Fl
uo
re
sc
en
ce
 in
te
ns
ity
 (
A
U
)
***
**
C
D
Merlin A Merlin B AD169
0 1 2 3 4
0
25
50
75
100
125
150
175
200
0
25
50
75
100
125
150
175
200
0
25
50
75
100
125
150
175
200
Control
PMA
UV-HCMV
PMA + UV-HCMV
Pyo
Pyo + UV-HCMV
Time (hours)
0 1 2 3 4
Time (hours)
0 1 2 3 4
Time (hours)
D
N
A
 s
ig
na
l
(%
 m
ax
im
um
 P
M
A
 r
es
po
ns
e)
D
N
A
 s
ig
na
l
(%
 m
ax
im
um
 P
M
A
 r
es
po
ns
e)
Co
ntr
ol
Me
rlin
 A
Me
rlin
 B
AD
16
9
PM
A
PM
A+
Me
rlin
 A
PM
A+
Me
rlin
 B
PM
A+
AD
16
9
Py
o
Py
o+
Me
rlin
 A
Py
o+
Me
rlin
 B
Py
o+
AD
16
9
0
50
100
150
200
*
*
**
R
O
S 
pr
od
uc
tio
n 
(u
ni
ts
)
ROS Generation
NETs formation
HCMV inoculum degrades NETs 
 
79 
7979 
This may be due to the strong cyan colouration of pyocyanin interfering with the 
luminescence signal.  An alternative technique, such as using MitoSox incubation followed 
by detection by flow cytometry, may be required to clarify its effects on ROS generation.  
Also unexpected was my observation that the AD169 strain of HCMV, which due to a long 
history of laboratory passages has genome deletions and mutations that nullify numerous 
genes including those in the UL/b’ gene region (UL133-UL151) which include UL146 
which encodes vCXC-1 (Cha et al., 1996; Prichard et al., 2001), also did not induce a ROS 
response in neutrophils.  Of note, AD169 also had no effect on the rate of apoptosis in 
neutrophils (see Figure 29 in Section 7.2.1), contrary to infection with Merlin. 
NET assays were conducted on neutrophils treated with and without PMA, pyocyanin, two 
preparations of Merlin strain HCMV (batches A and B), and the AD169 strain of HCMV.  
The extracellular DNA signal was background subtracted and normalised to the control 
PMA response at 4 hours (Figure 18C, D).  HCMV alone did not significantly increase the 
DNA signal at 4 hours, although neutrophils treated with PMA in combination with Merlin 
A or B had a significantly higher signal than with PMA treatments alone (p<0.05, p<0.01 
respectively), and Merlin B in combination with pyocyanin also induced a higher signal than 
with pyocyanin alone.  AD169 treatments did not augment the DNA signal.   
5.2.3 Merlin-strain HCMV inoculum degrades NETs 
To see if the Merlin strain of HCMV visually augments NETs production, neutrophils were 
treated with or without 20 nM PMA and/or Merlin at an MOI of 3 for 4 hours, and fixed and 
imaged using fluorescence microscopy (Figure 19).  Under control conditions the majority 
of neutrophils appeared viable, with a few cells appearing pyknotic, indicative of apoptosis, 
and a few cells displaying decondensed nucleic acid, potentially indicative of 
NETs.  Neutrophils treated with Merlin alone appear morphologically similar to control 
neutrophils, with few pyknotic cells, though some cells displaying decondensed nucleic 
acid.  Neutrophils treated with PMA alone show large, thready DNA structures that span 
beyond the field of view.  Surprisingly, fluorescence microscopy images of neutrophils 
treated simultaneously with PMA and Merlin appeared to lack any NETs structures, 
seemingly in contradiction to spectroscopy findings that suggested the presence of NETs.  
To explain this, I found that both live and UV-killed Merlin appeared able to degrade NETs 
as well as purified genomic DNA (Figure 20).   
Figure 19.  HCMV inoculum solubilises DNA released by neutrophils
(A) Neutrophils were cultured with Sytox Green in the presence or absence of 20 nM PMA or UV-killed Merlin 
strain HCMV (batch A; MOI 3), fixed at 4 hrs, mounted, and imaged by fluorescence microscopy.  Shown 
are representative immunofluorscence images.  Scale bars show 50 µm. (B) Neutrophils were cultured at 
1.0x106 cells/ml in 100 µl volumes with Sytox Green and with or without PMA (20 nM; n=4) or pyocyanin 
(Pyo;  10 µM; n=3) or HCMV Merlin A (MOI 3), Merlin B (MOI 0.1), or AD169 (MOI 0.1).  After 4 hours Sytox 
Green fluorescence was measured with a fluorescence microplate reader.  The top 90 µl of the supernatants 
were then delicately transfered to new wells and fluorescence of the supernatant was measured.  Data 
represent the mean ± SEM.  Statistical analysis by repeated measures ANOVA and post-hoc Dunnett's test for 
significance to compare the supernatant signal from infected treatments with their non-infected controls 
(**p<0.01).
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Figure 20.  Human cytomegalovirus strain Merlin degrades NETs and DNA
(A) Neutrophils were cultured with Sytox Green, with or without PMA (20 nM). DNase and HCMV (Merlin 
strain, batch A) were added to treatments at either 0 or 4 hours.  After 6 hours supernatants were delicately 
removed and added to EDTA (final concentration of 50 mM) to stop the reaction.  Supernatants were run on a 
2% DNA agarose gel (n=1).  The ladder did not run correctly on this gel;  Panel (C) shows the same ladder run 
correctly.  (B) Fluorescence microscopy images of neutrophils treated for 4 hours with Sytox Green, with or 
without PMA, and/or live or UV-inactivated HCMV.  (C) DNase I from bovine pancreas or HCMV were pre-in-
cubated at 37oC for 30 min with (+) or without (-)100 µg/ml actin from rabbit muscle (Sigma, contains both G- 
and F-actin) before addition of 2 µg calf thymus DNA. At 6 hrs reactions were stopped using EDTA (50 mM) and 
samples were run on a 1% DNA-agarose gel. 
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Also intriguing was that the DNA signal of PMA-treated neutrophils, as measured by 
fluorescence spectroscopy using Sytox Green, did not decrease in the presence of Merlin 
(Figure 18C).  I repeated these experiments and gently removed the supernatant at 4 hours 
to see if it contained solubilised DNA that remained fluorescent.  Concordant with the 
possibility that the Merlin inoculum solubilises NETs, neutrophils treated with a NETs 
stimulant (PMA or pyocyanin) and with Merlin had a significantly higher DNA signal in the 
supernatant fraction (Figure 19B;  p<0.01).  The AD169 strain of HCMV, which does not 
mount a ROS response or induce survival, did not degrade NETs, and most of the DNA 
signal remained in the cell-associated fraction.  
Loading supernatants from a 6-hour run of this experiment onto a DNA agarose gel showed 
the presence of nucleic acid only where neutrophils had been exposed to Merlin, whether or 
not in the presence of PMA (Figure 20).  Where HCMV was only added for the final 2 hours 
rather than all 6 hours of the experiment (lane 7), DNA from the supernatant did not migrate 
as far, suggesting that the band may be slightly heavier due to being less fragmented.  The 
finding that the supernatant of neutrophils treated with Merlin alone also produces a DNA 
band (lane 4) suggests that there is increased extracellular DNA in these samples, although 
this was below the detectable range of fluorescence microscopy or spectrophotometry.  
Because NETs are built of a DNA scaffold, which appears to be solubilised by Merlin 
HCMV, it follows that nuclease activity is likely present in the Merlin inoculum.  This was 
substantiated with the finding that the inoculum also degrades purified DNA (Figure 20C, 
lanes 15 and 17). 
5.2.4 NETs degradation by cytomegalovirus occurs in a time- and concentration-dependent 
manner 
When PMA-induced NETs are formed, nuclear decondensation precedes rupture of the 
plasma membrane and release of NETs (Yipp and Kubes, 2013).  To confirm that Merlin 
was degrading NETs rather than preventing the induction of NETs, neutrophils were induced 
to release NETs with PMA for 4 hours before addition of HCMV (Figure 21).  Using 
fluorescence microscopy for live cell imaging I found that Merlin A largely degraded NETs 
over 2 hours in what appears to be a concentration-dependent manner (Figure 21A).  If 
Merlin simultaneously induces, alters, or prevents NETs release, this effect will be masked 
by its degradative properties.   
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Figure 21.  Live cell imaging of 
HCMV-induced NETs degradation 
Neutrophils were cultured with Sytox Green in 
the presence or absence of 200 nM PMA for 4 
hrs before addition of Merlin strain HCMV at a 
multiplicity of infection of 1, 3, or 10.  (A) Cell 
cultures were intermittently removed from 
incubation for fluorescence imaging at 40x 
magnification.  Bright field and fluorescence 
channels were overlayed.  (B) Pre- and post-fixed 
images showing the morphological changes that 
occur to NETs when fixing and mounting for 
confocal fluorescent microscopy imaging.  Data 
respresent images typical of those produced in 
n=3 independent experiments, each performed 
in duplicate. 
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Live cell imaging showed globular NETs slowly diffusing from the cell, in contrast to the 
threads seen previously in fixed samples.  Comparing pre- and post- fixed samples, it appears 
that the preparation of neutrophils for microscopy alters the NETs structure from a globular 
to a thready morphology (Figure 21B), likely because the turbulence induced in fixation and 
the wash steps causes NETs to cohere. 
Electron micrographs showed that neutrophils treated for 4 hours with Merlin A had a ruffled 
surface morphology, indicative of priming and/or activation, compared to control cells 
(Figure 22).  PMA treatments displayed large sheets of what are likely NETs, which were 
largely absent when Merlin was also present.  Addition of Merlin for 2 hours after a 4-hour 
preincubation of PMA was sufficient to degrade sheets of NETs. 
Merlin A inoculum contains 1% fetal calf serum (FCS), and could potentially contain 
contaminants from the HFF-media from which the virus was purified.  Infected neutrophil 
cultures contain 1% viral inoculum by volume, therefore containing 0.1% FCS. FCS has 
been reported to contain heat-stable nuclease activity (von Köckritz-Blickwede et al., 2009), 
and cells including HFFs contain cellular nucleases that may be released into the media after 
viral lysis.  To see whether the nuclease activity of Merlin inoculum may be derived from 
FCS or HFF supernatants, neutrophils were stimulated to release NETs using PMA for 3 
hours before addition of FCS, HFF-conditioned media, or UV-treated inoculum (Figure 
23).  Only treatments containing Merlin substantially degraded NETs, and even using 100x 
the concentration of FCS only partially degraded NETs.  Further, Merlin B, which also 
degrades NETs, was resuspended into 100% IMDM instead of MEM-10 with FCS after 
purification (see Section 3.3.2). 
5.2.5 Cytomegalovirus nuclease physical properties and sensitivity to nuclease inhibitors 
Several broad categories of DNases exist, including DNase-I enzymes, caspase-activated 
DNases, and DNase-II.  In order to assess the properties of the Merlin nuclease and compare 
it with known ones, Merlin nuclease activity was tested across a range of pH, ions, and with 
known DNase inhibitors. 
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Figure 22.  Scanning electron micrographs of HCMV degradation of NETs
Neutrophils were seeded over poly-Lysine coated glass slides in 12 well plates and treated with or without PMA 
(200 nM) and HCMV (Merlin A; MOI 10).  At 4 hrs, cells were either fixed in glutaraldehyde and osmium tetrox-
ide or were treated with HCMV for an additional 2 hrs before fixing.  Cells were then dehydrated in ethanol and 
embedded in Spurr's resin for sectioning, and analysed on a CM 100 transmission electron microscope (Philips 
UK).  Scale bars show 5 µm.
Treatments added 
after 3 hrs
Control PMA
UV-Merlin MOI 3
0.1% FCS
1% HFF-conditioned media
UV-Merlin MOI 30
10% FCS
10% HFF-conditioned media
Figure 23.  HCMV inoculum nuclease activity does not come from foetal calf serum (FCS) or 
uninfected fibroblasts
Neutrophils with NETs extruded after 3 hrs of incubation with PMA (20 nM) were treated with UV-killed HCMV 
(Merlin A), and potentially contaminating components of viral inoculum: FCS and human foetal foreskin 
fibroblast (HFF)-conditioned media.  The UV-Merlin treatments contains FCS (0.1% at MOI 3, 1.0% at MOI 30). 
Live images by fluorescence microscopy were taken at 5 hours.  Results are from a single experiment.
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Purified calf thymus DNA was incubated with either UV-Merlin or commercial preparations 
of pancreatic bovine DNase-I or DNase-II in buffered solutions from pH 6.5 to 8.5 for 30 
minutes before separation on a DNA agarose gel (Figure 24).  The activity range of UV-
Merlin more closely reflected that of DNase-I, functioning over a broad range of pHs and 
peaking at a roughly physiological level.  DNase-II is found in highest concentrations in the 
lysosome (Dulaney and Touster, 1972; Liao et al., 1989), and has optimal activity at an 
acidic pH (Baker et al., 1998; Baranovskii et al., 2004). 
  
DNase-I enzymes such as DNase-gamma or DNase X are sensitive to G-actin inactivation 
and require the divalent cations Mg2+ and Ca2+ (Shiokawa and Tanuma, 2001).   Commercial 
DNase-I and UV-Merlin were pre-treated with 100 µg/ml G-actin before co-culture with 
PMNs stimulated with 20 nM PMA (Figure 25).  While commercial DNase-I degradation 
of NETs was strikingly abrogated with G-actin pre-incubation, the Merlin nuclease activity 
appears to be only slightly inhibited.  This is also reflected in the supernatant signal 
indicating solubilised NETs, with G-actin pre-incubation of DNase-I, but not UV-Merlin, 
significantly decreasing the supernatant signal (Figure 25B).  These findings indicate the 
Merlin nuclease has a profile resembling DNase-I enzymes, but has a lower affinity to G-
actin or is less susceptible its inhibitory properties. 
  
Finally, nucleases were incubated with or without the divalent cation chelator EDTA and 
the protein-nucleic acid interaction inhibitor aurintricarboxylic acid (ATA), or at low, 
physiological, and high NaCl concentrations (Figure 26).  Merlin nuclease was dependent 
on the presence of divalent cations, as was the case for DNase-I, though not DNase-II, 
consistent with previous reports (Melgar and Goldthwait, 1968).  In bovine pancreatic 
DNase-I, Ca2+ stabilises the DNase structure while Mg2+ coordinates histidine residues that 
hydrolyse nucleic acid (Guéroult et al., 2010).  Merlin nuclease also had increasing activity 
with increasing NaCl concentrations, though was strongly inhibited by high NaCl.  DNase-
I had a maximum activity at physiological NaCl and DNase-II was strongly inhibited by all 
except low NaCl concentrations.  DNase II sensitivity to monovalent ions such as sodium 
have been documented (Liu et al., 2008).  Finally, Merlin nuclease activity, like DNase-II, 
was sensitive to high concentrations of ATA.  ATA competes with nucleic acid for DNA-
binding sites in protein, such as the active histidyl residues of bovine pancreatic RNase 
(González et al., 1980).  
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Figure 24.  The effect of pH on HCMV-associated nuclease activity
Calf thymus DNA was incubated with either UV-treated Merlin (batch C; MOI 3 equivalent) or pancreatic bovine 
DNase I (500 ng/ml) or II (100 µg/ml) in a buffered solution at pHs from 6.5 to 8.5 for 30 minutes before separa-
tion on a DNA agarose gel.  Bottom right panel shows densitometry of fragmented DNA bands. Data 
represent the mean ± SEM of n=3 independent experiments.
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Figure 25.  Actin inhibits commercial DNase but not HCMV-associated nuclease
(A) Neutrophils were cultured with Sytox Green in the presence or absence of 20 nM PMA and UV-killed 
Merlin strain HCMV (MOI 3 equivalent) or 500 ng/ml DNase with or without a 30-minute pre-incubation with 
100 µg/ml G-actin, fixed at 4 hrs, mounted, and imaged by fluorescence microscopy. Shown are 
representative immunofluorscence images. (B) From the same experiments, the top 90 µl of the supernatants 
were delicately transferred to new wells and fluorescence of the supernatant was measured. Data represent 
the mean ± SEM of n=3 independent experiments conducted in duplicate. Statistical analysis by ANOVA 
followed by Tukey's (*p<0.05).
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Figure 26.  The effect of NaCl and aurintricarboxylic acid (ATA) on HCMV-associated nuclease 
activity
Calf thymus DNA made in TRIS media (pH 7.75) was incubated with either UV-treated Merlin (batch B; MOI 3 
equivalent), pancreatic bovine DNase I (500 ng/ml), or II (100 µg/ml) with or without 30 minute pre-
incubations in EDTA, NaCl, or ATA for 30 minutes before separation on a DNA agarose gel.  Right panels 
shows densitometry of fragmented DNA bands. Data represent the mean ± SEM of n=3 independent 
experiments.
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Altogether, Merlin nuclease acts as a DNase-I enzyme across a range of pH and ion 
concentrations, but contrary to DNase-I is resistant to inhibition by G-actin but more 
susceptible to inhibition by ATA. 
5.3 Discussion 
5.3.1 HCMV inoculum degrades neutrophil extracellular traps 
While a number of bacteria and parasites have been found to use nucleases to evade the 
immune actions of NETs, this is the first time that a virus has been found to degrade NETs.  
To date the only other NET-evasion strategy discovered in a virus has been in HIV-1, which 
induced dendritic cell secretion of IL-10, which inhibits the formation of ROS and NETs 
(Saitoh et al., 2012).  Interestingly, HCMV encodes a viral IL-10 homologue (Penfold et al., 
1999), which may also inhibit NET formation.   
Active infection with HCMV leads to an increased risk of secondary bacterial infections 
(Rupprecht et al., 2001), and it was previously hypothesised that this may be due to the 
dampening of neutrophil effector functions by HCMV (Skarman et al., 2006).  Contrary to 
expectation, it was found that HCMV primes neutrophil effector functions and increases 
phagocytosis.  However, here we have found that HCMV dissolves NETs, which are critical 
to preventing the infection and dissemination of a broad variety of pathogens.  Yipp et al. 
(2012) have previously found that injection of exogenous DNase after Staphylococcus 
aureus infection in mice dramatically increased bacteraemia. If HCMV recapitulates the 
effect of the DNase in this model it would be highly suggestive as a mechanism causing 
increased susceptibility to bacterial infection during HCMV pathogenesis. 
Future work is likely to involve translation of the advances in our understanding of pathogen 
evasion of NETs into pharmacological therapies. Development of a rapid technique to 
establish whether a pathogen like HCMV is NETs-resistant, or a therapy counteracting 
common mechanisms of NETs evasion by pathogens could complement antimicrobial 
approaches. Therapies aimed at neutralising pathogen-encoded nucleases are potentially an 
attractive target. G-actin, a natural pharmacologic inhibitor of type I DNases, has been 
shown to prevent Sda1-mediated degradation of NETs (Buchanan et al., 2006). Other 
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therapeutic opportunities involve protecting NETs from degradation — high concentrations 
of LL-37 increase DNA resistance to pathogen DNases (Neumann et al., 2014), and NETs 
are protected from degradation in SLE due to the deposition of autoantibodies, which are 
thought to shield them from serum DNase1 (Hakkim et al., 2010).  Finally, the above 
experiments build a framework that may be used for assessing the many other pathogens 
that contain nucleases. Investigation of their effects on NETs may reveal the evolutionary 
significance of such genes in evasion of the host innate immune response. 
 
5.3.2 HCMV inoculum nuclease properties 
The nuclease is likely encoded by either the viral or host genome.  It is unlikely the nuclease 
is passively taken up from infected cells by virus particles during purification as AD196 and 
Merlin undergo the same purification protocol, however it is possible that a factor in Merlin 
but not AD169 is capable of taking up a host DNase.  No host DNases were found among 
the over 70 proteins identified after mass spectrometry analysis of highly purified AD169 
(Varnum et al., 2004). 
  
DNase-I has previously been shown to be resistant to ATA inhibition up to 100 µM  
(Shiokawa and Tanuma, 2001), as was the DNase-I family enzyme DNase-X.  However, the 
DNase-ɣ and DNAS1L2 members of the DNase-I family were more sensitive at low 
concentrations.  Here, we found that the commercial DNase-I was resistant up to 150 µM 
ATA, and that DNase II and Merlin nuclease are sensitive to these ATA concentrations.  
ATA interferes with several biological activities such as protein synthesis, and is a potent 
anti-influenza agent through its inhibition of the hydrolase enzyme neuraminidase (Hashem 
et al., 2009).  This study suggests the possibility that ATA may also reduce virulence 
stemming from NETs degradation. 
  
While the Merlin nuclease shares several properties with well characterised nucleases, 
especially DNAS1L2 (Shiokawa and Tanuma, 2001), it does not match the signature of any 
one known enzyme.  Interestingly, the Merlin nuclease is resistant to UV.  By isolating the 
nuclease from live virus, it would be possible to explore further whether the nuclease is UV 
resistant, or whether resistance is conferred from protection by the virus particle. 
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The nuclease activity of Merlin does not appear to require any activation by a host cell, as 
the virus also degrades purified DNA in the absence of cells (Figure 20), suggesting that the 
nuclease is likely exposed, perhaps on the surface or integrated into the tegument of the 
virus.  Tables 2 to 4 show regions of the genome that are altered in AD169 (a highly passaged 
strain which, in contrast to Merlin, does not induce neutrophil ROS, survival, nor does it 
degrade NETs) in comparison to low-passaged clinical isolates such as Merlin.  Genes listed 
in Table 2 encode membrane proteins, genes in Table 3 encode tegument proteins, and genes 
encoding proteins from other or unknown regions are in Table 4. 
 
Table 2.  Genes encoding membrane proteins that are mutated in the AD169 variant of human 
cytomegalovirus.  Adapted from Mocarski (2007). 
 
 
Table 3.  Genes encoding tegument proteins that are mutated in the AD169 variant of human 
cytomegalovirus.  Adapted from Mocarski (2007). 
Affected gene Mutation (Bradley et al., 2009) Gene family or function (Mocarski, 2007) 
UL23 Non-coding or synonymous 
substitution 
US22 family; tegument protein; temperance for 
fibroblasts 
UL24 Non-coding or synonymous 
substitution 
US22 family; tegument protein; necessary in 
HMVECs 
UL32 E->G Major tegument phosphoprotein (pp150); highly 
immunogenic; binds to capsids 
UL36 Inactivated by substitution US22 family; IE protein; tegument protein; 
inhibitor of caspase-8-induced apoptosis 
UL82 R->D;  D->A UL82 family; tegument phosphoprotein (pp71; 
upper matrix protein); virion transactivator; 
ND10 localised; degrades Rb 
UL93 A->D Tegument protein; capsid transport? 
UL99 Non-coding or synonymous 
substitution 
Myristylated tegument phosphoprotein pp28; 
cytoplasmic egress tegument protein 
IRS1 Non-coding or synonymous 
substitution 
US22 family; IE transcriptional activator; 
tegument protein; blocks shut-off of host protein 
synthesis; virion protein 
US2 Deletion in some variants US2 family; membrane glycoprotein 
  
 
Affected gene Mutation (Bradley et al., 2009) Gene family or function (Mocarski, 2007) 
RL 13 Frameshift mutation RL11 family; putative membrane glycoprotein 
UL140 Deletion Putative membrane protein 
UL141 Deletion UL14 family; membrane glycoprotein; inhibits 
NK cell toxicity by downregulating CD155 
UL142 Deletion UL18 family; putative membrane glycoprotein; 
MHC-I homologue 
UL144 Deletion Membrane glycoprotein; TNF receptor 
homologue; Regulates lymphocytes 
UL74 Non-coding or synonymous 
substitution 
Virion glycoprotein O (gO); complexes with gH 
and gL 
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Table 4.  Genes encoding non-envelope/non-tegument/unknown proteins that are mutated in the AD169 
variant of human cytomegalovirus.  Adapted from Mocarski (2007). 
̂ffected gene Mutation (Bradley et al., 2009) Gene family or function (Mocarski, 2007) 
RL51 Frameshift RL11 family 
US1 Deletion US1 family 
UL44 A->S DNA polymerase processivity subunit (PPS) 
UL70 H->Y Component of DNA helicase-primase; primase 
homology (HP2) 
UL78 S->F GPCR family; putative chemokine receptor 
UL89 A->S Terminase ATPase subunit; inhibition by 
antiviral compounds (TER1) 
UL105 Non-coding or synonymous 
substitution 
Component of DNA helicase-primase; helicase 
homology (HP1) 
UL111A K->R Viral interleukin 10 (vIL-10) 
UL131A Frameshift Putative secreted protein 
 
In 1988 Ripalti and Landini detected HCMV-associated DNase activity in four polypeptides, 
two of a cellular origin weighing 46 kDa and 49 kDa, and two of an unknown origin 
weighing 52 kDa and 54 kDa.  Using purified IgG from the sera of individuals with active 
HCMV infection, they were able to neutralise the viral-associated DNase activity.  HCMV 
UL98 was later found to encode an alkaline nuclease that exhibits endo- and exo-nuclease 
activity against single- and double-stranded DNA (Sheaffer et al., 1997).  It has been 
successfully transfected into E. coli and it was found that the DNase is not sequence-specific 
and after cleavage forms mono-, di-, and tri-nucleotides.  A mutant lacking UL98 reduced 
replication by 1000-fold, but was viable (Kuchta et al., 2012).  However, the nuclease 
examined here was not an alkaline nuclease and showed activity across a broad pH range.  
Proteins of UL56 (pUL56) and UL89 (pUL89), terminase subunits that are involved in DNA 
packaging, were also found to have nuclease activity, which was enhanced by their 
interaction (Scheffczik et al., 2002).  pUL56 is able to bind DNA, and pUL89 exhibits in 
vivo nuclease activity and can metabolise toroidal DNA.  AD169 has a mutation resulting in 
an A to S modification in UL89 (Bradley et al., 2009).  Whether this affects its function and 
whether this gene encodes the protein that degrades NETs in this study is not yet known.  
The function of these proteins is described as being important in packaging viral DNA from 
the large concatemers that result during herpesvirus DNA replication (Scheffczik et al., 
2002). 
A future research priority should be to identify the HCMV nuclease agent and its associated 
gene.  The nuclease enzyme appears to be physically associated with the Merlin particle, as 
other components of the virus inoculum have very low nuclease activity (Figure 23).  
AD169, which is purified in the same way as Merlin, should also contain the same 
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potentially contaminating host components.  However, because AD169 does not degrade 
NETs, it provides further support to findings that the nuclease activity comes from the 
Merlin particle.  Of interest, these mechanisms occur in a cell that does not appear to be 
productively infected by the virus.  However, the finding here that the NETs-degrading 
nuclease activity does not share properties consistent with known HCMV nucleases reported 
to be present in Merlin but not AD169 gives reason for pause, and calls for a re-examination 
of potential exogenous or contaminating factors. 
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6 Mycoplasma contamination and nuclease activity 
6.1 Introduction 
While a number of studies have characterised the ability of bacterial pathogens such as 
Staphylococcus aureus to degrade NETs (e.g. Thammavongsa et al., 2013), the findings 
above suggest that HCMV may be the first virus capable of disintegrating this potent 
antipathogenic mechanism.  To ascribe this function to HCMV, we must first parse its effects 
from other components potentially present in the virus inoculum.  For example, the presence 
of nucleases on the surface of Mycoplasma spp., the most notorious contaminant of cultures 
(Drexler and Uphoff, 2002), has been well documented (Minion et al., 1993), and although 
their functions are not clearly understood, these nucleases may be capable of degrading the 
DNA backbone of NETs. 
Despite assurances that the original HCMV stocks used in Chapters 4 and 5 were 
mycoplasma free (Dr Matthew Reeves, personal communication), the findings in Chapter 5 
in particular led me to re-examine the possibility of mycoplasma contamination.  
Mycoplasmas are exceptional bacteria, characterised by their lack of a cell wall.  Ranging 
from 0.3-0.8 µm, they are considered to be the smallest self-replicating organisms known 
(Drexler and Uphoff, 2002).  This small size and flexibility allow them to pass through fine 
filters used to separate contaminants.  Mycoplasma species, at least 14 of which use humans 
as a primary host, also have a role in human pathology.  Most prominent is M. pneumoniae, 
which can cause severe respiratory infections that can require hospitalisation (Waites and 
Talkington, 2004).  M. pneumoniae is among the most severe respiratory disease-causing 
agents, responsible for up to 40% of community-acquired pneumonia cases in children 
(Huong et al., 2014), with evidence of involvement in asthma (Waites, 2003). 
6.1.1 Chapter 6 aims 
1) Is mycoplasma present in HCMV inoculum? 
The potential presence of Mycoplasma spp. was tested using an ATPase-based kit with 
detection of mycoplasma-generated substrates by luminometry. 
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2) Are there differential effects between mycoplasma-positive and mycoplasma-
negative HCMV on the degradation of NETs? 
The effect of different HCMV batches on NETs was studied using spectrophotometry and 
fluorescence microscopy. The experiments in this chapter are conducted with assistance of 
an undergraduate student Ms Angalee Nadesalingam and Dr Joanna Pocock, and their inputs 
duly acknowledged in the appropriate datasets. 
6.2 Results 
6.2.1 ATPase activity test for Mycoplasma 
Vials from HCMV batches used in this study were randomly selected and tested for 
mycoplasma using the MycoAlert Mycoplasma Detection Kit (Lonza).  Mycoplasmal 
ATPases convert ADP to ATP, which through a light signal via luciferase, is detected by a 
luminometer.  Mycoplasmal enzyme activity was detected by day 6 in all Merlin strains and 
the positive control (Figure 27A).  The AD169 strain of HCMV and the negative control did 
not have detectable levels of mycoplasmal enzymes.  The assay is able to detect as little as 
10 CFU/ml of mycoplasmas such as M. orale, M. hyorhinis, and Acholeplasma laidlawii.  
Samples from mycoplasma-positive HCMV grown on ureaplasma plates for 2-3 weeks by 
Dr Joanna Pocock show mycoplasmas with their distinctive ‘fried egg’-shaped colonies 
(Figure 27B).  This suggests that the differential findings between Merlin and AD169 strains 
above may be confounded by the presence of mycoplasma. 
6.2.2 Merlin-strain HCMV inoculum degrades NETs only when mycoplasma is present 
Given the above findings, which were obtained at a relatively late stage of my experimental 
work, NET assays were repeated on neutrophils treated with and without PMA, using two 
batches of Merlin strain HCMV: Merlin C, and a newly prepared batch that tested negative 
for mycoplasma, referred to as Merlin D.  The extracellular DNA signal was background 
subtracted and normalised to the signal obtained from 10% Triton-treated cells.  Triton is a 
surfactant that dissolves lipid membranes, releasing all DNA and thereby acts as a 100% 
control for DNA release.   
HCMV batch 
Merlin seed stock Fail 
Merlin A Fail 
Merlin B Fail 
Merlin C Fail 
AD169 Pass 
Positive control Fail 
Negative control Pass 
X125X60
Figure 27.  Merlin HCMV batches used it this study contain mycoplasma
(A) Non-UVed vials from HCMV batches used in this study were randomly selected and tested in duplicate 
for mycoplasma using the MycoAlert™ Mycoplasma Detection Kit (Lonza).  Batches labelled 'Fail' were 
positive for mycoplasmal enzyme activity whereas batches labelled 'Pass' are considered to be mycoplasma-
negative.  (B) Shown are representative photomicrographs at 60- and 125-times magnification, prepared by Dr 
Joanna Pocock, of mycoplasma-positive HCMV inoculum cultured on ureaplasma plates after 2-3 weeks 
incubation, displaying the 'fried egg'-shaped colonies typical of mycoplasma.
A B
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To see if the Merlin strain D of HCMV visually augments NETs production as Merlin C did, 
neutrophils were treated with or without 20 nM PMA and/or Merlin at an MOI of 3 for 9 
hours, and fixed and imaged using fluorescence microscopy (Figure 28A).  Under control 
conditions the majority of neutrophils appeared viable.  Neutrophils treated with Merlin C 
or D alone appear morphologically similar to control neutrophils.  Neutrophils treated with 
PMA alone show large, thready DNA structures indicative of NETs, while images of 
neutrophils treated simultaneously with PMA and Merlin C lack NETs structures, consistent 
with their degradation and solubilisation. In contrast to PMA findings from all Merlin 
batches that were mycoplasma-positive, the mycoplasma-negative Merlin D treatment 
appeared morphologically similar to the PMA treatment, with NETs intact. 
Merlin C or D alone did not significantly increase the DNA signal at any time point, although 
in neutrophils treated with PMA, Merlin C added at 0 or 4 hours consistently increased the 
DNA signal above any other PMA treatments (Figure 28B).  This is consistent with the 
previous curve signatures of Merlin A and B, both mycoplasma-positive.  The Merlin D 
curves are consistent with that previously seen with the mycoplasma-negative AD169. 
At 9 hours, the supernatant was gently removed to see if it contained solubilised DNA.  
Concordant with the possibility that the mycoplasma-positive viral inocula solubilise NETs, 
neutrophils treated with PMA and Merlin C had a significantly higher DNA signal in the 
supernatant fraction (Figure 28C; p<0.01).  The Merlin D strain of HCMV, which is 
mycoplasma-negative, did not degrade NETs, and most of the DNA signal remained in the 
cell-associated fraction.  
6.3 Discussion 
Evidence showing that the mycoplasma-negative AD169 and Merlin D batches of HCMV 
did not degrade NETs while the mycoplasma-positive Merlin A, B, and C do, suggests that 
the factor determining NETs degradation is the presence or absence of mycoplasma. 
Little is known about the function of Mycoplasma spp. nucleases (Paddenberg et al., 1998). 
One suggestion is that mycoplasmal nucleases are used to break down RNA and DNA in 
order to fulfil their nutritional requirement of nucleic acids (Minion et al., 1993).   
Merlin C (t=0)Control
Co
nt
ro
l
PM
A
Merlin C (t=4) Merlin D (t=0) Merlin D (t=4)
Figure 28.  Mycoplasma-positive HCMV, but not mycoplasma-negative HCMV, solubilises NETs 
(A) Neutrophils were cultured with Sytox Green in the presence or absence of 20 nM PMA or UV-killed Merlin 
strain HCMV (mycoplasma-positive batch C or mycoplasma-negative batch D; MOI 3) added at 0 or 4 hours. 
Samples were fixed at 9 hrs, mounted, and imaged by fluorescence microscopy. Shown are representative 
immunofluorscence images. (B) Kinetic analysis of NET formation from 0 to 4 hrs. Sytox Green fluoresence, 
indicative of externalised DNA, was measured using a fluorescence microplate reader. (C) After 9 hours, the 
top 90 µl of the supernatants were delicately transfered to new wells and fluorescence of the supernatant 
was measured. Data represent the mean ± SEM of n=3 independent experiments. Statistical analysis by 
repeated measures ANOVA and post-hoc Dunnett's test for significance to compare the supernatant signal 
from infected treatments with the PMA control  (***p<0.001).
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Nucleases from mycoplasmas such as M. fermentans may be clastogenic, inducing 
chromosomal breakages that have lead researchers to speculate whether mycoplasmas can 
cause cancer (Stewart et al., 1994).  In M. penetrans, a nuclease is associated with virulence, 
causing chromosomal damage (Bendjennat et al., 1997).  Some studies have also found that 
the nucleases are able to induce apoptosis (Paddenberg and Wulf, 1996; Paddenberg et al., 
1998), however it has later been suggested that the experimental methods in these studies 
may have induced apoptosis, with mycoplasma nucleases subsequently cleaving host DNA 
(Razin et al., 1998).  At concentrations present in this study, mycoplasma-positive HCMV 
appeared only to be anti-apoptotic (Figure 7). 
Nucleases have been documented to remain on the mycoplasma membrane or to be secreted 
(Minion et al., 1993), which would accord with findings in this study that show DNA 
degradation occurred readily, without the need for host cells to process or activate the 
nuclease (Figures 24 and 26). Nucleases partially purified from M. hyorhinis, one of the 
most prominent contaminating mycoplasmas (Drexler and Uphoff, 2002), was able to be 
inhibited by G-actin (Paddenberg et al., 1998), contrary to the findings in this study (Figure 
25).  However, Paddenberg et al. (1998) found M. hyorhinis nucleases had optimal activity 
at a weakly-basic pH (7.8-8.0) and was inhibited by EDTA.  Likewise, the activity of the 
mycoplasma-positive HCMV nuclease in this study peaked at a weakly-basic pH and was 
inhibited by EDTA (Figures 24 and 26). 
While the presence of nucleases on mycoplasmas has been well documented, including 
many surface nucleases (Minion et al., 1993), only recently has the potential of this 
taxonomic class, separate from all other bacteria, to degrade NETs, been examined 
(Yamamoto et al., 2017). 
Finally, this research underlines the dangers of mycoplasma contamination.  Its prevalence 
in many cell lines put the results of studies that demonstrate NETs degradation, and those 
more broadly, at risk.  Key results in Chapters 4 and 5 will need to be reviewed to distinguish 
the effects of HCMV versus that of Mycoplasma spp. (Reassuringly, subsequent work 
undertaken in collaboration with Dr Joanna Pocock in the Chilvers/Cowburn group and 
presented in Chapter 7 has been able to replicate my earlier findings in Chapter 4 regarding 
the effects of HCMV on neutrophil survival using freshly prepared, mycoplasma-free Merlin 
HCMV.)  
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7 Pathogens HCMV and mycoplasma exploit neutrophil immune 
mechanisms 
7.1 Introduction 
In Chapters 4 and 5 I report that neutrophils exposed to Merlin strain HCMV delay apoptosis 
in the absence of viral gene expression.  HCMV induced neutrophil secretion of a pro-
survival secretome that affected autologous donor monocytes, acting as a chemoattractant 
and increasing their permissivity to infection.  However, a major caveat to these findings 
follow that neutrophils were simultaneously exposed to Mycoplasma spp., and the effects of 
HCMV versus mycoplasma will need to be parsed before drawing final conclusions as to 
what microbe influenced these neutrophil functions.  For example, Chapter 6 demonstrates 
that the ability of Merlin HCMV inoculum to degrade NETs is most likely attributable to a 
contaminating mycoplasma. 
 
Previous research suggests that many of the clinical manifestations of mycoplasma 
pathology are attributed to induction of host inflammatory responses (Shimizu et al., 2014).  
While mycoplasma pathogens such as M. pneumoniae do not create endotoxins, they are 
known to activate immune cells such as macrophages and mediate the release of 
proinflammatory cytokines including TNF-α, IL-1, IL-6, and IL-8 (Razin et al., 1998).  
Mycoplasma-positive HCMV induced neutrophil release of IL-8 and IL-6 (though not TNF-
α in this study; Figure 11).  Therefore, the agents that specifically caused findings including 
neutrophil delayed apoptosis and cytokine secretion will need to be examined further as we 
cannot specifically attribute results to HCMV, mycoplasma, or the combinatory effect of the 
two together. 
 
Further, spectrophotometry, fluorescence and electron microscopy, and gel electrophoresis 
data initially suggested a novel viral strategy found in HCMV:  nuclease-mediated NETs 
degradation.  This was not present in AD169, a highly passaged HCMV strain that contains 
substantial gaps in its genome.  However, subsequent findings that the Merlin batches that 
degraded NETs were mycoplasma-positive, whereas the AD169 and Merlin D batches that 
were mycoplasma-negative did not degrade NETs, suggests that mycoplasma is the major 
or exclusive cause of NETs degradation. 
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7.1.1 Chapter 7 aims 
1) Does mycoplasma-free HCMV (Merlin D batch) contribute to delayed neutrophil 
apoptosis and the production of a pro-survival secretome?  
This was studied (in collaboration with Dr Joanna Pocock) using neutrophils isolated from 
human peripheral blood cultured in vitro in the presence or absence of Merlin strain 
HCMV batch D, which passed tests for mycoplasma contamination.  Morphology, 
Annexin V/PI staining, and caspase-3/7 activity was used to determine levels of apoptosis.  
Supernatants of mock- and Merlin D-treated neutrophils were collected and used to culture 
fresh neutrophils.  The effect of these secretomes on survival and autophagy were assessed 
as well as its composition of inflammatory cytokines. 
2) How does M. pneumoniae affect the generation and degradation of extracellular trap 
release? 
The effect of UV-killed M. pneumoniae on NETs was studied using spectrophotometry, 
fluorescence microscopy, and agarose gel electrophoresis from neutrophils isolated from 
human peripheral blood cultured in vitro in the presence or absence of M. pneumoniae and 
PMA. Experiments were designed and supported by Daniel Storisteanu and carried out by 
Angalee Nadesalingam. 
7.2 Results 
7.2.1 HCMV directly induces neutrophil survival and a pro-survival secretome 
Experiments using Merlin D were carried out in collaboration with Dr Joanna Pocock with 
the same experimental design used in Chapter 4 with the previous batches of mycoplasma-
contaminated Merlin. Light microscopy analysis of neutrophil morphology, flow cytometric 
analysis of neutrophils incubated with FITC-tagged Annexin V, and colorimetric assay for 
caspase 3-activity all show that mycoplasma-free Merlin D significantly attenuated 
neutrophil apoptosis (Figure 29A, B, C).  This survival effect could not be reversed by 
inhibition of TLR2 (Figure 29D), and was largely driven through ERK1/2 (Figure 29E). 
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Figure 29.  HCMV inhibits neutrophil apoptosis in an ERK1/2-dependent manner
(A) Neutrophils infected with Merlin at an MOI of 3, 1 or 0.3 were assayed for apoptosis by morphology 
(n=5-6), and by (B) flow cytometry (n=3-5) at 20 hours, and (C) by colorimetric assay for Caspase-3-activity 
performed at 0, 6 and 18 hours (n=3). Neutrophils were pre-incubated with inhibitors of (D) TLR2 (n=3) or 
(E) PI3-K, ERK1/2 and NF-κB inhibitors before Merlin D infection. Apoptosis was assessed by morphology at 
20 hours (MOI 3, n=3). Experiments in each panel were confirmed with at least a single experimental run by 
Dr Joanna Pocock.
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In order to see whether this survival effect might be propagated through continued neutrophil 
signalling, the supernatants of HCMV-treated and mock-infected neutrophils were added to 
fresh neutrophils.  The infected neutrophil secretome significantly delayed apoptosis in fresh 
neutrophils (Figure 30A, B), but not when using mock- or AD169-treated neutrophil 
secretomes.  Infection with (mycoplasma-free) Merlin D or AD169 significantly altered the 
concentration of major inflammatory cytokines in the neutrophil secretome, significantly 
increasing levels of IL-8, IL-6, TNF-α, MIP-1α, and IL-13, with the IL-10 increase only 
apparent with Merlin D-treated neutrophil secretome (Figure 30E). 
7.2.2 Mycoplasma pneumoniae degrades NETs 
To see if mycoplasma can also counter a key neutrophil effector function, neutrophils were 
treated with or without 20 nM PMA and/or UV-killed M. pneumoniae at an MOI of 0.01, 
0.03, 0.1, 0.3, 1, or 3 for 9 hours, and fixed and imaged using fluorescence microscopy 
(Figure 31A).  Under control conditions the majority of neutrophils appeared viable, with a 
few cells appearing to have pyknotic nuclei, indicative of apoptosis.  Neutrophils treated 
with M. pneumoniae alone appear morphologically similar to control neutrophils though had 
a stronger MPO signal, potentially indicating enhanced degranulation.  Because any NETs 
formed would be degraded and not appear by microscopy, supernatants from these 
experiments were run by electrophoresis on agarose gels and indicate that there was 
increasingly fragmented DNA present in treatments of higher M. pneumoniae MOIs (Figure 
31B). It may be that M. pneumoniae at an MOI of 3 induces low levels of NETs in 
neutrophils.  
In order to examine whether the NETs-degrading ability of mycoplasma-contaminated 
Merlin may be attributable to mycoplasma, NETs were induced with PMA and then 
incubated with UV-killed M. pneumoniae at 4 hours. Hourly DNA signals show a similar 
signature to that caused by the contaminated HCMV in Figure 18: all treatments with PMA 
steadily increase, with the addition of M. pneumoniae to PMA leading to a further increased 
signal above PMA-only treatments (Figure 32A). After 2 more hours, the DNA signal of 
high-concentration M. pneumoniae treatments decreased below that of PMA-only, perhaps 
because extensive DNA fragmentation released the intercalating DNA dye Sytox, causing it 
to stop fluorescing.  
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Figure 30.  Neutrophils exposed to HCMV produce a pro-survival secretome
Freshly isolated neutrophils were cultured with control media or supernatants from mock or Merlin D-
infected neutrophils (Merlin SN) collected at 20 hours, and apoptosis determined by (A) morphology and (B) 
flow cytometry at 20 hours (MOI 3, n=3). (C) Supernatant from mock or Merlin D-infected monocytes was 
added to freshly isolated neutrophils and apoptosis determined by morphology at 18 hours (MOI 3, n=3). (D) 
Supernatant from mock or AD169-infected neutrophils was added to freshly isolated neutrophils and apoptosis 
determined by morphology at 18 hours (MOI 3, n=3). (E) Results from MesoScale assay of mock and HCMV-
infected (strain Merlin and AD169) neutrophil supernatants identified significant upregulation of IL-8, IL-6, TNF-
α, MIP-1α, IL-13 and IL-10.  Experiments in each panel were confirmed with at least a single experimental run 
by Dr Joanna Pocock.
Figure 31. The effect of Mycoplasma pneumoniae on neutrophils
(A) Neutrophils were cultured with or without 100 nM PMA in the presence or absence of UV-killed M. pneumo-
niae (MOI 1), fixed at 5 hours, mounted, and stained for the nucleus (DAPI, blue), and myeloperoxidase (goat IgG 
antibody and Alexa Fluor 488, red) and imaged by fluorescence microscopy.  Scale bars show 50 µm.  (B) UV-killed 
M. pneumoniae (MOIs 0.01, 0.03, 0.1, 0.3, 1, 3) were added to neutrophils at either 0 or 4 hours.   After 9 hours 
samples were run on a 0.8% DNA agarose gel.  Data represent n=3 independent experiments performed in 
dupli-cate.  Experiments designed by myself and run by summer undergraduate student Angalee Nadesalingnam.
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Figure 32.  Mycoplasma pneumoniae solubilises neutrophil extracellular traps
(A) Representative kinetic analysis of NET formation from 0 to 9 hrs. Neutrophils were cultured with Sytox 
Green in the presence or absence of 100 nM PMA and/or UV-killed M. pneumoniae (MP) at MOIs of 0.01, 0.03, 
0.1, 0.3, 1, or 3.  Sytox Green fluorescence, indicative of externalised DNA, was measured using a fluorescence 
microplate reader.  (B) From the same experiments, the top 90 µl of the supernatants were delicately 
transferred-to new wells and fluorescence of the supernatant was measured. Data represent the mean ± SD of 
n=2 indepen-dent experiments conducted in triplicate.  Statistical analysis by repeated measures ANOVA 
and post-hoc Dunnett's test for significance to compare the supernatant signal from MP treatments with 
the PMA control (*p<0.05).  Experiments designed by myself and run by summer undergraduate student 
Angalee Nadesalingnam.
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Supernatants, from experiments where M. pneumoniae was added either at the same time as 
PMA (t=0) or after a 4-hour pre-incubation of PMA (t=4), were removed at 9 hours to see 
whether it contained solubilised DNA that remained fluorescent (Figure 32B).  Concordant 
with the possibility that M. pneumoniae solubilises NETs, neutrophils treated with PMA and 
the mycoplasma had a significantly higher DNA signal in the supernatant fraction.   
7.3 Discussion 
7.3.1 HCMV-exposed neutrophils delay apoptosis and induce a pro-survival secretome 
As was the case with mycoplasma-contaminated Merlin, Merlin D induced a substantial 
neutrophil survival effect (Figure 29A, B, C). However, the overall neutrophil survival rate 
appeared higher with contaminated HCMV (Figure 7), suggesting that survival was likely 
augmented by mycoplasma.  Whereas the survival effect from contaminated HCMV could 
be partially reversed by inhibition of TLR2 (Figure 8C), this was no longer found to be the 
case with Merlin D (Figure 29D). Furthermore, the contaminated HCMV survival effect was 
partially dependent on ERK1/2 activation and largely dependent on NF-κB (Figure 8D), 
whereas Merlin D survival was largely driven by ERK1/2 (Figure 29E). This was consistent 
with the finding of rapid ERK phosphorylation when neutrophils were exposed to Merlin D 
(Dr Joanna Pocock, personal communication). 
Consistent with findings in Figure 12, a positive feedback loop operates where HCMV-
treated neutrophils release a pro-survival secretome (Figure 30AB). This was not the case 
when using Mock- or AD169-treated neutrophil secretome (Figure 30CD). The Merlin D 
secretome showed increased concentrations of IL-6, IL-8, and MIP-1α (Figure 30E), as was 
the case with contaminated Merlin, as well as an increase of TNF-α and IL-10, that was not 
apparent in the contaminated Merlin (Figure 29E). Given that mycoplasmas such as M. 
pneumoniae have been found to increase TNF-α release from macrophages, it is surprising 
that its release was higher in response to the mycoplasma-free Merlin D. The consistent 
finding of elevated MIP-1α in Merlin D was consistent with the finding of increased 
monocyte migration also found in contaminated Merlin (Figure 11), as well as the increased 
monocyte passivity to infection that was mediated by the augmented IL-6 in the infected 
neutrophil secretome in both contaminated and clean Merlin (Dr Joanna Pocock, personal 
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communication). Neutrophil-mediated recruitment of monocytes is the typical response to 
infection, though in the case of HCMV may aid the viral infective programme. 
 
We did not re-examine autophagy in neutrophils using mycoplasma-free HCMV, however 
there are some indications to suggest that HCMV independently induces autophagy: 1) 
mycoplasma has been found to inhibit autophagic flux. Mycoplasma-contaminated HCMV 
in this study induced the initiation of autophagy without inhibiting autophagic flux.  For 
example, HeLa cells contaminated with Mycoplasma pulmonis increased expression of LC3-
II (Hu et al., 2014), as found here in neutrophils infected with mycoplasma-positive HCMV.  
Hu et al. used bafilomycin-A1 to discern whether the increase of LC3-II resulted from 
inhibition of autophagic flux or increased autophagy.  Mycoplasma was found to inhibit 
degradation of the autophagic vesicles, whereas this study found an increase in autophagic 
initiation.  2) In another study with M. pneumoniae-infected macrophages, mycoplasma 
cyto-adherence induced an inflammatory response through TLR4-triggered autophagy 
(Shimizu et al., 2014).  However, in this study, autophagy induced a survival that remained 
after blocking TLR4 (Figure 8C). Future research should repeat the above autophagy assays 
with mycoplasma-free HCMV to confirm this, and to assess whether the induction of 
autophagy by one pathogen might interfere with the degradation of the other, as has been 
speculated in mycoplasma co-infection (Hu et al., 2014). 
 
7.3.2 M. pneumoniae degrades PMA-stimulated NETS 
As predicted, given the degradation of NETs by mycoplasma-contaminated HCMV (Figure 
18) but not with mycoplasma-free HCMV (Figure 28), NETs degradation is an ability 
present in the Mycoplasma genus.  Although the contaminating mycoplasma species were 
not identified, M. pneumoniae was selected for these experiments as it is the most prominent 
mycoplasma with a significant role in human pathology (see Section 7.1), and encounters 
neutrophils in a clinical context — for example, M. pneumoniae pneumonia patients show 
heightened levels of neutrophils in alveoli (Chen et al., 2016).   
The observation here that M. pneumoniae degrades NETs has since been independently 
supported with the separate, recent finding showing that M. pneumoniae induces and 
degrades NETs (Yamamoto et al., 2017).  Inactivation of a gene for a nuclease, mpn491, 
prevented NETs degradation.  Yamamoto et al. (2017) found that at an MOI of 10, Mpn491-
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deficient M. pneumoniae was able to induce NETs. This is consistent with our findings that 
an MOI of 3 of M. pneumoniae induced fragmented DNA in the supernatant, as well as 
increased expression of myeloperoxidase in neutrophils.  
Of note, Mpn491 was found to be important in avoiding NETs-mediated killing in M. 
pneumoniae, both in vitro and in female BALB/c mice where recovered BALF from the 
murine lung showed lower levels of Mpn491-deficient M. pneumoniae compared to the 
wildtype. While Mpn491 was not heat resistant, and the authors didn’t examine its resistance 
to UV.  The contaminating nuclease in this study was UV-resistant as NETs degradation 
was also found using UV-killed mycoplasma.  However, I cannot conclude that the 
contaminating mycoplasma used in this study had Mpn491 or was M. pneumoniae. As noted 
previously, nuclease activity has been detected across mycoplasma species (Minion et al., 
1993; Razin et al., 1964), and it may be that NETs-degradation is common to all 
Mycoplasma spp.  In fact, Mpn491 is a secreted nuclease, and it seems unlikely that a 
secreted nuclease was able to survive the HCMV-purification process outlined in Section 
3.3. 
Further research into the NETs-degrading ability of mycoplasma species and the responsible 
nucleases would further elucidate the abilities of this genus to evade a significant innate 
immune killing mechanism. 
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8 Discussion 
8.1 Human cytomegalovirus 
Neutrophils are critical to maintaining a healthy immune system, and understanding the 
interplay between these cells and debilitating pathogens such as HCMV is instrumental to 
designing therapies to prevent and treat HCMV-mediated disease.  However, research into 
their interaction has been marked with disagreement over the permissivity and susceptibility 
of neutrophils to infection.  Further, the somewhat paradoxical finding that HCMV encodes 
a viral homologue of IL-8 (Penfold et al., 1999), a potent neutrophil chemoattractant, has 
not been explained.  This study was designed to shed light on the interaction between 
neutrophils and HCMV in order to identify and understand better the mechanisms viruses 
employ to evade or exploit immune action. 
Here I report that human peripheral blood neutrophils exposed to a clinical strain of HCMV 
display a profound survival phenotype that occurs in the absence of any viral gene 
expression. Merlin strain HCMV also induced neutrophils to secrete a number of 
inflammatory mediators that in turn induced survival in uninfected neutrophils. Concomitant 
with this secretome-mediated survival effect, the HCMV-induced neutrophil secretome also 
markedly affected autologous donor monocytes – the primary vehicle for viral dissemination 
in the infected host – by enhancing migration and subsequent differentiation to a permissive 
phenotype for HCMV infection. These were reconfirmed after initial setbacks stemming 
from mycoplasma contamination of the virus inoculum. 
8.2 Mycoplasma contamination 
Mycoplasma are notorious contaminants in cultures (Drexler and Uphoff, 2002).  Their 
small size, some comparable with larger viruses, and their flexibility, mean they are more 
likely to pass through fine filters used to purify reagents.  Their slow generation times of up 
to nine hours also mean that they are difficult to detect visually in samples or on agar plates.  
They can attain high concentrations in droplets and have prolonged survival when dried, 
making them more easily spread.  Though traditionally considered to live on cell surfaces 
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through cytoadherence, species including M. fermentans, M. genitalium, and M. pneumoniae 
have been found to survive in granulocytes and monocytes after phagocytosis (reviewed in 
Drexler and Uphoff, 2002).  Studies on the incidence of contamination by mycoplasmas 
have found that their presence in experimental cultures ranged from 15%-35%, and more 
recently to rates as high as 65-80% due to more sensitive testing (Drexler and Uphoff, 2002; 
Drexler et al., 2002).  It is therefore likely that many laboratories unwittingly work with 
mycoplasma-positive cultures. 
Most contaminations are caused by a small handful of mycoplasmas (Drexler and Uphoff, 
2002), with the primary culprits being M. orale (20-40% of mycoplasma contaminants), M. 
hyorhinis (10-40%), M. arginini (20-30%), M. fermentans (10-20%), M. hominis (10-20%), 
and A. Laidlawii (5-20%).  M. orale, M. fermentans, and M. hominis have human hosts and 
likely enter cultures through primary tissue isolates on rare occasion, and more commonly, 
via laboratory personnel.  M. hyorhinis and A. laidlawii, with bovine natural hosts, may enter 
through reagents such as fetal bovine serum.  Cross-contamination from other infected 
cultures is also a major source of mycoplasma contamination. 
Once a line is infected, it is incredibly difficult to remove and it is usually recommended to 
create a new one (Drexler and Uphoff, 2002).  Mycoplasma-positive batches Merlin A, B, 
and C, all came from seed stock that also tested positive for mycoplasma, which was the 
likely route of contamination.  Merlin D was mycoplasma-negative and came from seed 
stock that was also mycoplasma-negative. 
While most mycoplasmas do not cause disease in humans, several species, notably M. 
pneumoniae, can cause severe conditions including community-acquired pneumonia 
(Waites and Talkington, 2004).  Having evolved from Gram-positive bacteria, mycoplasmas 
greatly reduced their genetic material and cell wall, forming their own class within the 
Bacteria domain and living parasitically.  It is a mucosal pathogen that often lives on the 
epithelial surface, attaching through a specialised organelle to a host ligand.  This close 
interaction may prevent it from being disposed by mucociliary clearance mechanisms, and 
is associated with deterioration of the respiratory epithelium that likely gives rise to clinical 
manifestations including a persistent cough (Waites and Talkington, 2004).  Mycoplasma in 
this study must have been closely associated with HCMV and potentially adhered or had a 
similar density to the virus particle, as virus purification involves ultracentrifugation, 
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selective collection from discontinuous sorbitol layers, and multiple wash steps.  
Mycoplasmas can range from 1.5x to 4x the diameter of the HCMV particle. 
Finally, contaminating Mycoplasma spp. may affect the conclusions derived from 
experiments in ways impossible to anticipate, and the high rates of contamination found in 
labs and in early experiments in this study emphasize the need to be hypervigilant in 
detecting and disinfecting cultures.   
8.3 Degradation of NETs 
This research contributes to a growing body of research demonstrating the ability of many 
pathogens to degrade the DNA scaffold of NETs (Table 5). 
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Although only one study has examined the relationship between mycoplasma and NETs, the 
bacteria do interact closely with neutrophils during pathogenesis, an interaction which is 
likely to be clinically relevant.  Mycoplasmas have been demonstrated to induce epithelial 
cell-derived IL-8, a major neutrophil chemoattractant (Kruger and Baier, 1997; Pease and 
Sabroe, 2002).  In a M. pneumoniae respiratory infection model, the inflammatory response 
in mice was associated mainly with neutrophil influx (Martin et al., 2001), and neutrophils 
were the main cell found in the bronchoalveolar lavage fluid of M. pneumoniae-infected 
hamsters (Yano et al., 1991).   
 
Because mycoplasmas have lost much of the genetic material from their Gram-positive 
bacterial ancestors, many of their genes are highly conserved, suggesting that either these 
nucleases have other critical functions that may also enable NETs degradation, or that NETs 
degradation is a highly conserved ability.  These functions may act together; for example, it 
is speculated that mycoplasma nucleases help break down nucleic acids to meet its 
nutritional requirements (Minion et al., 1993).  The degradation of the NETs could therefore 
represent not only a mechanism to avoid host immune action, but also one that exploits a 
neutrophil antipathogenic mechanism to its own benefit.  With mycoplasma-neutrophil 
interaction prevalent in a number of respiratory conditions, further exploration is warranted. 
 
Future research should seek to assess the potential of a variety of mycoplasmas and 
mycoplasma nucleases as agents of NETs degradation, examine the effect of NETs on 
mycoplasmas, and further characterise their nuclease properties.  For example, using 
fluorescence spectroscopy, DNA gel electrophoresis, and confocal microscopy to determine 
whether neutrophils release NETs in response to purified strains of Mycoplasma spp. and 
whether the pathogen is able to degrade NETs would help elucidate the nature of this 
interaction.  As well, characterising the nuclease activity across a pH range in the presence 
or absence of ions including Ca2+ will allow us compare it with known nucleases and 
understand the clinical context. For example, the NETs-degrading Mpn491 nuclease is 
inhibited by Zn2+, which is found in lower concentrations in the sputum of patients with 
asthma (Jayaram et al., 2011; Yamamoto et al., 2017). 
Generating mycoplasma mutants that are deficient in NETs degradation would allow for 
powerful experiments to examine the functions of these nucleases, and the potential 
advantages it affords the bacteria.  Likewise, inhibiting the nuclease activity would allow us 
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to easily assay, using confocal microscopy, which Mycoplasma spp. induce NETs, and the 
consequences of NETs on these bacteria when their nucleases are inactivated.  Potential 
nuclease inhibitors such as G-actin (Lazarides and Lindberg, 1974) and LL-37 (Neumann et 
al., 2014) can be used, however most nuclease-blocking agents that have been identified 
have substantial secondary effects (e.g. inhibition of apoptosis by ATA in myeloid cell lines; 
Andrew et al., 1999).   
Such an approach may also help elucidate whether the NETs-degrading activity of 
mycoplasma is simply incidental or central to its purpose.  If NETs are detrimental to 
mycoplasma, as suggested in the Yamamoto et al. (2017) study, then the latter may be more 
likely.  Pre-incubating an array of mycoplasma species with nuclease inhibitors before 
exposure to naïve or PMA-stimulated neutrophils to see whether mycoplasma induces and 
is trapped or killed by NETs may shed light on this.  Examining the trapping and resulting 
viability of a nuclease-free knockout when exposed to neutrophils releasing NETs would 
also be of high interest.  Further, research should explore whether the solubilised NETs 
product may be bioactive.  Thammavongsa et al. (2013) found that two novel 
Staphylococcus aureus factors, staphylococcal nuclease (Nuc) and adenosine synthase A 
(AdsA), are able to solubilise NETs into small fragments of 2′-deoxyadenosine (dAdo).  
dAdo induces apoptosis in macrophages, allowing S. aureus to proliferate in the absence of 
their effector functions. 
Coinfections of mycoplasma and other pathogens, including human herpes virus-6, which 
is in the same family of HCMV, have been documented, though no evidence suggests that 
infection with one increases the probability of being infected with the other (Nicolson et al., 
2007; Nicolson et al., 2003).  However, mycoplasmas can act as a cofactor to other 
pathogens, as is the case with AIDS-associated mycoplasmas (Blanchard and Montagnier, 
1994).  HIV-1 has been found to induce NETs, and its degradation by mycoplasmas could 
potentially allow HIV-1 evasion of neutrophil neutralisation (Saitoh et al., 2012). 
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8.4 Final thoughts 
Although the rapid responsiveness and flexibility of neutrophils make them an integral part 
of the body’s immune system, this study suggests that HCMV is able to exploit neutrophil 
activation in order to modulate immune responses to potentially enhance viral 
dissemination, and that mycoplasma are able to degrade a key neutrophil defence 
mechanism.  This exploitation of neutrophils may be synergistically pathogenic during co-
infections, observed with both HCMV and Mycoplasma spp. infections (e.g. Blanchard and 
Montagnier, 1994; Jiang et al., 2017).  Also, further research is needed to understand the 
clinical manifestation of findings that suggest that neutrophil signalling may increase 
HCMV dissemination throughout the body via monocytes, as well as the clinical 
implications of mycoplasma-mediated degradation of NETs.   
Overall, these data illustrate the manipulation of neutrophil anti-pathogenic responses that 
may enhance infection and have implications on our understanding of mycoplasma and 
HCMV pathogenesis and provide new targets for the generation of therapies. 
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10 Appendix 
10.1 List of abbreviations 
3-MA  3-Methyladenine 
ADP  Adenosine diphosphate 
AIDS  Acquired immune deficiency syndrome 
AMP  Antimicrobial peptide 
ANOVA Analysis of variance 
APS  Ammonium persulphate 
ARDS  Acute Respiratory Distress Syndrome  
ATA  Aurintricarboxylic acid 
Atg  Autophagy-related gene 
ATP   Adenosine triphosphate  
Bcl  B-cell lymphoma 2 
BH3  Bcl-2 homology 3 
bp  Base pair 
BSA   Bovine serum albumin  
CGD  Chronic Granulomatous Disease 
cIAP  cellular inhibitor of apoptosis 
COPD  Chronic obstructive pulmonary disorder  
CQ  chloroquine 
CR  Complement receptor 
CXCR  C-X-C chemokine receptor 
DC  Dendritic cell 
DNA  Deoxyribonucleic acid 
DNase  Deoxyribonuclease 
dpi  Days post-infection 
ds  double-stranded 
E  Early 
EDTA  Ethylenediaminetetraacetic acid 
EGFR  Epidermal growth factor receptor 
ELISA  Enzyme-linked immunosorbent assay  
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ER   Endoplasmic reticulum  
ERK  Extracellular signal-regulated kinase 
Eros  Essential for reactive oxygen species 
FACS  Fluorescence-activated cell sorting 
FADD  Fas-associated protein with death domain 
FasL  Fas ligand 
FCS  Fetal calf serum 
FITC   Fluorescein isothiocyanate  
fMLP   N-formly-methionyl-leucyl-phenylalanine  
G-CSF  Granulocyte colony stimulating factor  
GM-CSF  Granulocyte-macrophage colony-stimulating factor 
HCMV Human cytomegalovirus 
HELF  Human embryonic lung fibroblasts 
HFF  Human fetal foreskin fibroblast 
HHV  Human Herpesvirus 
HIV  Human immunodeficiency virus 
hpi  Hours post-infection 
HRP  horseradish peroxidase 
HUVEC Human umbilical vein endothelial cells 
HV  Herpesvirus 
IE  Immediate early 
IFN  Interferon 
IL   Interleukin  
IMDM  Iscove’s modified Dulbecco’s medium 
IMS  Industrial methylated spirit 
JNK  c-Jun N-terminal kinase 
kDa   Kilodalton  
KO  Knockout 
LAMP-2 Lysosome-associated membrane protein 2 
LFA  Lymphocyte function-associated antigen 
LIR  LC3-interacting region 
LPS   Lipopolysaccharide  
LTB4   Leukotriene B4  
MAb  Monoclonal antibody 
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MAPK  Mitogen-activated protein kinase  
MCP  Monocyte chemoattractant protein 
MEK  Mitogen-activated protein kinase kinase 
MEM  Minimum Essential Media 
MHC  major histocompatibility complex 
MIP  Macrophage inflammatory protein 
MOI  multiplicity of infection 
MPO   Myeloperoxidase  
MYD88 Myeloid differentiation primary response 88 
NADPH Nicotinamide adenine dinucleotide phosphate  
NE   Neutrophil elastase 
NET   Neutrophil extracellular trap  
NF-κB  Nuclear factor kappa-light-chain-enhancer of activated B cells 
NIEP  Non-infectious enveloped particle 
NOX  NADPH oxidase 
P/S  Penicillin/streptomycin 
PAD4  Peptidylarginine deiminase 4 
PAF   Platelet-activating factor  
PAGE   Polyacrylamide gel electrophoresis  
PAMP  Pathogen-associated molecular patterns 
PBS-/-   Phosphate-buffered saline without calcium chloride nor magnesium chloride.  
PBS+/+  Phosphate-buffered saline with calcium chloride and magnesium chloride  
PDGF-R Platelet-derived growth factor receptor 
PE  Phosphatidylethanolamine 
PFA  Paraformaldehyde 
PGN  Peptidoglycan 
PI  Propidium iodide 
PI3K   Phosphoinositide 3-kinase 
PI3P  phosphatidylinositol 3-phosphate 
PKB  Protein kinase B 
PKC   Protein kinase C  
PMA   Phorbol myristate acetate  
PMN   Polymorphonuclear leukocyte  
PPP   Platelet-poor plasma  
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PRP   Platelet-rich plasma  
PRR  Pattern recognition receptor 
PS  Phosphatidylserine 
PVDF  Polyvinylidene fluoride 
qPCR  Quantitative polymerase chain reaction 
RNA  Ribonucleic acid 
ROS   Reactive oxygen species  
RT  Room temperature 
RT-PCR Reverse transcription polymerase chain reaction 
SDF-1  Stromal cell-derived factor-1 
SDS   Sodium dodecyl sulphate  
SEM  Standard error of the mean or scanning electron microscopy 
SOD   Superoxide dismutase  
ss  Single-stranded 
TEM  Transmission electron microscopy 
TEMED N,N,N’,N’-tetramethylethylenediamine 
TLR  Toll like receptor 
TNF  Tumour necrosis factor 
TOR  Target of rapamycin 
TRADD TNF receptor type 1-associated death domain 
Vps  Vesicular protein sorting 
WT  Wild type 
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Abstract
The release of neutrophil extracellular traps (NETs) is a major
immunemechanism intended to capture pathogens. These histone-
and protease-coated DNA structures are released by neutrophils in
response to a variety of stimuli, including respiratory pathogens,
and have been identiﬁed in the airways of patients with respiratory
infection, cystic ﬁbrosis, acute lung injury, primary graft
dysfunction, and chronic obstructive pulmonary disease. NET
production has been demonstrated in the lungs of mice infected
with Staphylococcus aureus, Klebsiella pneumoniae, and Aspergillus
fumigatus. Since the discovery of NETs over a decade ago, evidence
that “NET evasion” might act as an immune protection strategy
among respiratory pathogens, including group A Streptococcus,
Bordetella pertussis, andHaemophilus inﬂuenzae, has been growing,
with themajority of these studies being published in the past 2 years.
Evasion strategies fall into three main categories: inhibition of
NET release by down-regulating host inﬂammatory responses;
degradation of NETs using pathogen-derived DNases; and
resistance to the microbicidal components of NETs, which involves
a variety of mechanisms, including encapsulation. Hence, the
evasion of NETs appears to be a widespread strategy to allow
pathogen proliferation and dissemination, and is currently a topic
of intense research interest. This article outlines the evidence
supporting the three main strategies of NET evasion—inhibition,
degradation, and resistance—with particular reference to common
respiratory pathogens.
Keywords: neutrophil extracellular traps; immune evasion;
deoxyribonuclease; Streptococcus
Clinical Relevance
The importance of neutrophil extracellular traps (NETs) in
pathogen killing has received considerable attention, and it is now
increasingly clear thatmany pathogens have evolvedmechanisms
to evade NET-mediated entrapment and killing. This article
highlights this important and rapidly evolving ﬁeld, and aims to
alert respiratory scientists and clinicians to therapeutic
opportunities to modulate pathogen–NET interactions.
What Are Neutrophil
Extracellular Traps?
Neutrophil granulocytes, comprising over
half of all circulating white blood cells, are
terminally differentiated phagocytes that
form a key ﬁrst line of defense against
invading microbes. Neutrophils engage
invading microbes through a multitude
of surface receptors, including antibody Fc
receptors, complement receptors, and Toll-
like receptors (TLRs), which recognize and
respond to pathogen-associated molecular
patterns (1). Once activated, neutrophils are
responsible for phagocytic clearance, and
can elaborate an arsenal of antimicrobial
peptides, proteases, and reactive oxygen
species (ROS) to achieve pathogen killing.
Our understanding of neutrophil
“antipathogenic” mechanisms was
broadened a decade ago with the ﬁnding
that neutrophils can release extracellular
networks of chromatin coated with granule
proteins (2); this response could be
triggered by a variety of infectious agents,
including bacteria, viruses and parasites,
host-derived cytokines, inﬂammatory
mediators, and chemical factors, such as
phorbol myristate acetate (PMA; Figure 1).
The discovery of these so-called
“neutrophil extracellular traps” (NETs) has
catalyzed a growing body of research, and
the ability of NETs to capture pathogens
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has been demonstrated in many in vivo
contexts, restricting their movement and
surrounding them in a microenvironment
of concentrated antimicrobial agents (3). The
classically described NET pathway commits
neutrophils to a specialized form of cell death,
“NETosis,” although some pathogens appear
to induce a “vital NETosis,” where certain
neutrophil chemotactic and phagocytic
functions remain temporarily intact, even
after the cell becomes anuclear (3).
In the classical “suicidal pathway” of
NETosis, agonists, such as PMA or IL-8,
activate the extracellular signal–regulated
kinase (ERK) cascade, which stimulates
the nicotinamide adenine dinucleotide
phosphate (NADPH) oxidase to produce ROS,
which, in turn, triggers granule membrane
disintegration and release of neutrophil
elastase (NE) and myeloperoxidase.
More remains to be discovered about
the signaling events that trigger NET
formation, as this response is neither
uniform nor observed in every situation
where NADPH is activated. Nevertheless,
when NE translocates to the nucleus, it
acts to cleave histones, and, along with
myeloperoxidase, decondenses chromatin
and degrades the nuclear membrane. This
process extrudes DNA, histones, and
proteases into the cytosol, where they
combine to form NETs, with eventual
plasma membrane rupture and NET
expulsion from the cell (3). This
extracellular release of DNA occurs
typically 2–3 hours after stimulation.
A second, NADPH oxidase–
independent, calcium-mediated NETosis
pathway has also been described, involving
the enzyme, protein arginine deiminase
4 (PAD4) (4). Upon the increase of
intracellular calcium in response to agents
such as calcium ionophores, PAD4 binds
calcium, crosses into the nucleus, and
deiminates positively charged arginine
residues to generate uncharged citrullin on
histones H3 and H4. This loss of positive
charge leads to the dissociation of the
histones from negatively charged DNA,
resulting in decondensation of the
nucleosome. Citrullination of histones
has been shown to be involved in
calcium-dependent, but not NADPH
oxidase–dependent, NETosis (4). It was
demonstrated that PAD4 deﬁciency or use of
Cl-amidine to chemically inhibit PAD4
activity causes a reduction of histone
decondensation and NET formation (5).
Other studies suggest that PAD4-deﬁcient
mice and wild-type mice clear infections
equally well (6); therefore, the role of PAD4 in
infection-related NETosis is uncertain.
In contrast, vital NETosis appears to be
a rapid event seen in response to a more
limited group of bacteria (3). Hence, with
infection with gram-negative bacteria, such as
Escherichia coli, TLR4-activated platelets can
stimulate NETs through a direct CD11a
interaction with neutrophils, and gram-
positive bacteria, such as Staphylococcus
aureus, activate neutrophil TLR2 and
complement receptor 3, leading to induction
of vital NETosis. Much remains to be
elucidated regarding the mechanisms
underlying this latter process, but ﬂuorescence
and electron micrographs show intact plasma
membranes despite the release of NETs.
The electrostatic charge of nucleic acid
(3) and the presence of pathogen-binding
molecules, such as surfactant protein D (7),
combine to support bacterial–NET
interactions. Intravital microscopy has
demonstrated the binding of E. coli to NETs
released in the liver microcirculation
during sepsis, with inhibition of NET
formation resulting in increased bacterial
dissemination to distant organs (8). It appears
that neutrophils can spread NETs over wide
distances in vivo, and Yipp and Kubes (3)
suggested that DNA-binding sites on interstitial
ﬁbronectin may explain this remarkable ability
to disperse NETs over large areas.
A growing body of evidence supports
the ability of NETs to kill pathogens.
For example, neutrophils treated with
cytochalasin D, which inhibits phagocytosis
and thus most traditional neutrophil-killing
mechanisms, are still bactericidal (2), and
treatment of these neutrophils with DNase
or anti-histone antibodies diminishes this
killing. NETs have also been shown to kill
Aspergillus (9), group A Streptococcus
(GAS) (10), and yeast and hyphal forms of
Candida albicans (11). However, some
other studies have failed to show NETs
killing, including reports where a subset of
S. aureus trapped by NETs continued to
proliferate after DNase-induced release
(12). What is clear, however, is that the
trapping of bacteria by NETs acts to
reduce proliferation and prevent bacterial
1 2
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Inflammatory cytokines
Activated platelets
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Figure 1. Neutrophil extracellular trap (NET) release. (1) Upon stimulation by a variety of triggers,
including many pathogens, neutrophils release NETs into the extracellular space. (2) These structures are
composed of DNA coated with histones and chromatin, and trap microbes in a concentrated environment
of antimicrobial proteins, such as neutrophil elastase and myeloperoxidase. Insets are images showing (left)
human NETs released by phorbol myristate acetate–stimulated neutrophils by fluorescence microscopy
using Sytox Green (arrows), and (right) green-stained Salmonella typhimurium bacteria (arrows) trapped in
murine NETs. (3) As well as exerting antimicrobial effects, NETs may play a proinflammatory role
contributing to the pathogenesis of conditions, such as acute lung injury and venous thromboembolism.
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dissemination from certain organs,
including the lung (13).
Beyond trapping and killing pathogens,
other suggested antipathogenic effects of NETs
include their ability to neutralize virulence
factors, such as IpaB from Shigella ﬂexneri
(2), functional opsonization of Aspergillus
fumigatus, and inhibition of microbial growth
via calprotectin-mediated chelation of zinc
during Aspergillus infection (9).
Pathogen Evasion of NETs
Although the host immune system has
evolved numerous strategies to neutralize
pathogens, invading microbes have also
developed various mechanisms to avoid being
attacked by the immune system; examples
include inhibiting host inﬂammatory
responses, degrading antimicrobial molecules
with catalytic enzymes, and avoiding or
resisting host proteases. Research over the
past decade has now shown that three
comparable mechanisms are also employed
by pathogenic bacteria, viruses, and
parasites: inhibition of NETs release,
degradation of NETs, and resistance to
NETs killing (Figure 2). Perhaps the best
example of this is GAS, which has evolved
mechanisms to evade NETs using all three
of these strategies (10, 14–17).
Inhibition of NETs
The induction of many neutrophil effector
functions, including NETs, relies on the
generation of ROS. Many pathogens inhibit
oxidative pathways to evade immune
function, and a handful of studies have
shown that this capability may also
down-regulate NET induction. ROS
inhibition may occur through interference
with ERK phosphorylation upstream of
NADPH oxidase (18), or by pathogen
induction of the NET-suppressive cytokine,
IL-10, to block TLR-induced ROS generation
(15). Many pathogens are able to induce cellular
IL-10, whereas some viruses encode their own
IL-10 homologs (19). Although induction of
this immunosuppressive cytokine likely beneﬁts
infecting pathogens in several ways, the
importance of its ability to down-regulate NET
induction has yet to be determined. It is likely,
however, that attenuation of ROS generation
will prove to be a broad NET-evasion strategy
employed by a variety of pathogens.
Degradation of NETs
Studies investigating the production of
NET-degrading factors by pathogens have
focused largely, but not exclusively, on the
nucleases produced by common gram-
positive respiratory pathogens, including
GAS, Streptococcus pneumoniae, and
S. aureus (Table 1). Soon after its discovery,
the evasion of NETs was suggested as a
potential function of GAS nucleases (14),
and, in the following year, two groups
demonstrated that the degradation of NETs
by Streptococcal nucleases resulted in
increased bacterial dissemination and
pathogenicity (10, 13). Of interest, it was
later reported that S. aureus not only
degrades NETs, but that the degraded
products even support disease progression
(20). Most of these studies used NETs
induced either by PMA or the pathogen,
and to prevent confounding by
phagocytosis, the actin-polymerization
inhibitor, cytochalasin D, was often added
to neutrophils before infection.
Recently, we found evidence of a host
strategy to attenuate pathogen degradation
of NETs: the antimicrobial peptide, LL-37
(cathelicidin), is constitutively expressed
in neutrophils and present at high
concentrations in NETs; however, it loses its
microbicidal activity when bound to DNA.
We found that puriﬁed neutrophil DNA and
NETs released by PMA-treated neutrophils,
when supplemented with LL-37, were
resistant to degradation by S. aureus,
S. pneumoniae, and GAS nucleases (21).
These results were recapitulated using other
cationic AMPs, with the cationicity of the
agents correlating with the degree of
resistance to degradation.
Resistance to NETs
In addition to the prevention of NET
formation and the degradation of NETs,
certain respiratory pathogens appear to
resist NET trapping and killing by other
mechanisms, including bioﬁlm formation
and electrochemical modiﬁcation of the
bacterial surface. Modiﬁcation or masking of
the negatively charged bacterial surface
by bacterial enzymes or a capsule exploits the
cationic nature of most NET components,
preventing the electrostatic attraction thought
to be responsible for bacterial adherence (17).
Furthermore, certain bacterial virulence factors
have been shown to confer resistance to the
antimicrobial peptides present in NETs (22).
Respiratory Pathogens that
Employ NET Evasion
GAS: NET Inhibition, Degradation, and
Resistance
GAS employs multiple NET evasion
mechanisms, including the ability to prevent
NET formation, to digest preformed NETs,
and to resist killing by microbicidal NET
components. First, GAS inhibits NET
formation by multiple mechanisms. The
GAS pore-forming cytolysin streptolysin
O blocks neutrophil ROS generation and,
consequently, the generation of NETs
(23). GAS also produces a peptide,
S. pyogenes cell envelope protease, that cleaves
IL-8, a potent neutrophil chemoattractant and
activator, resulting in lower levels of neutrophil
transmigration as well as reduced NET
1
INHIBITION OF RELEASE
2
DEGRADATION
3
RESISTANCE
e.g., induction of host IL-10 e.g., nucleases e.g., encapsulation, resistance proteins such as M1
Figure 2. The three main NET evasion strategies. Certain respiratory pathogens have evolved the
ability to evade the antimicrobial effects of NETs, using three main mechanisms: inhibition of the
release of NETs; degradation of NETs by the production of pathogen nucleases; and resistance to
the effects of the antimicrobial proteins that are enmeshed within NETs.
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induction (16). In addition, the GAS
hyaluronic acid capsule binds to the inhibitory
neutrophil receptor, Sialic acid binding Ig-like
lectin 9 (Siglec 9), down-regulating both ROS
generation and NET formation (24).
Many gram-positive bacteria express
DNases that are associated with virulence
(13, 14, 22); however, the pathogenic
beneﬁt of these enzymes was unknown
for many decades. Sumby and colleagues (14)
have shown in murine models that GAS
organisms deﬁcient in speciﬁc DNases are
more susceptible to extracellular killing and
clearance compared with wild type. Virulence
in the wild type was largely attributed to the
activity of Streptodornase 1, the principal
extracellular DNase in the M1 serotype GAS
strain, which is associated with necrotizing
fasciitis (14). The authors of this study
were the ﬁrst to speculate that the DNase may
be important in the avoidance of NETs, which
has since been conﬁrmed by several reports
documenting NET degradation by DNases.
Concrete evidence supporting the
ability of pathogens to escape from NETs
was ﬁrst documented in our study on GAS (10),
and another paper published concurrently on
S. pneumoniae (13). We found that wild-type
GAS survived coincubation with NETs
signiﬁcantly better than an Sda1-deﬁcient
mutant, and that nonpathogenic Lactococcus
lactis heterologously expressing Sda1 on a
plasmid vector showed signiﬁcantly greater
survival (10). Confocal microscopy conﬁrmed
that this survival was associated with the ability
of the pathogen to degrade NETs. Expression of
the DNase also made GAS signiﬁcantly more
virulent in a mouse model of necrotizing fasciitis
with increased skin lesions and bacterial load at
the site of injection. Administration of GAS
together with G-actin, a naturally occurring
inhibitor of type I family DNases, decreased
wild-type bacterial survival to a level comparable
to the Sda1-deﬁcient mutant, and substantially
decreased the lesion size. Every strain of GAS
appears to express at least one DNase (25). Our
subsequent study found that the heightened
resistance to NET killing in vivo in GAS
expressing Sda1 may serve as a selective force to
generate hypervirulent bacterial variants (26).
Resistance to NET-associated
antimicrobial peptides has also been shown to
play an important role in the pathogenesis of
invasive GAS infection. In 2009, a novel role for
the virulence protein M1 was discovered,
involving both stimulation of, and bacterial
survival within, NET structures (27). Targeted
mutagenesis of the emm1 gene coding for
the M1 protein revealed an absence of
GAS-induced NET generation in the mutant
and an increased susceptibility to NET killing.
Resistance could be restored by either an M1-
expressing plasmid or recombinant M1
protein, and expression of the M1 gene in the
M49 serotype or in L. lactis increased
resistance to NET-mediated killing. The DM1
mutant was found to be susceptible to killing
by the antimicrobial peptide, LL-37, and
further investigation using puriﬁed
recombinant M1 fragments demonstrated this
effect to be mediated by sequestration by the
M1 N-terminal hypervariable domain. The
M1 protein serotype is linked to severe GAS
disease, and clinical analysis of a large panel of
GAS clinical isolates found all M1 isolates to
be cathelicidin resistant, and demonstrated an
association between cathelicidin resistance and
invasive GAS disease (27).
S. aureus: NET Degradation
In 2012, the Rooijakkers group was the
ﬁrst to show that an S. aureus nuclease
confers resistance to extracellular killing by
neutrophils, and leads to enhanced disease
in vivo (28). After this, an elegant study
by Thammavongsa and colleagues (20)
demonstrated that S. aureus takes evasion a
step further by degrading NETs into a
product toxic to macrophages. Lesions
containing replicating bacteria surrounded
by ﬁbrin form the abscesses commonly
found during S. aureus infection. Mice were
infected with variant S. aureus with an
assortment of silencing inserts in multiple
known virulent genes. Whereas neutrophils
inﬁltrated the abscess and formed NETs,
macrophages were shown to be typically
excluded. However, mice infected with a
strain deﬁcient in nuclease (nuc), a nuclease
important in S. aureus bioﬁlm dispersal
(28), or adenosine synthase A (AdsA)
showed increased macrophage penetration
into the abscess. The authors found that
trypan blue staining of macrophages, which
indicates loss of viability, increased
signiﬁcantly in response to a product
generated from exposing PMA-induced
NETs to S. aureus. This response was
attenuated when using the nuc or the
adsA mutant, which also generated
reduced 29-deoxyadenosine (dAdo), a
deoxyribonucleoside base. Treatment of
NETs with puriﬁed versions of both nuc and
AdsA was necessary to produce dAdo, and
puriﬁed dAdo also induced caspase-3
activation and apoptosis in macrophages.
Taken together, these data show that the
S. aureus products, nuc and AdsA, are capable
of degrading NETs and producing a toxin,
dAdo, which kills macrophages, preventing
their inﬁltration into abscesses and thereby
reducing their antimicrobial functions.
S. pneumoniae: NET Degradation and
Resistance
Beiter and colleagues (13) were the ﬁrst to
demonstrate in vitro that S. pneumoniae is
trapped rather than killed by NETs. The
authors found that the pneumococcal strain,
TIGR4 (serotype 4), was able to degrade and
escape PMA-induced NET capture, whereas a
mutant strain deﬁcient in the membrane-
bound nuclease endA was captured by intact
NETs. Intranasal infection with wild-type and
the endA mutant organisms induced
neutrophil recruitment, NET release, and the
induction of pneumonia in murine lungs,
whereas mice infected with the endA mutant
showed improved survival. After simultaneous
infection with wild-type and mutant bacteria,
equal numbers of the two strains were
recovered from the upper respiratory tract;
however, considerably more wild-type
organisms were recovered in the lungs and
bloodstream, demonstrating the importance of
endA for bacterial invasion. Using the presence
of NE in cell supernatants as a reporter of NET
degradation, the authors also showed that six
of seven pneumococcal strains were able to
degrade NETs. These early observations of
NET evasion by a pathogen, and its association
with virulence, stressed the importance of NET
formation as an antipathogenic mechanism,
and highlight the therapeutic potential of
agents that preserve NET integrity.
More recently, the pneumococcal
bacterial capsule has also been shown to
confer resistance to NET trapping and
killing (17). Encapsulated S. pneumoniae
strains show signiﬁcantly reduced trapping
by NETs compared with nonencapsulated
strains, and the addition of a capsule was
thought to mask the negatively charged
bacterial surface, preventing binding to the
mostly cationic antimicrobial peptides
enmeshed in NETs. In addition,
S. pneumoniae has developed the ability
to modify its surface charge through
the action of a set of enzymes, which
incorporate D-alanine into surface
lipoteichoic acids (LTAs); these are tethered to
the bacterial membrane, and result in
a positive charge, which further repels cationic
peptides (17). Wartha and colleagues (17)
showed that the encapsulation and
D-alanylation of LTA is associated with
resistance to NET-mediated killing in vitro,
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and deletion of the dlt operon encoding the
enzymes responsible for D-alanylation of LTA
increases bacterial sensitivity to NET-mediated
killing in nonencapsulated strains. The group
went on to show, in a murine model of
pneumococcal pneumonia, that mutant strains
lacking functional dltA produce a ower bacterial
burden in vivo than wild-type organisms.
Group B Streptococcus: NET
Degradation and Inhibition
Another streptococcal nuclease, nucA,
was found to be secreted by group B
Streptococcus (GBS) and demonstrated to
be capable of degrading NETs (29). As in
the previous examples, the nuclease-
deﬁcient mutant was associated with
higher bacterial clearance and lower
mortality. The up-regulation of the
NET-suppressing cytokine, IL-10, and
subsequent attenuation of the respiratory
burst was also demonstrated to be
employed as a NET inhibition strategy
by GBS (15). Recently, we found that
the sialylated capsular polysaccharide of
GBS acts as a mimic “self”-ligand to
neutrophil Siglec-9, down-regulating
effector responses (15). Blocking of Siglec-9
caused dampening of GBS-induced IL-10
up-regulation, resulting in a stronger
oxidative burst, increased NET release and
increased extracellular killing.
Other Streptococci: NET
Degradation
Streptococcus suis, which induces and is
trapped by porcine NETs, expresses
Streptococcus suis-secreted nuclease A,
a cell wall–anchored DNase that is partially
released into the supernatant (30). In 2014,
de Buhr and colleagues (30) demonstrated
degradation of PMA-induced NETs by
S. suis, but not by a mutant that lacked
SsnA function, and that wild-type S. suis
showed signiﬁcantly higher viability
after incubation with PMA and
cytochalasin-treated neutrophils. A
second S. suis nuclease homologous to
pneumococcal endonuclease A (EndA),
designated endonuclease A suis (EndAsuis),
was described the following year (31),
accounting for residual NET degradation seen
in DSsnA mutants during the exponential
growth phase. However, an EndAsuis mutant
did not show increased susceptibility to
NET-mediated killing, suggesting that
EndAsuis was not as important as SsnA
for protection against NETs, and an
alternative role was suggested for the second
nuclease, potentially to degrade pathogen
DNA, thus avoiding TLR9 stimulation.
Morita and colleagues (32) discovered
in Streptococcus sanguinis (an organism
that colonizes the surfaces of teeth), a
cation-dependent nuclease with a cell
wall sorting signal, which they termed
Streptococcal wall anchored nuclease (SWAN).
A SWAN deletion mutant showed a 20%
reduction in survival compared with wild type
after incubation with PMA and cytochalasin
D–treated neutrophils, suggesting a modest
contribution to evasion from NETs.
Furthermore, expression of SWAN in L. lactis
signiﬁcantly increases bacterial survival.
Pseudomonas aeruginosa:
NET Inhibition and
Resistance
P. aeruginosa, a signiﬁcant pathogen in
cystic ﬁbrosis (CF), has evolved multiple
mechanisms to attenuate NET production
and resist NET-mediated killing. The
pathogen has been shown to express surface
sialic acids that are capable of binding and
inducing signaling through neutrophil, Siglec-
9, which suppresses the oxidative burst, and
thus NET formation (33). The authors in this
study showed that treatment with sialidase or
use of P. aeruginosa strains lacking in sialic
acids led to increased NET production
compared with sialic acid–positive strains.
Furthermore, paired P. aeruginosa strains
isolated from patients with CF at early and late
stages of disease showed that resistance to
NET-mediated killing evolved over time, and
correlated with the development of the mucoid
phenotype characterized by excess alginate
production (34). However, a mutant P.
aeruginosa strain that overexpressed
alginate did not show increased survival
on incubation with PMA-treated
neutrophils, suggesting that the acquired
resistance of P. aeruginosa to NET-
mediated killing in the CF airway was due
to an as-yet unknown mechanism (34).
Haemophilus inﬂuenzae: NET
Resistance
The respiratory pathogen, H. inﬂuenzae,
evades NET killing through both the
production of antioxidants and the formation
of bioﬁlms—surface-adherent bacterial
communities that resist clearance by immune
cells and antimicrobials through encasement
in a polymer matrix (22). Nontypeable H.
inﬂuenzae (NTHi), a leading cause of chronic
otitis media, has been demonstrated to form a
bioﬁlm within the middle ear during infection,
a process promoted by the production of lipo-
oligosaccharides, which is thought to promote
bacterial persistence. Bioﬁlm presence was
shown to correlate with bacterial load in an
experimental model of otitis media (22), with
microscopy revealing the presence of NTHi
communities with bioﬁlm phenotypes within a
DNA lattice containing neutrophils, elastase,
and histones, consistent with the appearance
of NETs. The bacteria were found to be
resistant to phagocytosis and extracellular
neutrophil killing in vitro, which was lipo-
oligosaccharide dependent.
NTHi also produces the antioxidants,
peroxiredoxin–glutaredoxin and catalase,
two molecules that confer resistance to
hydrogen peroxide in vitro. Mutant strains
with a deletion of the two genes encoding
these factors, hktE and pdgX, displayed
reduced survival in the presence of
hydrogen peroxide, increased susceptibility
to NET-mediated killing in vitro, and
attenuated persistence in the middle ear
(35). Susceptibility to NET-mediated killing
was partially rescued by the addition of
exogenous catalase, and is thought to be
due to the antioxidants providing resistance
against the microbicidal activity of ROS
within NETs. The possibility that the
antioxidants may, in fact, prevent NET
induction by neutralization of ROS,
which are required for NET release, is an
intriguing one, although there is, as yet, no
evidence supporting this in H. inﬂuenzae
or other catalase-expressing bacteria.
Bordetella pertussis and
Cryptococcus neoformans:
NET Inhibition
B. pertussis (18) and the fungus,
C. neoformans (36), both inhibit NET
formation by the suppression of ROS
generation. Wild-type strains do not
induce NETs, but mutants of these two
pathogens lacking ROS- and NET-
suppressing agents can certainly induce
NET release. NETs are inhibited
by C. neoformans via its capsular
polysaccharide glucuronoxylomannan,
and in B. pertussis through generation
of adenylyl cyclase toxin (ACT). ACT
generates high levels of cyclic AMP, which
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has a wide range of effects, including
inhibition of ERK phosphorylation, thus
suppressing ROS generation and NET
formation. Intriguingly, convalescent-phase
sera from patients with pertussis are able
to reverse ACT-mediated inhibition of
PMA-induced ROS and NETs (18).
Burkholderia pseudomallei:
NET Inhibition
Evasion of NET killing has also been
demonstrated by the gram-negative
bacterium, B. pseudomallei, the causative
agent of mellioidosis, an infection
endemic to Southeast Asia, with multiple
manifestations, including pneumonia.
Neutrophils play a crucial role in
controlling infection in murine models
of the disease, and investigation of
the response of human neutrophils to
B. pseudomallei showed that the pathogen
triggers the induction of NETs, which
exert microbicidal activity (37).
Riyapa and colleagues (37) also showed
that the bacteria modify the magnitude of
NET formation through the action
of two known virulence factors, the
bacterial type III protein secretion system
encoded by the bsa locus, including the
components bsaZ and bsaQ, and capsular
polysaccharide 1 encoded by the wcb
operon. Mutant strains deﬁcient in either of
these components induce higher levels of
NET production, which result in increased
bacterial killing by NETs compared with
wild-type bacteria (37). Increased NET
production was mirrored by higher levels
of phagocytosis of the mutants with an
elevated oxidative burst, implying that the type
III protein secretion system and capsular
polysaccharide 1 attenuate NET release
through inhibition of the NADPH oxidase
pathway. These mechanisms are postulated to
be responsible for the attenuated replication and
plaque formation seen with bsaZ and basQ
mutants in vitro and the reduced virulence of
wcb mutants in murine models of disease.
Other Pathogens: NET
Degradation
The degradation of NETs has also been
suggested as a function of nucleases in gram-
negative bacteria. Seper and colleagues (38)
found that a Vibrio cholerae strain
deﬁcient for two extracellular nucleases,
deoxyribonuclease and xds, was less
invasive than wild-type V. cholerae in
immunocompetent mice, although no
difference between strains was seen in
neutropenic mice, and quantitative
RT-PCR revealed that the presence of either
NETs or DNA was able to up-regulate
the expression of deoxyribonuclease and
xds (38). Neisseria gonorrheae has also
been shown to encode the heat-stable
nuclease, nuc, thought to be important
for remodeling N. gonorrheae bioﬁlms (39).
NETs were shown to be rapidly induced
by N. gonorrheae, but thereafter NET
integrity decreased over time in nuc-
containing strains compared with a Dnuc
mutant, as measured by Sytox Green
immunoﬂuorescence. The presence of Nuc
enhanced survival of the pathogen on
exposure to PMA-stimulated neutrophils,
implicating nuc as a virulence factor
important for host immune evasion.
In 2014, two studies documented NETs
degradation in biological kingdoms other
than bacteria. The parasite Leishmania
infantum was shown to express high levels
of 39-nucleotidase/nuclease when cultured
in low-phosphate media, a phenotype that
showed higher survival in NETs (40). A highly
active nuclease is also present in the saliva of
the parasite’s sandﬂy carrier, Lutzomyia
longipalpis (41), and a recombinant form of
the nuclease, Lutzomyia NET destroying
protein, was shown to degrade NETs and
increase parasite survival when coincubated
with neutrophils. Coinjection of the
recombinant nuclease with Leishmania in
mice increased lesion size and parasite load,
suggesting that the nuclease may aid
promastigote evasion of NETs as well as lower
blood viscosity to facilitate sandﬂy feeding.
Conclusions
Broadly, there exist three main strategies
by which respiratory pathogens counteract
NETs: inhibition of NETs release,
degradation of NETs by pathogen- or
vector-encoded nucleases, and resistance to
NET-mediated killing, for example, by
production of inhibitors of antimicrobial
peptides. These effects likely overlap
signiﬁcantly with other functions (40).
The prevalence of NET evasion
mechanisms within respiratory pathogens
supports the view that NETs are an
important antipathogenic mechanism.
The relevance of NET evasion by pathogens
is further supported by evidence that the
body also appears to “ﬁght back”—for
example, high concentrations of the
antimicrobial peptide, LL-37, within NETs
increases resistance to the action of DNases
(21), and the presence of anti-ACT in the
sera of patients infected with B. pertussis
indicates the participation of humoral
responses in combating the speciﬁc
pathways by which pathogens modify NETs.
This body of knowledge must, however,
be interpreted acknowledging the
limitations of many commonly used NETs
assays. For example, although the use of PMA
is convenient to assess the effect of a compound
on already-released NETs, the physiological
relevance of this chemical factor has been
repeatedly questioned (42). There are stark
differences between PMA-induced NETs and
those induced by more physiological agonists;
for example, PMA induces all neutrophils to
release DNA, whereas only 25% of neutrophils
do so with S. aureus. Furthermore,
cytochalasin D is often used to inhibit
phagocytosis to separate traditional neutrophil
killing mechanisms from NET-associated
effects; however, phagocytosis is integral to so
many neutrophil functions that its inhibition
may confound. Hence, Branzk and colleagues
(43) show that phagocytosis via dectin-1 can
inhibit the release of NETs as part of a
neutrophil size–sensing mechanism that
determines their antipathogenic response.
Therefore, NET-mediated killing that
is demonstrated in the presence of
cytochalasin D could be misleading, if
NET induction would have been inhibited by
phagocytosis in its absence. These inherent
caveats pertain to many NET studies, and can
only be mitigated with the use of multiple
complimentary techniques and the inclusion
of physiological NET stimulants.
Future work is likely to involve
translation of the advances in our
understanding of pathogen evasion of
NETs into pharmacological therapies.
Development of a rapid technique to
establish whether a pathogen is NET
resistant, or a therapy counteracting
common mechanisms of NET evasion by
pathogens, could complement antimicrobial
approaches. All three pathogen-evasion
strategies may be targetable. Therapies
aimed at neutralizing bacterial pathways
that down-regulate NET induction may
hold promise, including targeting the GAS
IL-8 protease SpyCep or neutrophil Siglec-9,
which is engaged by multiple pathogens to
inhibit NETs induction (15). Pathogen-
encoded nucleases are another attractive
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target. G-actin, a natural pharmacologic
inhibitor of type I DNases, has been shown to
prevent Sda1-mediated degradation of NETs
(10) and certain patients with systemic lupus
erythematosus produce speciﬁc DNase1
inhibitors that act against endogenous serum
DNase1 (44). Other therapeutic opportunities
involve protecting NETs from degradation—
high concentrations of LL-37 increase DNA
resistance to pathogen DNases (21), and NETs
are protected from degradation in systemic
lupus erythematosus due to the deposition of
autoantibodies, which are thought to
shield them from serum DNase1 (44).
Furthermore, targetable bacterial regulators of
nuclease expression have been described,
including period circadian protein homolog 1,
which regulates GAS Sda1 expression (45),
and the mgrA and Staphylococcal accessory
regulator Z transcriptional regulators, which
up-regulate S. aureus nuc expression (46).
These are part of a wide family of
bacterial peroxide-sensing transcriptional
regulators, making this a promising area
of research. Bacterial mechanisms of resistance
to NETs may also be targeted, including
modiﬁcation of the protective capsule or
inhibiting resistance genes, such as the GAS
M1 protein.
Lastly, the above studies build a
framework that may be used for assessing
the many other bacterial species that contain
nucleases, such as species of the bacterium
Mycoplasma, which all contain surface
nucleases. Investigation of their effects
on NETs may reveal the evolutionary
signiﬁcance of such genes in evasion of
the host innate immune response.
It is also important to recognize that
certain immunosuppressive agents, such
as the calcineurin inhibitors, have been
shown to impair NET formation (47), which
could further enhance susceptibility to
opportunistic infections, whereas other
drugs, such as statins and tamoxifen,
appear to increase NET production and
promote bacterial clearance both in vitro
and in vivo (48). However, despite the
positive role that NETs play in mediating
infections, NET components have been
shown to cause inﬂammation and tissue
damage, and aberrant or excessive NETosis
might play a role in inﬂammatory processes,
including acute lung injury and venous
thrombosis development (47). Excess NET
formation damages the epithelium and leads
to lung tissue damage, and has been reported
in the lungs of patients with a wide range of
pulmonary conditions that are associated
with neutrophil inﬁltrates, including
neutrophilic asthma, chronic obstructive
pulmonary disease, CF, respiratory syncytial
virus bronchiolitis, inﬂuenza, and tuberculosis
(49). It is thought that NET-induced injury
can be particularly severe in the lungs, due to
the ability of NETs to expand easily in the
alveolar space and to directly induce death in
endothelial and epithelial cells by the action
of histones. Excessive NET formation can
also facilitate blood coagulation, thus
disturbing the alveolar microcirculation (49).
Furthermore, extracellular DNA has been
recognized as a critical component of bioﬁlms
with the presence of neutrophil actin and DNA
enhancing their formation (50), and NETs as a
potential source for the formation of harmful
bioﬁlms is deserving of future research. Hence,
extreme care will be needed in designing agents
that modulate NET biology.
In conclusion, pathogens have
evolved a range of mechanisms to evade
NETs that can be categorized into three main
categories: NET inhibition; NET degradation;
and NET resistance. NET formation is now
recognized as an important host mechanism
to ﬁght respiratory infections, and future
research will involve identifying additional
mechanisms to resist NETs as well as options
to develop therapeutic interventions to
counteract evasion. n
Author disclosures are available with the text
of this article at www.atsjournals.org.
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Mark R. Wills1, Andrew S. Cowburn1,3*‡ and Edwin R. Chilvers1‡
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London, United Kingdom, 3 Department of Physiology, Development and Neuroscience, University of Cambridge, 
Cambridge, United Kingdom
Human cytomegalovirus (HCMV) is a major cause of viral disease in the young and 
the immune-suppressed. At sites of infection, HCMV recruits the neutrophil, a cell with 
a key role in orchestrating the initial immune response. Herein, we report a profound 
survival response in human neutrophils exposed to the clinical HCMV isolate Merlin, but 
not evident with the attenuated strain AD169, through suppression of apoptosis. The 
initial survival event, which is independent of viral gene expression and involves activation 
of the ERK/MAPK and NF-κB pathways, is augmented by HCMV-stimulated release 
of a secretory cytokine profile that further prolongs neutrophil lifespan. As aberrant 
neutrophil survival contributes to tissue damage, we predict that this may be relevant to 
the immune pathology of HCMV, and the presence of this effect in clinical HCMV strains 
and its absence in attenuated strains implies a beneficial effect to the virus in patho-
genesis and/or dissemination. In addition, we show that HCMV-exposed neutrophils 
release factors that enhance monocyte recruitment and drive monocyte differentiation 
to a HCMV-permissive phenotype in an IL-6-dependent manner, thus providing an ideal 
vehicle for viral dissemination. This study increases understanding of HCMV–neutrophil 
interactions, highlighting the potential role of neutrophil recruitment as a virulence mech-
anism to promote HCMV pathology in the host and influence the dissemination of HCMV 
infection. Targeting these mechanisms may lead to new antiviral strategies aimed at 
limiting host damage and inhibiting viral spread.
Keywords: human cytomegalovirus, neutrophil, monocyte, polymorphonuclear leukocyte, apoptosis
inTrODUcTiOn
Neutrophils are the most abundant circulating leukocytes and represent the first line of innate 
immunity against infection. They are terminally differentiated polymorphonuclear granulocytes 
with a short half-life in the circulation and a propensity to undergoing rapid constitutive apoptosis 
when aged in vitro. This latter response, which is observed during inflammatory resolution in vivo, 
triggers a highly efficient process of macrophage-mediated engulfment or efferocytosis, which 
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prevents these cells from releasing their cytotoxic content (1). 
Apoptosis is a highly adaptable cellular process influenced by a 
number of external factors including adhesion (2), hypoxia (3), 
inflammatory cytokines (4), and microbial agents (5), which 
mostly act to delay apoptosis and prolong neutrophil survival. 
While the prolongation of neutrophil lifespan may be critical for 
efficient handling of bacteria and certain fungi (6), inappropriate 
neutrophil longevity at sites of inflammation is thought to be 
pathogenic and contribute to inflammation-mediated damage 
(7). Conversely, an enhanced susceptibility to apoptosis may 
contribute to the likelihood of recurrent infections (8, 9), imply-
ing that neutrophil apoptosis needs to be tightly regulated to 
ensure efficient pathogen clearance yet timely and safe immune 
cell clearance.
Certain bacteria have developed mechanisms to manipulate 
the apoptotic machinery of the neutrophil, either delaying 
apoptosis to allow time for intracellular replication (10, 11) and/
or using the cell as a “Trojan horse” to facilitate dissemination 
through the transfer of viable microorganisms within apoptotic 
neutrophils to efferocytosing macrophages, thus promoting sub-
sequent spread (12, 13).
Several lines of evidence suggest an equally important role 
for neutrophils during viral infection. Hence, enhanced defensin 
expression has been shown to aid control of viruses such as HIV, 
adenovirus, and herpes simplex virus (14–16). Furthermore, 
recent evidence suggests that neutrophils play a key role in 
controlling murine CMV replication at secondary sites of infec-
tion (17). Neutrophils also attract and stimulate other immune 
cells both through direct interaction with cells such as dendritic 
cells (DCs) (18) and through the release of pro-inflammatory 
chemokines and cytokines (19); this illustrates their potential to 
orchestrate an adaptive immune response to viral infection.
Human cytomegalovirus (HCMV) is an opportunistic patho-
gen, which causes severe morbidity in neonates and the immune 
compromised (20–22). Disease can result from primary infection 
or reactivation from previously established latent infection and, 
due to the extensive cellular tropism of the virus, can manifest in 
a diverse range of tissues (23). Understanding the onset and pro-
gression of HCMV pathogenesis is an important area of ongoing 
research. However, the precise nature of any interaction between 
HCMV and neutrophils still remains unclear. Neutrophils from 
healthy latent seropositive patients are HCMV genome negative 
(24), and although the HCMV antigen pp65 has been detected 
in the neutrophils of viremic patients (25, 26), this does not 
reflect a full viral replicative life cycle, as demonstrated by the 
lack of detectable immediate early (IE) or late viral mRNA (27). 
Due to the highly phagocytic nature of neutrophils, it has been 
suggested that intracellular pp65 may in fact represent ingestion 
of viral material rather than primary lytic infection (27), and the 
presence of viral DNA in the neutrophil cytoplasm might also be 
consistent with its presence in phagosomes (28).
Although certain HCMV nucleic acids have been detected in 
the neutrophils of viremic patients (29, 30), neutrophils appear 
unable to produce viral transcripts following direct infection 
in  vitro, and experimental studies have relied on co-culture of 
neutrophils with infected endothelial cells (31, 32) or human 
embryonic lung fibroblasts (33) before any evidence of an abortive 
infection in neutrophils (31). The short lifespan of neutrophils 
would also argue against them being a major site of productive 
infection especially given the protracted life cycle of HCMV; 
despite this, HCMV carriage in neutrophils can occur in immune-
compromised patients and may play a role in a number of CMV 
disease states including retinitis in late-stage AIDS patients 
(34, 35). HCMV has also been reported to encode the chemokine 
mimic viral CXC-chemokine-1 (vCXC-1), a potent chemoat-
tractant for neutrophils (36, 37), and it has been hypothesized 
that this may support rapid viral dissemination from the site of 
infection—a characteristic of HCMV.
In this study, we have further investigated the interaction 
of HCMV with neutrophils. We show that, independently of 
a co-culture system, cell-free HCMV has a profound effect on 
neutrophil survival and cytokine expression, independent of viral 
gene expression but dependent on intracellular signaling involv-
ing ERK1/2 and NF-κB, and MCL-1 stabilization. This effect was 
observed to be viral strain dependent, with the AD169 HCMV 
strain, which displays a large deletion in the ULb′ genome region, 
unable to promote neutrophil survival.
Furthermore, the HCMV-stimulated neutrophil secretome 
was found to have significant paracrine effects on both neutro-
phils and monocytes. The ensuing neutrophil inflammatory cyto-
kine profile further promotes neutrophil survival, enhances the 
chemotactic response of autologous monocytes, and promotes 
monocyte differentiation to a state permissive for HCMV infec-
tion. These findings support the hypothesis that the neutrophil–
HCMV interaction aids efficient dissemination of the virus, by 
generating a favorable environment to modulate the phenotype 
of infiltrating monocytes—the primary vehicle for viral dissemi-
nation and persistence in the infected host (38).
MaTerials anD MeThODs
ethics statement
The Cambridge Local Research Ethics Committee approved all 
experiments utilizing primary human cells. The collection of 
venous blood samples from anonymous donors was performed 
in accordance with established guidelines for the handling 
and processing of tissue as defined by the Cambridge Local 
Research Ethics Committee, including informed written consent 
(06/Q0108/281).
Virus culture and reagents
The viral isolates TB40/e, Merlin, and AD169 were purified 
from the supernatants of infected human foreskin fibroblasts 
(HFFs) using sorbitol gradients as previously described (39) 
and stored in Iscove’s Modified Dulbecco’s Medium (IMDM) at 
−70°C. Briefly, viral strains were seeded onto HFF monolayers 
and cultured in DMEM containing 10% fetal calf serum and 1% 
penicillin/streptomycin for 10–14  days until 100% cytopathic 
effect was observed. HFF supernatants containing virus were 
collected every 48 h and stored at −70°C. Virions were pelleted 
by centrifugation of supernatants (12,000  rpm, 2  h, 4°C) and 
then loaded onto six sorbitol gradients (20–70%) before further 
density centrifugation (20,000  rpm, 1  h, 4°C). Purified virus 
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particles were collected from the 50 and 60% gradients, washed 
in PBS, and resuspended in IMDM for storage at −70°C as viral 
inoculum. The viral inoculum was titred by sowing onto a known 
quantity of HFFs and staining for IE antigen after 24 h to calculate 
the concentration in plaque-forming units per milliliter, and the 
volume of viral inoculum calculated to give a standardized MOI 
was added to neutrophil wells for experiments.
AD169 was obtained from the ATCC and TB40/e from 
Professor Christian Sinzger (University of Ulm, Germany). WT 
and mutant Merlin strains were obtained from Dr. Peter Tomasec 
(University of Cardiff, UK). The Merlin strain deletion mutants 
were generated by recombineering of the bacterial artificial chro-
mosome of the original Merlin strain (GenBank GU179001.1) as 
previously described (40), and the genomes were confirmed by 
Illumina sequencing.
For inactivation of the virus, purified viral stocks were UV 
irradiated in a class II MSC for 40 min, with the activation status 
confirmed by inoculation of fresh HFFs and examination for 
cytopathic effects at 7–14 days postinfection.
leukocyte Purification
Primary human blood neutrophils were obtained from healthy 
adult donors or CMV pneumonitis patients and purified by dex-
tran sedimentation and discontinuous plasma-Percoll™ gradi-
ents as previously detailed (41). For protocols requiring ultrapure 
neutrophils, cells were isolated by semiautomated negative 
selection using a RoboSep® (StemCell Technologies, Vancouver, 
BC, Canada), according to the manufacturer’s instructions, with 
neutrophil purity >98% as determined by light microscopy of 
cytospins.
CD14+ isolation of human monocytes was performed using 
a CD14+ cell direct isolation kit (Miltenyi Biotec, Auburn, CA, 
USA) and magnet-activated cell sorting. Primary CD14+ cells 
were cultured in X-vivo-15 media (Cambrex, Walkersville, MD, 
USA) and differentiated into DCs by the addition of interleukin-4 
(100 ng/ml) and GM-CSF (100 ng/ml) (Peprotech, Rocky Hill, 
NJ, USA).
leukocyte culture and infection
Purified neutrophils were suspended at a final cell concentration 
of 5 × 106/ml in IMDM (Thermo Fisher Scientific, Loughborough, 
UK) supplemented with 10% autologous serum and 50  U/ml 
streptomycin and penicillin (Thermo Fisher Scientific, Loughbor-
ough, UK). Cells were plated using cell-saver pipette tips into 
round-bottom ultra-low attachment 96-well Flexiwell plates 
(Becton Dickinson, Oxford, UK) and purified cell-free viral 
inoculum, at a volume calculated to give a standardized MOI, 
was added to the wells. For experiments involving virion-free 
inoculum, the inoculum was ultracentrifuged (130,000  g, 2  h, 
4°C) in a Beckman Coulter Optima ultracentrifuge (Beckman 
Coulter, Buckinghamshire, UK), to pellet and remove all infec-
tious virions prior to adding to wells. For experiments involving 
transferrable survival or supernatant effects, purified neutrophils 
from a second healthy donor, or autologous monocytes, were 
resuspended in the warmed supernatant harvested from infected 
neutrophils at 18 h, at a concentration of 5 × 106 cells/ml before 
plating as described.
For monocyte infections, 5 × 106 monocytes were incubated 
for 30 min with HCMV and cultured overnight in fresh X-vivo-15 
supplemented with 2 mM l-glutamine. For experiments involv-
ing inhibitors, compounds or diluent control media were added 
to wells prior to HCMV addition and were present for the dura-
tion of culture.
inhibitors, agonists, and antibodies
The following agonists were used: Pam3CSK4 (TLR1/2, 0.01–
1000 ng/ml, Invivogen, San Diego, CA, USA), ultrapure LPS-EB 
(TLR4, 10–1000  ng/ml Invivogen, San Diego, CA, USA). The 
following inhibitors were used: U0126 (ERK1/2, 1 µM, 60 min 
pre-incubation), PD98059 (MEK1/2, 50 µM), LY294002 (PI3K, 
10  µM, 60  min pre-incubation), wortmannin (PI3K, 100  nM), 
BAY-11-7085 (NF-κB, 3 µM, 60 min pre-incubation), IKK inhibi-
tor VII (IKK, 10 µM), SB203580 (p38, 10 µM), SP600125 (JNK, 
5  µM), cytochalasin D (endocytosis, 10  µg/ml; Sigma, Poole, 
UK), latrunculin A (endocytosis, 10  µM; Sigma, Poole, UK), 
PAb hTLR2 (TLR2, 10 µg/ml; Invivogen, San Diego, CA, USA), 
CLI-095 (TLR4, 1 µg/ml, 60 min pre-incubation; Invivogen, San 
Diego, CA, USA), 324841 (FGF-R1/PDGF-R1/EGF-R, 1  µM, 
60 min pre-incubation), actinonin (CD13, 100 nM; Sigma, Poole, 
UK), and anti-CD13 clone WM15 (CD13, 8 µg/ml) (all Merck 
Millipore, Nottingham, UK, unless stated). Inhibitors were added 
30 min prior to infection unless stated. Wortmannin (100 nM) 
was added again at 4, 8, and 12 h incubation due to its instability 
in aqueous solution.
immunofluorescence
For immunofluorescent detection of viral IE gene expression, 
cells were fixed in 70% ethanol (30 min, −20°C) and then incu-
bated with an anti-IE antibody (1:1,000; Millipore, Darmstadt, 
Germany) followed by Alexafluor 594 nm-conjugated goat anti-
mouse antibody (1:1,000; Millipore, Darmstadt, Germany), both 
for 1  h at room temperature (RT). Nuclei were counterstained 
with Hoechst (1:1,000; Sigma, Poole, UK).
Western Blotting
Neutrophils were harvested and analyzed by Western blot 
using polyclonal antibodies to AKT, phospho-AKT, phospho-
ERK1/2, IκB, Mcl-1, Bax, and β-actin (New England Biolabs, 
Hertfordshire, UK). Detection was performed with the appro-
priate peroxidase-conjugated secondary antibodies (1:2,000) 
for 1  h. Chemiluminescence (ECL-plus-kit GE Life Sciences, 
Buckinghamshire, UK) and exposure to X-ray film (XOMAT-AR; 
GE life sciences, Buckinghamshire, UK) were used to detect 
banding.
nucleic acid isolation, reverse 
Transcription, amplification,  
and gel electrophoresis
RNA (cDNA) and DNA were amplified using the gene-specific 
primers GAPDH: 5′-GAG TCA ACG GAT TTG GTC GT and 
5′-TTG ATT TTG GAGGGA TTC TCG, IE: 5′-CAT CCA CAT 
CTC CCG CTT AT and 5′-CAC GAC GTT CCT GCA GAC 
TAT G, in PCR 2x Mastermix (Promega, Madison, WI, USA). 
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The following cycling conditions were applied: 95°C (5  min), 
then 20–40 cycles of 94°C (40 s), 55°C (40 s), and 72°C (60 s) and 
a final extension at 72°C for 10 min.
qPcr analysis
Total RNA was isolated from neutrophils using TRI-reagent (Sigma, 
Poole, UK) followed by clean-up and DNase digest using RNeasy 
column kits (Qiagen). First-strand synthesis was performed with 
1  µg of RNA (high-capacity cDNA kit, Applied Biosystems). 
Relative gene expression was determined by qPCR (ABI) and 
amplified in Sybr-green master mix (Applied Biosystems) with 
relevant primers from Qiagen. Gene expression levels were rela-
tive to β2 microglobulin using the 2−CT method (42).
Detection of neutrophil apoptosis by 
Morphology, electron Microscopy (eM), 
Flow cytometry, and caspase-3 activity
Neutrophils were harvested at the time points indicated, cytocen-
trifuged (300 rpm, 3 min, RT) in a Shandon cytospin 3 (Shandon, 
UK), fixed in methanol, stained with May-Grünwald-Giemsa 
(Merck Millipore, Nottingham, UK), and examined under oil 
immersion (×100 objective) light microscopy, with the observer 
blinded to the experimental condition. Apoptotic neutrophils 
were defined as those with darkly stained pyknotic nuclei (300 
cells counted/slide, 3 slides per condition and time point) (43).
For EM analysis (CM100 transmission electron microscope; 
Philips, UK), infected neutrophils were harvested by centrifuga-
tion, fixed in glutaraldehyde and osmium tetroxide, dehydrated 
in ethanol, and embedded in Spurr’s resin for sectioning.
Flow cytometric analysis was performed by incubating cells 
with 5 µl annexin V-FITC and 5 µl propidium iodide for 20 min at 
4°C (both BD Biosciences, Oxfordshire, UK). Cells were analyzed 
by flow cytometry on a BD Accuri™ cytometer (BD Biosciences, 
Oxfordshire, UK) with 10,000 cells analyzed per condition and 
data were handled using FlowJo V8.7.1 software (Tree Star, 
Ashland, OR, USA).
Caspase-3 activity was ascertained on neutrophils incubated 
with and without HCMV for 18 h by colorimetric caspase-3 assay 
(Abcam, Cambridgeshire, UK). Neutrophils were cultured for the 
time period indicated, pelleted, washed in PBS, and resuspended 
in lysis buffer according to the manufacturer’s instruction, for 
plate reading to detect cleaved colorimetric caspase-3-substrate 
at 405 nm.
secretome analysis
Mock and HCMV condition neutrophil supernatants were har-
vested following 20 h culture and stored at −80°C until use. Some 
were ultracentrifuged (130,000 g, 2 h, 4°C) in a Beckman Coulter 
Optima ultracentrifuge (Beckman Coulter, Buckinghamshire, UK) 
prior to storage, to pellet and remove all remaining infectious 
virions. Depletion of virions from ultracentrifuged supernatants 
was confirmed by sowing the supernatants onto confluent HFFs 
and staining for IE antigen after 24 h. The presence of inflam-
matory mediators in the supernatant of mock and HCMV-
treated neutrophils was determined by multispot array using 
the MesoScale Discovery Platform (Meso Scale Diagnostics, 
Rockville, MA, USA), with resultant blots quantified by electro-
chemical luminescence detection.
To assess IL-6 and IL-8 in supernatants, in-house ELISAs 
were used (44). Briefly, a 96-well microplate was incubated 
with mouse monoclonal anti-human IL-6 or anti-human IL-8 
antibody (2  µg/ml) for 2  h at RT. After washing, wells were 
blocked using 5% fetal calf serum in PBS-T for 1 h at RT, washed 
again, and incubated overnight (4°C) with samples and rhIL-6 
or rhIL-8 standards. Detection of IL-6 and IL-8 was performed 
using a biotinylated anti-human IL-6 or anti-human IL-8 detec-
tion antibody and ExtrAvidin-AP (Sigma, Poole, UK), followed 
by p-nitrophenyl phosphate (1 mg/ml in diethanolamine). Plates 
were read using a Biorad Micro 680 microplate reader at 450 nm.
IL-8 and IL-6 neutralization in neutrophil supernatants was 
performed using human-IL-8 mAb (1 µg/ml; R&D systems, UK) 
and human-IL-6 mAb (1 µg/ml; R&D Systems, UK). Antibodies 
were added to supernatants 60  min prior to the addition of 
washed protein A micro-beads (Sigma, Poole, UK) for a further 
120 min (4°C). The beads were removed by placing vessels in a 
magnet and IL-6 and IL-8 depletion confirmed by ELISA.
cell Migration and Phenotyping assays
To assess cell migration to supernatants, transwell plates (5 µm 
pores, 30 µl well volume) (Neuroprobe, USA) were used. Monocytes 
were labeled using Calcein (BD Biosciences, Oxfordshire, 
UK). 2 × 104 labeled cells in 20 µl of RPMI 1640 per well were 
transferred to the transwell plate and incubated at 37°C for 2 h 
with supernatants from mock or HCMV-infected neutrophils. 
Migrated cells were counted using an inverted UV microscope 
(sum of five fields of view from each well, assays performed in 
triplicate for each donor).
Monocyte immunophenotyping analysis was performed on 
purified CD14+ cells after 3  days culture in X-vivo-15 media, 
neutrophil conditioned media, or Merlin-infected neutrophil 
conditioned media, using antibodies directed against HLA-ABC 
(MHC class I) and HLA-DR (MHC class II) with the appropriate 
fluorochrome-conjugated isotype controls (BD Life Sciences, 
Frankin Lakes, NJ, USA). 105 cells were pelleted (400 g for 5 min), 
resuspended and incubated with the target antibody or control 
for 20 min, washed once, and resuspended in 500 µl PBS before 
analyzing by flow cytometry (BD FACScalibur). Data were han-
dled using WinMDI2.9 software.
A mixed leukocyte reaction was performed using 5  ×  104 
CD14+ monocytes and incubated for 3  days with X-vivo-15 
media or supernatants from mock- or HCMV-infected neutro-
phils. Media was then replaced with fresh media (RPMI-10) sup-
plemented with IL-2, containing 105 purified allogeneic T cells 
purified from peripheral blood mononuclear cells by negative 
selection using the RosetteSep Procedure (StemCell Technologies, 
Grenoble, France). T  cell proliferation was quantified by cell 
counting after 6 days of co-culture.
statistical analysis
Data were plotted as mean ±  SEM and analyzed using Prism 
V6 (GraphPad) software. A paired or unpaired t-test was used 
to evaluate differences in experimental results, or a one-way 
analysis of variance with post hoc significance testing by Dunnet’s 
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test in experiments with >2 variables. Statistical significance 
was defined as p < 0.05.
resUlTs
hcMV Promotes neutrophil survival 
independently of Viral gene expression
Neutrophil co-culture with HCMV-infected fibroblasts has previ-
ously been shown to upregulate neutrophil effector function and 
survival (32). Since clinical strains of HCMV encode chemokines, 
which promote neutrophil recruitment (17, 45) but only exhibit 
limited replication in neutrophils, we investigated the nature of 
the neutrophil interaction with cell-free HCMV, specifically to 
identify any potential benefit to the virus. We used the Merlin 
strain that has become the genetic reference for clinical isolates 
of HCMV (40). Exposure of neutrophils to Merlin protected 
them from undergoing constitutive time-dependent apoptosis, 
as judged by morphological analysis under light microscopy 
(Figure  1A), which revealed a reduction in apoptotic cells 
containing darkly stained pyknotic nuclei at 20 h (Figure 1B). 
This was supported by flow cytometry using the apoptosis marker 
annexin V, which binds to externalized phosphatidylserine on the 
membrane of apoptotic cells. Co-staining with propidium iodide 
excluded necrotic cells (Figures  1C,D). EM visually separated 
the ruffled plasma membrane of viable HCMV-treated cells from 
the smooth featureless surface of apoptotic cells (Figure  1E). 
Classically, neutrophil apoptosis requires activation of the caspase 
cascade, and we show here that HCMV reduced caspase-3 activ-
ity at 6 and 18 h postinfection (Figure 1F). Moreover, inhibition 
of apoptosis occurred in a viral dose-dependent manner, as 
assessed by both morphology and flow cytometry (Figures 1G,H). 
Testing of a further HCMV strain, TB40/e, an endothelial-tropic 
strain of HCMV that infects most cell types (46), revealed an 
identical dose-dependent effect (Figure 1I).
Ultracentrifugation of the viral inoculum, to pellet and remove 
all infectious virus, removed the survival effect (Figure  2A), 
indicating that the virion itself, rather than substances present in 
the viral inoculum, was responsible for survival. Of note, HCMV-
induced neutrophil survival was evident even in the absence of 
viral lytic gene expression. Hence, there was no evidence to sup-
port robust IE gene transcription within the neutrophil as judged 
by RT-PCR (Figure 2B) and only minute quantities detected by 
RT-qPCR (Figure 2C). Consistent with a lack of transcription, no 
IE protein was present on staining for IE expression 24 h postin-
fection (Figure  2D). Of note, neutrophil survival was equally 
evident with UV-inactivated virus (Figures 2E,F), implying that a 
virion component and not a viral protein synthesized de novo was 
responsible for the pro-survival effect. Thereafter, UV-inactivated 
HCMV was used for most subsequent experiments.
hcMV-induced neutrophil survival does 
not require internalization and signals 
through erK and nF-κB
To investigate the mechanism by which neutrophil survival was 
mediated, we first set out to determine whether viral uptake was 
necessary to trigger survival signaling. While EM images taken 
30  minutes postinfection revealed that very occasional HCMV 
virions are present within intracellular vesicles (Figure 3A), sug-
gestive of phagocytic uptake, the majority of particles remained 
extracellular, and pretreatment of neutrophils with the phagocy-
tosis/endocytosis inhibitors cytochalasin D or latrunculin A had 
no impact on the survival phenotype (Figure 3B). These obser-
vations suggested that HCMV-mediated neutrophil survival was 
dependent on a cell surface binding and/or postentry event medi-
ated in the absence of viral gene expression. This was explored 
by inhibiting a number of receptors known to be activated by 
HCMV. Blockade of CD13 (Figure 3C) or EGF-R (Figure 3D), 
previously reported receptors for HCMV, did not reduce 
survival. The role of TLRs in neutrophil survival has been well 
documented (47), and HCMV has been shown to signal through 
TLR2 (48); however, no impact on survival was demonstrated 
with inhibition of TLR2 (Figure 3E). Furthermore, blockade of 
TLR4 signaling, another receptor known to be involved in viral 
detection and pro-survival signaling, again did not influence the 
pro-survival phenotype (Figure 3F). The inhibitors were shown 
to be effective in inhibition of TLR signaling by blocking IL-8 
release by neutrophils in response to stimulation with agonists 
for TLR2 and TL4 (data not shown), but the agonists of TLR2 
(Pam3CSK4) and TLR4 (LPS) themselves did not exert a pro-
survival effect on neutrophils, further excluding the involvement 
of TLR2 and TLR4 in HCMV-induced survival (Figures 3G,H). 
We isolated ultrapure neutrophils (purity >99%) to mitigate any 
indirect effect of HCMV on contaminating monocytes, of which 
low numbers are present in our routine neutrophil preparations. 
The release of survival factors from contaminating monocytes has 
previously been noted to drive RSV-induced neutrophil survival 
(49, 50); however, our survival phenotype was still present in 
ultrapure neutrophil preparations (Figure  3I). The lack of any 
neutrophil survival effect when using mock transfected prepara-
tions, which had been prepared in an otherwise identical man-
ner as the HCMV preparations, also excluded any inadvertent 
contaminant effect such as lipopolysaccharide.
Human cytomegalovirus activates a number of signaling path-
ways in both permissive and non-permissive cells, including the 
PI3K and ERK-MAPK pathways, identified previously as impor-
tant for HCMV-mediated cell survival (51, 52), and the NF-κB 
pathway (53). We have previously published data indicating 
the importance of the PI3-kinase, MAPK, and NF-κB signaling 
pathways in neutrophil survival following GM-CSF and TNFα 
stimulation (44). Therefore, we used previously optimized con-
centrations of inhibitors of these pathways to assess involvement 
in the HCMV-induced neutrophil survival phenotype. Inhibition 
of the PI3K pathway, along with the p38-MAPK and JNK-MAPK 
pathways, did not affect HCMV-induced survival (Figure 4A), 
despite western blot showing activation of the PI3K pathway 
(Figure  4B). However, inhibition of both NF-κB (Figure  4C) 
and the ERK1/2 pathway (Figure 4D) led to a partial reduction 
in the HCMV survival effect, which was completely abrogated on 
blockade of both signaling pathways (Figures 4C,D). Consistent 
with these findings, Western blot analyses showed that HCMV 
treatment of neutrophils induced rapid ERK phosphorylation 
and IκB degradation (Figure 4E). ERK1/2 and NF-κB signaling 
have been implicated in the regulatory control of the balance 
FigUre 1 | Human cytomegalovirus (HCMV) inhibits the rate of constitutive neutrophil apoptosis. (a) Morphological analysis of neutrophil apoptosis in uninfected 
control (Mock) and infected (HCMV strain Merlin) cells at 20 h postinfection, shown with GM-CSF-treated positive control (MOI 3, n = 9), with (B) representative 
photomicrographs of cells with apoptotic cells indicated by arrows (magnification ×1,000). (c) Flow cytometry analysis of neutrophil apoptosis in cells infected  
with Merlin, by annexin V binding at 20 h (MOI 3, n = 7), with (D) representative flow cytometry plots shown. (e) Scanning electron microscopy (EM) images of 
neutrophils infected with Merlin for 20 h versus control, with smooth apoptotic cells indicated by arrow (bar represents 20 µm). (F) Colorimetric assay for  
caspase-3-activity performed at 0, 6, and 18 h on Mock (−) or HCMV strain Merlin (+) infected cells (MOI 3, n = 3). (g) Neutrophils infected with Merlin at an  
MOI of 3, 1, or 0.3 were assayed for apoptosis by morphology (n = 5–6) and by (h) flow cytometry (n = 3–5) at 20 h. (i) Neutrophils infected with HCMV strain 
TB40/e at an MOI of 3, 1, or 0.3 were assayed for apoptosis by morphology at 20 h (n = 3–8). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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between the pro-apoptotic protein Bax and the antiapoptotic 
protein MCL-1, the relative levels of which are crucial for the 
onset of constitutive neutrophil apoptosis (54), and Western 
blotting for these two proteins revealed stabilization of MCL-1 
in response to HCMV infection but no change in Bax expression 
levels (Figure 4F).
FigUre 2 | Human cytomegalovirus (HCMV) promotion of neutrophil survival is independent of viral gene expression. (a) HCMV Merlin inoculum was 
ultracentrifuged at 180,000 g for 2 h, and the supernatant was removed from the virion pellet and used to infect neutrophils (virion-free inoculum). Apoptosis was 
assessed at 20 h by morphology (n = 3) compared to mock-infected cells and cells infected with non-centrifuged Merlin inoculum (Merlin). (B) RNA or DNA was 
isolated from neutrophils and RNA from human foreskin fibroblasts (HFFs) 18 h after infection with HCMV strain Merlin, and RNA was subjected to reverse 
transcription, and all samples were then amplified in an IE72 PCR or GAPDH PCR control before loading onto the gel. (c) qPCR showing gene expression levels  
of IE72 RNA isolated at 6 h from neutrophils infected with Merlin versus control, relative to Merlin-infected fibroblasts (MOI 3, n = 3). (D) Neutrophils were mock 
infected or incubated with HCMV for 24 h and then stained for immediate early (IE) antigen, shown with Hoescht nuclear counter stain and Merlin-infected HFFs  
as a positive control. (e) Morphological (n = 6) and (F) flow cytometric analysis (n = 5) of neutrophil apoptosis in cells infected with Mock or UV-inactivated Merlin  
at 20 h (MOI 3). Data represent mean ± SE, **p < 0.01, ***p < 0.001.
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hcMV-induced neutrophil survival  
is Viral strain specific
The pro-survival effect of HCMV on neutrophils was considered 
surprising, given the inability of HCMV to replicate efficiently 
inside the neutrophil. As such, the clinical relevance of this find-
ing was unclear, i.e., whether this represents an antipathogenic 
mechanism employed by the neutrophil or a form of immune 
subversion by the virus. The fact that clinical strains of the virus 
retain the evolutionarily conserved chemokine vCXC-1, a potent 
IL-8 homolog and neutrophil chemoattractant, suggested that 
recruitment of this cell type may be beneficial to the virus in the 
host setting.
To investigate this, neutrophils were co-incubated with 
the attenuated HCMV strain AD169, which has lost many of 
the genes carried in virulent isolates, including vCXC-1; this 
has been achieved through extensive passage resulting in the 
loss of multiple genes including the entire UL/b′ gene region 
encompassing UL133-UL151 (Figure  5A) (55). Rather strik-
ingly, neutrophils incubated with AD169 showed no survival 
phenotype (Figures 5B,C), strongly suggesting that a viral locus 
FigUre 3 | Human cytomegalovirus (HCMV)-stimulated neutrophil survival does not require internalization and does not signal through known receptors for 
HCMV. (a) Detection of viral particles (arrows) by transmission electron microscopy both outside and (inset) within HCMV strain Merlin-infected neutrophils 30 min 
postinfection (bar represents 500 nm). (B) Cytochalasin D or latrunculin A (10 µM) pretreatment did not influence neutrophil apoptosis following infection, 
compared with vehicle control (MOI 3, n = 3). (c) Morphological analysis of neutrophil apoptosis at 18 h in cells preincubated with the receptor tyrosine kinase 
inhibitor 324841 prior to Mock or Merlin infection (MOI 3, n = 3). (D) Morphological analysis of neutrophil apoptosis at 18 h in neutrophils pretreated with the CD13 
inhibitors actinonin or anti-CD13 clone WM15 before Mock or Merlin infection (MOI 3, n = 3). Neutrophils were incubated with inhibitors of (e) TLR2 (n = 3) or  
(F) TLR4 (n = 3) prior to infection with Merlin (MOI 3), and apoptosis was assessed by morphology at 20 h. Dose–response curves are shown measuring 
neutrophil apoptosis at 20 h by cell morphology and flow cytometry using annexin V for (g) the TLR2 agonist Pam3CSK4 (n = 1) and (h) the TLR4 agonist LPS 
(n = 1). (i) Morphological analysis of neutrophil apoptosis in mock and Merlin-infected ultrapure neutrophils at 20 h (MOI 1, n = 3). Data represent mean ± SE, 
*p < 0.05. NS, not significant.
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within the ULb′ region or another gene mutated in this strain 
was responsible for the survival effect. Of these, nine genes are 
probable virion components (P Tomasec, personal correspond-
ence), including UL146, a particularly strong candidate as it has 
been demonstrated to induce survival in human neutrophils 
(56), and UL141, which binds and downregulates the TRAIL 
death receptor on HFFs protecting them from extrinsic apop-
tosis (57).
To investigate the viral gene product responsible for HCMV-
induced neutrophil survival, we screened a library of Merlin 
strains each containing a single-gene knockout covering the 
entire 19 gene ULb′ region. Surprisingly, all of these mutants 
induced neutrophil survival comparable to wild-type Merlin, 
including all nine genes thought to code for virion components 
(Figures 5D–G), indicating that the HCMV-induced neutrophil 
survival effect is not driven by a single ULb′ gene product. These 
data implicate either an additional gene mutated in AD169 out-
side the ULb′ region or a combinatorial effect of multiple gene 
products. One prominent candidate gene outside the ULb′ region 
is the UL131A locus, which is mutated in AD169 (58, 59), and 
in Merlin is involved in the formation of the viral pentameric 
complex required for HCMV entry into myeloid lineage and epi-
thelial cells (60). However, when tested in isolation, the UL131A 
mutant also generated an intact survival response in neutrophils 
FigUre 4 | Human cytomegalovirus (HCMV)-induced neutrophil survival signals through multiple pathways. (a) Neutrophils were preincubated with the PI3K 
inhibitors LY294002 or wortmannin, the p38-MAPK inhibitor SB203580 or the JNK inhibitor SP600125 prior to infection with Merlin, and apoptosis was assessed by 
morphology at 20 h (MOI 3, n = 3–5). (B) Western blot analysis for total and phosphorylated AKT in neutrophils incubated with mock or HCMV at 5, 10, 15, and 
20 min (MOI 3). (c) Neutrophils were preincubated with the NF-κB inhibitors IKK inhibitor VII or BAY-11-7085 (3 or 10 µM), with or without addition of the ERK1/2 
inhibitor U0126, prior to HCMV infection, and apoptosis was assessed by flow cytometry using annexin V at 20 h (MOI 3, n = 2–4). (D) Neutrophils were 
preincubated with the ERK1/2 inhibitors PD98059 or U0126 (1, 10, or 20 µM), with or without the addition of BAY-11-7085, prior to infection with HCMV, and 
apoptosis was assessed by flow cytometry using annexin V at 20 h (MOI 3, n = 2–4). (e) Western blot analysis for ERK1/2 phosphorylation or IκB degradation was 
performed on mock or Merlin-infected neutrophils at 0, 5, 10, 15, 20, 30, and 40 min postinfection (MOI 3). (F) Western blot analysis for MCL-1 and Bax expression 
performed at 0 or 6 h after infection with mock or HCMV (MOI 3). Data represent mean ± SE, *p < 0.05, **p < 0.01, and ***p < 0.001.
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(Figures  5H,I), suggesting that the pentameric complex is not 
required for the survival phenotype.
hcMV infection induces a cellular 
secretome that Further Potentiates 
neutrophil survival
Since events associated with HCMV binding and entry are by 
definition transient, we then considered whether a positive 
feedback loop might also operate to prolong neutrophil survival, 
hypothesizing that any secretome produced by the neutrophils 
in response to HCMV may propagate the survival phenotype. 
Consistent with this, virus-free supernatants derived from 
neutrophils exposed to the Merlin strain imparted a profound 
antiapoptotic effect when transferred to freshly isolated neu-
trophils (Figures  6A,B). Of note, supernatants prepared in an 
otherwise identical manner from HCMV-infected monocytes 
did not promote neutrophil survival (Figure 6C). Furthermore, 
FigUre 5 | Human cytomegalovirus (HCMV)-induced neutrophil survival is viral strain specific. (a) The ULb′ region of the HCMV genome containing viral genes 
UL133–UL151 is lost in AD169 and replaced with inverted repeat RL14-1. (B) Neutrophils were incubated with the laboratory-adapted HCMV strain AD169 for 20 h, 
and apoptosis was assessed by cell morphology and (c) flow cytometry, compared to mock-infected neutrophils or neutrophils incubated with the clinical HCMV 
strain Merlin (MOI 3, n = 3–4). Neutrophils were incubated with wild-type Merlin or mutant Merlin strains lacking one of three genes from the ULb′ region of the 
HCMV genome known to code for virion components, and apoptosis was assessed at 20 h by (D) morphology and (e) flow cytometry (MOI 3, n = 3–4). Neutrophils 
were incubated with mutant strains lacking one of five ULb′ genes potentially coding for virion components, and apoptosis was assessed at 20 h by (F) morphology 
and (g) flow cytometry (MOI 3, n = 3). Neutrophils were incubated with wild-type Merlin versus Merlin lacking the UL131A gene, and apoptosis was assessed at 
20 h by (h) morphology and (i) flow cytometry (MOI 3, n = 3). Data represent mean ± SE. **p < 0.01, ***p < 0.001, and ****p < 0.0001. NS, not significant.
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supernatants from AD169-infected neutrophils did not convey a 
survival effect (Figure 6D), implying that this effect was restricted 
to clinical HCMV strains. The transferrable survival effect was 
not due to carryover of virus, as ultracentrifugation of superna-
tants to remove all virions (Figure 6E) caused no reduction in 
the survival conferred by the supernatant (Figure 6F), supporting 
instead a neutrophil-derived secreted factor.
As the HCMV secretome appeared to elicit downstream 
effects that were acting in a paracrine manner, we consequently 
performed a MesoScale™ cytokine array on supernatants from 
mock and HCMV-treated neutrophils to try to identify potential 
pro-survival agents from a panel of cytokines (Figure 7A). Initial 
analysis revealed significant increases in the concentrations of the 
known pro-survival cytokines TNFα, IL-6, and IL-8 along with 
the chemokine MIP-1α and the immune-regulatory cytokines 
IL-13 and IL-10 (Figure  7B), together with decreased levels 
of the chemotactic molecules IL-16 and MDC (Figure  7C). 
There was no upregulation of other potential survival cytokines 
including GM-CSF, IL-1β, IL-2, IL-4, IFNγ, IL-12p70, and VEGF 
(data not shown), and the only cytokine significantly higher in 
FigUre 6 | Human cytomegalovirus (HCMV)-exposed neutrophils produce a pro-survival secretome. Freshly isolated neutrophils were cultured with control media 
or supernatants from mock or Merlin-infected neutrophils (Merlin SN) collected at 20 h, and apoptosis was determined by (a) morphology and (B) flow cytometry at 
20 h (MOI 3, n = 3). (c) Supernatant from mock or Merlin-infected monocytes was added to freshly isolated neutrophils and apoptosis determined by morphology 
at 18 h (MOI 3, n = 3). (D) Supernatant from mock or AD169-infected neutrophils was added to freshly isolated neutrophils and apoptosis determined by 
morphology at 18 h (MOI 3, n = 3). (e) Supernatant harvested from mock and HCMV-infected neutrophils at 20 h was centrifuged at 130,000 g for 2 h, and residual 
virus in the ultracentrifuged pellet and supernatant (UC HCMV SN) was assessed by transferring to fibroblasts for 24 h prior to staining for HCMV immediate early 
(IE) antigen, compared to mock SN and non-ultracentrifuged HCMV supernatant (HCMV SN) (representative image shown). (F) The ultracentrifuged supernatant 
was transferred to fresh neutrophils and survival assessed by morphology at 20 h compared to non-ultracentrifuged supernatant (n = 4–5, MOI 3). Data represent 
mean ± SE. *p < 0.05, **p < 0.01, ***p < 0.001.
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Merlin-infected neutrophil supernatants compared to AD169 
supernatants was IL-10 (Figure 7B). HCMV has been shown to 
stimulate IL-10 production in monocytes (61), but rather than 
being pro-survival IL-10 has been shown to induce apoptosis in 
neutrophils (62). Consistent with this, we were unable to detect 
any survival effect of recombinant human IL-10 on human neu-
trophils (data not shown).
We investigated IL-8, a recognized pro-survival cytokine, 
which was secreted in high concentrations in HCMV-exposed 
neutrophils as measured by MesoScale array and confirmed by 
ELISA (Figure 7D) and which showed a trend to increased expres-
sion in Merlin supernatants over AD169 supernatants. However, 
although IL-8 has been shown to cause a modest inhibition of 
neutrophil apoptosis (63, 64), we were unable to recapitulate this 
effect in our system using recombinant human IL-8 (data not 
shown), and crucially, antibody depletion of the endogenous IL-8 
in the protective secretome using protein A beads (Figure 7E) 
had no effect on the transferrable survival (Figure 7F), indicating 
that IL-8 was not contributing to the survival effect observed.
interaction of hcMV with neutrophils 
Promotes a Permissive and immune-
suppressive Phenotype in Migrating 
Monocytes
Throughout these studies, the paradox between HCMV encoding 
a neutrophil chemoattractant and triggering marked neutrophil 
survival and heightened effector functions of neutrophils (32), 
and the minimal evidence that these cells represent a major site of 
productive infection or dissemination remains intriguing. While 
this could represent a host antiviral strategy, we speculated that 
the HCMV-induced neutrophil secretome may have a beneficial 
impact on the subsequent infection or activity of other cell types 
important for HCMV pathogenesis and dissemination. We set 
out to ascertain the effects of the neutrophil secretome on other 
immune cell types, predominantly the monocyte which plays 
a key role in HCMV dissemination and pathogenesis, to better 
understand the biological significance of HCMV prolonging 
neutrophil survival.
FigUre 7 | The human cytomegalovirus (HCMV)-exposed neutrophil secretome is high in IL-8. (a) MesoScale assay plate with three representative images, with 
each spot from three 10-plex wells representing one cytokine. The surrounding rings are imaging artifacts. (B) Results from MesoScale assay of mock and 
HCMV-infected (strain Merlin and AD169) neutrophil supernatants identified significant upregulation of IL-8, IL-6, TNFα, MIP-1α, IL-13, and IL-10 and downregulation 
of (c) MDC and IL-16 (MOI 3, n = 5). (D) IL-8 levels were measured in supernatants from mock- or HCMV-infected neutrophils at 20 h by ELISA (MOI 3, n = 5).  
(e) Following incubation with neutralizing antibodies against IL-8, supernatants were added to neutrophils and (F) apoptosis by morphology determined at 20 h, 
shown relative to control cells (MOI 3, n = 2–4). Data represent mean ± SE. *p < 0.05, **p < 0.01.
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The elevated levels of the chemokine MIP-1α in the secretome 
(Figure  7B) suggested the potential for increase in monocyte 
migration. A transwell migration assay confirmed this to be the 
case (Figure 8A). The ability of neutrophils to enhance monocyte 
recruitment is a classical response to pathogen invasion; however, 
in this instance, migration of monocytes occurred together with 
transformation of the monocytes to a cell status permissive for 
HCMV infection, which is comparable to classical DCs gener-
ated in vitro (Figures 8B,C). This monocyte switch to a HCMV-
permissive phenotype was dependent on the high levels of IL-6 
in the secretome (Figure 7B), as demonstrated by a substantial 
reduction in this effect in the presence of a neutralizing IL-6 
antibody (Figure 8D). IL-6 can be produced by monocytes and 
contaminating cells, so to eliminate the possibility that the IL-6 
was a product of contaminating monocytes, or already present 
in the viral inoculum generated from HFF supernatants, an IL-6 
ELISA was carried out on viral inoculum and on supernatants 
harvested from ultrapure neutrophil preparations infected with 
HCMV. IL-6 was not present in viral inoculum but was found 
in the ultrapure neutrophil supernatants, indicating that it is 
released from the neutrophils upon infection (Figure 8E).
The differential levels of IL-10 in our Merlin and AD169 
supernatants, although not responsible for survival, also led us 
to investigate its effect on monocyte immune function. IL-10 has 
been shown to polarize monocytes to an anti-inflammatory M2 
phenotype, with reduced MHC class II expression and decreased 
ability of monocytes to activate CD4+ T cells (65, 66). Consistent 
with this, our monocytes cultured in HCMV-exposed neutrophil 
supernatants failed to stimulate T cell division in a mixed leukocyte 
reaction (Figure 8F) and showed strong downregulation of MHC 
class II (Figure 8G). Thus, HCMV interaction with neutrophils 
was shown to promote the secretion of a cytokine profile that is 
chemotactic for monocytes and drives their subsequent activa-
tion to a HCMV-permissive and immune-suppressive phenotype.
DiscUssiOn
The precise nature of the interaction of HCMV with neutro-
phils has been challenging to resolve. Although HCMV has been 
reported to heightened certain neutrophil effector functions (32) 
and HCMV can transfer to neutrophils following co-culture with 
permissive cells through microfusion events (31), the ability of 
neutrophils to support full lytic viral replication has never been 
shown conclusively, with viral cycling restricted to early replica-
tion events only (31, 32). The reason for this block in replication 
is not known. Although the detection of viral antigens has been 
identified in the neutrophils of viremic patients (25), this is 
likely to represent non-specific phagocytosis, because in healthy 
FigUre 8 | Supernatants from human cytomegalovirus (HCMV)-exposed neutrophils promote monocyte migration and activation to a permissive phenotype in an 
IL-6-dependent manner. (a) Monocytes were cultured in transwell plates in the presence of control media, or media from mock- or HCMV-infected neutrophils, or 
from LPS-activated monocytes as a positive control, and migration assessed by microscopy after 2 h (n = 3). (B) Autologous donor monocytes were cultured in 
control media, mock-infected neutrophil media, or Merlin-infected neutrophil media, and freshly infected with Merlin, alongside IL-4/GM-CSF-induced dendritic cells 
(DCs) as a positive control. Cells were stained for immediate early (IE) gene expression at 24 h and counterstained with Hoechst nuclear dye, and (c) relative levels 
of infection calculated from 10 fields of view (MOI 3, n = 3). (D) Neutralization of IL-6 in supernatant from mock or Merlin-infected neutrophils significantly inhibited 
the number of monocytes positive for IE gene expression (n = 3). (e) IL-6 levels by ELISA in viral inoculum and in mock-infected and Merlin-infected ultrapure 
neutrophils (purity >99%) (n = 2). (F) Monocytes were incubated with media (monocyte) or supernatants from mock- or Merlin-infected neutrophils for 3 days.  
Media was then removed, and allogeneic CD4+ T cells were added to each well along with phytohemagglutinin (PHA) to all conditions except control. T cell 
proliferation after 6 days of co-culture was assessed by counting and shown relative to T cells cultured alone (control) or in the presence of PHA alone (PHA)  
(n = 2). (g) Representative flow cytometry plots of autologous monocytes cultured in X-vivo-15 media (control), mock-infected neutrophil media, or HCMV-infected 
neutrophil media (MOI 3) for 3 days before staining for MHC class I and II. Data represent mean ± SE. *p < 0.05.
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seropositive individuals, neutrophils do not appear to be a site 
of viral carriage (24). As such, the precise benefit of HCMV 
retaining vCXC-1 or why HCMV-infected permissive cell lines 
secrete the chemokines IL-8 and CXCL-1 and induce neutrophil 
chemotaxis (67, 68) is uncertain.
In this study, we sought to understand the nature of the 
interaction between HCMV and neutrophils at a cellular level, 
to elucidate the mechanisms involved in the neutrophil survival 
we observed, and to determine potential downstream effects 
of the virus–cell interaction on neighboring neutrophils and 
monocytes, to determine the potential significance of our find-
ings in  vivo. Herein, we show for the first time a pronounced 
effect of cell-free clinical HCMV isolates on the biology of this 
cell, an effect that is preserved in UV-treated virus but absent in 
an attenuated HCMV strain. We describe how the interaction of 
HCMV with neutrophils triggers a profound survival phenotype 
that involves ERK phosphorylation and IκB degradation and 
correlates with MCL-1 stabilization, along with the secretion of 
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a bioactive secretome that promotes further neutrophil survival, 
monocyte chemotaxis, and development of monocyte permis-
siveness for HCMV infection.
Previous studies have reported that co-culture with HCMV-
infected endothelial cells or fibroblasts protects neutrophils from 
apoptosis, at least in part due to IL-8 secreted by the co-cultured 
cells (32, 33). Skarman et al. described a co-culture system of neu-
trophils with HCMV-infected endothelial cells, in which the neu-
trophils showed reduced apoptosis (32); the authors concluded 
that neutrophil survival was linked to lytic gene expression due to 
the detection of IE antigen. In those experiments, neutrophils did 
not become positive for the main viral antigen pp65 when incu-
bated with cell-free virus; hence, no investigation of neutrophil 
survival with cell-free virus was made. Furthermore, the study 
referred to endothelial cells infected with laboratory HCMV 
strains, which were then co-cultured with neutrophils; however, 
here, we report that direct inoculation of neutrophils with wild-
type strains of HCMV promotes survival and demonstrate that 
the lab strain used in the previous study does not promote survival 
directly. A further study has also shown that, when co-cultured 
with HCMV-infected endothelial cells or fibroblasts, neutrophils 
display a reduction in apoptosis (33). Indeed, that study reported 
that the neutrophils also showed reduced apoptosis when co-
cultured with non-infected endothelial cells and demonstrated 
that the survival was due to IL-8 produced by both infected and 
non-infected endothelial cells. Hence, the Skarman study failed 
to disentangle the effects of a secretome generated from a virally 
infected bystander cell from direct engagement of the neutrophil 
with cell-free HCMV.
The inhibition of neutrophil apoptosis may be significant in 
multiple ways for the host, as it has the potential to exacerbate 
tissue damage but also to aid viral clearance. Neutrophil influx 
to sites of viral infection is associated with inflammation and 
tissue damage in influenza (69) and RSV (70). It is suggested 
that increased neutrophil viability may lead to greater HCMV-
induced tissue damage in PCR-positive inflammatory bowel 
disease (32, 71), and the observation that neutrophil survival is 
absent with the attenuated HCMV strain AD169 would support 
the hypothesis that it is a virulence mechanism.
Conversely, in murine CMV infection, neutrophils form a 
critical part of the antiviral response and are shown to play a 
direct role in controlling viral replication and limiting morbidity 
(17), a role also seen in RSV (72), HSV (15), and HIV infection 
(73). Interestingly, neutrophils support viral replication in West 
Nile virus infection and are actively recruited during infection, 
acting as a reservoir for replication, and only become involved in 
viral clearance at a later stage (74). The presence of vCXC-1 and 
other chemokines would support a similar role in HCMV.
The potential benefit to the virus of a reduction in neutrophil 
apoptosis may be multifaceted. Prolonged neutrophil survival 
can delay the adaptive immune response, through a reduc-
tion in formation of apoptotic vesicles that would otherwise be 
ingested by monocytes or DCs and trafficked to lymph nodes 
for antigen presentation, as occurs in Mycobacterium tuberculosis 
(12). In addition, despite limited viral replication in neutrophils, 
there is evidence that the neutrophil may be used by the virus 
for dissemination. Circulating HCMV-infected neutrophils may 
act as a “Trojan horse” to infect other cell types, as neutrophils 
infected by co-culture are seen to transmit to naive permissive 
cells via cell-to-cell transfer of viral particles, even up to 48  h 
after initial separation (33). HCMV infection often results in a 
concerted antiapoptotic response to prolong host cell lifespan 
for replication, and during lytic infection, the virus encodes an 
array of antiapoptotic proteins that target caspase-8 (UL36) (75), 
mitochondrial membrane stability (UL37 ×  1) (76), ER stress 
(UL38) (77), ATP production (b2.7) (78), and p53 (IE2) (79). 
The survival effect we observe in neutrophils, involving a likely 
virion–cell surface interaction, is similar to that observed during 
non-permissive infection of CD14+ and CD34+ cells (51, 52), 
where ERK and PI3K signaling were shown to be key. In that 
study, HCMV glycoprotein B was an important agonist of the 
survival response in CD34+ cells, yet this seems unlikely to be 
the case here since AD169 is not protective. It is possible that the 
model proposed for the survival of monocytes, which requires 
multiple signaling events, could be relevant in the neutrophil (80).
Furthermore, the cytokine profile we see here released by the 
longer-lived HCMV-exposed neutrophils appears to provide a 
further advantage to the virus through further potentiation of 
neutrophil survival and through effects on circulating monocytes, 
through recruitment, differentiation, and activation to render 
these cells permissive for HCMV. We were unable to identify the 
survival factor(s) present in the secretome, as our screen of 29 
cytokines did not highlight any prosurvival factors upregulated 
in Merlin supernatants and an array of 39 more growth factors 
and soluble receptors failed to identify any other significantly 
upregulated factors (data not shown). However, we were able 
to pinpoint IL-6 as a contributor to monocyte permissivity. The 
reactivation of HCMV has been previously reported from mono-
cytes activated by cytokine stimulation including IL-6 (81), 
suggesting that limited monocyte differentiation/activation may 
be sufficient to trigger a permissive phenotype, which is consist-
ent with our data. However, acute treatment with recombinant 
IL-6 has not been shown to induce monocyte permissiveness for 
HCMV infection alone (82), implying that either the effects of 
IL-6 are chronic long-term effects or, in fact, may be working in 
concert with other factors. A likely candidate is IL-13, which we 
observed the upregulation of in our secretome analyses. IL-13 
is a member of the IL-4 cytokine family and has been shown to 
support monocyte differentiation (83)—a hypothesis consistent 
with the knowledge that differentiation is a key determinant of 
myeloid cell permissiveness for HCMV infection (84).
In the context of a HCMV infection in vivo, the induction of 
a pro-survival secretome is highly suggestive of a host antiviral 
response, so this appears to represent an antiviral strategy of unex-
pected benefit to HCMV. Neutrophils are among the first cells to 
traffic to the site of primary HCMV infection, with cross-cellular 
communications a crucial component of the initial response. This 
in turn leads to monocyte recruitment, to promote clearance of 
apoptotic debris generated by the initial neutrophil response, 
which here would facilitate enhanced dissemination of HCMV, a 
process in which monocytes are argued to be key (85, 86).
The absence of the phenotype with the non-virulent strain 
AD169 implies that the survival effect is due to a virulence gene, 
non-essential for growth, which has been lost or mutated in 
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AD169 through extensive passage. Unfortunately, our screen of 
ULb′ knockouts did not identify any single gene to be responsi-
ble, and AD169 carries many other mutations besides the ULb′ 
deletion that could be responsible. We included a Merlin mutant 
lacking UL131A, which lies just outside the ULb′ region and is 
essential for the formation of the intact gH-gL-UL128-UL130-
UL131A pentameric complex, required for leukocyte tropism and 
entry; although UL131A carries a truncation mutation in AD169 
and would seem a likely candidate, once again no change to the 
phenotype was seen. Repeated attempts to generate a knockout of 
the whole ULb′ region against a Merlin backbone have not been 
successful to date, but if available in the future, such a mutant 
would help to address the question of whether the survival effect 
is due to a combinatorial effect of ULb′ genes, or another gene 
mutated in AD169 and present in the virion. HCMV contains 
at least 59 structural proteins (87), including the antiapoptotic 
UL38, and some of these carry mutations in AD169, including 
the membrane glycoprotein O (UL74) that forms the gH-gL-gO 
entry complex (88, 89). Of particular interest are UL36, an inhibi-
tor of caspase-induced apoptosis (75), its antiapoptotic intronic 
micro-RNA mir-UL36-5p (90), and the pro-survival non-coding 
RNA b2.7 (78). All three are present in or carried on the virion 
(91, 92), carry at least minor mutations in AD169 (88, 89, 91), 
and are targets for further investigation.
In summary, we have demonstrated for the first time that 
the HCMV virion has a profound effect on neutrophil biology, 
delaying apoptosis and inducing the release of a highly bioactive 
secretome with the capacity to propagate neutrophil survival and 
to induce monocyte chemotaxis and differentiation to a permis-
sive, anti-inflammatory phenotype. In the context of clinical 
infection, this is likely to represent a host response that provides 
an unexpected benefit to the virus, and although significant 
resolution of infection is likely to occur, differentiating mono-
cytes provide the ideal vehicle for viral dissemination and the 
establishment of a lifelong persistent infection. A persistent infec-
tion without pathology in the host would, in evolutionary terms, 
represent an ideal scenario for the virus. This report highlights 
how the interaction of a viral pathogen with a cell type not capa-
ble of supporting lytic infection can still have a pronounced effect 
on both the biology of that cell and the wider immune response.
eThics sTaTeMenT
This study was carried out in accordance with the recommen-
dations of the Cambridge Local Research Ethics Committee 
(06/Q0108/281) with written informed consent from all subjects. 
All subjects gave written informed consent in accordance with 
the Declaration of Helsinki. The protocol was approved by the 
Cambridge Local Research Ethics Committee.
aUThOr cOnTriBUTiOns
JP, DS, JJ, MR, EC, and AC designed and performed experiments 
and analyzed data. JP wrote the manuscript with input from MR. 
MR, MW, AC, and EC all provided editorial input. All authors 
contributed to the drafting and revising of the manuscript and 
have approved the final version.
acKnOWleDgMenTs
We are grateful to Keith Burling (NIHR-Cambridge BRC Core 
Biochemical Assay Laboratory) for technical support and Dr. 
Peter Tomasec (University of Cardiff) for gifting the HCMV 
mutant strains.
FUnDing
This work was funded by the MRC, the Gates Foundation, NIHR 
Cambridge Biomedical Research Centre (BRC), and Papworth 
Hospital. JP is supported by a MRC Clinical Research Training 
Fellowship (MR/L002108/1) and the Addenbrooke’s Charitable 
Trust, MR is supported by a MRC Career Development Award 
(G:0900466) and MW is supported by a MRC Programme Grant 
(G:0701279).
reFerences
1. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of 
apoptotic cells regulates immune responses. Nat Rev Immunol (2002) 2(12): 
965–75. doi:10.1038/nri957 
2. Watson RW, Rotstein OD, Nathens AB, Parodo J, Marshall JC. Neutrophil 
apoptosis is modulated by endothelial transmigration and adhesion molecule 
engagement. J Immunol (1997) 158(2):945–53. 
3. Walmsley SR, Print C, Farahi N, Peyssonnaux C, Johnson RS, Cramer T, 
et  al. Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-
dependent NF-kappaB activity. J Exp Med (2005) 201(1):105–15. doi:10.1084/
jem.20040624 
4. Cowburn AS, Cadwallader KA, Reed BJ, Farahi N, Chilvers ER. Role of 
PI3-kinase-dependent Bad phosphorylation and altered transcription in cyto-
kine-mediated neutrophil survival. Blood (2002) 100(7):2607–16. doi:10.1182/
blood-2001-11-0122 
5. Sabroe I, Dower SK, Whyte MK. The role of Toll-like receptors in the regula-
tion of neutrophil migration, activation, and apoptosis. Clin Infect Dis (2005) 
41(Suppl 7):S421–6. doi:10.1086/431992 
6. Haslett C, Savill JS, Whyte MK, Stern M, Dransfield I, Meagher LC. Granulo-
cyte apoptosis and the control of inflammation. Philos Trans R Soc Lond B Biol 
Sci (1994) 345(1313):327–33. doi:10.1098/rstb.1994.0113 
7. Edwards SW, Hallett MB. Seeing the wood for the trees: the forgotten role 
of neutrophils in rheumatoid arthritis. Immunol Today (1997) 18(7):320–4. 
doi:10.1016/S0167-5699(97)01087-6 
8. Aleman M, Schierloh P, de la Barrera SS, Musella RM, Saab MA, Baldini M, 
et al. Mycobacterium tuberculosis triggers apoptosis in peripheral neutrophils 
involving toll-like receptor 2 and p38 mitogen protein kinase in tubercu-
losis patients. Infect Immun (2004) 72(9):5150–8. doi:10.1128/IAI.72.9.5150- 
5158.2004 
9. Ramirez MJ, Titos E, Claria J, Navasa M, Fernandez J, Rodes J. Increased 
apoptosis dependent on caspase-3 activity in polymorphonuclear leuko-
cytes from patients with cirrhosis and ascites. J Hepatol (2004) 41(1):44–8. 
doi:10.1016/j.jhep.2004.03.011 
10. Yoshiie K, Kim HY, Mott J, Rikihisa Y. Intracellular infection by the human 
granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis. Infect 
Immun (2000) 68(3):1125–33. doi:10.1128/IAI.68.3.1125-1133.2000 
11. Schwartz JT, Barker JH, Kaufman J, Fayram DC, McCracken JM, Allen LA. 
Francisella tularensis inhibits the intrinsic and extrinsic pathways to delay 
constitutive apoptosis and prolong human neutrophil lifespan. J Immunol 
(2012) 188(7):3351–63. doi:10.4049/jimmunol.1102863 
12. Blomgran R, Desvignes L, Briken V, Ernst JD. Mycobacterium tuberculosis 
inhibits neutrophil apoptosis, leading to delayed activation of naive CD4 
T cells. Cell Host Microbe (2012) 11(1):81–90. doi:10.1016/j.chom.2011.11.012 
16
Pocock et al. Interaction of HCMV with Neutrophils
Frontiers in Immunology | www.frontiersin.org September 2017 | Volume 8 | Article 1185
13. Laskay T, van Zandbergen G, Solbach W. Neutrophil granulocytes as host 
cells and transport vehicles for intracellular pathogens: apoptosis as infection- 
promoting factor. Immunobiology (2008) 213(3–4):183–91. doi:10.1016/j.
imbio.2007.11.010 
14. Bastian A, Schafer H. Human alpha-defensin 1 (HNP-1) inhibits adenoviral 
infection in  vitro. Regul Pept (2001) 101(1–3):157–61. doi:10.1016/S0167- 
0115(01)00282-8 
15. Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, et  al. Theta 
defensins protect cells from infection by herpes simplex virus by inhibiting 
viral adhesion and entry. J Virol (2004) 78(10):5147–56. doi:10.1128/JVI.78. 
10.5147-5156.2004 
16. Wu Z, Cocchi F, Gentles D, Ericksen B, Lubkowski J, Devico A, et al. Human 
neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro. FEBS Lett (2005) 
579(1):162–6. doi:10.1016/j.febslet.2004.11.062 
17. Stacey MA, Marsden M, Pham NTA, Clare S, Dolton G, Stack G, et al. Neutro-
phils recruited by IL-22 in peripheral tissues function as TRAIL-dependent 
antiviral effectors against MCMV. Cell Host Microbe (2014) 15(4):471–83. 
doi:10.1016/j.chom.2014.03.003 
18. van Gisbergen KP, Sanchez-Hernandez M, Geijtenbeek TB, van Kooyk Y. 
Neutrophils mediate immune modulation of dendritic cells through 
glycosylation-dependent interactions between Mac-1 and DC-SIGN. J Exp 
Med (2005) 201(8):1281–92. doi:10.1084/jem.20041276 
19. Scapini P, Lapinet-Vera JA, Gasperini S, Calzetti F, Bazzoni F, Cassatella MA. 
The neutrophil as a cellular source of chemokines. Immunol Rev (2000) 177: 
195–203. doi:10.1034/j.1600-065X.2000.17706.x 
20. Legendre C, Pascual M. Improving outcomes for solid-organ transplant recip-
ients at risk from cytomegalovirus infection: late-onset disease and indirect 
consequences. Clin Infect Dis (2008) 46(5):732–40. doi:10.1086/527397 
21. Limaye AP, Kirby KA, Rubenfeld GD, Leisenring WM, Bulger EM, Neff MJ, 
et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. 
JAMA (2008) 300(4):413–22. doi:10.1001/jama.2008.697 
22. Peggs KS, Mackinnon S. Cytomegalovirus: the role of CMV post- 
haematopoietic stem cell transplantation. Int J Biochem Cell Biol (2004) 36(4): 
695–701. doi:10.1016/j.biocel.2003.08.008 
23. Sinzger C, Digel M, Jahn G. Cytomegalovirus cell tropism. In: Shenk TE, Stinski 
MF, editors. Human Cytomegalovirus: Current Topics in Microbiology and 
Immunology, Vol. 325. (Berlin; Heidelberg: Springer) (2008). p. 63–83
24. Taylor-Wiedeman J, Hayhurst GP, Sissons JG, Sinclair JH. Polymorphonuclear 
cells are not sites of persistence of human cytomegalovirus in healthy 
individuals. J Gen Virol (1993) 74(Pt 2):265–8. doi:10.1099/0022-1317-74- 
2-265 
25. Gerna G, Zipeto D, Percivalle E, Parea M, Revello MG, Maccario R, et  al. 
Human cytomegalovirus infection of the major leukocyte subpopulations 
and evidence for initial viral replication in polymorphonuclear leukocytes 
from viremic patients. J Infect Dis (1992) 166(6):1236–44. doi:10.1093/infdis/ 
166.6.1236 
26. Gerna G, Baldanti F, Lilleri D, Parea M, Torsellini M, Castiglioni B, et  al. 
Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for 
guiding preemptive therapy in heart and lung transplant recipients: a pro-
spective, randomized, controlled, open-label trial. Transplantation (2003) 
75(7):1012–9. doi:10.1097/01.TP.0000057239.32192.B9 
27. Kas-Deelen AM, The TH, Blom N, van der Strate BW, De Maar EF, Smit J, et al. 
Uptake of pp65 in in vitro generated pp65-positive polymorphonuclear cells 
mediated by phagocytosis and cell fusion? Intervirology (2001) 44(1):8–13. 
doi:10.1159/000050024 
28. Turtinen LW, Saltzman R, Jordan MC, Haase AT. Interactions of human 
cytomegalovirus with leukocytes in  vivo: analysis by in  situ hybridization. 
Microb Pathog (1987) 3(4):287–97. doi:10.1016/0882-4010(87)90062-3 
29. Dankner WM, McCutchan JA, Richman DD, Hirata K, Spector SA. Localiza-
tion of human cytomegalovirus in peripheral blood leukocytes by in  situ 
hybridization. J Infect Dis (1990) 161(1):31–6. doi:10.1093/infdis/161.1.31 
30. Grefte A, Harmsen MC, van der Giessen M, Knollema S, van Son WJ, The TH. 
Presence of human cytomegalovirus (HCMV) immediate early mRNA but 
not ppUL83 (lower matrix protein pp65) mRNA in polymorphonuclear and 
mononuclear leukocytes during active HCMV infection. J Gen Virol (1994) 
75(8):1989–98. doi:10.1099/0022-1317-75-8-1989 
31. Gerna G, Percivalle E, Baldanti F, Sozzani S, Lanzarini P, Genini E, et  al. 
Human cytomegalovirus replicates abortively in polymorphonuclear 
leukocytes after transfer from infected endothelial cells via transient micro-
fusion events. J Virol (2000) 74(12):5629–38. doi:10.1128/JVI.74.12.5629- 
5638.2000 
32. Skarman PJ, Rahbar A, Xie X, Soderberg-Naucler C. Induction of polymor-
phonuclear leukocyte response by human cytomegalovirus. Microbes Infect 
(2006) 8(6):1592–601. doi:10.1016/j.micinf.2006.01.017 
33. Saez-Lopez C, Ngambe-Tourere E, Rosenzwajg M, Petit JC, Nicolas JC, Gozlan J. 
Immediate-early antigen expression and modulation of apoptosis after in   
vitro infection of polymorphonuclear leukocytes by human cytomegalovirus. 
Microbes Infect (2005) 7(9–10):1139–49. doi:10.1016/j.micinf.2005.03.021 
34. Duggan MA, Pomponi C, Robboy SJ. Pulmonary cytology of the acquired 
immune deficiency syndrome: an analysis of 36 cases. Diagn Cytopathol (1986) 
2(3):181–6. doi:10.1002/dc.2840020302 
35. Granter SR, Doolittle MH, Renshaw AA. Predominance of neutrophils in 
the cerebrospinal fluid of AIDS patients with cytomegalovirus radiculopathy. 
Am J Clin Pathol (1996) 105(3):364–6. doi:10.1093/ajcp/105.3.364 
36. Penfold ME, Dairaghi DJ, Duke GM, Saederup N, Mocarski ES, Kemble GW, 
et al. Cytomegalovirus encodes a potent alpha chemokine. Proc Natl Acad Sci 
U S A (1999) 96(17):9839–44. doi:10.1073/pnas.96.17.9839 
37. Luttichau HR. The cytomegalovirus UL146 gene product vCXCL1 targets 
both CXCR1 and CXCR2 as an agonist. J Biol Chem (2010) 285(12):9137–46. 
doi:10.1074/jbc.M109.002774 
38. Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH. Monocytes are 
a major site of persistence of human cytomegalovirus in peripheral blood 
mononuclear cells. J Gen Virol (1991) 72(9):2059–64. doi:10.1099/0022-1317- 
72-9-2059 
39. Compton T. Analysis of cytomegalovirus ligands, receptors, and the entry 
pathway. In:  Sinclair  J, editor. Methods in Molecular Medicine: Cytomegalo­
virus Protocols. New York, NY: Humana Press (2000). p. 53–65.
40. Stanton RJ, Baluchova K, Dargan DJ, Cunningham C, Sheehy O, Seirafian S, 
et al. Reconstruction of the complete human cytomegalovirus genome in a 
BAC reveals RL13 to be a potent inhibitor of replication. J Clin Invest (2010) 
120(9):3191–208. doi:10.1172/JCI42955 
41. Haslett C, Guthrie LA, Kopaniak MM, Johnston  RB Jr, Henson PM. 
Modulation of multiple neutrophil functions by preparative methods or 
trace concentrations of bacterial lipopolysaccharide. Am J Pathol (1985) 
119(1):101–10. 
42. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative 
CT method. Nat Protoc (2008) 3:1101–8. doi:10.1038/nprot.2008.73 
43. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C. 
Macrophage phagocytosis of aging neutrophils in inflammation. Programmed 
cell death in the neutrophil leads to its recognition by macrophages. J Clin 
Invest (1989) 83(3):865–75. doi:10.1172/JCI113970 
44. Cowburn AS, Deighton J, Walmsley SR, Chilvers ER. The survival effect of 
TNF-alpha in human neutrophils is mediated via NF-kappa B-dependent IL-8 
release. Eur J Immunol (2004) 34(6):1733–43. doi:10.1002/eji.200425091 
45. He R, Ruan Q, Qi Y, Ma YP, Huang YJ, Sun ZR, et al. Sequence variability 
of human cytomegalovirus UL146 and UL147 genes in low-passage clinical 
isolates. Intervirology (2006) 49(4):215–23. doi:10.1159/000091468 
46. Sinzger C, Hahn G, Digel M, Katona R, Sampaio KL, Messerle M, et al. Cloning 
and sequencing of a highly productive, endotheliotropic virus strain derived 
from human cytomegalovirus TB40/E. J Gen Virol (2008) 89(Pt 2):359–68. 
doi:10.1099/vir.0.83286-0 
47. François S, El Benna J, Dang PM, Pedruzzi E, Gougerot-Pocidalo MA, 
Elbim C. Inhibition of neutrophil apoptosis by TLR agonists in whole blood: 
involvement of the phosphoinositide 3-kinase/Akt and NF-kappaB signaling 
pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad. 
J Immunol (2005) 174(6):3633–42. doi:10.4049/jimmunol.174.6.3633 
48. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, 
et  al. Human cytomegalovirus activates inflammatory cytokine responses 
via CD14 and toll-like receptor 2. J Virol (2003) 77(8):4588–96. doi:10.1128/
JVI.77.8.4588-4596.2003 
49. Sabroe I, Jones EC, Usher LR, Whyte MK, Dower SK. Toll-like receptor 
(TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role 
for monocytes in leukocyte lipopolysaccharide responses. J Immunol (2002) 
168(9):4701–10. doi:10.4049/jimmunol.168.9.4701 
50. Coleman CM, Plant K, Newton S, Hobson L, Whyte MK, Everard ML. The 
anti-apoptotic effect of respiratory syncytial virus on human peripheral blood 
neutrophils is mediated by a monocyte derived soluble factor. Open Virol 
J (2011) 5:114–23. doi:10.2174/1874357901105010114 
17
Pocock et al. Interaction of HCMV with Neutrophils
Frontiers in Immunology | www.frontiersin.org September 2017 | Volume 8 | Article 1185
51. Reeves MB, Breidenstein A, Compton T. Human cytomegalovirus activation 
of ERK and myeloid cell leukemia-1 protein correlates with survival of latently 
infected cells. Proc Natl Acad Sci U S A (2012) 109(2):588–93. doi:10.1073/
pnas.1114966108 
52. Chan G, Nogalski MT, Bentz GL, Smith MS, Parmater A, Yurochko AD. PI3K-
dependent upregulation of Mcl-1 by human cytomegalovirus is mediated by 
epidermal growth factor receptor and inhibits apoptosis in short-lived mono-
cytes. J Immunol (2010) 184(6):3213–22. doi:10.4049/jimmunol.0903025 
53. Yurochko AD, Hwang ES, Rasmussen L, Keay S, Pereira L, Huang ES. The 
human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands 
initiate the rapid activation of Sp1 and NF-kappaB during infection. J Virol 
(1997) 71(7):5051–9. 
54. Dyugovskaya L, Polyakov A, Cohen-Kaplan V, Lavie P, Lavie L. Bax/Mcl-1 
balance affects neutrophil survival in intermittent hypoxia and obstructive 
sleep apnea: effects of p38MAPK and ERK1/2 signaling. J Transl Med (2012) 
10:211. doi:10.1186/1479-5876-10-211 
55. Cha TA, Tom E, Kemble GW, Duke GM, Mocarski ES, Spaete RR. Human 
cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory 
strains. J Virol (1996) 70(1):78–83. 
56. Miller-Kittrell M, Sai J, Penfold M, Richmond A, Sparer TE. Functional char-
acterization of chimpanzee cytomegalovirus chemokine, vCXCL-1(CCMV). 
Virology (2007) 364(2):454–65. doi:10.1016/j.virol.2007.03.002 
57. Smith W, Tomasec P, Aicheler R, Loewendorf A, Nemčovičová I, Wang EC, 
et  al. Human cytomegalovirus glycoprotein UL141 targets the TRAIL death 
receptors to thwart host innate antiviral defenses. Cell Host Microbe (2013) 
13(3):324–35. doi:10.1016/j.chom.2013.02.003 
58. Murphy E, Yu D, Grimwood J, Schmutz J, Dickson M, Jarvis MA, et  al. 
Coding potential of laboratory and clinical strains of human cytomegalo-
virus. Proc Natl Acad Sci U S A (2003) 100(25):14976–81. doi:10.1073/pnas. 
2136652100 
59. Chee MS, Bankier AT, Beck S, Bohni R, Brown CM, Cerny R, et al. Analysis of 
the protein-coding content of the sequence of human cytomegalovirus strain 
AD169. Curr Top Microbiol Immunol (1990) 154:125–69. 
60. Hahn G, Revello MG, Patrone M, Percivalle E, Campanini G, Sarasini A, et al.  
Human cytomegalovirus UL131-128 genes are indispensible for virus growth 
in endothelial cells and virus transfer to leukocytes. J Virol (2004) 78(18): 
10023–33. doi:10.1128/JVI.78.18.10023-10033.2004 
61. Avdic S, McSharry BP, Steain M, Poole E, Sinclair J, Abendroth A, et al. Human 
cytomegalovirus-encoded human interleukin-10 (IL-10) homolog amplifies 
its immunomodulatory potential by upregulating human IL-10 in monocytes. 
J Virol (2016) 90(8):3819–27. doi:10.1128/JVI.03066-15 
62. Lewkowicz N, Mycko MP, Przygodzka P, Ćwiklińska H, Cichalewska M, 
Matysiak M, et  al. Induction of human IL-10-producing neutrophils by 
LPS-stimulated Treg cells and IL-10. Mucosal Immunol (2016) 9(2):364–78. 
doi:10.1038/mi.2015.66 
63. Leuenroth S, Lee C, Grutkoski P, Keeping H, Simms HH. Interleukin-8-
induced suppression of polymorphonuclear leukocyte apoptosis is mediated 
by suppressing CD95 (Fas/Apo-1) Fas-1 interactions. Surgery (1998) 
124:409–17. doi:10.1016/S0039-6060(98)70148-5 
64. Kettritz R, Gaido ML, Haller H, Luft FC, Jennette CJ, Falk RJ. Interleukin-8 
delays spontaneous and tumor necrosis factor-alpha mediated apoptosis of 
human neutrophils. Kidney Int (1998) 53:84–91. doi:10.1046/j.1523-1755. 
1998.00741.x 
65. Avdic S, Cao JZ, McSharry BP, Clancy LE, Brown R, Steain M, et al. Human 
cytomegalovirus interleukin-10 polarizes monocytes toward a deactivated M2c 
phenotype to repress host immune responses. J Virol (2013) 87(18):10273–82. 
doi:10.1128/JVI.00912-13 
66. Lee KS, Baek DW, Kim KH, Shin BS, Lee DH, Kim JW, et al. IL-10-dependent 
down-regulation of MHC class II expression level on monocytes by perito-
neal fluid from endometriosis patients. Int Immunopharmacol (2005) 5(12): 
1699–712. doi:10.1016/j.intimp.2005.05.004 
67. Grundy JE, Lawson KM, MacCormac LP, Fletcher JM, Yong KL. 
Cytomegalovirus-infected endothelial cells recruit neutrophils by the secre-
tion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial 
cell contact and during neutrophil transendothelial migration. J Infect Dis 
(1998) 177(6):1465–74. doi:10.1086/515300 
68. Craigen JL, Yong KL, Jordan NJ, MacCormac LP, Westwick J, Akbar AN, et al. 
Human cytomegalovirus infection upregulates interleukin-8 gene expression 
and stimulates neutrophil transendothelial migration. Immunology (1997) 
92:138. doi:10.1046/j.1365-2567.1997.00310.x 
69. La Gruta NL, Kedzierska K, Stambas J, Doherty PC. A question of self- 
preservation: immunopathology in influenza virus infection. Immunol Cell 
Biol (2007) 85:85–92. doi:10.1038/sj.icb.7100026 
70. Cortjens B, de Boer OJ, de Jong R, Antonis AF, Sabogal Piñeros YS, Lutter R, 
et  al. Neutrophil extracellular traps cause airway obstruction during respi-
ratory syncytial virus disease. J Pathol (2016) 238(3):401–11. doi:10.1002/
path.4660 
71. Rahbar A, Bostrom L, Lagerstedt U, Magnusson I, Soderberg-Naucler C, 
Sundqvist V. Evidence of active cytomegalovirus infection and increased 
production of IL-6 in tissue specimens obtained from patients with inflam-
matory bowel diseases. Inflamm Bowel Dis (2003) 9(3):154–61. doi:10.1097/ 
00054725-200305000-00002 
72. Zhang G, Zhou KF, Lu ZH. Interleukin-17 enhances the removal of respiratory 
syncytial virus in mice by promoting neutrophilmigration and reducing 
interferon-gamma expression. Genet Mol Res (2016) 15(1):1–8. doi:10.4238/
gmr.15017002 
73. Zhang L, Yu W, He T, Yu J, Caffrey RE, Dalmasso EA, et  al. Contribution 
of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 
antiviral factor. Science (2002) 298(5595):995–1000. doi:10.1126/science. 
1076185 
74. Bai F, Kong KF, Dai J, Qian F, Zhang L, Brown CR, et al. A paradoxical role 
for neutrophils in the pathogenesis of West Nile virus. J Infect Dis (2010) 
202:1804–12. doi:10.1086/657416 
75. Skaletskaya A, Bartle LM, Chittenden T, McCormick AL, Mocarski ES, 
Goldmacher VS. A cytomegalovirus-encoded inhibitor of apoptosis that sup-
presses caspase-8 activation. Proc Natl Acad Sci U S A (2001) 98(14):7829–34. 
doi:10.1073/pnas.141108798 
76. Goldmacher VS, Bartle LM, Skaletskaya A, Dionne CA, Kedersha NL, Vater CA, 
et  al. A cytomegalovirus-encoded mitochondria-localized inhibitor of apop-
tosis structurally unrelated to Bcl-2. Proc Natl Acad Sci U S A (1999) 96(22): 
12536–41. doi:10.1073/pnas.96.22.12536 
77. Terhune S, Torigoi E, Moorman N, Silva M, Qian Z, Shenk T, et al. Human 
cytomegalovirus UL38 protein blocks apoptosis. J Virol (2007) 81(7):3109–23. 
doi:10.1128/JVI.02124-06 
78. Reeves MB, Davies AA, McSharry BP, Wilkinson GW, Sinclair JH. 
Complex I binding by a virally encoded RNA regulates mitochondria-in-
duced cell death. Science (2007) 316(5829):1345–8. doi:10.1126/science. 
1142984 
79. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, et al. Potential 
role of human cytomegalovirus and p53 interaction in coronary restenosis. 
Science (1994) 265(5170):391–4. doi:10.1126/science.8023160 
80. Stevenson EV, Collins-McMillen D, Kim JH, Cieply SJ, Bentz GL, 
Yurochko AD. HCMV reprogramming of infected monocyte survival and 
differentiation: a goldilocks phenomenon. Viruses (2014) 6(2):782–807. 
doi:10.3390/v6020782 
81. Hargett D, Shenk TE. Experimental human cytomegalovirus latency in CD14+ 
monocytes. Proc Natl Acad Sci U S A (2010) 107(46):20039–44. doi:10.1073/
pnas.1014509107 
82. Kew VG, Wills MR, Reeves MB. LPS promotes a monocyte phenotype 
permissive for human cytomegalovirus immediate-early gene expression 
upon infection but not reactivation from latency. Sci Rep (2017) 7(1):810. 
doi:10.1038/s41598-017-00999-8 
83. Sato K, Nagayama H, Tadokoro K, Juji T, Takahashi TA. Interleukin-13 is 
involved in functional maturation of human peripheral blood monocyte- 
derived dendritic cells. Exp Hematol (1999) 27(2):326–36. doi:10.1016/S0301- 
472X(98)00046-0 
84. Lathey JL, Spector SA. Unrestricted replication of human cytomegalovirus 
in hydrocortisone-treated macrophages. J Virol (1991) 65(11):6371–5. 
85. Chan G, Nogalski MT, Stevenson EV, Yurochko AD. Human cytomegalovirus 
induction of a unique signalsome during viral entry into monocytes mediates 
distinct functional changes: a strategy for viral dissemination. J Leukoc Biol 
(2012) 92(4):743–52. doi:10.1189/jlb.0112040 
86. Daley-Bauer LP, Roback LJ, Wynn GM, Mocarski ES. Cytomegalovirus 
hijacks CX3CR1(hi) patrolling monocytes as immune-privileged vehicles for 
dissemination in mice. Cell Host Microbe (2014) 15(3):351–62. doi:10.1016/ 
j.chom.2014.02.002 
18
Pocock et al. Interaction of HCMV with Neutrophils
Frontiers in Immunology | www.frontiersin.org September 2017 | Volume 8 | Article 1185
87. Varnum SM, Streblow DN, Monroe ME, Smith P, Auberry KJ, Pasa-Tolic L, 
et al. Identification of proteins in human cytomegalovirus (HCMV) particles: 
the HCMV proteome. J Virol (2004) 78(20):10960–6. doi:10.1128/JVI.78.20. 
10960-10966.2004 
88. Bradley AJ, Lurain NS, Ghazal P, Trivedi U, Cunningham C, Baluchova K, 
et al. High-throughput sequence analysis of variants of human cytomegalo-
virus strains Towne and AD169. J Gen Virol (2009) 90:2375–80. doi:10.1099/
vir.0.013250-0 
89. Mocarski ESJ. Betaherpes Viral Genes and Their Functions (Chap. 15). 
Cambridge: Cam bridge University Press (2007).
90. Guo X, Huang Y, Qi Y, Liu Z, Ma Y, Shao Y, et al. Human cytomegalovirus 
miR-UL36-5p inhibits apoptosis via downregulation of adenine nucleo-
tide translocator 3 in cultured cells. Arch Virol (2015) 160(10):2483–90. 
doi:10.1007/s00705-015-2498-8 
91. Patterson CE, Shenk T. Human cytomegalovirus UL36 protein is dispensable 
for viral replication in cultured cells. J Virol (1999) 73(9):7126–31. 
92. Mohammad AA, Costa H, Landázuri N, Lui WO, Hultenby K, Rahbar A, 
et al. Human cytomegalovirus microRNAs are carried by virions and dense 
bodies and are delivered to target cells. J Gen Virol (2017) 98(5):1058–72. 
doi:10.1099/jgv.0.000736 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2017 Pocock, Storisteanu, Reeves, Juss, Wills, Cowburn and Chilvers. 
This is an open­access article distributed under the terms of the Creative Commons 
Attribution License (CC BY). The use, distribution or reproduction in other forums is 
permitted, provided the original author(s) or licensor are credited and that the original 
publication in this journal is cited, in accordance with accepted academic practice. 
No use, distribution or reproduction is permitted which does not comply with these terms.
Article
The Rockefeller University Press  $30.00
J. Exp. Med. 2017 Vol. 214 No. 4 1111–1128
https://doi.org/10.1084/jem.20161382
T
h
e 
Jo
u
rn
al
 o
f 
E
xp
er
im
en
ta
l 
M
ed
ic
in
e
1111
IntroductIon
Infectious diseases cause major morbidity and mortality 
worldwide. For example, specific serovars of Salmonella such 
as typhi and paratyphi cause typhoid fever (enteric fever), 
whereas nontyphi Salmonella can also cause invasive systemic 
infection (Dougan et al., 2011; Gilchrist et al., 2015). Both 
can be fatal, particularly in immunocompromised hosts. Our 
understanding of the immune response to such common and 
serious pathogens remains incomplete, though infection of 
mice with S. Typhimurium provides a useful model of immu-
nity to this bacterium and others that colonize macrophages 
(Chatfield et al., 1992; Conlan, 1997; Richter-Dahlfors et 
al., 1997; Mastroeni et al., 2000; Vazquez-Torres et al., 2000a, 
2004; Burton et al., 2014). Specific elements of both innate 
and adaptive immunity are needed to control Salmonella and 
other intracellular pathogens. Mononuclear phagocytes, par-
ticularly those in the liver and spleen, restrict bacterial rep-
lication in the initial phase of a primary invasive infection. 
Control of the pathogen requires (i) the effective initiation 
of an inflammatory response via TLR (Vazquez-Torres et al., 
2004) and NOD-like receptors (NLRs; Broz et al., 2012), 
(ii) the production of inflammatory cytokines, such as IFN-γ 
and TNF (Nakano et al., 1990), and (iii) the activation of an 
arsenal of antibacterial strategies within the phagosome, in-
cluding the generation of the phagocyte respiratory burst, 
the generation of reactive nitrogen species (Burton et al., 
2014) and the use of efflux pumps to deprive the bacteria 
of divalent cations (Vidal et al., 1995; Mastroeni et al., 2000; 
Vazquez-Torres et al., 2000a).
The importance of these strategies is well documented, 
but the phagocyte respiratory burst is of particular interest be-
cause it has a nonredundant role in preventing overwhelming 
infection that is highly conserved between mouse (Mastroeni 
et al., 2000; Vazquez-Torres et al., 2000a,b) and man (van den 
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Berg et al., 2009). The respiratory burst is a process by which 
superoxide and hydrogen peroxide ions are generated within 
the phagosome and at the cell surface. The ions are likely 
to be both directly and indirectly cytotoxic to the bacteria 
(and fungi), as the production of superoxide and hydrogen 
peroxide anions also activates other anti-bacterial mecha-
nisms (Segal, 2005). Hydrogen peroxide reacts with halide 
ions (such as chloride or iodide) to produce the anti-bacterial 
compound, hypochlorite (Klebanoff et al., 1966; Klebanoff, 
1967). Crucially, this process is catalyzed by myeloperoxi-
dase, which is abundant in neutrophil granules. Hypochlorite, 
the product of this reaction, is itself a potent microbiocidal 
agent. It is also a precursor of the chloramines, which are oxi-
dized halogens that also exhibit antimicrobial activity and are 
formed by the reaction of oxidized halogens with ammonia 
or amines (Babior, 1984).
The reactive oxygen species are generated by the phago-
cyte NAD PH oxidase, a multiprotein complex that comprises 
both membrane bound and cytosolic components. The mem-
brane-associated heterodimer, cytochrome b558, consists of 
gp91phox and p22phox subunits (Segal, 1987; Teahan et al., 
1987) and is essential for electron transfer from NAD PH to 
molecular oxygen. The cytosolic components p47phox (Kim 
and Dinauer, 2006), p67phox, p40phox, and the small G pro-
teins Rac1 and Rac2 (Roberts et al., 1999; Yamauchi et al., 
2004) are required for full activation. Deficiencies in indi-
vidual subunits of the complex cause chronic granulomatous 
disease (CGD; Berendes et al., 1957; Rae et al., 2000, a severe 
immunodeficiency characterized not only by life threaten-
ing infections but also by autoimmune manifestations, such 
as inflammatory bowel disease (Singel and Segal, 2016). The 
most common cause of CGD, X-linked gp91phox deficiency 
(Segal, 1987; Teahan et al., 1987), is associated with a signifi-
cantly reduced life expectancy. Of note, the most frequent 
causes of septicemia in patients with CGD are Salmonella 
species (van den Berg et al., 2009).
The genome-wide set of targeted mutations in mouse 
ES cells established by the KOMP, EUC OMM, and MirKO 
programs provides an opportunity to conduct systematic, 
large-scale gene function analysis in a mammalian system 
(Ayadi et al., 2012; White et al., 2013). Therefore, to uncover 
new pathways involved in host defense, we screened hun-
dreds of knockout mouse lines for susceptibility to infection 
by inoculating mice generated through KOMP with an at-
tenuated form of the intracellular pathogen, S. Typhimurium 
() In this study, we show that mice deficient in a previously 
uncharacterized gene, bc017643, are highly susceptible to 
Salmonella and Listeria infection and are impaired in their 
ability to control replication of either pathogen. We show that 
this is because bc017643 encodes a gene, which we name 
Eros (essential for reactive oxygen species), that is necessary 
for the phagocyte respiratory burst. Eros is necessary for sta-
ble expression of the gp91phox and p22phox subunits of the 
cytochrome b558 heterodimer. Intriguingly, a plant ortho-
log of Eros, Ycf4, is necessary for expression of the subunits 
of photosystem I in chloroplasts, also an NAD PH oxio-re-
ductase. Collectively, our work identifies a novel and essen-
tial regulator of the phagocyte respiratory burst and points 
to an ancient and conserved function for a hitherto unde-
scribed family of proteins.
rESultS
Mice deficient in the uncharacterized gene, bc017643, are 
highly susceptible to Salmonella enterica serovar 
typhimurium but not citrobacter rodentium infection
Infections by facultative intracellular pathogens such as Sal-
monella cause major morbidity and mortality globally, but 
our understanding of host defense to such pathogens remains 
incomplete. To address this in a systematic fashion and to 
explore host susceptibility to infection more generally, we 
screened mice generated through the Wellcome Trust Sanger 
Institute Knockout Mouse Project for immunity to Salmonella 
enterica serovar Typhimurium (S. Typhimurium) challenge 
(White et al., 2013). Mice harboring a targeted mutation in 
bc017643, a previously uncharacterized protein-coding gene 
located on chromosome 11 (Fig. S1 A), were highly suscepti-
ble to S. Typhimurium, dying 4–5 d after intravenous inocula-
tion with the attenuated S. Typhimurium M525 (Fig. 1 A). As 
we demonstrate that bc017643 is crucial for the generation 
of a phagocyte respiratory burst in the innate immune sys-
tem, we have renamed the gene Eros. Eros−/− mice were also 
susceptible to the highly attenuated S. Typhimurium vaccine 
strain SL261 ΔaroA (Fig. 1 B), underlining the severity of the 
phenotype. The susceptibility of Eros−/− mice to Salmonella 
infection was caused by a failure to control bacterial replica-
tion as they harbored 103–104 log-fold more CFU of Salmo-
nella per gram of spleen or liver than control mice at day 4 
after challenge. In addition, there was evidence of infection 
in the kidney and colon (Fig.  1, C–F), sites which are less 
heavily colonized by S. Typhimurium. Eros+/− heterozygous 
mice were not more susceptible to S. Typhimurium (Fig. S1 
B). In contrast to the early lethality with S. Typhimurium in-
fection, Eros−/− mice were not more susceptible to the extra-
cellular mucosal pathogen Citrobacter rodentium (Fig. 1 G 
and not depicted). Confirmation of the causative role of the 
previously uncharacterized Eros gene in driving susceptibility 
to Salmonella was provided by repairing the knockout allele 
and reintroducing Eros expression. This was accomplished 
by crossing the Eros-deficient mice with flippase-expressing 
mice to remove the FRT-flanked stop codon that generates 
the original null allele. This restoration of Eros abolished the 
susceptibility to Salmonella infection (Fig. 1 H).
Eros is a transmembrane protein with homology to Ycf 4
There is no published literature on murine Eros. The protein 
shares ∼89% sequence identity with human C17ORF62 and 
is predicted to be a single domain protein and shares sequence 
homology with domain of unknown function (DUF) 4564. 
Sequence similarity searching using jackhmmer (Finn et al., 
2011) identified orthologs of Eros in all vertebrates, as well as 
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in some lower order animals such as poriferan sponges and sea 
urchins. This suggests that Eros has an ancient evolutionary 
origin. Eros also shares significant sequence similarity with the 
conserved plant protein Ycf4 (Boudreau et al., 1997; Krech et 
al., 2012), which participates in the assembly of the photosys-
tem I complex (Boudreau et al., 1997). Phobius software (Käll 
et al., 2004) predicted an N-terminal transmembrane region 
comprising two transmembrane helices (residues 21–39 and 
45–63) with the N- and C-terminal regions present within 
the cytoplasm and the two transmembrane helices separated 
by a short linker sequence of five residues (Fig. 2 A). The pro-
tein is also likely to contain a disordered C-terminal (residues 
168–187) that is rich in serine residues (7 out of 20 residues). 
Databases of RNA and protein expression (European Bioin-
formatics Institute Expression Atlas and Immgen) show that 
Eros is highly expressed in cells of the innate immune system, 
particularly in neutrophils, monocytes, and macrophages. The 
protein has been detected in the phagosome of macrophages 
(Trost et al., 2009; Dill et al., 2015) and in dendritic cell endo-
somes (Nakamura et al., 2014). The human ortholog of Eros, 
C17ORF62, is also highly expressed in the immune system. 
Microarray analysis of separated blood subsets from healthy 
volunteers detected the highest expression in neutrophils and 
monocytes (Fig.  2  B). This is consistent with a proteomic 
analysis of separated human tissues that showed high expres-
sion of C17ORF62 in monocytes and CD4 T cells and B 
cells, although neutrophils were not evaluated in this study 
(Kim et al., 2014). Mass spectrometry data from human in-
duced pluripotent stemcell–derived macrophages in our own 
laboratory showed that C17ORF62 protein expression was 
up-regulated after treatment with IFN-γ or a combination 
of IFN-γ and S. Typhimurium (Fig. S1, C and D). Consistent 
with high expression of the protein in monocytes, macro-
phages, and neutrophils, the severe phenotype associated with 
Eros deficiency was still evident when the mice were crossed 
to the Rag-knockout background (Fig. 2 C), confirming that 
abnormalities in the innate immune system alone could ac-
count for the susceptibility to S. Typhimurium.
Figure 1.  Eros  is essential for host de-
fense against S. typhimurium. (A and B) 
Survival of Eros−/− mice after i.v. challenge 
with S. Typhimurium M525 (A) or after oral 
challenge with S. Typhimurium ΔaroA (B). 
Data in A show eight mice per group and are 
representative of greater than five indepen-
dent experiments. Data in B show eight mice 
per group and are representative of two in-
dependent experiments. (C–F) Bacterial bur-
den expressed as CFU per organ in liver (C), 
spleen (D), kidney (E), and colon (F) at day 4 
after infection with S. Typhimurium M525. 
Eight mice were used in each group. Results 
are representative of greater than five inde-
pendent experiments (G) C. rodentium burden 
in colon after oral challenge. Eight mice were 
used per group and data are representative of 
two independent experiments. (H) Survival of 
control (eight mice), Eros-deficient (five mice), 
gp91phox-deficient (four mice), and Eros-suf-
ficient flippase mice (repaired Eros allele; eight 
mice) after infection with 5 × 105 CFU of S. 
Typhimurium M525. Data are representative 
of two independent experiments. The P-value 
shown in H denotes the significant difference 
in survival between Eros-flippase and Eros-de-
ficient mice. Error bars represent the SEM. ***, 
P < 0.001; ****, P < 0.0001. Data in A, B, and 
H were analyzed by Log-Rank test and data in 
C–G were analyzed by Mann-Whitney test.
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Eros-deficient macrophages fail to 
kill S. typhimurium ex vivo
Flow cytometric analysis of cells from uninfected Eros−/− mice 
demonstrated no abnormality in the number or frequency of 
any of the major immune cell subsets (Table  1). The nor-
mal function of macrophages (Vazquez-Torres et al., 2004), 
monocytes (Tam et al., 2008; Rydström and Wick, 2010), and 
neutrophils (Conlan, 1997) is required to control Salmonella 
replication. Accordingly, we tested the functional capabilities 
of peritoneal macrophages from Eros−/− mice in vitro. Eros−/− 
peritoneal macrophages were able to phagocytose bacte-
ria apparently normally (Fig. 2 D) and electron microscopy 
showed that Eros−/− macrophages could internalize bacteria 
into a Salmonella-containing vacuole (unpublished data). 
However, peritoneal macrophages from Eros−/− mice showed 
a marked defect in the ability to control intracellular Salmo-
nella replication 1–2 h after ex vivo infection, as measured by 
gentamicin protection assays (Fig. 2 E), complementing our 
observations in vivo. Although IL-12, IFN-γ, and TNF are 
all important for the control of Salmonella, there were no 
obvious defects in cytokine secretion by Eros−/− BM-derived 
macrophages in response to live opsonized S. Typhimurium 
M525 (Table 2). Neutrophils have also been implicated as es-
sential to control of S. Typhimurium (Conlan, 1997; Tam et 
al., 2008; Burton et al., 2014). We confirmed this in our model 
by using the anti-Ly6G antibody, 1A8, to deplete neutrophils. 
Figure 2. Eros is a transmembrane protein, and Eros-deficient macrophages fail to kill S. typhimurium. (A) Schematic diagram of Eros structure 
based on prediction algorithms described in text. Serines at the C terminus are denoted by S. (B) Expression of Eros ortholog C17ORF62 in peripheral blood 
cells of healthy volunteers by probe level expression on microarray. Each dot represents one individual. (C) Survival of Eros−/− Rag−/− double-deficient mice 
and Rag−/− mice (eight mice per group) after i.v. infection with 106 CFU of S. Typhimurium M525. Results are representative of three independent exper-
iments. (D) Flow cytometric analysis of uptake of opsonized spi2-inducible GFP expressing S. Typhimurium by F480+ peritoneal macrophages. Results are 
representative of three independent experiments. (E) Killing of M525 S. Typhimurium by control or Eros−/− peritoneal macrophages in a gentamicin protec-
tion assay. Macrophages from three independent mice were used in each group, and data are representative of three independent experiments. Error bars 
represent the SEM. ***, P < 0.001. Data in A were analyzed by log-rank test and data in E were analyzed by unpaired Student’s t test.
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We then infected mice with S. Typhimurium M525 and mea-
sured bacterial burden in liver and spleen 72 h later. Control 
mice treated with 1A8 had higher counts (of the order of 
1-log fold) than controls (Fig. S1, E and F), indicating that 
neutrophils do contribute to the control of S. Typhimurium. 
We also found that Eros-deficient neutrophils were unable to 
control S. Typhimurium replication. Using an RFP-express-
ing S. Typhimurium SL1344 strain, we showed that uptake of 
bacteria was equivalent as at 1 h after infection; the percent-
age of infected neutrophils was not different between control 
and Eros−/− neutrophils. However, at 3 h, both the proportion 
of cells infected with S. Typhimurium (Fig. S1, G and H) and 
the mean fluorescence intensity (a surrogate marker of bacte-
rial load) were higher in Eros-deficient cells.
the phagocyte respiratory burst is highly impaired in Eros-
deficient neutrophils and macrophages
We noted that Eros-deficient mice had a very similar pheno-
type to that of mice deficient in components of the NAD PH 
oxidase complex, including gp91phox (Nox2) and p22phox 
(Mastroeni et al., 2000; van den Berg et al., 2009; and Fig. 
S1, I and J). These mice, like Eros−/− mice, are highly sus-
ceptible to S. Typhimurium but survive C. rodentium infec-
tion (Fattouh et al., 2013; and unpublished data). Testing this 
phenotype, we found that neutrophils from Eros−/− mice had 
a highly impaired superoxide burst in vitro. This was most 
marked in response to the N-formylated peptide N-formyl-
methionyl-leucyl-phenylalanine (fMLP), to which the re-
sponse was almost absent (Fig. 3 A). There was a 5–10-fold 
impairment of the response to the protein kinase C activa-
tor phorbol 12-myristate 13-acetate (PMA; Fig. 3 B), but a 
variable and slightly less marked defect in the response to 
zymosan (Fig. 3 C). The defect in the phagocyte respiratory 
burst was equally apparent using alternative luminescent indi-
cators, such as lucigenin and DIO GEN ES (unpublished data). 
The phenomenon extended to other Eros−/− phagocytes. 
BM-derived macrophages from Eros−/− mice exhibited a se-
verely impaired generation of superoxide in response to PMA 
(Fig.  3 D) and zymosan (Fig.  3 E), as did peritoneal mac-
rophages (Fig. 3 F). To put the impaired phagocyte respira-
tory burst in context, we compared Eros−/− neutrophils with 
mice lacking gp91phox or p22phox, the two essential mem-
brane-bound components of flavocytochrome b558. These 
experiments confirmed that, in neutrophils, the phagocyte 
respiratory burst is highly impaired rather than totally absent 
in Eros−/− mice (Fig. S2, A and B). The deficits observed in 
Eros−/− BM-derived macrophages were even more severe 
than those in neutrophils, and their ROS generation was as 
impaired as that of gp91phox−/− mice, including the ex vivo 
response to S. Typhimurium itself (Fig. S2, C–E). Consistent 
with some residual oxidase activity in neutrophils, compari-
son of Salmonella infection in Eros−/− mice with those defi-
Table 1. normal immune cell numbers in Eros−/− mice
Control (22 mice) Eros−/− (18 mice)
cell number (spleen) × 10−6
Total splenocytes 50.67 ± 0.63 44.9 ± 0.45
F480+ macrophages 1.62 ± 0.11 1.639 ± 0.12
CD11chi dendritic cells 1.82 ± 0.01 1.83 ± 0.11
CD11chi CD8+ dendritic cells 0.46 ± 0.03 0.43 ± 0.03
Ly6Chi monocytes 0.91 ± 0.07 0.75 ± 0.04
Neutrophils 2.56 ± 0.21 2.1 ± 0.09
cell number (blood) × 10−6/ml
Ly6Chi monocytes blood 5.9 ± 0.7 4.3 ± 0.46
Ly6Clo monocytes blood 1.9 ± 0.25 2.0 ± 0.20
Neutrophils 9.24 ± 0.46 8.3 ± 0.34
Mean cell number of the indicated subsets in the relevant organs ± SEM. Data were analyzed by Mann-Whitney test and represent pooled data from three independent experiments. There 
were no significant differences between control and Eros−/− mice in any subset studied.
Table 2. cytokine/chemokine production by BM-derived macrophages from control and Eros−/− BM-derived macrophages 18 h after incuba-
tion with live S. typhimurium M525
Cytokines Control Eros−/−
pg/ml pg/ml
TNF 8,596 ± 490 7,564 ± 463
IL-12p70 138 ± 15 100 ± 15
KC/GRO 6,736 ± 282 5,751 ± 482
IL-10 4.955 ± 182 5,245 ± 325
IL-6 5,497 ± 384 6,188 ± 571
IFN-γ 41 ± 2 43 ± 3
Values presented represent the mean cytokine production in culture supernatants ± SEM. Data were analyzed by unpaired Student's t test and are representative of three independent 
experiments. There were no significant differences between control and Eros−/− mice in any subset studied.
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cient in either gp91phox or p22phox showed that they had 
a slightly less severe defect in controlling bacterial replication 
than gp91phox or p22phox-deficient mice, which have no 
oxidase activity at all (Fig. S3 A).
Eros−/− mice exhibit other sequelae of a defective 
phagocyte respiratory burst
We reasoned that the consequences of Eros deficiency should 
extend to other processes that are dependent on an intact 
phagocyte respiratory burst, such as clearance of Listeria 
monocytogenes (Dinauer et al., 1997; Noubade et al., 2014). 
Eros−/− mice were highly susceptible to L. monocytogenes 
infection (Fig. 4 A) and died within 5 d of infection, with 
high bacterial loads in liver and spleen (Fig.  4  B). Under 
certain specific circumstances, the generation of neutrophil 
extracellular traps (NETS) is also dependent on an intact 
phagocyte respiratory burst (Remijsen et al., 2011). NET 
production in response to PMA was markedly impaired 
in Eros−/− mice (Fig. 4, C and D). We then asked whether 
Eros deficiency could ever be advantageous. The phagocyte 
respiratory burst can, for example, hinder tumor immunity. 
gp91phox, Ncf1 (p47phox), and Rac2-deficient mice all 
Figure 3. Eros−/− neutrophils and macrophages have a severely impaired phagocyte respiratory burst in vitro. (A–C) ROS production (three tech-
nical replicates, each control and Eros−/− sample is pooled from two mice) measured in relative light units (RLU) by purified BM neutrophils from control or 
Eros−/− mice in response to (A) fMLP, (B) PMA, or (C) zymosan. Data are representative of at least three independent experiments. (D and E) ROS production 
(replicates from BM derived from three individual mice, measured in RLU) by purified BM-derived macrophages from control or Eros−/− mice in response to 
PMA (D) and zymosan (E). (F) ROS production by peritoneal cells from Rag−/− (three mice) or Eros−/− Rag−/− mice (three mice) in response to PMA. Data are 
representative of at least three independent experiments. Area under the curve (AUC) was calculated for each sample. Error bars represent the SEM. **, P < 
0.01; ***, P < 0.001; ****, P < 0.0001, analyzed by unpaired Student’s t test.
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exhibit fewer lung metastases than control mice in experi-
mental melanoma models (Okada et al., 2006; Kelkka et al., 
2013; Joshi et al., 2014). We challenged mice with B16 mel-
anoma cells and demonstrated that Eros-deficient mice had 
significantly fewer lung metastases 10 d later (Fig. 4 E). This 
demonstrates that the influence of Eros extends to other bi-
ological processes in which the phagocyte respiratory burst is 
known to be important.
Eros−/− neutrophils and macrophages express very low levels 
of gp91phox and p22phox proteins
The phenotypes we observed led us to examine whether 
Eros−/− mice had abnormal expression of components of the 
phagocyte NAD PH oxidase. Eros deficiency had no mea-
surable effect on basal RNA expression in freshly isolated 
BM neutrophils or in whole spleen; the only differentially 
expressed gene identified by microarray analysis in Eros−/− 
mice was Eros itself (Fig. 5 A and Fig. S4 A). In particular, 
there was no difference in the mRNA level of the genes 
encoding the subunits of the NAD PH oxidase (Fig.  5 B). 
Expression of both the gp91phox and p22phox proteins 
was, however, markedly reduced but not entirely absent in 
Eros−/− neutrophils. This was demonstrated by comparison 
of Eros−/− neutrophils with those from gp91phox-deficient 
(Cybb knockout) mice where the protein was undetect-
able (Fig. 5 C). gp91phox and its membrane-bound partner, 
p22phox, are only stable as a heterodimer. Therefore, if one 
member of the heterodimer is weakly expressed, abundance 
of the partner protein is reduced (Segal, 1987; Pollock et 
al., 1995). Peritoneal lavage cells, IFN-γ–primed BM-de-
rived macrophages and splenic B and T cells also exhibited 
very low levels of gp91phox and p22phox in Eros−/− cells. 
(Fig. 5, D–F). In contrast, the cytoplasmic components of the 
NAD PH oxidase complex, p47phox, p67phox, and p40phox 
were not significantly differentially expressed by Western 
blot (Fig. 5 G) or by mass spectrometry (unpublished data). 
gp91phox has several homologues which are highly expressed 
in other tissues. In particular Nox1 is highly expressed in the 
colon and endothelium, Nox3 is specifically expressed in the 
inner ear, and Nox4 is predominantly expressed in the kid-
ney. Nox1-4 all use p22phox to form a stable heterodimer. 
Among members of the Nox family, the role of Eros protein 
seems to be specifically restricted to regulating the abundance 
of gp91phox (Nox2). We measured expression of Nox1 and 
Nox4 by Western blot. As expected, we saw the highest levels 
of Nox1 in the colon and high expression of Nox4 in the 
kidney. Both proteins were equivalently expressed between 
control and Eros−/− mice (Figs. S3, B and C). Nox3 is highly 
Figure 4. Eros−/− mice are susceptible to l. 
monocytogenes infection and fail to form 
nEtS but are resistant to melanoma me-
tastasis. (A) Survival of control (three mice) 
and Eros−/− (five mice) mice after i.v. injection 
with L. monocytogenes. (B) Bacterial burden in 
liver and spleen of control and Eros−/− mice 3 
d after infection with L. monocytogenes. Data 
in A and B are representative of three indepen-
dent experiments. (C) Neutrophil extracellular 
trap formation in response to PMA by control 
and Eros−/− mice. NETosis is measured by ab-
sorbance of Sytox Green. (D) Representative 
staining of control and Eros−/− neutrophils 
with sytox green and anticitrullinated histone 
3 antibody. (E) Number of lung metastases in 
control or Eros−/− mice 10 d after i.v. injec-
tion of B16-F10 melanoma cells. Error bars 
represent the SEM. **, P < 0.01; ***, P < 0.001. 
Data in A were analyzed by Log-rank test. 
Data in B and E were analyzed by Mann Whit-
ney test. Data in C was analyzed by Tukey’s 
test. Data are representative of at least three 
independent experiments.
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expressed in the inner ear and Nox3-deficient mice exhibit 
a vestibular/balance defect characterized by head tilt, and 
therefore we could assess Nox3 using functional assays that 
were used to phenotype mice as part of the Knockout Mouse 
Project (White et al., 2013). p22phox is essential for the sta-
bilization of Nox3 in the inner ear, and thus nmf333 mice, 
which carry a homozygous mutation in p22phox, exhibit 
similar balance defects (Nakano et al., 2008). Consistent with 
this data, p22phox-deficient mice show spontaneous trunk 
curl and head bobbing, and fail to exhibit a contact-righting 
reflex, whereas Eros−/− mice do not show any of these ves-
tibular defects (Fig. S3, D–F).
Eros deficiency has very specific effects on 
gp91phox and p22phox expression
Given that the components of the cytochrome b558 het-
erodimer were almost absent in Eros−/− mice, we next asked 
whether the expression of other proteins was dysregulated in 
the innate immune system of Eros−/− mice in the same pro-
found manner as gp91phox and p22phox. We used label-free 
quantitative mass spectrometry to compare the whole mac-
rophage proteome of control and Eros−/− BM macrophages 
(Fig. 6 A). As expected, Eros protein was detectable in all sam-
ples from control cells but not those from Eros−/− cells. In 
addition, gp91phox and p22phox were much less abundant 
in Eros−/− cells, with many fewer unique peptides for both 
proteins detected in Eros−/− neutrophils. Furthermore, Eros 
deficiency changed the abundance of a remarkably small sub-
set of proteins, with the effects on gp91phox and p22phox 
the most profound. The log-fold change for gp91phox was 
4.7. This was greater than for any other protein, except Eros, 
whereas the log-fold change for p22phox was 3.17. We per-
formed a similar analysis in BM neutrophils (Fig. 6 B) and we 
found that only gp91phox and p22phox were differentially 
Figure 5. Eros−/− mice have severely reduced expression of cytochrome b558 (gp91phox/p22phox heterodimer). (A) mRNA microarray analysis 
of purified BM neutrophils from control (five individuals) and Eros−/− (four individuals) mice showing bc017643 (Eros) as the only statistically significant 
differentially expressed gene. 1 (B) Heat map of selected genes from A. Samples from individual Eros–/– mice are denoted E1-E4 and those from control 
mice are denoted C1-C5. (C) gp91phox and p22phox expression in purified BM neutrophils from control, Eros−/−, and gp91phox−/− neutrophils. Data are 
representative of at least three independent experiments. (D) gp91phox expression in peritoneal macrophages from control, Eros−/−, and gp91phox−/− mice. 
NS, nonspecific band. Data are representative of at least three independent experiments. (E) gp91phoxand p22phox expression in BM-derived macrophages 
from control, Eros−/−, and Eros+/− (het) mice. Data are representative of three independent experiments. (F) gp91phox expression in lymphocytes from con-
trol and Eros−/− mice. Data are representative of two independent experiments. (G) Expression of the indicated cytoplasmic subunits of the phagocyte NAD 
PH oxidase in neutrophils from control and Eros−/− mice. Data are representative of three independent experiments.
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expressed between control and Eros−/− cells. Other functional 
components of neutrophil defense were unaffected; for ex-
ample, neither the amount of myeloperoxidase in neutrophil 
granules, nor elastase release, was affected in Eros−/− cells (Fig. 
S4, B and C). Taking neutrophils and macrophages together, 
the only proteins that were significantly less abundant in both 
macrophages and neutrophils of Eros-deficient mice, were 
gp91phox, p22phox, and Eros protein itself.
Eros localizes to the endoplasmic reticulum and co-
immunoprecipitates with gp91phox
We examined the mechanism underlying the low expres-
sion of the gp91phox and p22phox proteins in Eros−/− cells. 
Defects in transcription, biosynthesis via glycosylation, and 
protein degradation of gp91phox and p22phox have all been 
shown to affect levels of the b558 flavocytochrome. An im-
pact on translation is improbable given that mass spectrome-
try shows that Eros deficiency has an extremely specific effect 
on the macrophage and neutrophil proteome. An effect on 
biosynthesis is also unlikely, as there is no defect in glyco-
sylation of the small amount of gp91phox protein present in 
Eros−/− cells, which showed the same shift as control cells 
after treatment with PNGase (Fig. 7 A). Thus, Eros is likely 
to impact gp91phox and p22phox degradation, particularly as 
the abundance of gp91phox and p22phox protein is known to 
be controlled by endoplasmic reticulum–associated (ERAD) 
and proteasomal degradation (DeLeo et al., 2000; Chen et al., 
2011, 2012). To test this, we incubated IFN-γ–primed BM 
macrophages with the proteasomal inhibitor MG132 and the 
p97 inhibitor NMS873, which blocks ERAD. We also treated 
such cells with the lysosomal inhibitor chloroquine and the 
autophagy inhibitor bafilomycin to determine if these path-
ways were driving accelerated degradation of gp91phox and 
p22phox. Chloroquine could not significantly rescue ex-
pression of either p22phox or gp91phox (unpublished data) 
in Eros−/− cells. Bafilomycin could rescue p22phox expres-
sion to some extent, alone or in combination with MG132 
(Fig. 7 B and Fig. S5 A). Both the proteasome inhibitor lac-
tacystin and the calpain inhibitor ALLN were able to sig-
nificantly rescue p22phox expression (Fig. 7 C and Fig. S5 
B). Potent restoration of p22phox expression was observed 
with NMS873, consistent with data showing that this subunit 
is degraded by ERAD (Fig. 7 D and Fig. S5 C) and again 
consistent with increased degradation of p22phox in Eros−/− 
mice. We were able to rescue gp91phox to a modest, though 
statistically significant, degree with ALLN and lactacystin, but 
not with the proteasome inhibitor MG132 or the ERAD in-
hibitor NMS873 (Fig. S5, D–F). In view of the fact that the 
rescue of gp91phox was minimal, the rescue of p22phox by 
ALLN, lactacystin, and NMS873 was probably the maximum 
that could be expected given that gp91phox is required to 
stabilize p22phox protein expression.
We next investigated the subcellular localization of Eros 
by transducing RAW264.7 cells with a lentiviral vector ex-
pressing recombinant Eros with an N-terminal FLAG-tag (Fig. 
S5, G and H) and found that Eros localized to the endoplas-
mic reticulum by electron microscopy (Fig. 7 E). gp91phox 
and p22phox are also known to localize to the endoplas-
mic reticulum of macrophages, as unassembled monomers. 
We found that by confocal microscopy, gp91phox and Eros 
co-localized in HEK293 cells (Fig. 7 F). As Eros, gp91phox, 
Figure 6. Eros  deficiency has very specific effects on gp91phox 
and p22phox expression. Volcano plots of label-free mass spectrometry 
from control and Eros−/− innate immune cells. Data are shown for mac-
rophages (A; four biological replicates for control and Eros−/− mice) and 
neutrophils (B; three biological replicates for control and Eros−/− mice). 
The volcano plots display statistical significance (Log10 P-value) versus 
the log2 fold change. Cybb and Cyba are the gene symbols for gp91phox 
and p22phox respectively.
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and p22phox all localize to the endoplasmic reticulum, we 
tested whether these proteins interact. Immunoprecipitation 
of Eros protein from RAW264.7 macrophages showed spe-
cific co-purification of gp91phox (Fig. 7 G), consistent with a 
role for this protein in stabilizing gp91phox expression. Thus, 
it is likely that Eros, in common with other proteins such 
as Nrros (Noubade et al., 2014), hsp70, and hsp90 (Chen et 
al., 2011, 2012), controls the degradation of gp91phox and 
p22phox in the ER through an interaction with, and stabili-
zation of, the cytochrome b558 heterodimer.
dIScuSSIon
Eros is a highly conserved, novel protein that is necessary for 
expression of the cytochrome b558 heterodimer and is there-
fore essential for the phagocyte respiratory burst and for host 
defense. Sequence analysis of Eros offered few clues to its func-
tion, though it does contain a domain of unknown function, 
DUF4564. Intriguingly, Ycf4, an ancient plant ortholog of Eros, 
also contains DUF4564 and also regulates the activity of an 
NAD PH oxio-reductase, namely the ferredoxin oxio-reduc-
tase, photosystem I (PSI), which is essential for photosynthesis. 
Figure 7. Eros immunoprecipitates with gp91phox and also localizes to the endoplasmic reticulum. (A) Western blot for gp91phox expression 
in BM-derived macrophages with or without treatment with PNGaseF. NS, nonspecific band. Data are representative of two independent experiments. (B 
and C) p22phox expression in control and Eros-deficient macrophages after incubation with bafilomycin (B) and ALLN and lactacystin (C) NMS873 (D). 
Data are representative of three independent experiments. (E) Electron micrographs of RAW264.7 cells transduced with Eros-FLAG, stained with anti-FLAG 
immunogold. Arrows indicate FLAG localization to the endoplasmic reticulum. Data are representative of three independent experiments. (F) Confocal 
microscopy of HEK 293T cells transfected with Eros-GFP and gp91phox-myc constructs. Data are representative of three independent experiments. (G) 
Immunoprecipitation of Eros-FLAG with a control antibody or anti-FLAG and blotting for FLAG or gp91phox, as indicated. Data are representative of three 
independent experiments.
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The available data on Ycf4 offers some fascinating parallels 
with our observations on the behavior of Eros. Ycf4 was first 
identified in the unicellular green alga Chlamydomonas re-
inhardtii (Boudreau et al., 1997) and has also been studied in 
tobacco plants. (Krech et al., 2012). In Ycf4-deficient organ-
isms, the components of PSI are not detectable at the protein 
level, despite normal mRNA expression (Boudreau et al., 1997; 
Krech et al., 2012). In addition, association of PSI transcripts 
with ribosomes was unaffected, implying that translation of 
PSI components was normal in Ycf4 mutant plants. Parallel 
with the ability of Eros to co-immunoprecipitate with gp-
91phox, Ycf4 interacts physically with PSI components. (Krech 
et al., 2012). We believe, then, that Eros is likely to play a similar 
role in the assembly of cytochrome b558 to that demonstrated 
for Ycf4 in algae and plants. Furthermore, our work implies an 
ancient conservation of function for the DUF4564 family of 
proteins in stabilizing the protein levels of oxio-reductase com-
plexes. Eros is necessary for the stable expression of gp91phox 
and p22phox, most likely by acting as a chaperone. There is 
already strong evidence that the expression of gp91phox and 
p22phox is controlled at the level of protein degradation and 
that ER-resident chaperone proteins play a key role in this pro-
cess. Studies on the mechanism of how gp91phox and p22phox 
assemble to form cytochrome b558 show that the unglyco-
sylated gp91phox precursor and p22phox are synthesized in 
the ER and that gp91phox associates with p22phox before 
glycosylation in the Golgi apparatus. However, formation of 
the gp91phox-p22phox heterodimer is relatively inefficient 
and monomers that do not find a partner are rapidly degraded 
via the proteasome (DeLeo et al., 2000). There is precedence 
for the regulation of this interaction by chaperones. For in-
stance, hsp70 and hsp90 play reciprocal roles in cytochrome 
b558 stability (Chen et al., 2011, 2012). Hsp90 stabilizes gp-
91phox expression whereas hsp70 facilitates its degradation 
via the hsp70-regulated ubiquitin ligase, CHIP (Chen et al., 
2012). Nrros (negative regulator of reactive oxygen species) 
is also involved in cytochrome b558 stability, associating with 
gp91phox to facilitate its degradation (Noubade et al., 2014). 
Deficiency of Nrros in mice causes increased expression of 
the gp91phox-p22phox heterodimer with a concomitant in-
crease in the magnitude of the phagocyte respiratory burst 
that has beneficial effects for clearance of bacterial infection 
but detrimental in that it leads to a more severe disease course 
of experimental allergic encephalomyelitis (Noubade et al., 
2014). Eros is necessary for the stability of gp91phox-p22phox 
heterodimer and its deficiency has very specific effects on the 
abundance of these proteins, without affecting expression of 
their mRNA. Furthermore, gp91phox and Eros co-localize in 
the ER, and we have shown that these two proteins interact, as 
they can co-immunoprecipitate with each other. In addition, 
partial rescue of the expression of gp91phox and particularly 
p22phox can be achieved with inhibitors of the proteasome. 
Collectively, these data indicate that Eros plays a central role as 
a chaperone critical for expression of gp91phox and p22phox 
and hence for the cytochrome b558 heterodimer.
A fuller understanding of the phagocyte respiratory 
burst is not only necessary for the study of immunity to in-
fection. CGD patients are more prone to a variety of au-
toimmune manifestations including inflammatory bowel 
disease and systemic lupus erythematosus (SLE; Singel and 
Segal, 2016), whereas polymorphic variation in components 
of the phagocyte NAD PH oxidase machinery can play a role 
in the pathogenesis of polygenic autoinflammatory disease. 
Coding variants in the cytosolic p67phox subunit (NCF2) 
are associated with increased SLE (Jacob et al., 2012), and 
this is consistent with data suggesting that gp91phox defi-
ciency predisposes to lupus in both mouse and man (Cale et 
al., 2007; Campbell et al., 2012). Aside from SLE and inflam-
matory bowel disease, genetic variation in p40phox (NCF4) 
has also been implicated in atopic dermatitis and ankylos-
ing spondylitis. The lack of gp91phox and p22phox seen in 
Eros−/− mice is certainly sufficient to cause abnormalities that 
extend beyond immunity to infection. We found that Eros 
deficiency influenced the formation of neutrophil extracellu-
lar traps and the host response to metastasis. The latter result 
is particularly intriguing as mice deficient in other compo-
nents of the respiratory burst apparatus are also resistant to 
metastasis in mouse models (Okada et al., 2006; Kelkka et al., 
2013; Joshi et al., 2014).
Hence, Eros is a novel and essential component of the 
phagocyte respiratory burst and is necessary for effective 
in vivo responses to common pathogens and the host re-
sponse to tumor metastasis.
MAtErIAlS And MEtHodS
Mice
bc017643/Eros knockout mice were generated using a tm1a 
(KOMP) knockout-first approach. Gene targeting was per-
formed as part of the International Knockout Mouse Consor-
tium (Skarnes et al., 2011). Targeted ES cells were selected for 
neomycin resistance and β-galactosidase expression, and the 
bc017643tm1a(KOMP) allele structure was confirmed by long-
range PCR and sequencing. A single-integration event was 
confirmed by neomycin-copy number analysis with quan-
titative RT-PCR (qRT-PCR). The bc017643tm1a/tm1a mouse 
line was derived from the EPD0079_5_A11 ES cell clone 
and maintained on a C57BL/6N genetic background. The 
care and use of all mice was in accordance with UK Home 
Office regulations (UK Animals Scientific Procedures Act 
1986). The mice were maintained in specific pathogen–free 
conditions and matched by age and sex within experiments.
S. typhimurium challenge
Eight Eros−/− mice and eight C57BL6/N control mice aged 
6–8 wk were infected i.v. with 0.2 ml S. Typhimurium M525 
(phoN::tetC) containing 5 × 105 CFU of bacteria in sterile 
PBS (Sigma-Aldrich). They were monitored in accordance 
with the protocol used for pathogen screening in the mouse 
genetics project (White et al., 2013). At various time points 
as indicated in the main text, mice were sacrificed and the 
 o
n
 Septem
ber 30, 2017
jem.rupress.org
D
ow
nloaded from
 
Eros: A novel protein essential for innate immunity | Thomas et al.1122
spleen, liver, kidneys, blood, and cecal contents were harvested. 
Bacteria were enumerated by serial dilution and plating onto 
agar plates (Oxoid). Mice were weighed daily throughout the 
infection and were culled if they lost >20% of their starting 
weight in accordance with UK Home Office regulations (UK 
Animals Scientific Procedures Act 1986). In some specific ex-
periments, mice deficient in gp91phox (cybb) or p22phox 
(cyba) were also included in the experiment. The procedure 
for infection with the S. Typhimurium SL1344 ΔaroA mutant 
was as described above except that on the day of infection, the 
mice were infected orally with 109 CFU of bacteria. The pro-
cedure for infection with L. monocytogenes was as described 
above except that mice were infected with 0.2 ml containing 
5 × 105 CFU of L. monocytogenes. Statistical differences in 
survival between groups of mice were analyzed by log-rank 
test and differences in bacterial burden by Mann-Whitney 
test using the GraphPad Prism statistical package.
c. rodentium challenge
Eight female Eros−/− mice and eight female C57BL6/N con-
trol mice were infected orally with 0.2ml of C. rodentium 
ICC180 (109 CFU) at 6 wk of age and monitored over 28 
d. Every 2–3 d, faeces were collected from each mouse and 
the bacterial burden was enumerated by serial dilutions and 
plating onto agar plates. At day 14 after infection, four Eros−/− 
and four control mice were sacrificed. The spleen, liver, cecal 
patch, cecum, cecal contents, and the last 6 cm of colon were 
extracted and the bacterial burden in the tissue or gut contents 
was assessed by serial dilution and plating onto agar plates. At 
day 28 after infection, the remaining mice were sacrificed and 
the day 14 after infection procedures were repeated. Mice 
are weighed daily throughout the infection. Statistical differ-
ences in bacterial burden were analyzed by Mann-Whitney 
test GraphPad Prism statistical package.
Microarray hybridization and data analysis
Human peripheral blood samples were obtained from healthy 
volunteers (with ethical approval from NRES Committee 
East of England-Cambridge Central [refs: 08/H0308/176, 
04/023, and 08/0306/21]). Neutrophils were obtained by 
lysing the pellet obtained after centrifugation over Histo-
paque 1077 (Sigma-Aldrich), then by positive selection using 
CD16+ MicroBeads (Miltenyi Biotec). Monocytes and CD4+ 
T cells were obtained by sequential positive selection using 
CD14+ and CD4+ MicroBeads (Miltenyi Biotec) and B-cells 
and CD8+ T cells were obtained by sequential positive selec-
tion using CD19+ and CD8+ MicroBeads (Miltenyi Biotec). 
mRNA for both mouse and human samples was extracted 
from cell lysates using RNEasy or AllPrep Mini kits (QIA 
GEN). RNA integrity was assessed by capillary electropho-
resis using a BioAnalyser 2100 (Agilent Technologies) and 
its concentration was determined using a NanoDrop ND-
1000 spectrophotometer. 200 ng total RNA was then labeled 
using the CON TROL Sense Target labeling kit (Affymet-
rix) and hybridized to either the Mouse Gene 1.0 ST arrays 
(mouse samples) or the Human Gene 1.1 ST array (human 
samples) according to the manufacturer's instructions. After 
washing, arrays were scanned using either a GS 3000 scanner 
or a GeneTitan instrument (Affymetrix). The resulting raw 
microarray data were normalized and summarized using the 
rma function of the oligo package in BioConductor. Human 
samples were hybridized across several batches; batch effects 
were removed using the ComBat algorithm with leukocyte 
subset as a covariate. Differentially expressed genes were iden-
tified using the limma package. Differential expression was 
defined as fold changes >1.5-fold that were statistically sig-
nificant after correction for multiple testing by setting the 
false discovery rate to 5%.
Bacterial uptake assay
Peritoneal cells were elicited from uninfected control or 
Eros−/− mice with 5 ml of PBS at 4°C. Cells were centri-
fuged at 1,200 rpm for 5 min in an Allegra X-15R centrifuge 
(Beckman Coulter). The pellet was red cell lysed by resus-
pension in lysis buffer containing 0.15 M ammonium chlo-
ride and 0.01 M sodium hydrogen carbonate. The cells were 
washed with PBS and resuspended in Optimem (Gibco) at 
2 × 106 cells per well in a 24-well plate. S. Typhimurium 
SL1344 PssaG::GFP (which express GFP when Spi2 is ac-
tive) were resuspended in PBS and incubated with 10% fresh 
mouse serum from control mice for 20 min at room tempera-
ture. They were added at 50 CFU per cell to the peritoneal 
cells and after 40 min, cells were harvested by gentle scraping, 
placed on ice, and incubated with anti–F480-PE (eBiosci-
ence) for 30 min at 4°C. The cells were washed in FACS 
buffer (PBS, 5% FBS, and 0.05% sodium azide) at 4°C and 
resuspended in PBS. FACS analysis was performed on a Cyan 
(Dako) or LSR-II (BD) flow cytometer. Peritoneal cells com-
prised 40–50% F480hi macrophages and ∼50–60% B-1 B cells 
in all strains studied. In some experiments, involving neutro-
phils a S. Typhimurium SL1344 PssaG::RFP strain was used.
In vitro bacterial killing assay
Macrophages were isolated by peritoneal lavage of control or 
Eros−/− mice into PBS at 4°C. They were resuspended in Op-
timem (Gibco) at 2 × 106 cells per well in a 24-well plate and 
incubated at 37°C overnight. Nonadherent cells were removed 
and the cells were incubated with S. Typhimurium M525 
(phoN::tetC) opsonized with fresh autologous mouse serum 
at a ratio of 50 CFU per cell. After 1 h, extracellular bacteria 
were lysed by the replacement of the media with Optimem 
containing 50 µg/ml of gentamicin for 30 min. The solution 
was then replaced by one containing Optimem supplemented 
with 5 µg/ml gentamicin and cells were lysed 1 or 2 h later 
in double de-ionized water. Lysates were plated overnight on 
LB/ampicillin plates (Oxoid) to assess bacterial killing.
Western blot for p47phox, p67phox, and p40phox
Control and Eros−/− murine BM neutrophils (5 × 106) were 
pelleted and resuspended in 100  µl of ice-cold lysis buffer 
 o
n
 Septem
ber 30, 2017
jem.rupress.org
D
ow
nloaded from
 
1123JEM Vol. 214, No. 4
(20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 
1  mM EGTA, 1% Triton X-100, 2.5  mM sodium pyro-
phosphate, 1 mM β-glycerophosphate, 1 mM PMSF, 1 mM 
sodium fluoride, 2  mM sodium orthovanadate, 10 µg/ml 
leupeptin, and protease inhibitor tablet Complete Mini Cat 
11836170001 [Roche]) for 20 min on ice. Samples were 
briefly sonicated and the Triton insoluble fraction was spun 
down for 10 min at 10,000 g at 4°C. The supernatant was 
transferred to a fresh tube and the protein concentration was 
determined by the BCA (Bio-Rad Laboratories) protein 
assay kit, according to the manufacturer’s instructions. Sam-
ples were mixed with 5xSDS sample buffer and incubated at 
95°C for 5 min 15 µg of protein from each sample was loaded 
on a 12% SDS-polyacrylamide mini-gel, and then subjected 
to electrophoresis at 150V. Precision Plus Protein Dual Color 
standards (10–250 kD; Bio-Rad Laboratories) were used as 
molecular weight markers and the gel was stopped when 
the 50-kD band reached within 0.5 cm of the bottom of 
the gel. The gel was washed with transfer buffer (25  mM 
Tris, 200 mM glycine, 0.2% SDS, and 20% methanol) blot-
ted onto nitrocellulose membrane (N+ bond; GE Health-
care) using a semi-dry transfer at 150 A for 90 min. After 
transfer of the electrophoresed proteins, the membrane was 
blocked with 5% milk nonfat dry milk powder dissolved in 
Tris-HCL buffered saline (pH 8.0) containing 0.1% (wt/vol) 
Tween-20 for 1 h at room temperature. The membrane was 
immunoblotted with primary antibody, anti-p40phox pAb 
Upstate 07–501 (1:2,000), anti-p47phox pAb Upstate 07–
500 (1:4,000), and anti p67phox pAb Upstate 07–502 (1:500) 
in Tris-HCL buffered saline (pH 8.0) containing 0.1% (wt/
vol) Tween 20 at 4°C overnight.
Western blot for gp91phox, p22phox, and rac
Whole-cell extracts were prepared using a low-salt lysis buf-
fer extracts (150 mM NaCl and 0.1% NP-40) as previously 
described (Pardo et al., 2010). Samples were separated by 
PAGE (NuPAGE Bis-Tris gels; Life Technologies) and an-
alyzed by Western blotting. The following antibodies were 
used: gp91phox (sc-130543; Santa Cruz Biotechnology, Inc.), 
p22phox (sc-20781; Santa Cruz Biotechnology, Inc.), β-ac-
tin (Abcam, ab75186), and Rac1/2/3 (PA5-17159; Thermo 
Fisher Scientific). Blots were developed using ECL Prime re-
agents (GE Healthcare) and Lumigen TMA-6. Lysis in RIPA 
buffer produced similar results. 
Experimental metastasis assay
Murine metastatic melanoma B16-F10 cells (ATCC) were 
cultured in DMEM (Lonza) supplemented with 10% FBS, 
2  mM glutamine, and 100 IU/ml penicillin/streptomycin. 
Cells in log-phase growth were harvested and resuspended 
in PBS, and 5 × 105 cells (in 0.1 ml) were injected into the 
tail vein of 6–8-wk-old female control and Eros−/− mice. The 
animals were sacrificed 10 d later, and the lungs removed and 
rinsed in PBS. The number of metastatic foci were counted 
in a blinded fashion under a dissecting microscope. The data 
are reported as total number of metastatic foci per mouse. 
Any single value outliers from each genotype were identi-
fied using the Grubbs’ test (α = 0.05) and statistics were per-
formed using the Mann-Whitney t test.
co-immunoprecipitation experiments
RAW macrophages expressing Eros-FLAG were lysed in 0.1% 
NP-40 lysis buffer containing 150 mM NaCl using a Dounce 
homogenizer. Cell extracts were incubated with anti-FLAG 
M2 antibody (F1804; Sigma-Aldrich) covalently coupled to 
Dynal Protein G magnetic beads (Invitrogen) for 90 min 
at 4°C. Beads were washed with 10 vol IPP150 buffer, and 
bound proteins were eluted by incubation in 1x LDS load-
ing buffer (Life Technologies) at 70°C for 10 min, followed 
by reduction with 50 mM DTT. Proteins were separated by 
SDS-PAGE and transferred to nitrocellulose membranes. 
Membranes were blocked with 5% nonfat milk in PBS-0.1% 
Tween-20. All antibody incubations were done in this buffer 
with primary antibody recognizing gp91phox (sc-130543; 
Santa Cruz Biotechnology, Inc.). Secondary HRP-coupled 
anti–mouse, anti–rabbit, anti–goat antibodies (GE Health-
care), or HRP-Protein G (Millipore) were used. Detection 
was performed with ECL Plus (GE Healthcare).
Purification of neutrophils
6–10-wk-old mice were sacrificed and BM was obtained 
by flushing femurs and tibias with PBS supplemented with 
0.5% BSA at 4°C. The cells were resuspended in PBS at 4°C 
plus 0.5% BSA. Neutrophils were isolated using a Neutrophil 
Isolation kit (Miltenyi Biotec) used according to the manu-
facturer’s instructions.
Extracellular dnA extrusion (nEtosis assays)
BM-derived neutrophils were isolated as described above and 
were resuspended into IMDM media with 5 µM Sytox Green 
extracellular DNA dye (Life Technologies), with or without 
20 nM PMA (Sigma-Aldrich), and seeded onto optical mi-
croplates (BD). To quantify the kinetics of NET formation, 
total fluorescence was measured hourly using a VIC TOR3 
Multilabel Reader using Wallac 1420 Workstation v3.00 soft-
ware (PerkinElmer) and subtracted by t = 0 measurements. 
The presence or absence of NETs was confirmed visually by 
fluorescence microscopy. Experiments represent the mean ± 
SEM from three independent experiments conducted in du-
plicate. Statistical analysis was conducted by one-way analysis 
of variance and Tukey's test for significance.
confocal microscopy for nEtosis assays
Samples were fixed by bringing the cell solution to 4% (vol/
vol) paraformaldehyde (Thermo Fisher Scientific) in Dul-
becco's PBS (Sigma-Aldrich). Samples were blocked in 2% 
BSA and 5% goat serum (Sigma-Aldrich) in PBS. Rabbit 
Histone H3 (citrulline R2+R8+R17) antibody (ab5103; 
Abcam) was used to immunostain for citrillinated histones. 
The primary antibody was incubated overnight at 4°C used 
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at a dilution of 1/500 in PBS supplemented with 2% BSA 
and 5% goat serum. Anti–rabbit Alexa Fluor 568 (A11011; 
Invitrogen) was used as a secondary antibody. It was used 
at a dilution of 1/500 and incubated for 1 h at room tem-
perature. Fluorescence microscopy images were taken using 
a Leica TCS SPE confocal microscope on a 63×/1.40–0.60 
oil-immersion objective using Leica Application Suite Ad-
vanced Fluorescence v2.7 software (Leica Microsystems). 
Cells that had extruded DNA were marked yellow as a result 
of dual staining with both the Sytox green and the anticitrul-
linated histone antibody.
Assessment of the phagocyte respiratory burst
To assess the kinetics of the phagocyte respiratory burst, 
purified neutrophils or macrophages at a dilution of 107 per 
ml were warmed to 37°C for 15 min. 150  µl of neutro-
phils were preincubated for 3 min with luminol (2 µM) and 
horseradish peroxidase (62.5 IU/ml) before being stimulated 
with PMA (200 ng/ml; Sigma-Aldrich), fMLP (16 mM; Sig-
ma-Aldrich), zymosan (100 µg/ml; Sigma-Aldrich), arachi-
donic acid (10 µM), or opsonized Salmonella Typhimurium 
M525 (50 bacteria per cell, opsonized for 20 min at 37°C 
with 10% fresh mouse serum). Light emission was assessed 
using a Berthold MicroLumat Plus luminometer (Berthold 
Technologies). fMLP and PMA were added through the in-
jection port. Data output is in relative light units per second. 
In some experiments, alternative chemiluminescent sub-
strates were used. The procedure was the same except that 
DIO GEN ES (National Diagnostics CL-202 used according 
to manufacturer’s instructions) or lucigenin (100 µM) were 
used in place of luminol. Curves shown are constructed 
using three technical or biological replicates where indicated. 
Area under the curve (AUC) was calculated using GraphPad 
Prism, and values were compared using an unpaired Stu-
dent’s t test for each condition.
cloning of n-terminally FlAG-tagged Eros/bc017643
Eros/bc017643 was N-terminally FLAG-tagged by cloning 
into a modified pHRSin lentiviral vector (a gift from Paul 
Lehner, CIMR, Cambridge University, Cambridge, En-
gland, UK; the vector was originally made in the laboratory 
of Y. Ikeda). In brief, bc017643 coding sequence was ampli-
fied from a plasmid template (MG201751; Origene) using 
the primers listed below. The amplicon was cloned into the 
pHRsin FLAG-tag vector using BamHI and NotI restriction 
sites. For the empty vector control, a modified version of 
pHRsinUbEm was made by ligating the annealed oligonu-
cleotide pair into the vector using BamHI and NotI. Primers 
used for cloning were as follows: 5′-GGA TCC TAT ATG CAG 
GTG GAG AC-3′ (bc017643_F_BamHI) and 5′-GCG GCC 
GCT CAA CTC TGG CCA CCAG-3′ (BC017643_R_NotI). 
Oligonucleotides used for making linker sequence were as 
follows: 5′-GAT CCG TCG ACG AAT TCT GAC TAA-3′ and 
3′-GGC CTT AGT CAG AAT TCG TCG AC-5′.
Production of lentivirus and transduction of rAW264.7 cells
1 d before transfection, HEK293T cells were plated in T75 
flasks to reach 40–50% confluency the next day. Cells were 
then transfected using polyethylenimine (PEI) at ratio of 
3:1 (PEI :DNA). PEI was mixed with 1.6ml Optimem (Life 
Technologies), before addition of the packaging vectors 
pSPAX2, pMD2G, and pHRSin_bc017643/Eros_FLAG or 
pHRSin_Empty_Vector at a ratio of (3:1:4), using 7 µg of 
lenti-vector. The solution was gently mixed before incubating 
at room temperature for 15 min. The solution was then topped 
up to 12.5 ml with warm, complete media. All media was then 
removed from the flask of HEK293T cells before the addition 
of the transfection-ready media. Transfected HEK293T cells 
were checked for GFP positivity the following day but left 
undisturbed for 24 h. At 48 h, virus containing media was 
then collected and syringe-filtered through a 0.8-µm filter 
onto RAW 264.7 cells at a confluency of 30–40%. 12.5 ml 
of media was then replaced onto the transfected HEK cells 
and the process was repeated again the next day. Transduction 
efficiency of RAW 264.7 cells was determined by assaying 
for GFP positivity by flow cytometry on a FAC SAria II (BD). 
Transduction efficiency was consistently between 90 and 95%.
Flow cytometric analysis
Spleens were homogenized by manual disruption and red 
cells were lysed as described above. The cells were resus-
pended at 4°C in FACS buffer (PBS, 5% FBS and 0.1% 
sodium azide). Antibodies were incubated with cells for 
30 min at 4°C at the indicated dilution and washed with 
FACS buffer before resuspension in fresh FACS buffer. 
Samples were analyzed on a Cyan flow cytometer (Dako) 
or an LSR-II flow cytometer (BD). The antibodies used 
were as follows: anti-Ly6G (48–5931-82; eBioscience; di-
lution 1/200), anti-CD11c (17–0114-81; eBioscience; dilu-
tion 1/200), anti-CD19 (48–0193-82; eBioscience; 1/200), 
anti CD11b (17–0112-82 or 45–0112-80; eBioscience), 
anti-CD8a (11–0081-82; eBioscience; 1/400 dilution), 
anti-CD4 (558107; BD), anti-F4/80 (12–4801-82; eBio-
science; 1/200), anti-CD115 (12–1152-82; eBioscience; 
1/250), anti CD45.1 (25–0453-82; eBioscience; 1/200), 
anti-CD45.2 (17–0454-81; eBioscience; 1/200), and an-
ti-Ly6C (53–5932; eBioscience; 1/200).
BM-derived macrophages
BM was harvested from the femurs and tibias of 6–10-wk-old 
control and Eros−/− mice into RPMI (Sigma-Aldrich), sup-
plemented with 10% FBS, penicillin, and streptomycin at the 
concentration described above. Red cells were lysed with am-
monium chloride lysis buffer as described above and grown in 
100 × 20 mm Petri dishes at 4 × 106 per plate, and grown in 
10 ml RPMI medium as described above supplemented with 
10% L929 cell supernatant (a gift from S. Mukhopadhay, Well-
come Trust Sanger Institute, Hinxton, England, UK). At day 
3, the cultures were supplemented with an additional 10 ml 
of the same medium. In some cases, 10 ng/ml of recombinant 
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mouse IFN-γ (PeproTech) was added overnight on day 5. On 
day 6, adherent cells were harvested by gentle scraping and 
were typically 80–90% F480hi by flow cytometry.
Analysis of cytokines in culture supernatants or serum
BM-derived macrophages were prepared as described above 
and 2 × 105 cells in 100 µl of complete RPMI medium were 
plated in flat bottomed 96-well tissue culture plates (Cellstar). 
They were cultured alone or in the presence of live S. Typh-
imurium M525 (phoN::tetC) at 50 CFU per cell. Supernatants 
from stimulation of BM-derived macrophages were harvested 
at 18 h. Alternatively, serum was harvested after euthanasia of 
mice and subsequent cardiac puncture. Supernatants and serum 
were analyzed for the presence of the cytokines indicated in 
the figure using multiplex kits from Mesoscale discovery. Elec-
trochemical luminescence was used as the detection system, 
and samples were analyzed according to the manufacturer’s 
protocol and read on a Sector 6000 plate reader. Results were 
calculated using the Mesoscale Workbench software package.
Elastase degranulation assay
Neutrophils were resuspended PBS+ (11.106/ml). 270 µl al-
iquots were transferred to 2-ml Eppendorf tubes and incu-
bated at 37°C for 1 h. After 1 h, the cells were primed with 
cytochalasin B (5 µg/ml; Sigma-Aldrich) for 5 min, and then 
activated with 10 µM fMLP (Sigma-Aldrich) or vehicle for 10 
min. Cells were pelleted, and the supernatant was transferred 
to fresh tubes. Samples were frozen and stored at −80°C until 
further analysis. Measurement of NE activity was performed 
using the EnChek activity assay (Molecular Probes), which is 
based on the cleavage of DQ-Elastin.
Human macrophage differentiation and infection
An undifferentiated human iPS cell line was maintained on a 
monolayer of mitotically inactivated mouse embryonic feeder 
(MEF) cells in Advanced Dulbecco’s modified Eagles/F12 
medium (DMEM/F12), supplemented with 20% knockout 
replacement serum (KSR), 2 mM l-Glutamine, 0.055 mM 
β-mercaptoethanol, and 8 ng/ml recombinant human FGF2 
(R&D Systems) as described previously (van Wilgenburg et 
al., 2013). These cells were differentiated into macrophages 
following a previously published method (van Wilgenburg et 
al., 2013)). In brief, this protocol involves three key stages of 
differentiation: (1) formation of three germ layers containing 
embryoid bodies (EBs) from iPSCs on withdrawing FGF; (2) 
long-term production of myeloid precursor cells from EBs in 
presence of 25 ng/ml IL-3 and 50 ng/ml M-CSF (both R&D 
Systems); and (3) terminal differentiation and maturation of 
myeloid precursors into matured macrophagess in the pres-
ence of higher concentrations of M-CSF (100 ng/ml).
Matured macrophages were primed overnight with 20 
ng/ml IFN-γ. On the day of infection, cells were washed 
with PBS and S. Typhimurium and were added to the media 
at indicated MOI 10 and incubated at 37°C for 1 h. After 
incubation, cells were washed three times and incubated for 
another hour with media containing 50 ng/ml Gentamicin 
to kill extracellular bacteria. Fresh media was added and incu-
bated for an additional 4 h, and then cells were harvested and 
snap frozen for future analysis.
Protein digestion and tMt labeling for human macrophages
Each cell pellet was lysed in 200 µl 0.1 M triethylammonium 
bicarbonate (TEAB), and then 0.1% SDS buffer with two 
rounds of pulsed probe sonication for 20  s, followed by 5 
min boiling at 90°C. Cell debris was removed by centrifu-
gation at 10,000 rpm for 10 min. Protein concentration was 
measured with Quick Start Bradford Protein Assay (Bio-Rad 
Laboratories) according to the manufacturer’s instructions. 
Aliquots containing 80 µg of total protein were prepared 
for trypsin digestion. Cysteine disulfide bonds were reduced 
by the addition of 2 µl 50 mM tris-2-carboxymethyl phos-
phine (TCEP), followed by 1 h incubation in heating block at 
60°C. Cysteine residues were blocked by the addition of 1 µl 
200 mM freshly prepared Iodoacetamide (IAA) solution and 
30 min incubation at room temperature in dark. Trypsin (MS 
Grade; Thermo Fisher Scientific) solution was added at a final 
concentration 70 ng/µl to each sample for overnight diges-
tion. After proteolysis, the peptide samples were diluted up to 
100 µl with 0.1 M TEAB buffer. A 41-µl vol of anhydrous ace-
tonitrile was added to each TMT 10-plex reagent (Thermo 
Fisher Scientific) vial and, after vortex mixing, the content of 
each TMT vial was transferred to each sample tube. Sample 
were labeled in biological replicates according to the follow-
ing scheme: 127_N and 129_N, Unstimulated; 127_C and 
129_C, INFG; 128_N and 130_N, Salmonella; and 128_C 
and 130_C, INFG and Salmonella. Labeling reaction was 
quenched with 8 µl 5% hydroxylamine for 15 min after 1 h 
incubation at room temperature. Samples were pooled, and 
the mixture was dried with speedvac concentrator and stored 
at −20°C until the high-pH Reverse Phase fractionation.
Analysis for human macrophages
Offline peptide fractionation based on high pH Reverse Phase 
chromatography was performed using the XBridge C18 col-
umn (2.1 × 150 mm, 3.5 µm, 120 Å; Waters) on an Ultimate 
3000 HPLC system (Dionex) equipped with autosampler. 
Mobile phase (A) was composed of 0.1% ammonium hydrox-
ide and mobile phase (B) was composed of 100% acetonitrile 
and 0.1% ammonium hydroxide. The TMT-labeled peptide 
mixture was reconstituted in 100 µl mobile phase (A), cen-
trifuged, and injected for fractionation. The multi-step gradi-
ent elution method at 0.2 ml/min was as follows: for 5 min 
isocratic at 5% (B), for 35 min gradient to 35% (B), gradient 
to 80% (B) in 5 min, isocratic for 5 min, and reequilibration 
to 5% (B). Signal was recorded at 280 nm and fractions were 
collected in a time-dependent manner every 1 min. The col-
lected fractions were dried with SpeedVac concentrator and 
stored at −20°C until the LC-MS analysis.
LC-MS analysis was performed on the Ultimate 3000 
UHP LC system (Dionex) coupled with the high-resolution 
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LTQ Orbitrap Velos mass spectrometer (Thermo Fisher Sci-
entific). Each peptide fraction was reconstituted in 40 µl 0.1% 
formic acid and a volume of 5 µl was loaded to the Acclaim 
PepMap 100, 100 µm × 2 cm C18, 5 µm, 100 Å trapping 
column with a user-modified injection method at 10 µl/min 
flow rate. The sample was then subjected to a multi-step gra-
dient elution on the Acclaim PepMap RSLC (75 µm × 50 
cm, 2 µm, 100 Å) C18 capillary column (Dionex) retrofitted 
to an electrospray emitter (New Objective) at 45°C. Mobile 
phase (A) was composed of 96% H2O, 4% DMSO, and 0.1% 
formic acid and mobile phase (B) was composed of 80% ace-
tonitrile, 16% H2O, 4% DMSO, and 0.1% formic acid. The 
gradient separation method at flow rate 300 nl/min was as 
follows: for 95 min gradient to 45% B, for 5 min up to 95% 
B, for 8 min isocratic at 95% B, reequilibration to 5% B in 2 
min, and for 10 min isocratic at 5% B.
The 10 most abundant multiply charged precursors 
within 380 −1,500 m/z were selected with FT mass reso-
lution of 30,000 and isolated for HCD fragmentation with 
isolation width 1.2 Th. Normalized collision energy was set 
at 40, and the activation time was 0.1 ms for one microscan. 
Tandem mass spectra were acquired with FT resolution of 
30,000, and targeted precursors were dynamically excluded 
for further isolation and activation for 40 s with 10 ppm mass 
tolerance. FT max ion time for full MS experiments was set 
at 200 ms, and FT MSn max ion time was set at 100 ms. 
The AGC target vales were 3 × 10−6 for full FTMS and 1 × 
10−5 for MSn FTMS. The DMSO signal at m/z 401.922718 
was used as a lock mass.
database search and protein quantification
The acquired mass spectra were submitted to SequestHT 
search engine implemented on the Proteome Discoverer 
1.4 software for protein identification and quantification. 
The precursor mass tolerance was set at 30 ppm and the 
fragment ion mass tolerance was set at 0.02 D. TMT6plex 
at N terminus, and Carbamidomethyl at C terminus were 
defined as static modifications. Dynamic modifications in-
cluded oxidation of M and Deamidation of N,Q. Peptide 
confidence was estimated with the Percolator node. Peptide 
FDR was set at 0.01, and validation was based on q-value 
and decoy database search. All spectra were searched against 
a UniProt fasta file containing 20,190 reviewed human en-
tries. The Reporter Ion Quantifier node included a cus-
tom TMT 10plex Quantification Method with integration 
window tolerance 20 ppm and integration method the 
Most Confident Centroid.
Mass spectrometry analysis of mouse neutrophils
Samples were resolved by SDS-PAGE, reduced, alkylated, 
and digested in-gel using trypsin. The resulting peptides 
were analyzed by LC-MSMS using either a Q Exactive 
(Thermo Fisher Scientific) coupled to an RSLC3000 UHP 
LC (Thermo Fisher Scientific) or an Orbitrap Fusion Tribrid 
(Thermo Fisher Scientific) coupled to an RSLC3000 UHP 
LC (Thermo Fisher Scientific). Data were acquired in a DDA 
fashion with quadrupole precursor selection and MS2 spectra 
in the Fusion acquired in the LTQ. Replicate runs were pro-
cessed using Maxquant 1.5.2.8 searching a Mus musculus Un-
iprot database (downloaded 25/11/14, 73,415 entries) with 
protein N-terminal acetylation and methionine oxidation 
as variable modifications and carbamidomethyl cysteine as a 
fixed modification. Label-free quantitation was enabled, and 
the resulting data were processed in Perseus 1.5.1.6. Reverse 
and potential contaminant proteins were removed, and LFQ 
intensities were log2 transformed. Data were filtered so pro-
teins required a minimum of three intensity values, and miss-
ing values were replaced from a normal distribution. Before 
imputation, the only protein with LFQ intensities in all con-
trol samples and no values in Eros−/− samples was BC017643. 
The resulting files were exported to limma for analysis.
online supplemental material
Fig. S1 shows identification of bc017643/Eros as a novel gene 
involved in susceptibility to S. Typhimurium. Fig. S2 shows 
that Eros−/− neutrophils can generate some reactive oxygen 
species when compared directly with those from gp91phox−/− 
and p22phox−/− mice, but BM-derived macrophages from 
Eros−/− mice have an almost absent response. Fig. S3 shows 
that Eros−/− mice are slightly less susceptible to S. Typh-
imurium infection in vivo than gp91phox−/− mice. Fig. S4 
shows that Eros is the only differentially expressed gene when 
splenocytes from control and Eros−/− mice are compared by 
microarray. Fig. S5 shows that densitometry plots for data 
shown in Fig. 7 (B–D) and only modest rescue of gp91 with 
inhibitors of protein degradation in Eros−/− cells and con-
structs used for co-localization and pull-down experiments.
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Acute Respiratory Distress Syndrome Neutrophils Have a Distinct
Phenotype and Are Resistant to Phosphoinositide 3-Kinase Inhibition
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Abstract
Rationale: Acute respiratory distress syndrome is
refractory to pharmacological intervention. Inappropriate
activation of alveolar neutrophils is believed to underpin this
disease’s complex pathophysiology, yet these cells have been
little studied.
Objectives: To examine the functional and transcriptional proﬁles
of patient blood and alveolar neutrophils compared with healthy
volunteer cells, and to deﬁne their sensitivity to phosphoinositide
3-kinase inhibition.
Methods: Twenty-three ventilated patients underwent
bronchoalveolar lavage. Alveolar and blood neutrophil apoptosis,
phagocytosis, and adhesion molecules were quantiﬁed by
ﬂow cytometry, and oxidase responses were quantiﬁed by
chemiluminescence. Cytokine and transcriptional proﬁling were
used in multiplex and GeneChip arrays.
Measurements and Main Results: Patient blood and alveolar
neutrophils were distinct from healthy circulating cells, with
increased CD11b and reduced CD62L expression, delayed
constitutive apoptosis, and primed oxidase responses. Incubating
control cells with disease bronchoalveolar lavage recapitulated the
aberrant functional phenotype, and this could be reversed by
phosphoinositide 3-kinase inhibitors. In contrast, the prosurvival
phenotype of patient cells was resistant to phosphoinositide 3-kinase
inhibition. RNA transcriptomic analysis revealed modiﬁed
immune, cytoskeletal, and cell death pathways in patient cells,
aligning closely to sepsis and burns datasets but not to
phosphoinositide 3-kinase signatures.
Conclusions: Acute respiratory distress syndrome blood and
alveolar neutrophils display a distinct primed prosurvival proﬁle
and transcriptional signature. The enhanced respiratory burst was
phosphoinositide 3-kinase–dependent but delayed apoptosis and
the altered transcriptional proﬁle were not. These unexpected
ﬁndings cast doubt over the utility of phosphoinositide 3-kinase
inhibition in acute respiratory distress syndrome and highlight
the importance of evaluating novel therapeutic strategies in
patient-derived cells.
Keywords: acute respiratory distress syndrome; neutrophil
function; phosphoinositide 3-kinase
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The acute respiratory distress syndrome
(ARDS) is characterized by diffuse alveolar
injury and immune cell inﬁltration,
resulting in intractable hypoxemia (1).
Despite the adoption of lung-protective
ventilation, mortality remains high (2),
and many survivors have long-term
physical or neurocognitive sequelae, with
fewer than 50% returning to work (2).
Management remains largely supportive
with optimization of ventilator parameters
(3), judicious ﬂuid balance, and treatment
of underlying causes; no pharmacological
interventions have proven beneﬁcial.
Accumulation of polymorphonuclear
neutrophils (PMNs) in the lung
microvasculature, interstitial and alveolar
compartments is a key feature of ARDS (4),
and an association has been reported between
intensity of alveolar neutrophil inﬁltration
and disease severity (5). Inappropriate
accumulation and/or activation of PMNs
within the alveoli is proposed to cause
unrestrained release of oxygen radicals,
proteases, and neutrophil extracellular traps
(NETs). Due to challenges inherent in
isolating alveolar PMNs (alvPMNs), their
functional activity in ARDS is largely
unknown. Historically, mouse models have
been used as surrogates for alvPMNs (6);
however, rodent neutrophils differ markedly
from their human counterparts.
Traditionally, PMNs have been viewed
as a homogeneous population of short-lived
cells with limited transcriptional capacity
and a ﬁxed functional repertoire. More
recently, concepts of long-lived PMNs,
retrograde transendothelial migration, and
PMN plasticity have emerged (7–12).
Given recent demonstrations that PMNs can
modify their transcriptional proﬁle following
an inﬂammatory insult (13), genome-wide
transcriptional analysis provides a powerful
tool to identify novel targets relevant to
altered PMN functions, and it has been
successfully applied in asthma, pulmonary
arterial hypertension, and ARDS (14);
however, studies in ARDS are based on the
analysis of total peripheral white blood cells
rather than puriﬁed neutrophils.
Lung epithelial cells (15) synthesize
granulocyte-macrophage colony-stimulating
factor (GM-CSF), a cytokine essential for
alveolar macrophage function (16, 17)
and surfactant homeostasis (18, 19).
Conversely, during inﬂammation, GM-CSF
potentiates superoxide anion production (20),
promotes PMN survival (21), and is
detrimental in models of acute lung
injury (22). PMN longevity increases
dramatically in ARDS, and some studies have
identiﬁed GM-CSF as a major prosurvival
mediator (23). While the molecular
mechanisms governing PMN lifespan in
ARDS are incompletely understood, the
cytoprotective effect of GM-CSF in PMNs
in vitro is class I phosphoinositide 3-kinase
(PI3K) dependent (21). PI3K inhibition
prevents lung tissue edema and leukocyte
recruitment in models of ARDS (24), and
inhibition of PI3K-g in a sepsis model
reduces end-organ damage (25). Following
the early exuberant proinﬂammatory
response in ARDS, patients develop
immune paresis, increasing susceptibility
to nosocomial infections (26). Recent studies
have demonstrated that inhibition of PI3K-d
may improve PMN responses during this
phase (27). These observations have triggered
considerable interest in the therapeutic use of
PI3K inhibitors in ARDS.
To our knowledge, we present the
ﬁrst comprehensive characterization of
puriﬁed ARDS blood PMNs (bloodPMNs)
and alvPMNs and the ﬁrst genome-wide
transcriptome analysis of puriﬁed
ARDS bloodPMNs. We show that
ARDS alvPMNs are hypersegmented,
with enhanced CD11b and reduced
CD62L expression, and display delayed
apoptosis but preserved oxidative burst,
phagocytosis, and NET responses.
ARDS bloodPMNs display an intermediate
phenotype, with a transcriptome showing
signiﬁcant alterations in cell survival and
inﬂammatory pathways but little overlap
with the PI3K-dependent gene signature.
This work improves understanding of
PMN function in ARDS and reveals that
apoptosis of ARDS neutrophils is resistant
to PI3K inhibition. Together, these
observations strengthen the case for
modulating PMN function in ARDS, but
they cast doubt over the utility of PI3K
inhibitors in this condition. Some results of
these studies have been reported previously
in the form of an abstract (28).
Methods
Ethics
All studies complied with the Declaration of
Helsinki. Written informed consent was
obtained from the legal surrogate of patients
with ARDS (UK08/H0306/17). Paired blood
samples were obtained simultaneously from
age- and sex-matched healthy volunteers
(HVs) (UK06/Q0108/281).
Bronchoalveolar Lavage
Patients fulﬁlling the Berlin criteria for
ARDS (29) were recruited from mixed
medical-surgical and neurosciences-trauma
intensive care units in a U.K. teaching
hospital. Exclusion criteria were age
younger than 18 years, HIV-positive status,
or informed assent could not be obtained.
The median tidal volume in the patients
with ARDS was 7.64 ml/kg predicted body
weight (interquartile range, 6.94–8.64
ml/kg). Patients underwent venipuncture,
ﬁberoptic bronchoscopy (FOB), and
bronchoalveolar lavage (BAL) within
48 hours of diagnosis. Sterile isotonic
saline (33 50 ml) was instilled into a
At a Glance Commentary
Scientiﬁc Knowledge on the
Subject: Accumulation of
polymorphonuclear neutrophils
(PMNs) in the lung microvasculature
and interstitial and alveolar
compartments is a key feature of acute
respiratory distress syndrome (ARDS),
and inappropriate accumulation
and/or activation of alveolar PMNs is
proposed to cause local injury by
release of oxygen radicals, proteases
and neutrophil extracellular traps.
Because of the challenges inherent in
isolating alveolar PMNs in ARDS, their
functional activity and responses to
pharmacological agents are largely
unknown.
What This Study Adds to the
Field: ARDS alveolar PMNs are
phenotypically distinct from their
circulating counterparts, and display
delayed apoptosis but preserved
oxidative burst, phagocytosis, and
neutrophil extracellular trap responses.
ARDS blood PMNs have an
intermediate phenotype between
ARDS alveolar PMNs and healthy
circulating cells, with a transcriptome
showing signiﬁcant alterations in cell
survival and inﬂammatory pathways.
This work improves our understanding
of PMN function in ARDS and
highlights the importance of studying
tissue- and disease-speciﬁc cell
populations.
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subsegmental bronchus. Recovery averaged
90 ml (range, 20–120 ml) and did not differ
between patients and HVs. Bronchoalveolar
lavage ﬂuid (BALF) was immediately
ﬁltered and placed on ice. Control BALF
was collected from patients (n = 10)
undergoing elective FOB for indications
unrelated to infection or ARDS.
PMN Puriﬁcation
alvPMNs and autologous bloodPMNs were
isolated from patients alongside bloodPMNs
from age- and sex-matched HVs. alvPMNs
were puriﬁed by immunomagnetic negative
selection (RoboSep kit; STEMCELL
Technologies, Vancouver, BC, Canada)
(30) to greater than 90% purity and greater
than 98% viability. bloodPMNs were puriﬁed
over discontinuous plasma Percoll
gradients (28).
PMN Morphology
PMNs were classiﬁed by nuclear morphology,
with the assessor blinded to sample origin.
Mature PMNs displayed three or four
nuclear lobes connected by heterochromatin
ﬁlaments. Band PMNs had less condensed
chromatin and incompletely segmented nuclei
(31), while hypersegmented PMNs possessed
at least ﬁve lobes.
PMN Activation and Apoptosis
HV and ARDS bloodPMNs and unprocessed
BALF were resuspended in phosphate-
buffered saline containing 5% bovine serum
albumin and protease inhibitor cocktail
(cOmplete Mini, ethylenediaminetetraacetic
acid free; Roche Diagnostics, Indianapolis,
IN). Samples were stained with
CD62L-allophycocyanin (clone 559772;
BD Pharmingen, San Jose, CA),
CD11b-ﬂuorescein isothiocyanate
(clone IM0530; Beckman Coulter, Brea,
CA), or isotype-matched controls. PMN
apoptosis was assessed after 20 hours
by ﬂow cytometry using ﬂuorescein
isothiocyanate–labeled Annexin
V/propidium iodide (BD Pharmingen).
PMN Oxidative Burst
Neutrophils (53 106/ml) were primed
with tumor necrosis factor (TNF)-a (R&D
Systems, Minneapolis, MN), GM-CSF,
control BALF, or ARDS BALF at 378C for
30 minutes. The oxidative burst in response
to formylmethionylleucylphenylalanine
(FMLP) (100 nM), zymosan, or heat-killed
Streptococcus pneumoniae (serum
opsonized, ﬁve to seven particles per PMN)
was assessed by luminol-dependent
chemiluminescence (30).
Quantiﬁcation of Inﬂammatory
Mediators
BALF and serum mediators were measured
by ELISA (LPS; Kamiya Biomedical Co.,
Seattle, WA), surviving, and leukotriene
B4 (R&D Systems) or using the V-PLEX
Human Biomarker 40-Plex Kit and the
Human MMP 3-Plex Ultra-Sensitive Kit
(both from Meso Scale Discovery,
Rockville, MD). Where stated, BALF
samples were corrected to the total protein
concentration (Pierce bicinchoninic
acid protein assay; Thermo Scientiﬁc,
Rockford, IL).
PMN Phagocytosis
PMN phagocytic capacity was assessed
using 1 mg/ml pHrodo Red Staphylococcus
aureus Bioparticles (Life Technologies,
Carlsbad, CA). Internalization was veriﬁed
by live confocal imaging.
NET Formation
bloodPMNs and alvPMNs (13 106/ml)
incubated with SYTOX Green (5 mM; Life
Technologies) were seeded onto 96-well
optical microplates (BD Biosciences, San
Jose, CA). NET formation was quantitated
by hourly ﬂuorescence measurements and
veriﬁed by ﬂuorescence microscopy using
rabbit antihistone H3 (Ab5103; Abcam,
Cambridge, UK).
Neutrophil Cytoskeletal Remodeling
Freshly isolated PMNs (13 106/ml)
were ﬁxed (4% paraformaldehyde),
permeabilized (0.5% Triton X-100), and
stained with antineutrophil elastase
(1:1,000; Santa Cruz Biotechnology, Dallas,
TX) and rhodamine phalloidin (1:200;
Invitrogen, Carlsbad, CA).
Genome-Wide Transcriptomic
Changes
Genome-wide transcriptomic changes
were assessed in paired bloodPMNs from
Table 1. Demographics and Clinical Characteristics of Patients with Acute Respiratory Distress Syndrome
ARDS
Mild Moderate Severe
Number of patients 8 11 4
Age, yr 496 16.3 62.76 11.1 48.36 21.0
Sex ratio, male:female 7:1 5:6 3:1
Patient mortality, n 2 7 2
PaO2, mm Hg 92.26 17.6 82.46 16.8 68.46 2.3
PaO2/FIO2, mm Hg 246.16 18.9 139.56 18.8 90.06 5.7
PEEP, cm H2O 8.96 2.1 8.96 2.6 8.56 1.9
Blood WBC count 11.16 10.1 10.86 8.0 12.96 8.4
Blood PMN count 8.46 7.2 9.76 7.9 11.46 7.5
PMNs in BALF, % 69.76 2 (n = 6) 73.76 11.1 (n = 10) 59.86 2 (n = 3)
Etiology of ARDS Community-acquired pneumonia,
neutropenic sepsis, freshwater
drowning, liver failure
post-transplant donation, ethylene
glycol poisoning
Community-acquired pneumonia,
aspiration pneumonia,
neutropenic sepsis
Community-acquired pneumonia,
aspiration pneumonia, neutropenic
sepsis
Definition of abbreviations: ARDS = acute respiratory distress syndrome; BALF = bronchoalveolar lavage fluid; PEEP = positive end-expiratory pressure;
PMN= polymorphonuclear neutrophil; WBC =white blood cell.
Data are presented as mean 6 SD unless otherwise indicated.
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12 consecutively recruited patients with
ARDS who were representative of the full
patient cohort in terms of age, sex, and
ARDS severity and causation, as well
as from 12 HVs. Further studies were
undertaken in the following groups of
HV bloodPMNs (n = 10 per group):
(1) 0 hours, vehicle control; (2) 6 hours,
vehicle control; (3) 6 hours, recombinant
human GM-CSF (rhGM-CSF) (1 ng/ml);
(4) 6 hours, pan-PI3K inhibitor ZSTK474
(10 mM); and (5) 6 hours, rhGM-CSF
plus ZSTK474.
Complementary DNA (cDNA)
prepared from 2.5 ng of RNA using the
WT-Ovation Pico RNA Ampliﬁcation
System (NuGEN Technologies, San
Carlos, CA) was fragmented and labeled
using the FL-Ovation cDNA Biotin
Module V2 (NuGEN). Labeled cDNA
was hybridized onto GeneChip Human
Genome U133 Plus 2.0 oligonucleotide
arrays (Affymetrix, Santa Clara, CA).
Raw data (see online supplement) were
normalized using the robust multiarray
average method (32) and quality checked
in R/Bioconductor. A linear model was
ﬁtted to normalized data for each probe
set, and a post hoc test (Fisher’s least
signiﬁcant difference) generated
fold changes and P values. Probes were
identiﬁed as signiﬁcant if their fold change
was greater than 1.5 and the P value was
less than 0.05, and they were mapped to
pathways using Ingenuity Pathway
Analysis software (QIAGEN, Redwood
City, CA). The NextBio analysis platform
(Illumina, San Diego, CA) was used to
compare our ARDS data with
(preanalyzed) publicly available
transcriptomic data.
Statistical Analysis
For each dataset analyzed, an appropriate
linear mixed model was ﬁtted. When
required, the data were logarithmically
transformed to meet the assumptions of
the analysis (i.e., normally distributed
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Figure 1. Circulating and alveolar neutrophils from patients with acute respiratory distress syndrome (ARDS) are phenotypically distinct from healthy
volunteer (HV) neutrophils. (A) Morphology of freshly purified polymorphonuclear neutrophils (PMNs) from HVs in comparison with ARDS blood PMNs
(bloodPMNs) and alveolar PMNs (alvPMNs) was assessed. Representative photomicrographs of cytospins (3100 original magnification; modified Wright
stain) of HV bloodPMNs and patient alvPMNs and bloodARDS PMNs isolated in parallel (n = 19) are shown. Classical PMNs have three or four nuclear lobes
connected by filaments of dense heterochromatin; band PMNs (red arrow) contain a curved nucleus that is not completely segmented into lobes; and
hypersegmented PMNs (black arrow) have nuclei comprised of five or more lobes. ARDS bronchoalveolar lavage fluid (BALF) contains abundant
hypersegmented PMNs with up to 12 nuclear lobes (inset). PMN subsets present in the blood (HV, n = 19; ARDS, n = 19) and ARDS BALF (n = 11) were
quantitated morphologically by light microscopy (right panel). The PMN percentage subsets were analyzed on the log10 scale using a linear fixed effects
model (***P, 0.0001 for hypersegmented cells; ns = not significant). (B) HV bloodPMNs and autologous ARDS alvPMNs and bloodPMNs stained for
F-actin polarization (rhodamine phalloidin, green) and elastase (red), with nuclei depicted in blue (49,6-diamidino-2-phenylindole). Representative
immunofluorescence confocal photomicrographs (n = 3; 340 original magnification) show that ARDS alvPMNs and bloodPMNs display a prominent
circumferential F-actin ring (white arrows). (C) PMN cell surface CD62L-fluorescein isothiocyanate and CD11b-allophycocyanin expression of freshly
isolated HV bloodPMNs, autologous ARDS alvPMNs, and bloodPMNs assessed by flow cytometry. Results are representative of three independent
experiments. The CD11b expression (mean fluorescence intensity [MFI] corrected for isotype control readings) for HV blood neutrophils was 11.76 0.9,
that of ARDS blood neutrophils was 746 6, and that of ARDS BALF neutrophils 4276 50. The CD62L expression (MFI corrected for isotype control
readings) for HV blood neutrophils was 1146 12, that of ARDS blood neutrophils was 8.46 0.6, and that of ARDS BALF neutrophils was 8.76 1.9.
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errors and homogeneity of variance).
Correction for false discovery rates in the
transcriptional and cytokine analysis was
done according to the method of Benjamini
and Hochberg (33). The analyses were
conducted in SAS version 9.3 software
(SAS Institute, Cary, NC). The results are
presented as means6 SEM of independent
experiments, with P, 0.05 considered
statistically signiﬁcant. Full details of the
number of patients and HVs included in
each assay are provided in Figure E1 in the
online supplement.
Results
ARDS Patient Characteristics
Twenty-three mechanically ventilated
patients fulﬁlling the 2011 Berlin
deﬁnition for ARDS were recruited.
Their clinical, demographic, and
physiological characteristics are outlined
in Table 1. Standardized ventilator
strategies in accordance with the ARDS
Network low tidal volume protocol were
employed. At sample collection, 4 of
23 patients had severe ARDS (PaO2/FIO2
ratio, <100 mm Hg), 11 of 23 had
moderate ARDS (PaO2/FIO2 ratio,
101–200 mm Hg), and 8 of 23 had mild
ARDS (PaO2/FIO2 ratio, 201–300 mm Hg).
Sepsis and pneumonia were the
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Figure 2. Circulating and alveolar neutrophils from patients with acute respiratory distress syndrome (ARDS) exhibit delayed apoptosis and heterogeneous
nicotinamide adenine dinucleotide phosphate oxidase responses. (A) Healthy volunteer (HV) blood polymorphonuclear neutrophils (bloodPMNs) (53 106/ml)
were cultured in Iscove’s modified Dulbecco’s medium with 10% autologous serum. Apoptosis was quantitated by flow cytometry following Annexin V
(AnV) staining after 20 hours in culture. The data were analyzed using a linear fixed effects model (**P, 0.001; ***P, 0.0001). (B) Representative kinetic profile
of the neutrophil oxidative burst. Freshly purified HV bloodPMNs (unprimed, solid squares; primed with recombinant human tumor necrosis factor [TNF]-a
[10 ng/ml], open squares), autologous ARDS alveolar PMNs (alvPMNs) (solid circles), and bloodPMNs (open circles) were incubated with luminol and
horseradish peroxidase in a 96-well luminometer plate, and formylmethionylleucylphenylalanine (FMLP) (100 nM) was added via the injection port of a
Centro LB 960 luminometer (Berthold Technologies, Bad Wildbad, Germany). Light emission (relative light units) was recorded at 6-second intervals
over 10 minutes. (C) The oxidative response in freshly isolated unprimed and recombinant human TNF-a–primed HV blood following stimulation with
FMLP is expressed as the relative peak height to the rhTNF-a–primed response in HV bloodPMNs. (D) Peak height of the neutrophil oxidative response in
freshly isolated autologous ARDS alvPMNs and bloodPMNs normalized to the HV blood PMN response (i) to FMLP (100 nM), (ii) to serum-opsonized
zymosan (five to seven particles per PMN), and (iii) to serum-opsonized, heat-killed Streptococcus pneumoniae (five to seven particles per PMN).
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commonest precipitating insults. Thirteen
of 23 patients survived to discharge. All
patients underwent FOB within 48 hours
of diagnosis. PMNs constituted 69.76
4.2% of the differential leukocyte count in
ARDS BALF (6.56 3.2% in control
BALF) (Table 1). PMN abundance in
BALF did not correlate with initial
ARDS severity, abnormalities in gas
exchange, or BALF protein concentration
(data not shown).
ARDS PMNs Are Phenotypically
Distinct
Comparison of puriﬁed HV bloodPMNs,
ARDS bloodPMNs, and alvPMNs revealed
striking differences in cell morphology.
While HV bloodPMNs had few
hypersegmented PMNs, alvARDS PMNs
displayed abundant hypersegmented
nuclei and cytoplasmic vacuolation
(Figure 1A); hypersegmented PMNs
were not identiﬁed in control BALF.
Immature “band” PMNs were also
more common in ARDS bloodPMNs
and alvPMNs than in control BALF
(Figure 1A).
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Figure 3. Circulating and alveolar neutrophils from patients with acute respiratory distress syndrome (ARDS) exhibit preserved phagocytic capacity
and heterogeneous neutrophil extracellular trap (NET) responses. (A) Analysis of phagocytosis by freshly isolated polymorphonuclear neutrophils
(PMNs). Representative immunofluorescence confocal photomicrographs (n = 5 experiments) taken after 1-hour incubation demonstrate internalized
pHrodo-conjugated Staphylococcus aureus (red) and PMN nuclei counterstained with 49,6-diamidino-2-phenylindole (blue). (B) PMN phagocytosis
was quantitated by flow cytometry with fluorescence excitation set at 530 nm and emission set at 590 nm. These data were analyzed using a linear
fixed effects model (ns [not significant], P. 0.05). (C) NET formation by freshly isolated autologous blood and alveolar ARDS PMNs and healthy
volunteer (HV) PMNs was assessed following treatment with phorbol myristate acetate (PMA) (20 nM) or vehicle control. Representative fluorescence
photomicrographs of NETs (n = 4) taken at 363 original magnification are shown. Unmerged images (lower panels) stained for extracellular DNA
scaffold (SYTOX, green) and citrullinated histones (CitHis, red). The precise overlap of these two colors in merged images generates the ochre
representing NETS in the PMA-treated cells. No NETs are visible in the control samples. (D) The kinetics of NET formation was assessed over 4 hours
by measuring total fluorescence using a VICTOR3 Multilabel Reader using Wallac 1420 Workstation v3.00 software (both from PerkinElmer, Waltham, MA)
and subtracting baseline fluorescence. Scale bars represent 10 mm.
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PMN activation status was assessed
by confocal imaging of F-actin and cell
surface staining of CD62L (L-selectin) and
CD11b (Mac1). Prominent circumferential
F-actin ﬂuorescence was observed in a
substantial proportion of the ARDS
bloodPMNs compared with HV bloodPMNs
(Figure 1B). The proﬁle of surface receptor
expression (upregulation of CD11b and
downregulation of CD62L [34, 35]) on
both ARDS bloodPMNs and alvPMNs was
consistent with a primed and/or activated
phenotype (Figure 1C).
ARDS Blood and Alveolar PMNs Show
Delayed Apoptosis and Primed
NADPH Oxidase Responses
Consistent with a previous report (23), we
demonstrate that, after 20-hour ex vivo
incubation, ARDS alvPMNs and bloodPMNs
demonstrated a signiﬁcantly reduced number
of apoptotic cells (28.56 19.2% and 42.76
23% [percentage of apoptosis 6 SEM],
respectively) compared with PMNs isolated
from HV blood (69.26 12%) (Figure 2A).
The magnitude of the survival response
exhibited by ARDS PMNs was equivalent
(28.66 10%) to the cytoprotective effect
conferred by incubating HV bloodPMNs with
a maximally effective concentration of
rhGM-CSF (1 ng/ml) (data not shown).
We next compared the ability of ARDS
alvPMNs and bloodPMNs to mount an
oxidative burst in response to FMLP,
opsonized zymosan, and S. pneumoniae
(Figures 2B–2D) (36). In contrast to
unprimed HV bloodPMNs, which displayed
minimal reactive oxygen species (ROS)
generation to FMLP (Figures 2B and 2C),
alvPMNs and bloodPMNs from patients with
ARDS displayed robust ROS generation to
all three stimuli, which in certain
individuals exceeded those of TNF-a–
primed HV bloodPMNs (Figure 2D).
These data indicate basal priming and
preserved NADPH oxidase responses of
ARDS alvPMNs and bloodPMNs, challenging
the notion that inﬂammatory PMNs
become “exhausted” at peripheral sites.
ARDS Blood and Alveolar PMNs Have
Preserved Capacity for Phagocytosis
and NET Formation
Previous investigators have identiﬁed a
defect in the phagocytic and microbicidal
activity of neutrophils from patients with
ARDS (37). However, in our cohort, ﬂow
cytometry and confocal microscopy
demonstrated that the capacity of ARDS
alvPMNs and bloodPMNs to phagocytose
pHrodo Red–labeled S. aureus was fully
preserved (Figures 3A–3B). This assay,
supported by live-cell imaging, is based on
differential ﬂuorescence of this bioparticle
in an acidic environment, ensuring that
only organisms within functional
phagosomes are detected.
In addition to phagocytosis and the
oxidative burst, PMNs deploy NETs
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Figure 4. Heat map of the inflammatory markers in the serum of healthy volunteers (HVT) and patients with acute respiratory distress syndrome (ARDS).
Inflammatory mediators in serum were measured using either an ELISA kit or a Meso Scale Discovery electrochemical luminescence multiplex
immunoassay kit. In the heat map, each row is a different cytokine and each column is a different patient. The coloring represents the abundance of the
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to facilitate pathogen clearance. NETs
are composed principally of a DNA
scaffold decorated with antimicrobial
granule proteins, which acts as a mesh
to immobilize pathogens (Figure 3C). In
response to phorbol myristate acetate
(Figures 3C and 3D) or pyocyanin (data
not shown), ARDS alvPMNs and
bloodPMNs displayed a similar capacity
for NET production to that of HV
bloodPMNs. Collectively, our results
demonstrate preservation of the
antimicrobial functions of ARDS alvPMNs
and bloodPMNs.
Deﬁning the Impact of ARDS on
Serum/BALF Cytokine Proﬁles and
the Transcriptional Signatures of
Blood PMNs
To address whether factors present in
the serum or BALF in patients with
ARDS could account for the primed
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Figure 5. Genes altered greater than fivefold in acute respiratory distress syndrome (ARDS) blood neutrophils compared with healthy volunteer (HV) blood
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and/or prosurvival PMN phenotype, a
series of multiplex ELISAs and bioassays
were used to characterize the cytokine
and growth factor proﬁles (n = 18). As
shown in Figure 4 and Figure E2, a
consistent proﬁle of increased acute-
phase markers (e.g., C-reactive protein,
serum amyloid A) and inﬂammatory
cytokines (e.g., TNF-a, thymus and
activation-regulated chemokine,
monocyte chemoattractant protein 1,
IL-8, and IL-6) was observed in ARDS
serum and BALF compared with HV
samples. By contrast, when BALF
samples were corrected for total protein
concentration, only C-reactive protein,
IL-6, and monocyte chemoattractant
protein 1 levels were signiﬁcantly
higher in ARDS samples than in control
samples (Figure E2). Of note, at the
single time point sampled, GM-CSF was
quantiﬁable in only 5 of 23 ARDS
BALF samples (lower limit of
quantiﬁcation, 7.6 pg/ml).
RNA transcriptomic analysis
comparing freshly isolated ARDS
bloodPMNs with HV bloodPMNs revealed a
total of 1,319 altered genes (using cutoffs
of fold change .1.5 and P, 0.05; top-
ranked up- and downregulated transcripts
are shown in Figure 5A; a full list of all
1,319 genes and their relative fold changes
is provided in Table E3). Using the
NextBio analysis platform (which
recognized 1,282 of the 1,319 differentially
expressed genes), we compared these
changes with publicly available datasets,
ﬁnding a striking similarity to data in
leukocytes from patients with severe burns
or sepsis (38, 39); not only was there a
strong overlap in gene changes, but also
the direction of change correlated almost
completely (Figure 5B). Ingenuity Pathway
Analysis revealed a signiﬁcant increase
in pathways associated with the immune
response, cytoskeletal remodeling, and
mucin production, as well as signiﬁcant
decreases in cell death and/or apoptosis
pathways, consistent with the neutrophil
phenotype observed (Figure E3). Of note,
of the 1,319 observed transcript changes,
only 216 were differentially expressed in
the same direction compared with HV
bloodPMNs treated ex vivo with GM-CSF
(Figure E4). The data discussed in this
publication have been deposited in the
National Center for Biotechnology
Information Gene Expression Omnibus
(GEO) and are accessible through
GEO series accession number
GSE76293 (https://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc=GSE76293).
Inﬂuence of the Local Airway
Environment on the ARDS PMN
Phenotype
To establish the signiﬁcance of the alveolar
inﬂammatory environment, we sought to
induce a phenotypic switch using ARDS
BALF. Incubating HV bloodPMNs with
Iscove’s modiﬁed Dulbecco’s medium with
10% autologous serum containing ARDS
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Figure 5. (Continued ). All P, 0.05 (n = 12 for ARDS and HV blood polymorphonuclear neutrophils [PMNs]). (B) Diagrammatic representation
of gene transcript changes between ARDS and HV blood PMNs and the overlap in the ARDS transcript signature with pediatric early stage
burn data (38).
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BALF (50:50 vol/vol) reduced the extent
of apoptosis observed ex vivo at 20 hours
(37.46 21.7%; 50:50 vol/vol control BALF,
70.56 12.4%) (Figure 6A). Furthermore,
treatment with ARDS BALF (50:50 vol/vol)
for 30 minutes enhanced FMLP-induced
ROS production in HV bloodPMNs
(Figure 6B) to a level comparable to
optimally TNF-a– or GM-CSF–primed HV
bloodPMNs (not shown), while control
BALF had little effect. Thus, ARDS BALF
supernatant recapitulated the prosurvival,
primed NADPH oxidase signature seen in
ARDS blood/alvPMNs.
Potential Role of PI3K Inhibition as a
Strategy to Modulate ARDS Blood
and Alveolar PMN Behavior
A key objective of this study was to deﬁne
the sensitivity of inﬂammatory PMNs to
PI3K inhibition, since this pathway is
pivotal in neutrophil survival, priming
and/or activation, and ROS production (30).
First, we conﬁrmed that a pan-PI3K
inhibitor, ZSTK474 (10 mM) (40), and to
a lesser extent the p38 mitogen-activated
protein kinase inhibitor SB741445 (10 mM),
blocked GM-CSF–induced PMN survival
in HV bloodPMNs in vitro (Figure 7A).
ZSTK474 also blocked the survival effect
of ARDS BALF supernatant on HV
bloodPMNs (Figure 7B). However, neither
compound restored normal neutrophil
apoptosis in ARDS bloodPMNs (Figure 7C),
implying that the aberrant disease-
associated neutrophil survival is either
irreversible or operates through a PI3K-
independent pathway. Given that even
the delayed addition of ZSTK474 to
GM-CSF–treated HV bloodPMNs retained
effectiveness in overcoming the prosurvival
effect of this cytokine (data not shown),
the involvement of a PI3K-independent
pathway seems most likely. This conclusion
is supported by the minimal overlap we
observed between the transcriptomal
signatures seen in the ARDS bloodPMNs and
those seen in HV bloodPMNs treated with
ZSTK474 (Figure E5). In contrast, ROS
production by PMNs from HVs and
patients with ARDS was completely
abrogated by ZSTK474 (Figure 7D).
Discussion
Isoform-selective PI3K inhibitors have
been proposed as antiinﬂammatory agents
in diseases such as ARDS (41). Hence, it is
important to study their efﬁcacy in
patient-derived cells. ARDS alvPMNs have
been little studied due to the difﬁculty of
obtaining these cells from acutely unwell
patients. Using puriﬁed blood and alveolar
neutrophils from 23 patients with ARDS,
we demonstrate a stepwise change from
HV bloodPMNs through ARDS bloodPMNs
to ARDS alvPMNs. ARDS alvPMNs,
and to a lesser extent ARDS bloodPMNs,
were distinct from HV bloodPMNs, with
hypersegmented nuclei, increased CD11b
expression, prolonged survival, and
primed NADPH oxidase responses.
Surprisingly, while the respiratory burst
remained fully sensitive to PI3K inhibition,
the prosurvival phenotype was not reversed
by this strategy.
Few previous studies have included
assessment of the characteristics of
paired circulating and postmigration
inﬂammatory tissue neutrophils. The
hypersegmented CD11bhigh/CD62Llow
cells with enhanced oxidative capacity
we identiﬁed in ARDSblood and ARDS
alvPMNs are reminiscent of circulating
neutrophils isolated following endotoxin
challenge (42, 43). These latter cells were
immunosuppressive, inhibiting T-cell
proliferation by release of hydrogen
peroxide at the neutrophil–T-cell
interface. Increased nuclear segmentation
and oxidative potential has also been
observed in tumor-associated neutrophils
(44), associated with increased antitumor
activity. Prolonged survival of ARDS
alvPMNs has been reported previously
and attributed to GM-CSF and/or
granulocyte colony-stimulating factor in
BALF (23); however, in contrast to
Matute-Bello and colleagues, we did not
observe signiﬁcantly elevated levels of
these cytokines, perhaps related to
disease heterogeneity and differences in
sampling time. Delayed apoptosis has
been measured in neutrophils recruited to
skin chambers versus paired circulating
neutrophils, but synovial ﬂuid–derived
PMNs from patients with rheumatoid
arthritis exhibited normal apoptosis
(45). These differences correlated with
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Figure 6. Treatment of healthy volunteer (HV) blood neutrophils with bronchoalveolar lavage fluid
(BALF) from patients with acute respiratory distress syndrome (ARDS) replicates the prosurvival and
primed neutrophil phenotype. (A) HV polymorphonuclear neutrophils (PMNs) were incubated in
Iscove’s modified Dulbecco’s medium with 10% autologous serum containing either 50:50 vol/vol
control BALF or ARDS BALF, and apoptosis was assessed at 20 hours (HRS) by flow cytometry
following Annexin V (AnV) staining. These data were analyzed using a linear mixed effects model with
the HV donor fitted as a random effect (not significant [ns], P. 0.05; ***P, 0.0001). (B) Freshly
isolated HV PMNs were treated with 50:50 vol/vol control BALF or ARDS BALF for 30 minutes at
378C before stimulation with formylmethionylleucylphenylalanine (100 nM). Chemiluminescence was
recorded using a Centro LB 960 luminometer and expressed graphically as the absolute peak height
in relative light units. These data were analyzed on the log10 scale using a linear mixed effects model
with the HV donor fitted as a random effect (ns, P. 0.05; ***P, 0.0001).
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local IL-1b levels, but IL-1b in the
ARDS BALF in our study was not
signiﬁcantly elevated. The variable
functional capacity of neutrophils from
different locations underscores the need
to explore the efﬁcacy of potential
therapeutic agents in disease-relevant
cell populations.
We observed a proinﬂammatory
cytokine proﬁle in the blood of patients
with ARDS, including several established
priming agents. In our present
study, ARDS blood and ARDS alvPMNs
were functionally primed, and such cells
have previously been implicated in
lung injury (46, 47). We previously
demonstrated that the pulmonary
capillary bed can trap and “de-prime”
neutrophils and that this mechanism
may fail in ARDS, augmenting the
circulating pool of these potentially
injurious cells (48). Additional priming
signals may be imparted during vascular
transmigration (49), and ARDS BALF
also primed the oxidative burst of HV
bloodPMNs. Thus, a number of different
factors may contribute to the pooling of
primed neutrophils within the alveolar
environment in ARDS.
ARDS bloodPMNs, and in particular
ARDS alvPMNs, survived longer than HV
bloodPMNs during ex vivo culture. This
prosurvival phenotype was recapitulated
by incubating HV bloodPMNs with
ARDS BALF, implying that the enhanced
longevity of these cells results at least in
part from local exposure to mediators.
However, while the pan-PI3K inhibitor
ZSTK474 did not reduce the lifespan of
ARDS bloodPMNs, it did reverse the
prosurvival effects of both GM-CSF and
BALF on HV bloodPMNs in culture,
suggesting that the complex cytokine
environment in BALF is not the only
factor conferring PI3K resistance. It is
possible that the duration of exposure to
prosurvival mediators in vivo before
inhibitor exposure is relevant and
that survival signals imparted during
transmigration will likewise have been
entrained before PI3K inhibition.
Finally, hypoxia may impart additional
signals that are also relatively PI3K
resistant, and hypoxia-inducible
factor–dependent signaling was
upregulated (ranked 14th in the pathways
changed in this setting; see Table E3).
Together with the limited overlap
between the ZSTK474 bloodPMN or
GM-CSF bloodPMN transcriptomes and
the ARDS bloodPMN signature, our results
suggest that targeting of PI3K during
ARDS, while suppressing the damaging
ROS formation, would not enhance cell
clearance via apoptotic pathways.
We further interrogated the activation
state of ARDS bloodPMNs by undertaking
the ﬁrst reported transcriptomic analysis
of puriﬁed peripheral bloodPMNs from
patients with ARDS. Our data revealed
remarkable overlap between the
transcriptomic proﬁle of ARDS bloodPMNs
and those published for mixed leukocytes in
burns (see Figure 4B) and sepsis cohorts
(33, 36). The top ﬁve canonical pathways
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Figure 7. Effects of phosphoinositide 3-kinase (PI3K) and p38 mitogen-activated protein kinase
(MAPK) inhibition on healthy blood and acute respiratory distress syndrome (ARDS) neutrophils.
(A) Healthy volunteer (HV) blood polymorphonuclear neutrophils (PMNs) were preincubated with
either 0.1% dimethyl sulfoxide vehicle control, p38 MAPK inhibitor (SB741445 [10 mM]) or pan–class I
PI3K inhibitor (ZSTK474 [10 mM]) for 20 minutes and then treated with recombinant human
granulocyte-macrophage colony-stimulating factor (rhGM-CSF [1 ng/ml]). Apoptosis was quantitated
after 20 hours (HRS) in culture by flow cytometry following Annexin V (AnV) and propidium iodide (PI)
staining. These data were analyzed using a linear mixed effects model with the HV donor fitted as a
random effect (***P, 0.0001). (B) HV blood PMNs were preincubated with the indicated inhibitors for
20 minutes before culture in 50:50 vol/vol ARDS bronchoalveolar lavage fluid. Apoptosis was
quantitated after 20 hours in culture by flow cytometry following AnV and PI staining. These data were
analyzed using a linear mixed effects model with the HV donor fitted as a random effect (not
significant [ns], P. 0.05; **P, 0.001). (C) ARDS blood PMNs were incubated with SB741445 or
ZSTK474, and apoptosis was quantitated by flow cytometry following AnV and PI staining. These
data were analyzed using a linear mixed effects model with the HV donor fitted as a random effect (ns,
P. 0.05; *P, 0.05). (D) ARDS blood and alveolar PMNs were preincubated with ZSTK474 (10 mM)
for 30 minutes at 378C before stimulation with formylmethionylleucylphenylalanine (100 nM).
Chemiluminescence was recorded using a Centro LB 960 luminometer and expressed graphically
as the absolute peak height in relative light units. Data were analyzed on the log10 scale using a
linear mixed effects model with the HV donor fitted as a random effect (*P, 0.05; ***P, 0.0001).
TNF = tumor necrosis factor.
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identiﬁed in the ARDS blood neutrophil
gene signature were the glucocorticoid,
IL-4, p38 mitogen-activated protein
kinase, antigen presentation, and CDC52
pathways. These were also within the top
ﬁve pathways identiﬁed in the previous
burns and sepsis cohorts using mixed
leukocytes (38, 39). This suggests that,
despite their heterogeneity, there is a strong
commonality in a range of acute severe
inﬂammatory disorders. This also provides
possible directions for novel therapeutic
interventions aimed at, for example, the
IL-4 receptor or p38 pathways.
In this study, we sought to characterize
the functional and transcriptional proﬁle
of PMNs isolated from the blood and
airways of patients with ARDS. Although
our study captured only 23 patients at a
single time point, our data add considerably
to knowledge of alvPMN and bloodPMN
function and signaling proﬁles in ARDS.
They challenge data derived from both
animal models and healthy cells, with a
marked primed and prosurvival phenotype,
the latter recalcitrant to PI3K inhibition.
We conclude that intervention with a PI3K
inhibitor in these patients is unlikely to
be an effective therapeutic strategy, since
it will impair PMN bactericidal function
without facilitating inﬂammation
resolution. Our ﬁndings highlight
the importance of working with
patient-derived cells, particularly for
biomedical research into novel treatments
for ARDS. n
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Identification of LukPQ, a novel, 
equid-adapted leukocidin of 
Staphylococcus aureus
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Bicomponent pore-forming leukocidins are a family of potent toxins secreted by Staphylococcus aureus, 
which target white blood cells preferentially and consist of an S- and an F-component. The S-component 
recognizes a receptor on the host cell, enabling high-affinity binding to the cell surface, after which 
the toxins form a pore that penetrates the cell lipid bilayer. Until now, six different leukocidins have 
been described, some of which are host and cell specific. Here, we identify and characterise a novel S. 
aureus leukocidin; LukPQ. LukPQ is encoded on a 45 kb prophage (ΦSaeq1) found in six different clonal 
lineages, almost exclusively in strains cultured from equids. We show that LukPQ is a potent and specific 
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killer of equine neutrophils and identify equine-CXCRA and CXCR2 as its target receptors. Although the 
S-component (LukP) is highly similar to the S-component of LukED, the species specificity of LukPQ 
and LukED differs. By forming non-canonical toxin pairs, we identify that the F-component contributes 
to the observed host tropism of LukPQ, thereby challenging the current paradigm that leukocidin 
specificity is driven solely by the S-component.
The human and animal pathogen Staphylococcus aureus is capable of colonizing and infecting a broad range of 
host species. S. aureus has been shown to adapt to its hosts through acquisition of mobile genetic elements and the 
introduction of allelic variation through chromosomal mutations. For example, ruminant and equine S. aureus 
strains have acquired pathogenicity islands encoding host-specific variants of von Willebrand factor-binding 
protein1,2 and recently a single nucleotide polymorphism in the dltB gene was shown to make a human S. aureus 
strain capable of infecting rabbits3.
Leukocidins are a family of bicomponent pore-forming toxins contributing to S. aureus pathogenicity. 
Currently there are six known leukocidins of S. aureus (HlgAB, HlgCB, LukAB/HG, LukED, Panton-Valentine 
leukocidin (LukSF-PV/PVL), and LukMF’), all consisting of two subunits (an S- and an F-component) that 
together induce pore formation. In the current model of pore formation, the S-component first binds to a specific 
receptor on the cell surface, after which the F-component can associate to form octameric beta-barrel pores in the 
host cell membrane4. Both gamma-hemolysins (hlgAB and hlgCB) and lukAB/HG are encoded in the core genome 
of S. aureus, while lukED is located on a common pathogenicity island (vSaβ ). In contrast, pvl and lukMF’ are 
located on prophages4. While pvl is mostly found in S. aureus isolates from human origin, lukMF’ is almost exclu-
sively harboured by strains from ruminant origin5–8. Corresponding with their distribution, these leukocidins 
display specific host tropisms, explained by the high-affinity interaction of the toxins with receptor molecules 
which differ between host species9–12. This leads to large differences in leukocidin activity between host species. 
For example, PVL has been shown to lyse neutrophils from rabbits and humans, but to have no effect on Java 
monkey neutrophils13, while LukMF´ is highly toxic to ruminant neutrophils, but not to human neutrophils14,15.
Here, we describe a novel phage-encoded member of the S. aureus bicomponent leukocidin family named 
LukPQ, which shares 91% and 80% amino-acid sequence identity with LukE and LukD respectively. We show 
that LukPQ is strongly associated with S. aureus strains isolated from Equidae (horses and donkeys) and, in 
accordance with this distribution, preferentially kills neutrophils from equine origin with a higher efficiency than 
its closest relative LukED. We identify the equine-CXCRA and CXCR2 as receptors for the S-component, but, 
in contrast to the current paradigm, we show that the observed host specificity is not solely determined by the 
S-component, but also in part by the F-component.
Results
LukPQ: a new phage encoded leukocidin associated with equids. In the genome sequences of a 
collection of S. aureus clonal complex (CC)133 from horses and donkeys we identified a 45 kb prophage (named: 
Φ Saeq1) that displayed considerable sequence similarity and synteny to the previously reported phage Φ Saov3, 
which encodes the ruminant LukMF’ (Fig. 1a). Φ Saeq1 was highly conserved among equid CC133 strains and 
was integrated at a position ~0.5 Mb into the chromosome at approximately the same site as Φ Saov1 and SaPIbov1 
in ED133 and RF122, respectively2. Φ Saeq1 encoded a novel leukocidin, close to the amidase genes of the phage 
(Fig. 1a). As the strains carrying this new variant were isolated from two species of Equidae, we propose that the 
new toxin be named LukPQ (P for Paardachtigen, Dutch for Equidae) and use isolate 3711 as a reference strain 
for describing this phage and leukocidin locus. Phylogenetic analysis of LukPQ in comparison to the rest of the 
leukocidin family showed that LukP was most closely related to LukE (91% amino acid identity), whereas LukQ 
was most similar to the ruminant associated LukF’ (83% amino acid identity), but also shared 80% amino acid 
sequence with LukD (Fig. 1b). Molecular modelling of LukP and LukQ confirmed that both subunits adopt 
classical leukocidin folds (Supplementary Fig. 1). To further validate the association with equids we screened our 
collection of sequenced genomes by BLASTn and found lukPQ with 99–100% nucleotide identity in 29 isolates 
from 5 different clonal complexes (CC1, CC133, CC350, CC522, CC1660), and from a broad geographical dis-
tribution of countries (Brazil, Switzerland, Tunisia, United Kingdom), primarily from equid hosts, but also in 5 
isolates from ruminants (Supplementary Table 1). In the majority of positive isolates (96%), lukPQ was present on 
a phage, but in two strains from Brazilian buffalo, lukPQ was flanked by only two phage-related genes (amidase 
and holin); the remainder of the phage was not present in the genome of these strains. Between CCs, the phage 
encoding lukPQ showed considerable variation, but lukPQ was highly conserved, showing only few SNPs, which 
were associated with clonal lineage (Supplementary Table 1), comparable to what has been shown for pvl-encod-
ing phages16.
We estimated the prevalence of lukPQ in an international collection of equid S. aureus isolates (The 
Netherlands (unpublished), Austria17, the United States18, Sweden19, Portugal20, Italy21 and Spain22) using a PCR 
assay to identify the three prophage-encoded leukocidins (lukSF-PV, lukMF’ and lukPQ). lukPQ was present in 
29 out of 194 strains (15%, 95% CI: 10 to 21%) from the Netherlands, Italy and Portugal, whereas lukSF-PV and 
lukMF’ were only found once and twice, respectively (Supplementary Table 2). Between isolate collections, the 
prevalence of lukPQ differed considerably. In the Dutch collection LukPQ was found in 25 of 74 isolates (34%); 
interestingly this included 11 out of 21 isolates (52%) from the spa-type t011 (CC398) - a lineage that has been 
reported to be specifically associated with horses23.
LukPQ preferentially kills horse neutrophils. As there was evidence for the association of LukPQ with 
equid hosts, we sought to identify if it exhibited specific activity against horse neutrophils, leukocytes known to be 
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instrumental in the host defence against S. aureus24. Equine, bovine and human neutrophils were incubated with 
the three prophage-encoded leukocidins with an assumed host specificity (LukPQ (putatively equid), LukMF’ 
(ruminant) and LukSF-PV (human)) and pore formation was quantified in a dose dependent manner. Equine 
neutrophils were highly susceptible to LukPQ-induced lysis with a half-maximal lytic concentration (EC50) of 
0.46 nM (± SD 0.23) (Fig. 2a). This was higher than the EC50 of LukMF’ on bovine neutrophils (0.08 nM (± SD 
0.02), p < 0.001) (Fig. 2b)14, but significantly lower than the EC50 of LukSF-PV on human neutrophils (1.63 nM 
(± SD 0.66), p = 0.006) (Fig. 2c). Both LukMF’ and LukSF-PV were unable to induce pore formation in equine 
neutrophils, emphasizing their described host restrictions13,15. LukPQ, however, was able to permeabilise both 
human and bovine neutrophils, but at significantly higher EC50’s (45.82 nM (± SD 11.10) and 5.68 nM (± SD 1.64) 
respectively, both p < 0.0001) (Fig. 2a).
LukPQ acts on CXCRA and CXCR2. Based on the high degree of similarity (91% amino-acid identity) 
between receptor binding components LukE and LukP, we hypothesized that the most likely receptors for LukPQ 
would comprise CXCR1, CXCR2, CCR5, and the Duffy antigen receptor (DARC) analogous to LukED10,11. We 
cloned and expressed the equine homologues of these receptors (the putative CXCR1 homologue in equids is 
CXCRA25) and CCR2 and C5aR in HEK293T cells and exposed these cells to LukPQ and LukED. This identified 
CXCRA and CXCR2 as the major receptors for LukPQ with EC50’s of 5.81 nM (± SD 3.9) and 3.46 nM (± SD 1.09) 
respectively (Fig. 3a). Pore formation through CCR5 was less efficient (EC50 > 270 nM), while no pore formation 
was observed in HEK293T cells expressing DARC, C5aR or CCR2. Additionally, we showed that LukED also per-
meabilises cells carrying equine CXCRA, CXCR2 and CCR5 at efficiencies similar to LukPQ (EC50’s of 8.97 nM 
(± SD 5.74) for CXCRA and 6.93 nM (± SD 3.24) for CXCR2) (Fig. 3b). To further investigate the interaction of 
the S-component LukP with the CXCRA and CXCR2 receptors, we tested its ability to functionally antagonize 
stimulation of these receptors. The horse CXCRA and CXCR2 receptors expressed on HEK293T cells were shown 
to respond to stimulation with human CXCL6 and CXCL8 (ligands for CXCRA) or CXCL5 and CXCL6 (ligands 
for CXCR2) by intracellular calcium mobilization (Fig. 3c). After priming the CXCRA and CXCR2 transfected 
cells with LukP, we observed that intracellular calcium mobilization upon stimulation with their specific cytokines 
was significantly reduced. This suggests that LukP interacts with CXCRA and CXCR2 at the ligand-binding site of 
Figure 1. The novel Staphylococcus aureus toxin LukPQ in the context of other leukocidins. (a) Comparison 
of the novel prophage Φ Saeq1 in isolate 3711, carrying the equid specific lukPQ, with Φ Saov3 (ruminant strain 
ED133) and Φ Sa2 (human PVL strain MW2). Areas of red show regions conserved between the sequences and 
homologous coding DNA sequences are marked in the same colour. (b) Phylogenetic tree based on amino acid 
sequences of mature leukocidins, with alpha-hemolysin as an outgroup.
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Figure 2. LukPQ is a potent killer of equine neutrophils. (a,b and c) Equine, bovine and human neutrophils 
were analysed for pore formation upon incubation with LukPQ (A), LukMF’ (B), and LukSF-PV (C). Mean 
percentages of permeable cells ± standard deviation (SD) are shown (n = 3–5).
**
**
**
*
*
p=0.06
Figure 3. CXCRA and CXCR2 mediate pore formation by LukPQ in equine neutrophils. (a) Pore formation 
in HEK293T cells stably transfected with equine CCR2, CCR5, C5aR, CXCRA, CXCR2 and the Duffy antigen 
receptor (DARC) upon treatment with LukPQ. Mean percentages of permeable cells ± SD are shown (n = 3). 
(b) HEK293T cells stably transfected with equine CXCRA, CXCR2 and CCR5 were incubated with LukED and 
analysed for pore formation. Mean percentages of permeable cells ± SD are shown (n = 3). (c) Relative calcium 
mobilization by CXCRA and CXCR2 transfected HEK293T cells preincubated with buffer or 10 μ g/ml LukP 
upon stimulation with CXCL5, CXCL6 and CXCL8. Bars indicate SD with n = 3. Statistically significant effects 
of preincubation with LukP are indicated. **P < 0.01 and *P < 0.05. Pre-incubation with LukP resulted in a 
significant decrease in calcium mobilization in both CXCRA and CXCR2 cells stimulated with CXCL6 (p < 0.01 
and p < 0.05 respectively), and in CXCR2 cells stimulated with CXCL5 (p < 0.05). A trend was seen in CXCRA 
cells stimulated with CXCL8 (p = 0.06).
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these receptors and has immunomodulatory properties when present as a single component. Alternatively, it may 
be that LukP induces internalization of the receptor, resulting in less surface receptor and therefore in reduced 
calcium mobilization.
LukPQ and LukED exhibit different species specificities. While the presence of lukPQ was enriched 
in equid isolates, the closely related lukED, located on a pathogenicity island, is present in most S. aureus isolates5. 
We identified that all of the sequenced equid strains in our collection (Supplementary Table 1) that harboured 
lukPQ also harboured lukED, although in CC133 strains, the lukE gene was disrupted by a nonsense mutation 
in amino acid position 174, as has been reported for other CC133 strains2. In order to assess the additional value 
of LukPQ in equid isolates in comparison to the ubiquitously present LukED, we compared the cytotoxicity of 
both toxins on equine, bovine and human neutrophils. Interestingly, when comparing EC50 values, LukED is a 
significantly less potent killer of equine neutrophils than LukPQ with an EC50 of 6.62 nM (± SD 4.45) (p = 0.004) 
(Fig. 4a). This finding was not apparent in the data from the receptors expressed in HEK293T cells, where 
LukPQ and LukED displayed almost equal toxicity (p = 0.73 for CXCRA and p = 0.46 for CXCR2 expressing 
cells) (Fig. 3). Human neutrophils are permeabilised significantly more efficiently by LukED than by LukPQ 
(p < 0.001), while for bovine neutrophils the increased efficiency of LukED is minimal and non-significant 
(p = 0.079) (Fig. 4b and c).
The F-component is involved in host-specificity. Next, because of the high degree of similarity between 
LukP and LukE, we analysed the effects of the non-canonical toxin pairs LukPD and LukEQ on the different neu-
trophils. LukEQ showed a significant increase in pore formation in equine neutrophils as compared to LukED 
with an EC50 of 0.74 nM (± SD 0.59) (p = 0.007) and was as potent as the native pair LukPQ (p = 0.98) (Fig. 4a). 
This suggests that LukQ is involved in host specificity to horse neutrophils, a finding that was corroborated by 
the poor activity of other non-canonical pair: LukPD. Against bovine neutrophils, LukEQ and LukED displayed 
equal activity with EC50’s of 1.51 nM (± SD 0.47) and 2.17 nM (± SD 1.31) respectively (p = 0.9), and the EC50 of 
LukEQ was marginally better than the EC50 of LukPQ (5.68 nM (± SD 1.64) p = 0.032, Fig. 4b), suggesting that 
LukE has a greater specificity for bovine neutrophils than LukP. Finally, against human neutrophils the canonical 
combination LukED displayed significantly higher activity than all other pairs (p < 0.001), which displayed 
low-level activity– suggesting that the targeting of human neutrophils requires both LukE and LukD (Fig. 4C). 
Taken together, the results demonstrate that both the S and F-components of LukED and LukPQ are involved 
in host specificity and importantly, reveal a previously unrecognised role for a leukocidin F-component in host 
specificity.
Figure 4. LukPQ and LukED exhibit distinct species specificities in an F-component-dependent manner. 
Pore formation in equine (a), bovine (b) and human (c) neutrophils upon incubation with LukPQ, LukED, 
LukEQ or LukPD. Mean percentages of permeable cells ± SD are shown (n = 3–5).
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Discussion
In this study, we describe a new member of the S. aureus bicomponent pore-forming toxin family: LukPQ, which 
is phage-encoded and associated with equid hosts. In accordance with its host distribution, we showed that 
LukPQ displays an enhanced cytotoxicity towards equine neutrophils. This suggests an important role for LukPQ 
in the evasion of the host defence mechanism of S. aureus in equids, in line with the assumed function of other 
phage-encoded leukocidins (LukMF’ and PVL) that have a similarly host-specific function13,14 and distribution26 
(Supplementary Table 3). S. aureus regularly causes problems in equine hospitals, leading primarily to joint, skin 
and wound infections27. Patient-to-patient transmission and outbreaks within equine hospitals as well as zoonotic 
transmission have been documented18,19,28–30. Recently, an epidemic subclone of CC398 MRSA was shown to have 
spread within and between equine hospitals23. This subclone consisted almost exclusively of spa-type t011 strains, 
which in our study had a high prevalence of LukPQ. Leukocidins protect S. aureus from migrating neutrophils, 
which are the hosts first line of defence24, by creating a protective zone around it14, enabling it to reproduce after 
initial entry into a new host. Likewise, LukPQ may enhance the transmission between equid hosts, driving the 
success of this clone in equine hospitals. However, further evaluation of the clinical impact of LukPQ in equid 
infection is required.
The γ -hemolysins and LukED target a broad host range and are widely distributed amongst S. aureus  
lineages15,31–33, consistent with a more generalist function. LukPQ demonstrates host specificity, but has a broader 
host range than LukMF’ and PVL as at higher concentrations it is capable of lysing bovine and to some extent 
human neutrophils. We demonstrated that LukPQ targets CXCRA and CXCR2, the equine CXCL8 (IL-8) 
receptors expressed on neutrophils34, as well as CCR5, albeit with lower affinity. While the receptor tropism 
of LukPQ and LukED is similar, we found a species-dependent difference in cytotoxicity towards neutrophils: 
LukPQ is more toxic to equine neutrophils than LukED, while the opposite is true for human neutrophils. 
The S-components LukE and LukP are highly similar. The rim domain, particularly the DR4 region, of the 
S-component of the toxin is important for receptor binding. Consistent with their shared receptor specificity, the 
DR4 regions of LukE and LukP are almost identical, whilst that of LukM, which binds CCR1, is considerably dif-
ferent (Fig. 5A). The DR4 region of HlgA, which also binds CXCR1 and CXCR2, is highly similar to that of LukE 
and LukP, but lacks a GS insertion which may explain why HlgA also targets CCR2 rather than CCR512 (Fig. 5A).
Analysis of the effect of the non-canonical pairs LukPD and LukEQ suggests that the F-components LukD and 
LukQ (which share only 80% sequence identity) are the key determinants of the difference in activity between 
LukPQ and LukED against equine and human neutrophils, whereas LukD and LukQ have equal specificity 
for bovine neutrophils. Comparing LukQ, LukD and LukF’ identifies 20 residues that are unique to LukQ, but 
which are conserved between LukD and LukF’ and a further 13 residues that differ between all three toxins 
(Supplementary Fig. 2). Some of these LukQ-unique residues are found in the likely interface for binding with 
LukP, and one of the unique residues, I285 in the LukQ rim domain, maps to a position previously identified in 
LukF-PV as important for interaction with the cell membrane35 (Fig. 5B). Further studies involving chimeric 
F-components may yield insight in the actual importance of these residues. Still, the variable residues do not 
group onto one specific surface, so it is unclear whether the host specificity mediated through LukD and LukQ 
stems from the interaction between the F-component and the S-component, or from the interaction between the 
Figure 5. Unique residues in F-components may underlie functional specificity. (a) Structure-guided 
alignment of the DR4 region (highlighted yellow) in the rim domain of LukE, LukP, HlgA and LukM.  
(b) Homology model of the LukPQ heterodimer with LukP as a cartoon and LukQ as a surface representation. 
Residues unique to LukQ, but identical between LukD and LukF’ are coloured yellow; residues that differ in all 
three toxins are coloured cyan. The position of isoleucine 285 in the rim domain is annotated.
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F-component and the cell membrane. Although F-components do not interact with the cognate GPCR recep-
tors of the leukocidins9, LukF-PV has been suggested to bind to an F-component receptor prior to complex 
formation, possibly explaining the differences in activity between canonical and non-canonical combinations of 
F-components with LukS-PV36,37. In the case of LukPQ, we found no significant binding of the F-component to 
equine neutrophils (Supplementary Fig. 3), suggesting that interaction with an F-component receptor prior to 
pore-formation is unlikely. However, there is a possibility that F-components recruit a different receptor to the 
complex of alternating S- and F-components during the pore formation process. Involvement of such a receptor 
might explain the difference in species specificity of LukED and LukPQ. Future studies will be needed to elucidate 
the molecular mechanism of pore formation and identify all players involved in the process38.
In conclusion, we describe a novel leukocidin with a high sequence similarity to LukED, but we show that 
the small differences in amino-acid sequence of the S-components in combination with a different F-component 
leads to a substantial change in affinity for neutrophils of various host species, and therefore to host specificity.
Methods
Ethics statement. All experiments were performed in accordance with relevant guidelines and regulations. 
Written informed consent was obtained from all human blood donors in accordance with the Declaration of 
Helsinki. The medical ethics committee of the University Medical Center Utrecht (The Netherlands) approved the 
use of human venous blood for this study. The use of blood from cattle was approved by the Ethical Committee 
for Animal Experiments of the Utrecht University (Permit No. DEC2012.II.10.152) and conducted according to 
national regulations.
Bacterial strains and genome sequencing. Strains used in this study were isolated in the course of pre-
vious and on-going studies39,40 or collected as part of routine surveillance. Genomic DNA was extracted with the 
MasterPure Gram-positive DNA purification kit (Cambio, United Kingdom). HiSeq sequencing was performed 
according to the manufacturer’s protocol (Illumina, Inc., United States). Phage identification was performed 
using PHAST41. The nucleotide sequence of the LukPQ positive phage from strain 3711 has been deposited in the 
Sequence Read Archive database in the European Nucleotide Archive (LT671578).
To estimate the prevalence of the three phage encoded leukocidins, previously reported collections of horse 
isolates17,18,20–22,42 and a selection of isolates from an undescribed Dutch collection were screened by PCR (see 
Supplementary Methods).
Leukocyte isolation. Bovine blood was collected from the coccygeal vein of healthy Holstein Friesian cows 
using a sterile blood collection system with EDTA anti-coagulant (BD Vacutainer). Neutrophils were isolated by 
using Percoll (1.09176 g/l) centrifugation14. Human blood was collected in heparin tubes from healthy volunteers 
and neutrophils were isolated by Ficoll/Histopaque centrifugation43. Blood was collected from healthy horses 
during the slaughter process (and immediately upon death) in tubes containing 3 mM EDTA anticoagulant. 
Equine neutrophils were isolated using 70 and 85% Percoll gradients as described44.
Cloning, expression and purification of recombinant proteins. Recombinant LukP, LukQ, and LukD 
proteins were generated in E. coli according to methods described previously45. See Supplementary Methods for 
details and primer sequences. Recombinant PVL and LukMF’ used in this study were generated as reported pre-
viously9,14. Recombinant LukE was kindly provided by Thomas Henry (Lyon, France)46.
Cloning of receptor expressing plasmids. Horse genomic DNA was obtained from Zyagen (San Diego, 
USA). Equine chemokine receptors CXCRA, CXCR2, CCR2, CCR5, C5aR1, and the predicted Duffy anti-
gen receptor (DARC) were amplified from equine genomic DNA by PCR using PfuTurbo DNA polymerase 
(Stratagene). Primers and accession numbers are listed in Supplementary Table 6. Exons encoding DARC were 
assembled using overlap extension PCR. All coding sequences were cloned into the pIRESpuro3 vector (Clontech) 
according to methods described elsewhere12. The human Ga16 cDNA (pCISG16 plasmid) was kindly provided 
by Melvin I. Simon47. The Ga16 gene was recloned in between the BstBI and EcoRV sites of the pIREShyg3 vector 
(Clontech) using the following primers:
5′ -AACTATTTCGAAGCCGCCACCATGGCCCGCTCGCTGACCTG-3′ and
5′ -ATCGAGGATATCTCACAGCAGGTTGATCTCGTC-3′ .
Cell lines and Transfections. HEK293T cells (a human embryonic kidney cell line obtained from the 
American Type Culture Collection) were maintained in DMEM supplemented with 10% FCS and 100 U/ml pen-
icillin and 100 μ g/ml streptomycin. HEK293T cells were stably transfected with human Gα 16 plasmids prior to 
transfection with equine receptor encoding plasmids. Cells were selected for Gα 16 expression using 250 μ g/ml 
hygromycin. Transfections with pIRESpuro3 and pIREShyg3-Gα 16 plasmids were performed as described12.
Cell permeability assays. HEK293T cells and neutrophils (3 × 106 cells/ml) were incubated with recom-
binant LukPQ, PVL, LukED, or LukMF’14 in a volume of 50 μ l in RPMI, containing 0.05% human serum albu-
min (Sanquin) for 30 minutes at 37 °C, 5% CO2. Cells were analyzed by flow cytometry and pore formation was 
defined as intracellular staining by 4′ ,6-diamidino-2-phenylindole (DAPI). Equimolar concentrations of S- and 
F-components were applied in all assays. For analysis, the percentage of DAPI-positive cells incubated with buffer 
(spontaneously permeabilised cells) was subtracted from the percentage of DAPI-positive cells that were incu-
bated with toxin. Half maximal lytic concentrations (EC50) were calculated using nonlinear regression analyses 
in Prism6 (Graphpad Software Inc., USA). EC50 data were log transformed and analysed using one-way ANOVA, 
followed by Tukey’s multiple comparison test.
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Intracellular Calcium mobilization assays. Calcium mobilization assays with CXCRA and CXCR2 
HEK293T cells were performed as described48, with slight modifications. Cells were resuspended to 5 × 106 
cells/ml in Hanks’ Balanced Salt Solution (HBSS) supplemented with 10 mM HEPES, 0.05% HSA and 25 μ M 
Probenecid and were loaded with 2 μ M Fluo-3-AM (Invitrogen) for 1 hour at 37 °C while shaking. Cells were 
washed, resuspended to 5 × 106 cells/ml in the described HBSS buffer and incubated with buffer or 10 μ g/mL 
LukP for 30 minutes at room temperature. Cells were stimulated with different concentrations of CXCL5, CXCL6, 
and CXCL8. The increase in calcium mobilization was assessed by flow cytometry for 10 seconds before and up to 
70 seconds after addition of the stimulus. Relative calcium mobilization was calculated by dividing the mean fluo-
rescence after stimulation by that of the background. The effect of stimulation with or without LukP was assessed 
using a general linear model, modelling the interaction between concentration of the ligand and presence or 
absence of LukP on the relative calcium mobilization.
Computational analysis and leukocidin homology modelling. Homology models were generated with 
Modeller (v9.14)49. For LukM, LukF’, LukP and LukQ templates were derived either from the Homstraad database 
or from LukE (PDB ID: 3ROH50); whilst human CXCR1 (PDB ID: 2LNL51) was used as a template for equine 
CXCRA. Models were created using thorough MD optimisation and very thorough VTFM optimisation before 
analysis with the integral DOPE function of Modeller. The model of highest initial quality was further refined and 
improved using SCWRL451,52 and Molprobity53. Structural alignments were performed using the superposition 
function of PYMOL (Schrodinger Inc.). All structural images were generated with PYMOL. Sequence alignments 
and pairwise identities were determined with Clustal Omega54. Topology predictions for the membrane spanning 
receptor proteins were calculated using the Constrained Consensus Topology prediction server55,56.
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